Mouse Genome Informatics Coronavirus Information Center

The Global COVID-19 Pandemic

Coronavirus disease (COVID-19) is an infectious disease caused by a novel member of the coronavirus family of viruses. Since Covid-19 was declared a global pandemic on March 11, 2020, millions of cases of have been documented in 192 countries and regions worldwide (Johns Hopkins University; World Health Organization)

About this Site: Coronavirus Research using the Laboratory Mouse

The laboratory mouse is an important preclinical model for studying coronavirus biology and treatment approaches. The information on this site summarizes information about mouse strains and genes relevant to the study of coronavirus infection and pathology. This information has been expertly curated from pre-prints and peer-reviewed publications dating back to the 1980s by biocuration scientists from the Mouse Genome Informatics (MGI) knowledgebase hosted at The Jackson Laboratory.

See all curated publications that report on mouse models and genes related to coronaviruses in MGI.

Mouse Strains Used in Coronavirus Research

Mouse strains used in coronavirus research with associated mouse phenotype categories and human disease terms and references citing the use of the mouse strains in coronavirus research. Under each reference is a list of keywords for the research areas and the viruses mentioned in the publication. A virus name appended with ‘MA’ indicates that the virus is a mouse adapted strain.

Mouse strain names are linked to strain detail pages at MGI. Human disease terms are linked to the Disease ontology resource at MGI. References are linked to the reference detail pages at MGI.

1-strain	2-mgi	3-attrs	4-geno-mgi	5-allele	6-allele-mgi	7-type	8-subtypes	9-do-term	10-do-id	11-mp-term	12-mp-id	13-cite	14-jnum	15-tags	Strain	Genotype Details	Human Disease and Mouse Phenotype Categories	References \| Keywords
129-Ifngr1^tm1Agt/J	MGI:2165098	mutant strain\|targeted mutation	MGI:6403197	Ifngr1^tm1Agt	MGI:1857286	Targeted	Null/knockout			immune system	MP:0005387	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849	J:286237	Pathology\|SARS-CoV-MA_virus	129-Ifngr1^tm1Agt/J mutant strain\|targeted mutation	MGI:6403197	immune system	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus
129S1/SvImJ	MGI:3037980	inbred strain	MGI:3582226							behavior/neurological immune system	MP:0005386 MP:0005387	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	129S1/SvImJ inbred strain	MGI:3582226	behavior/neurological immune system	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(129S1/SvImJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865672	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(129S1/SvImJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
129S2/SvPasCrl	MGI:3587894	inbred strain										Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Ying B, bioRxiv 2022 Feb;(): Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302	J:328107 J:321873 J:336008	SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Vaccine\|VOC_B.1.1.529_Omicron SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta	129S2/SvPasCrl inbred strain			Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Ying B, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta
129S6/SvEv-Stat1^tm1Rds/Tac	MGI:3771555	mutant strain\|targeted mutation	MGI:3771372	Stat1^tm1Rds	MGI:1861949	Targeted	Null/knockout	breast cancer severe acute respiratory syndrome	DOID:1612 DOID:2945	cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging	MP:0005385 MP:0005384 MP:0005381 MP:0005379 MP:0005397 MP:0005376 MP:0005387 MP:0010771 MP:0005370 MP:0005369 MP:0003631 MP:0005388 MP:0005390 MP:0002006 MP:0010768	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849	J:286237	Pathology\|SARS-CoV-MA_virus	129S6/SvEv-Stat1^tm1Rds/Tac mutant strain\|targeted mutation	MGI:3771372	cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging breast cancer severe acute respiratory syndrome	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus
129S6/SvEvTac	MGI:3044417	inbred strain										Roberts A, Virus Res 2008 Apr;133(1):20-32 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303	J:286331 J:286332	Infection\|SARS-CoV_virus\|Vaccine SARS-CoV_virus	129S6/SvEvTac inbred strain			Roberts A, Virus Res 2008 Apr;133(1):20-32 Infection\|SARS-CoV_virus\|Vaccine Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 SARS-CoV_virus
129X1/SvJ	MGI:3044210	inbred strain										Okumura A, J Virol 1996 Jun;70(6):4146-9	J:52540	Mouse_Hepatitis_virus	129X1/SvJ inbred strain			Okumura A, J Virol 1996 Jun;70(6):4146-9 Mouse_Hepatitis_virus
A/J	MGI:2159747	inbred strain	MGI:3807714					Coronavirus infectious disease	DOID:0080599	hearing/vestibular/ear hematopoietic system immune system nervous system	MP:0005377 MP:0005397 MP:0005387 MP:0003631	Dangi T, bioRxiv 2021 Jun;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Lee M, bioRxiv 2020 Dec;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Tian J, bioRxiv 2020;(): Tian J, bioRxiv 2021 Feb;(): Wang GZ, bioRxiv 2020;(): Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:308670 J:288204 J:268979 J:276026 J:161935 J:299101 J:27269 J:295388 J:302152 J:296066 J:36900 J:276183	SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus Mouse_Hepatitis_virus\|SARS-CoV-2_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Treatment Comorbidity\|SARS-CoV-2_virus	A/J inbred strain	MGI:3807714	Coronavirus infectious disease hearing/vestibular/ear hematopoietic system immune system nervous system	Dangi T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology Lee M, bioRxiv 2020 Dec;(): Mouse_Hepatitis_virus\|SARS-CoV-2_virus Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Mouse_Hepatitis_virus Tian J, bioRxiv 2020;(): Mouse_Hepatitis_virus\|Treatment Tian J, bioRxiv 2021 Feb;(): Mouse_Hepatitis_virus\|Treatment Wang GZ, bioRxiv 2020;(): Comorbidity\|SARS-CoV-2_virus Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Mouse_Hepatitis_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
A/JCr	MGI:6156905	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	A/JCr inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
(A/J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865666	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(A/J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
Arc:ARC(S)	MGI:5306408	outbred stock										Eldi P, bioRxiv 2021 Sep;():	J:310113	SARS-CoV-2_virus\|Vaccine	Arc:ARC(S) outbred stock			Eldi P, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine
B10.BR-H2^k2 H2-T18^a/SgSnJ	MGI:2386242	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	B10.BR-H2^k2 H2-T18^a/SgSnJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
B10.D2-Hc⁰ H2^d H2-T18^c/oSnJ	MGI:2160070	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	B10.D2-Hc⁰ H2^d H2-T18^c/oSnJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
B6.129(Cg)-Foxp3^{tm4(YFP/icre)Ayr}/J	MGI:5306407	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129(Cg)-Foxp3^{tm4(YFP/icre)Ayr}/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129(Cg)-Wwtr1^tm1.2Hmc/J	MGI:6285617	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129(Cg)-Wwtr1^tm1.2Hmc/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129-Ido1^tm1Alm/J	MGI:3603213	congenic\|mutant strain\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129-Ido1^tm1Alm/J congenic\|mutant strain\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129P2-Ace2^tm1Pngr/J	MGI:5912242	congenic\|mutant strain\|targeted mutation	MGI:5912243 MGI:6402915	Ace2^tm1Pngr	MGI:2661723	Targeted	Null/knockout			cardiovascular system immune system	MP:0005385 MP:0005387	Kuba K, Nat Med 2005 Aug;11(8):875-9	J:286299	Infection\|SARS-CoV_virus	B6.129P2-Ace2^tm1Pngr/J congenic\|mutant strain\|targeted mutation	MGI:5912243 MGI:6402915	cardiovascular system immune system	Kuba K, Nat Med 2005 Aug;11(8):875-9 Infection\|SARS-CoV_virus
B6.129P2(C)-Cd19^tm1(cre)Cgn/J	MGI:3710504	congenic\|mutant strain\|targeted mutation										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	B6.129P2(C)-Cd19^tm1(cre)Cgn/J congenic\|mutant strain\|targeted mutation			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
B6.129P2-Ccr2^tm1Mae	MGI:3841132	congenic\|targeted mutation	MGI:3841005	Ccr2^tm1Mae	MGI:2158345	Targeted	Null/knockout	age related macular degeneration Coronavirus infectious disease	DOID:10871 DOID:0080599	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye	MP:0005386 MP:0005385 MP:0005397 MP:0005387 MP:0003631 MP:0001186 MP:0005388 MP:0005391	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129P2-Ccr2^tm1Mae congenic\|targeted mutation	MGI:3841005	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye age related macular degeneration Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129P2-Ccr5^tm1Kuz	MGI:4418878	congenic\|mutant strain\|targeted mutation	MGI:4418655	Ccr5^tm1Kuz	MGI:1861911	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging	MP:0005386 MP:0005385 MP:0005387 MP:0003631 MP:0005388 MP:0005391 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129P2-Ccr5^tm1Kuz congenic\|mutant strain\|targeted mutation	MGI:4418655	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129P2(Cg)-Yap1^tm1.1Dupa/J	MGI:6259136	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129P2(Cg)-Yap1^tm1.1Dupa/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129P2-Cxcr3^tm1Dgen/J	MGI:3604638	congenic\|mutant strain\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129P2-Cxcr3^tm1Dgen/J congenic\|mutant strain\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129P2-Cxcr6^tm1Litt/J	MGI:3696273	congenic\|mutant strain\|targeted mutation										Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:327836	SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	B6.129P2-Cxcr6^tm1Litt/J congenic\|mutant strain\|targeted mutation			Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
B6.129P2-Igh^em1Rcas/J	MGI:6725129	congenic\|endonuclease-mediated mutation\|mutant strain										Xu J, Nature 2021 Jun 7;():	J:307753	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma	B6.129P2-Igh^em1Rcas/J congenic\|endonuclease-mediated mutation\|mutant strain			Xu J, Nature 2021 Jun 7;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma
B6.129P2-Lyz2^tm1(cre)Ifo/J	MGI:2680712	congenic\|mutant strain\|targeted mutation										Musiu C, Cell Death Differ 2021 Sep 13;():	J:313338	Pathology\|SARS-CoV-2_virus	B6.129P2-Lyz2^tm1(cre)Ifo/J congenic\|mutant strain\|targeted mutation			Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology\|SARS-CoV-2_virus
B6.129P2-Myd88^tm1Aki	MGI:3697090	congenic\|mutant strain\|targeted mutation	MGI:3577712	Myd88^tm1Aki	MGI:2385681	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	cardiovascular system cellular digestive/alimentary system hearing/vestibular/ear hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging	MP:0005385 MP:0005384 MP:0005381 MP:0005377 MP:0005397 MP:0005376 MP:0005387 MP:0003631 MP:0005367 MP:0005388 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129P2-Myd88^tm1Aki congenic\|mutant strain\|targeted mutation	MGI:3577712	cardiovascular system cellular digestive/alimentary system hearing/vestibular/ear hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129P2-Nos2^tm1Lau/J	MGI:2163101	congenic\|mutant strain\|targeted mutation										Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	B6.129P2-Nos2^tm1Lau/J congenic\|mutant strain\|targeted mutation			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
B6.129P2-Rbpj^tm1Hon/HonRbrc	MGI:3761296	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129P2-Rbpj^tm1Hon/HonRbrc congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129P2-Sirpa^tm1Nog/Rbrc	MGI:3763171	congenic\|mutant strain\|targeted mutation										Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	B6.129P2-Sirpa^tm1Nog/Rbrc congenic\|mutant strain\|targeted mutation			Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
B6.129P2(SJL)-Myd88^tm1.1Defr	MGI:6272303	congenic\|mutant strain\|targeted mutation	MGI:6272304	Myd88^tm1.1Defr	MGI:4421295	Targeted	Null/knockout			behavior/neurological hematopoietic system immune system nervous system mortality/aging	MP:0005386 MP:0005397 MP:0005387 MP:0003631 MP:0010768	Butchi N, J Virol 2015 Sep 15;89(18):9299-312	J:224849	Infection\|Mouse_Hepatitis_virus\|Pathology	B6.129P2(SJL)-Myd88^tm1.1Defr congenic\|mutant strain\|targeted mutation	MGI:6272304	behavior/neurological hematopoietic system immune system nervous system mortality/aging	Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Infection\|Mouse_Hepatitis_virus\|Pathology
B6.129S2-Cd8a^tm1Mak/J	MGI:2163961	congenic\|mutant strain\|targeted mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.129S2-Cd8a^tm1Mak/J congenic\|mutant strain\|targeted mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6.129S2(Cg)-Ace2^{tm1(ACE2)Dwnt}/J	MGI:6469882	congenic\|mutant strain\|targeted mutation										Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Zhou B, Nature 2021 Apr;592(7852):122-127	J:338414 J:331773 J:305777	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|SARS-CoV-2_virus	B6.129S2(Cg)-Ace2^{tm1(ACE2)Dwnt}/J congenic\|mutant strain\|targeted mutation			Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Zhou B, Nature 2021 Apr;592(7852):122-127 Infection\|SARS-CoV-2_virus
B6.129S2-Ciita^tm1Ccum/J	MGI:2164648	congenic\|mutant strain\|targeted mutation										Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	B6.129S2-Ciita^tm1Ccum/J congenic\|mutant strain\|targeted mutation			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
B6.129S2-Ifnar1^tm1Agt/Mmjax	MGI:4836218	congenic\|mutant strain\|targeted mutation										Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:319459 J:345954	Infection\|SARS-CoV-2_virus Infection\|MERS-CoV-MA_virus	B6.129S2-Ifnar1^tm1Agt/Mmjax congenic\|mutant strain\|targeted mutation			Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Infection\|SARS-CoV-2_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S2-Ighm^tm1Cgn/J	MGI:2163831	congenic\|mutant strain\|targeted mutation										Israelow B, bioRxiv 2021 May;():	J:308733	Infection\|SARS-CoV-2_virus	B6.129S2-Ighm^tm1Cgn/J congenic\|mutant strain\|targeted mutation			Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus
B6.129S2-Plat^tm1Mlg/J	MGI:2162973	congenic\|mutant strain\|targeted mutation	MGI:6433845	Plat^tm1Mlg	MGI:1857288	Targeted	Null/knockout			immune system mortality/aging	MP:0005387 MP:0010768	Gralinski LE, mBio 2013 Aug 6;4(4):	J:288556	Infection\|Pathology\|SARS-CoV-MA_virus	B6.129S2-Plat^tm1Mlg/J congenic\|mutant strain\|targeted mutation	MGI:6433845	immune system mortality/aging	Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus
B6.129S2-Serpine1^tm1Mlg/J	MGI:2162090	congenic\|mutant strain\|targeted mutation	MGI:3690223	Serpine1^tm1Mlg	MGI:1857287	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging	MP:0005385 MP:0005376 MP:0005387 MP:0005370 MP:0005388 MP:0010768	Gralinski LE, mBio 2013 Aug 6;4(4):	J:288556	Infection\|Pathology\|SARS-CoV-MA_virus	B6.129S2-Serpine1^tm1Mlg/J congenic\|mutant strain\|targeted mutation	MGI:3690223	cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging Coronavirus infectious disease	Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus
B6.129S2-Tcra^tm1Mom/J	MGI:2162335	congenic\|mutant strain\|targeted mutation										Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229	J:343550	Infection\|SARS-CoV-2_virus\|Treatment	B6.129S2-Tcra^tm1Mom/J congenic\|mutant strain\|targeted mutation			Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment
B6.129S2-Tnfrsf1b^tm1Mwm/J	MGI:2164652	congenic\|mutant strain\|targeted mutation	MGI:3580520	Tnfrsf1b^tm1Mwm	MGI:1857262	Targeted	Null/knockout			cellular hematopoietic system immune system	MP:0005384 MP:0005397 MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129S2-Tnfrsf1b^tm1Mwm/J congenic\|mutant strain\|targeted mutation	MGI:3580520	cellular hematopoietic system immune system	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6;129S4-C3^tm1Crr/J	MGI:2165043	mutant stock\|targeted mutation	MGI:3799624	C3^tm1Crr	MGI:1861799	Targeted	Null/knockout			homeostasis/metabolism immune system nervous system vision/eye	MP:0005376 MP:0005387 MP:0003631 MP:0005391	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	B6;129S4-C3^tm1Crr/J mutant stock\|targeted mutation	MGI:3799624	homeostasis/metabolism immune system nervous system vision/eye	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
B6.129S4-Ccr1^tm1Gao	MGI:3614571	congenic\|mutant strain\|targeted mutation	MGI:3614443	Ccr1^tm1Gao	MGI:1931850	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	B6.129S4-Ccr1^tm1Gao congenic\|mutant strain\|targeted mutation	MGI:3614443	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
B6.129S4-Ccr2^tm1Ifc/J	MGI:3038272	congenic\|mutant strain\|targeted mutation	MGI:3580323	Ccr2^tm1Ifc	MGI:2158213	Targeted	Null/knockout			cellular hematopoietic system immune system nervous system skeleton mortality/aging neoplasm	MP:0005384 MP:0005397 MP:0005387 MP:0003631 MP:0005390 MP:0010768 MP:0002006	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92	J:106738	Mouse_Hepatitis_virus\|Pathology	B6.129S4-Ccr2^tm1Ifc/J congenic\|mutant strain\|targeted mutation	MGI:3580323	cellular hematopoietic system immune system nervous system skeleton mortality/aging neoplasm	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Mouse_Hepatitis_virus\|Pathology
B6(129S4)-Ly6e^{tm1c(EUCOMM)Hmgu}/JwschJ	MGI:6507729	mutant strain\|targeted mutation										Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	B6(129S4)-Ly6e^{tm1c(EUCOMM)Hmgu}/JwschJ mutant strain\|targeted mutation			Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
B6;129S5-Ace2^tm1Lex/Mmucd	MGI:5498467	mutant strain\|targeted mutation										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6;129S5-Ace2^tm1Lex/Mmucd mutant strain\|targeted mutation			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6;129S6-Apaf1^tm1Her/J	MGI:2178674	mutant stock\|targeted mutation										Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	B6;129S6-Apaf1^tm1Her/J mutant stock\|targeted mutation			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
B6.129S6-Cd4^tm1Knw/J	MGI:2162768	congenic\|mutant strain\|targeted mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.129S6-Cd4^tm1Knw/J congenic\|mutant strain\|targeted mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6.129S6-Ch25h^tm1Rus/J	MGI:4947858	congenic\|mutant strain\|targeted mutation										Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648	J:343658	SARS-CoV-2_virus	B6.129S6-Ch25h^tm1Rus/J congenic\|mutant strain\|targeted mutation			Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus
B6.129S6-Nlrp3^tm1Bhk/J	MGI:5465029	congenic\|mutant strain\|targeted mutation										Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:331762 J:323769	Mouse_Hepatitis_virus Gene\|Pathology	B6.129S6-Nlrp3^tm1Bhk/J congenic\|mutant strain\|targeted mutation			Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6;129S6-Ppp1r14c^tm1Uhl/J	MGI:4839337	mutant stock\|targeted mutation	MGI:6433773	Ppp1r14c^tm1Uhl	MGI:4450989	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	immune system	MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6;129S6-Ppp1r14c^tm1Uhl/J mutant stock\|targeted mutation	MGI:6433773	immune system Coronavirus infectious disease	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129S6-Ptges2^tm1Bhk/J	MGI:3833371	congenic\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129S6-Ptges2^tm1Bhk/J congenic\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129S6-Shh^{tm2(cre/ERT2)Cjt}/J	MGI:3612945	congenic\|mutant strain\|targeted mutation										Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	B6.129S6-Shh^{tm2(cre/ERT2)Cjt}/J congenic\|mutant strain\|targeted mutation			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6.129S7-Cd47^tm1Fpl/J	MGI:2165071	congenic\|mutant strain\|targeted mutation										Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	B6.129S7-Cd47^tm1Fpl/J congenic\|mutant strain\|targeted mutation			Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
B6.129S7-Ifngr1^tm1Agt/J	MGI:2164369	congenic\|mutant strain\|targeted mutation										Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229	J:343550	Infection\|SARS-CoV-2_virus\|Treatment	B6.129S7-Ifngr1^tm1Agt/J congenic\|mutant strain\|targeted mutation			Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment
B6.129S7-Ifng^tm1Ts	MGI:3713227	congenic\|mutant strain\|targeted mutation	MGI:4365971	Ifng^tm1Ts	MGI:1857184	Targeted	Null/knockout			endocrine/exocrine glands hematopoietic system immune system neoplasm mortality/aging	MP:0005379 MP:0005397 MP:0005387 MP:0002006 MP:0010768	Parra B, J Immunol 1999 Feb 1;162(3):1641-7	J:112048	Infection\|Mouse_Hepatitis_virus	B6.129S7-Ifng^tm1Ts congenic\|mutant strain\|targeted mutation	MGI:4365971	endocrine/exocrine glands hematopoietic system immune system neoplasm mortality/aging	Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Infection\|Mouse_Hepatitis_virus
B6.129S7-Ifng^tm1Ts/J	MGI:2162391	congenic\|mutant strain\|targeted mutation										Sun J, Cell 2020 Jun 10;():	J:291881	Infection\|Pathology\|SARS-CoV-2_virus\|Treatment	B6.129S7-Ifng^tm1Ts/J congenic\|mutant strain\|targeted mutation			Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment
B6.129S7-Rag1^tm1Mom/J	MGI:2163461	congenic\|mutant strain\|targeted mutation										Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Hassan AO, Cell 2020 Jun 10;(): Israelow B, bioRxiv 2021 May;(): Mao T, bioRxiv 2021 Jun;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:88552 J:92752 J:290258 J:308733 J:308656 J:345954	Mouse_Hepatitis_virus Infection\|SARS-CoV_virus Infection\|SARS-CoV-2_virus\|Treatment Infection\|SARS-CoV-2_virus Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Infection\|MERS-CoV-MA_virus	B6.129S7-Rag1^tm1Mom/J congenic\|mutant strain\|targeted mutation			Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Mouse_Hepatitis_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S(C)-Batf3^tm1Kmm/J	MGI:5287249	congenic\|mutant strain\|targeted mutation										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	B6.129S(C)-Batf3^tm1Kmm/J congenic\|mutant strain\|targeted mutation			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S(Cg)-Stat1^tm1Dlv/J	MGI:4452071	congenic\|mutant strain\|targeted mutation										Hassan AO, Cell 2020 Jun 10;(): Ngo VL, Cell Host Microbe 2024 Jan 23;(): Sun J, Cell 2020 Jun 10;():	J:290258 J:345954 J:291881	Infection\|SARS-CoV-2_virus\|Treatment Infection\|MERS-CoV-MA_virus Infection\|Pathology\|SARS-CoV-2_virus\|Treatment	B6.129S(Cg)-Stat1^tm1Dlv/J congenic\|mutant strain\|targeted mutation			Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment
B6.129S-Csf2^tm1Mlg/J	MGI:5613598	congenic\|mutant strain\|targeted mutation										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	B6.129S-Csf2^tm1Mlg/J congenic\|mutant strain\|targeted mutation			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.129S(FVB)-Bcl6^tm1.1Dent/J	MGI:5518537	congenic\|mutant strain\|targeted mutation										Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	B6.129S(FVB)-Bcl6^tm1.1Dent/J congenic\|mutant strain\|targeted mutation			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
B6.129S-Notch2^tm3Grid/J	MGI:4441345	congenic\|mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129S-Notch2^tm3Grid/J congenic\|mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.129S-Sftpc^{tm1(cre/ERT2)Blh}/J	MGI:5661884	congenic\|mutant strain\|targeted mutation										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.129S-Sftpc^{tm1(cre/ERT2)Blh}/J congenic\|mutant strain\|targeted mutation			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.129S-Tnfrsf1b^tm1Imx Tnfrsf1a^tm1Imx/J	MGI:2164568	congenic\|mutant strain\|targeted mutation	MGI:6433775	Tnfrsf1a^tm1Imx Tnfrsf1b^tm1Imx	MGI:1857468 MGI:1860087	Targeted	Null/knockout			immune system	MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129S-Tnfrsf1b^tm1Imx Tnfrsf1a^tm1Imx/J congenic\|mutant strain\|targeted mutation	MGI:6433775	immune system	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129-Tlr2^tm1Kir/J	MGI:2673281	congenic\|mutant strain\|targeted mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.129-Tlr2^tm1Kir/J congenic\|mutant strain\|targeted mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6.129-Tnfrsf1a^tm1Mak/J	MGI:2164398	congenic\|mutant strain\|targeted mutation										McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	B6.129-Tnfrsf1a^tm1Mak/J congenic\|mutant strain\|targeted mutation			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
B6.129X1-Fgl2^tm1Pam	MGI:3583761	congenic\|mutant strain\|targeted mutation	MGI:3583697	Fgl2^tm1Pam	MGI:3582343	Targeted	Null/knockout\|Reporter			cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system renal/urinary system mortality/aging	MP:0005385 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005367 MP:0010768	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66	J:99453	Mouse_Hepatitis_virus	B6.129X1-Fgl2^tm1Pam congenic\|mutant strain\|targeted mutation	MGI:3583697	cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system renal/urinary system mortality/aging	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 Mouse_Hepatitis_virus
B6.129X1-Ifng^tm1Yiw	MGI:6430477	congenic\|mutant strain\|targeted mutation	MGI:6430478	Ifng^tm1Yiw	MGI:3036127	Targeted	Null/knockout			behavior/neurological digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging	MP:0005386 MP:0005381 MP:0005378 MP:0005376 MP:0005387 MP:0005370 MP:0010768	Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77	J:50405 J:91691	Mouse_Hepatitis_virus\|Pathology Infection\|Mouse_Hepatitis_virus\|Pathology	B6.129X1-Ifng^tm1Yiw congenic\|mutant strain\|targeted mutation	MGI:6430478	behavior/neurological digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging	Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Mouse_Hepatitis_virus\|Pathology Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 Infection\|Mouse_Hepatitis_virus\|Pathology
B6.129X1-Notch1^tm2Rko/GridJ	MGI:3777345	congenic\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6.129X1-Notch1^tm2Rko/GridJ congenic\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.B10ScN-Tlr4^lps-del/JthJ	MGI:3777588	congenic\|spontaneous mutation										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	B6.B10ScN-Tlr4^lps-del/JthJ congenic\|spontaneous mutation			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6C3-Tg(APP695)3Dbo Tg(PSEN1)5Dbo/Mmjax	MGI:2174641	mutant strain\|transgenic										Chen J, Transl Psychiatry 2023 Dec 16;13(1):396	J:348471	Gene\|Infection\|SARS-CoV-2_virus	B6C3-Tg(APP695)3Dbo Tg(PSEN1)5Dbo/Mmjax mutant strain\|transgenic			Chen J, Transl Psychiatry 2023 Dec 16;13(1):396 Gene\|Infection\|SARS-CoV-2_virus
B6.Cg-Aicda^tm1Hon/HonRbrc	MGI:3690652	congenic\|mutant strain\|targeted mutation										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	B6.Cg-Aicda^tm1Hon/HonRbrc congenic\|mutant strain\|targeted mutation			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
B6.Cg-B2m^tm1Unc Cd4^tm1Litt H2-Ab1^b-tm1Doi Tg(Cd4-CD4)2362Litt Tg(H2-Aa-HLA-DPA1)1Lone Tg(H2-Ab1-HLA-DPB1)1Lone Tg(HLA-A/H2-D/B2M)1Bpe/Orl	MGI:5494679	congenic\|mutant strain\|targeted mutation\|transgenic										Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	B6.Cg-B2m^tm1Unc Cd4^tm1Litt H2-Ab1^b-tm1Doi Tg(Cd4-CD4)2362Litt Tg(H2-Aa-HLA-DPA1)1Lone Tg(H2-Ab1-HLA-DPB1)1Lone Tg(HLA-A/H2-D/B2M)1Bpe/Orl congenic\|mutant strain\|targeted mutation\|transgenic			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
B6(Cg)-C1qa^{tm1d(EUCOMM)Wtsi}/TennJ	MGI:6151470	mutant strain\|targeted mutation										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	B6(Cg)-C1qa^{tm1d(EUCOMM)Wtsi}/TennJ mutant strain\|targeted mutation			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
B6.Cg-Ces1c^tm1.1Loc/J	MGI:4939039	congenic\|mutant strain\|targeted mutation										Martinez DR, bioRxiv 2021 Jan;(): Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 Zhu C, Nat Commun 2022 Aug 3;13(1):4503	J:302135 J:298752 J:335969	SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment	B6.Cg-Ces1c^tm1.1Loc/J congenic\|mutant strain\|targeted mutation			Martinez DR, bioRxiv 2021 Jan;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus\|Treatment
B6(Cg)-Ctnnb1^tm1Knw/J	MGI:5796192	mutant strain\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6(Cg)-Ctnnb1^tm1Knw/J mutant strain\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.Cg-Edil3^{Tg(Sox2-cre)1Amc}/J	MGI:3800753	congenic\|transgenic										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.Cg-Edil3^{Tg(Sox2-cre)1Amc}/J congenic\|transgenic			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.Cg-Fcgrt^tm1Dcr Prkdc^scid Tg(FCGRT)32Dcr/DcrJ	MGI:5424138	congenic\|mutant strain\|spontaneous mutation\|targeted mutation\|transgenic										Halwe S, bioRxiv 2021 Jun;():	J:308648	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	B6.Cg-Fcgrt^tm1Dcr Prkdc^scid Tg(FCGRT)32Dcr/DcrJ congenic\|mutant strain\|spontaneous mutation\|targeted mutation\|transgenic			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
B6.Cg-Foxn1^nu/J	MGI:2163103	congenic\|mutant strain\|spontaneous mutation										Houtman JJ, J Neurovirol 1996 APR;2(2):101-110	J:33974	Mouse_Hepatitis_virus	B6.Cg-Foxn1^nu/J congenic\|mutant strain\|spontaneous mutation			Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus
B6.Cg-Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}/J	MGI:3813512	congenic\|targeted mutation										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.Cg-Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}/J congenic\|targeted mutation			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.Cg-Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/J	MGI:3584524	congenic\|mutant strain\|targeted mutation										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	B6.Cg-Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/J congenic\|mutant strain\|targeted mutation			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6(Cg)-Ifnar1^tm1.1Ees/J	MGI:5692164	congenic\|mutant strain\|targeted mutation										Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	B6(Cg)-Ifnar1^tm1.1Ees/J congenic\|mutant strain\|targeted mutation			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6(Cg)-Ifnar1^tm1.2Ees/J	MGI:5692173	congenic\|mutant strain\|targeted mutation										Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Mao T, bioRxiv 2021 Jun;(): Sun J, Cell 2020 Jun 10;(): Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Yang J, Nature 2020 Jul 29;():	J:343550 J:308656 J:291881 J:338414 J:292665	Infection\|SARS-CoV-2_virus\|Treatment Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Infection\|Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron SARS-CoV-2_virus\|Vaccine	B6(Cg)-Ifnar1^tm1.2Ees/J congenic\|mutant strain\|targeted mutation			Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6(Cg)-Igh^{tm3.1(VRC01)Nemz}/J	MGI:5795592	mutant strain\|targeted mutation										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	B6(Cg)-Igh^{tm3.1(VRC01)Nemz}/J mutant strain\|targeted mutation			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}	MGI:6449003	congenic\|mutant strain\|targeted mutation\|transgenic	MGI:6449004	Commd10^{Tg(Vav1-icre)A2Kio} Ly6e^{tm1c(EUCOMM)Hmgu}	MGI:2449949 MGI:6448980	Transgenic Targeted	Null/knockout\|Recombinase Conditional ready			hematopoietic system homeostasis/metabolism immune system liver/biliary system mortality/aging	MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0010768	Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio} congenic\|mutant strain\|targeted mutation\|transgenic	MGI:6449004	hematopoietic system homeostasis/metabolism immune system liver/biliary system mortality/aging	Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
B6.Cg-Mx1^tm1.1Agsa/J	MGI:6280430	congenic\|mutant strain\|targeted mutation										Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	B6.Cg-Mx1^tm1.1Agsa/J congenic\|mutant strain\|targeted mutation			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6.Cg-Prkdc^scid/SzJ	MGI:2163184	congenic\|mutant strain\|spontaneous mutation										Houtman JJ, J Neurovirol 1996 APR;2(2):101-110	J:33974	Mouse_Hepatitis_virus	B6.Cg-Prkdc^scid/SzJ congenic\|mutant strain\|spontaneous mutation			Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus
B6.Cg-Shh^{tm1(EGFP/cre)Cjt}/J	MGI:3619470	congenic\|mutant strain\|targeted mutation										Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	B6.Cg-Shh^{tm1(EGFP/cre)Cjt}/J congenic\|mutant strain\|targeted mutation			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn}/J	MGI:2164673	congenic\|mutant strain\|transgenic										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	B6.Cg-Speer6-ps1^{Tg(Alb-cre)21Mgn}/J congenic\|mutant strain\|transgenic			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6(Cg)-Sting1^tm1.2Camb/J	MGI:5639268	congenic\|mutant strain\|targeted mutation										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	B6(Cg)-Sting1^tm1.2Camb/J congenic\|mutant strain\|targeted mutation			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
B6.Cg-Terc^tm1Rdp/J	MGI:2174164	congenic\|mutant strain\|targeted mutation										Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658	J:309195 J:326929	Comorbidity\|Gene Gene	B6.Cg-Terc^tm1Rdp/J congenic\|mutant strain\|targeted mutation			Sepe S, bioRxiv 2021 Jun;(): Comorbidity\|Gene Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene
B6.Cg-Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas/Mmjax	MGI:3811801	congenic\|transgenic										Hohsfield LA, Glia 2022 May;70(5):875-891	J:324342	Mouse_Hepatitis_virus	B6.Cg-Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas/Mmjax congenic\|transgenic			Hohsfield LA, Glia 2022 May;70(5):875-891 Mouse_Hepatitis_virus
B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ	MGI:5566534	congenic\|mutant strain\|transgenic										Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ congenic\|mutant strain\|transgenic			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
B6.Cg-Tg(DPP4)2Nnag	MGI:6403117	congenic\|mutant strain\|transgenic	MGI:6403118	Tg(DPP4)2Nnag	MGI:6403115	Transgenic	Humanized sequence\|Inserted expressed sequence	Middle East respiratory syndrome	DOID:0080642	homeostasis/metabolism immune system respiratory system	MP:0005376 MP:0005387 MP:0005388	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6):	J:286321	Infection\|MERS-CoV_virus	B6.Cg-Tg(DPP4)2Nnag congenic\|mutant strain\|transgenic	MGI:6403118	homeostasis/metabolism immune system respiratory system Middle East respiratory syndrome	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Infection\|MERS-CoV_virus
B6.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnc	MGI:6415225	congenic\|mutant strain\|transgenic										Jia H, Nat Commun 2020 Oct 14;11(1):5165 Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53	J:296535 J:287092	SARS-CoV-2_virus Infection	B6.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnc congenic\|mutant strain\|transgenic			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 Infection
B6.Cg-Tg(Itgax-cre)1-1Reiz/J	MGI:3763375	congenic\|mutant strain\|transgenic										Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 Anand G, bioRxiv 2020 Dec;():	J:333092 J:298270	Gene\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus	B6.Cg-Tg(Itgax-cre)1-1Reiz/J congenic\|mutant strain\|transgenic			Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 Gene\|VOC_B.1.351_Beta Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
B6.Cg-Tg(K18-ACE2)2Prlmn/J	MGI:6389236	congenic\|mutant strain\|transgenic	MGI:6455041	Tg(K18-ACE2)2Prlmn	MGI:6389235	Transgenic	Humanized sequence\|Inserted expressed sequence	COVID-19	DOID:0080600	behavior/neurological cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system respiratory system vision/eye mortality/aging	MP:0005386 MP:0005385 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005388 MP:0005391 MP:0010768	Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Afkhami S, bioRxiv 2021 Jul;(): Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 Amruta N, bioRxiv 2021 May;(): Avila-Nieto C, Nat Commun 2024 Mar 21;15(1):2349 Awosanya OD, Bone 2022 Jan;154():116227 Barreiro A, bioRxiv 2021 Dec;(): Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): Belouzard S, bioRxiv 2021 Jun;(): Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 Biswas R, bioRxiv 2021 Feb;(): Cao L, Sci Transl Med 2022 Sep 7;14(661):eabm7621 Carossino M, bioRxiv 2021 Jan;(): Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 Ceon E, bioRxiv 2022 Jan;(): Chan CEZ, PLoS One 2021;16(6):e0253487 Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 Chaparian RR, bioRxiv 2021 Apr;(): Chen EC, Cell Rep 2021 Aug 24;36(8):109604 Chen IP, Cell Rep 2022 Jul 19;40(3):111088 Chen JS, bioRxiv 2020 Sep 25;(): Chen JS, bioRxiv 2021 Jun;(): Chen JS, J Virol 2021 Jan 13;(): Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Clark JJ, bioRxiv 2020;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Conforti A, bioRxiv 2021 Jun;(): Dangi T, J Clin Invest 2022 Dec 1;132(23): de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Do MH, PLoS One 2023;18(9):e0291537 Drayman N, Science 2021 Aug 20;373(6557):931-936 Dubuc I, Front Immunol 2022;13():893792 Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 Duty JA, Med 2022 Oct 14;3(10):705-721.e11 Elia U, bioRxiv 2021 Mar;(): El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 Ewart G, PLoS Pathog 2023 Aug;19(8):e1011328 Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 Fumagalli V, bioRxiv 2021 Aug;(): Garcia-Arriaza J, J Virol 2021 Jan 7;(): Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Gawish R, Elife 2022 Jan 13;11():e74623 Gioia U, Nat Cell Biol 2023 Apr;25(4):550-564 Golden JW, JCI Insight 2020 Aug 25;(): Goncalves R, iScience 2023 Feb 17;26(2):105972 Grandi A, bioRxiv 2021 Jul;(): Greer CD, bioRxiv 2021 Aug;(): Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Hastie KM, Cell Rep 2023 May 30;42(5):112421 Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 Hilligan KL, bioRxiv 2021 Aug;(): Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Ho JSY , bioRxiv 2020 Dec;(): Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 Hong J, bioRxiv 2021 Oct;(): Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 Humphries F, Sci Immunol 2021 May 18;6(59): Hunt AC, bioRxiv 2021 Jul;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Jaki L, Nat Commun 2023 Apr 10;14(1):1999 Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 Jeong GU, bioRxiv 2022;(): Jeong H, Dis Model Mech 2022 Nov 1;15(11):dmm049632 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Joag V, J Immunol 2021 Mar 1;206(5):931-935 Johnson BA, Nature 2021 Mar;591(7849):293-299 Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kehrer T, Cell Host Microbe 2023 Oct 11;31(10):1668-1684.e12 Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 Kim JW, Front Immunol 2023;14():1271508 Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 Ku MW, bioRxiv 2021 Feb;(): Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 Lee KS, bioRxiv 2022;(): Lee S, Nature 2021 Nov;599(7884):283-289 Lee YJ, Am J Pathol 2023 Jul;193(7):866-882 Li K, mBio 2021 Aug 31;12(4):e0097021 Lin X, bioRxiv 2021 Dec;(): Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Li W, Cell Rep 2022 Jan 11;38(2):110210 Lu A, Int J Mol Sci 2024 Feb 8;25(4): Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 Manangeeswaran M, Front Immunol 2022;13():919815 Mao T, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2022;(): Mao T, Proc Natl Acad Sci U S A 2024 Apr 30;121(18):e2319566121 Mao T, Science 2022 Nov 25;378(6622):eabo2523 Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Marx S, bioRxiv 2021 Aug;(): Matchett WE, J Immunol 2021 Jun 30;(): McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Mei M, Proc Natl Acad Sci U S A 2024 May 28;121(22):e2314166121 Mejia OR, bioRxiv 2021 Nov;(): Nagai M, Nat Commun 2023 Jun 30;14(1):3863 Natekar JP, bioRxiv 2022 Apr;(): Noy-Porat T, bioRxiv 2021 Feb;(): Noy-Porat T, iScience 2021 May 21;24(5):102479 Oktay E, Commun Biol 2023 Mar 23;6(1):308 Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Olivarria GM, bioRxiv 2021 Nov;(): Oliveira VLS, Front Immunol 2024;15():1378591 Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 Perez P, Front Immunol 2022;13():995235 Perez P, Front Immunol 2023;14():1264323 Puhl AC, bioRxiv 2021;(): Puhl AC, bioRxiv 2021 Dec;(): Qin Z, Theranostics 2021;11(16):8076-8091 Radvak P, bioRxiv 2021 Jun;(): Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Rizvi ZA, Commun Biol 2023 Sep 13;6(1):935 Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Robertson SJ, bioRxiv 2021 Sep;(): Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 Salzer R, bioRxiv 2021 May;(): Scaglione A, bioRxiv 2021 Jun;(): Scaglione A, Front Immunol 2021;12():719077 Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 Seehusen F, bioRxiv 2021 Apr;(): Shapira T, bioRxiv 2021 May;(): Silvas J, bioRxiv 2021 Mar;(): Sims JJ, bioRxiv 2021 Apr;(): Slamanig S, EBioMedicine 2024 Jun 6;105():105185 Smeyne RJ, bioRxiv 2022 Feb;(): Sohn SY, mBio 2021 Nov 2;():e0275621 Song E, J Exp Med 2021 Mar 1;218(3): Soni DK, bioRxiv 2020 Dec;(): Suberi A, Sci Transl Med 2023 Aug 16;15(709):eabq0603 Subramaniam S, bioRxiv 2021 Aug;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Su P, Mol Brain 2022 Aug 9;15(1):71 Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 Syenina A, PLoS Biol 2022 May;20(5):e3001643 Tada T, Cell Rep 2020 Dec 22;33(12):108528 Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Tarres-Frexas F, bioRxiv 2021 Aug;(): Tatham L, bioRxiv 2022;(): Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Ullah i, bioRxiv 2021 Mar;(): Ullah I, iScience 2024 Mar 15;27(3):109049 van Bergen J, JCI Insight 2023 Nov 8;8(21): VanBlargan LA, Immunity 2021 Aug 19;(): Van Dyke MC, bioRxiv 2021 May;(): van Huizen M, PLoS Pathog 2024 Mar;20(3):e1012100 Venzon M, bioRxiv 2021 Jul;(): Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Weiss S, Int J Mol Sci 2023 May 5;24(9): Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 White KM, Science 2021 Feb 26;371(6532):926-931 Winkler ES, bioRxiv 2020 Dec;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Winkler ES, Nat Immunol 2020 Aug 24;(): Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Ying B, bioRxiv 2022 Feb;(): Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 Zhang L, bioRxiv 2022 Mar;(): Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 Zheng J, bioRxiv 2020 Aug 10;(): Zheng J, Nature 2021 Jan;589(7843):603-607 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Zhu C, Nat Commun 2022 Aug 3;13(1):4503 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47	J:335907 J:308640 J:335897 J:335960 J:308724 J:349496 J:319441 J:315723 J:310110 J:308621 J:335929 J:302158 J:348328 J:300428 J:294058 J:321756 J:309634 J:335919 J:308713 J:335928 J:331767 J:298866 J:308655 J:300110 J:321761 J:325089 J:296067 J:309512 J:308652 J:348326 J:331763 J:349970 J:336017 J:335961 J:335898 J:349963 J:303462 J:335924 J:343775 J:343658 J:308584 J:300041 J:335902 J:318828 J:339694 J:294084 J:348327 J:308639 J:308745 J:284000 J:335892 J:309629 J:319459 J:338412 J:335945 J:309197 J:343550 J:298250 J:308894 J:313447 J:335952 J:333769 J:308637 J:308733 J:331753 J:348329 J:335899 J:321757 J:348325 J:296535 J:303898 J:307033 J:335935 J:313337 J:296686 J:349972 J:319440 J:319447 J:349971 J:335933 J:302144 J:319366 J:321763 J:334872 J:343773 J:313329 J:315744 J:299104 J:303465 J:335931 J:349976 J:335930 J:331765 J:308656 J:321770 J:349979 J:335986 J:349938 J:308571 J:348320 J:283648 J:349980 J:315717 J:337953 J:324941 J:302148 J:308896 J:335997 J:300960 J:315722 J:348063 J:335939 J:335976 J:343770 J:311915 J:316769 J:319458 J:308643 J:296397 J:340506 J:335918 J:310124 J:338561 J:303472 J:308749 J:308666 J:335910 J:335943 J:304647 J:308716 J:302912 J:304613 J:350298 J:322638 J:312952 J:302314 J:299096 J:343790 J:309192 J:322631 J:331766 J:335949 J:335947 J:313439 J:338414 J:308579 J:321766 J:309630 J:303209 J:348954 J:349973 J:336018 J:308721 J:349977 J:308642 J:336189 J:328107 J:336005 J:323957 J:303457 J:299082 J:331773 J:294083 J:317125 J:335996 J:339218 J:321873 J:336008 J:324936 J:330045 J:305460 J:293212 J:303220 J:308903 J:335969 J:283999	Comorbidity\|SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine\|Variant SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus Gene\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|Variant SARS-CoV-2_virus\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Comorbidity\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus Vaccine Pathology\|SARS-CoV-2-MA_virus Infection\|Pathology\|SARS-CoV-2_virus\|Sex_bias Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.617.2_Delta MERS-CoV_virus\|SARS-CoV_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha Infection\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|Treatment Infection\|Pathology\|SARS-CoV-2_virus\|Variant SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|VOC_P.1_Gamma Pathology\|VOC_B.1.617.2_Delta Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Gene\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Infection\|SARS-CoV_virus Comorbidity\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha Infection\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Infection\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|Vaccine PASC\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.1.529_Omicron Pathology\|SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta Vaccine\|VOC_B.1.1.529_Omicron SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Treatment\|Variant\|VOC_B.1.1.529_Omicron\|VOC_P.1_Gamma	B6.Cg-Tg(K18-ACE2)2Prlmn/J congenic\|mutant strain\|transgenic	MGI:6455041	behavior/neurological cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system respiratory system vision/eye mortality/aging COVID-19	Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Comorbidity\|SARS-CoV-2_virus Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Pathology\|SARS-CoV-2_virus Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 SARS-CoV-2_virus\|Vaccine\|Variant Amruta N, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment Avila-Nieto C, Nat Commun 2024 Mar 21;15(1):2349 SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Awosanya OD, Bone 2022 Jan;154():116227 Pathology\|SARS-CoV-2_virus Barreiro A, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): SARS-CoV-2_virus Belouzard S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 SARS-CoV-2_virus\|Treatment Biswas R, bioRxiv 2021 Feb;(): Gene\|SARS-CoV-2_virus Cao L, Sci Transl Med 2022 Sep 7;14(661):eabm7621 SARS-CoV-2_virus\|Treatment\|Variant Carossino M, bioRxiv 2021 Jan;(): Pathology\|SARS-CoV-2_virus Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 SARS-CoV-2_virus\|Vaccine Ceon E, bioRxiv 2022 Jan;(): SARS-CoV-2_virus\|Treatment Chan CEZ, PLoS One 2021;16(6):e0253487 SARS-CoV-2_virus\|Treatment Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 SARS-CoV-2_virus\|Treatment Chaparian RR, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Chen EC, Cell Rep 2021 Aug 24;36(8):109604 SARS-CoV-2_virus\|Treatment Chen IP, Cell Rep 2022 Jul 19;40(3):111088 SARS-CoV-2_virus Chen JS, bioRxiv 2020 Sep 25;(): SARS-CoV-2_virus\|Treatment Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta Chen JS, J Virol 2021 Jan 13;(): SARS-CoV-2_virus\|Treatment Chong Z, bioRxiv 2022;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Clark JJ, bioRxiv 2020;(): Comorbidity\|Pathology\|SARS-CoV-2_virus Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Pathology\|SARS-CoV-2_virus Conforti A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Dangi T, J Clin Invest 2022 Dec 1;132(23): SARS-CoV-2_virus\|Treatment de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 SARS-CoV-2_virus Do MH, PLoS One 2023;18(9):e0291537 SARS-CoV-2_virus\|Treatment Drayman N, Science 2021 Aug 20;373(6557):931-936 SARS-CoV-2_virus\|Treatment Dubuc I, Front Immunol 2022;13():893792 Pathology\|SARS-CoV-2_virus Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 SARS-CoV-2_virus Duty JA, Med 2022 Oct 14;3(10):705-721.e11 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Elia U, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 SARS-CoV-2_virus\|Treatment Ewart G, PLoS Pathog 2023 Aug;19(8):e1011328 SARS-CoV-2_virus\|Treatment Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus Fumagalli V, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus Garcia-Arriaza J, J Virol 2021 Jan 7;(): Vaccine Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Gene\|SARS-CoV-2_virus Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus Gioia U, Nat Cell Biol 2023 Apr;25(4):550-564 SARS-CoV-2_virus Golden JW, JCI Insight 2020 Aug 25;(): Infection\|Pathology\|SARS-CoV-2_virus\|Sex_bias Goncalves R, iScience 2023 Feb 17;26(2):105972 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.617.2_Delta Grandi A, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Greer CD, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 MERS-CoV_virus\|SARS-CoV_virus Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 SARS-CoV-2_virus\|Vaccine Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 SARS-CoV-2_virus\|Vaccine Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Infection\|SARS-CoV-2_virus Hastie KM, Cell Rep 2023 May 30;42(5):112421 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 SARS-CoV-2_virus Hilligan KL, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment Ho JSY , bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 SARS-CoV-2_virus\|Treatment Hong J, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Humphries F, Sci Immunol 2021 May 18;6(59): SARS-CoV-2_virus\|Treatment Hunt AC, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Infection\|SARS-CoV-2_virus Jaki L, Nat Commun 2023 Apr 10;14(1):1999 SARS-CoV-2_virus\|Treatment Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta Jeong GU, bioRxiv 2022;(): Pathology\|SARS-CoV-2_virus Jeong H, Dis Model Mech 2022 Nov 1;15(11):dmm049632 Pathology\|SARS-CoV-2_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Joag V, J Immunol 2021 Mar 1;206(5):931-935 SARS-CoV-2_virus\|Vaccine Johnson BA, Nature 2021 Mar;591(7849):293-299 SARS-CoV-2_virus Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 SARS-CoV-2_virus\|Vaccine Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Pathology\|SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Kehrer T, Cell Host Microbe 2023 Oct 11;31(10):1668-1684.e12 Infection\|Pathology\|SARS-CoV-2_virus\|Variant Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Pathology\|SARS-CoV-2_virus Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 SARS-CoV-2_virus\|Vaccine Kim JW, Front Immunol 2023;14():1271508 SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 SARS-CoV-2_virus\|Vaccine Ku MW, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 SARS-CoV-2_virus\|Vaccine\|VOC_P.1_Gamma Lee KS, bioRxiv 2022;(): Pathology\|VOC_B.1.617.2_Delta Lee S, Nature 2021 Nov;599(7884):283-289 SARS-CoV-2_virus\|Treatment Lee YJ, Am J Pathol 2023 Jul;193(7):866-882 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Li K, mBio 2021 Aug 31;12(4):e0097021 MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Lin X, bioRxiv 2021 Dec;(): Gene\|Pathology\|SARS-CoV-2_virus Liu R, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 SARS-CoV-2_virus\|Vaccine Li W, Cell Rep 2022 Jan 11;38(2):110210 SARS-CoV-2_virus\|Treatment\|Variant Lu A, Int J Mol Sci 2024 Feb 8;25(4): SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Manangeeswaran M, Front Immunol 2022;13():919815 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Mao T, bioRxiv 2022;(): SARS-CoV-2_virus\|Vaccine Mao T, Proc Natl Acad Sci U S A 2024 Apr 30;121(18):e2319566121 SARS-CoV-2_virus\|Treatment Mao T, Science 2022 Nov 25;378(6622):eabo2523 SARS-CoV-2_virus\|Vaccine Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Pathology\|SARS-CoV-2_virus Marx S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Treatment Matchett WE, J Immunol 2021 Jun 30;(): SARS-CoV-2_virus\|Vaccine McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Infection\|SARS-CoV_virus Mei M, Proc Natl Acad Sci U S A 2024 May 28;121(22):e2314166121 Infection\|SARS-CoV-2_virus Mejia OR, bioRxiv 2021 Nov;(): Comorbidity\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Nagai M, Nat Commun 2023 Jun 30;14(1):3863 SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha Natekar JP, bioRxiv 2022 Apr;(): Infection\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Noy-Porat T, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Treatment Noy-Porat T, iScience 2021 May 21;24(5):102479 SARS-CoV-2_virus\|Treatment Oktay E, Commun Biol 2023 Mar 23;6(1):308 SARS-CoV-2_virus\|Vaccine Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Pathology\|SARS-CoV-2_virus Olivarria GM, bioRxiv 2021 Nov;(): Pathology\|SARS-CoV-2_virus Oliveira VLS, Front Immunol 2024;15():1378591 Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Perez P, Front Immunol 2022;13():995235 SARS-CoV-2_virus\|Vaccine Perez P, Front Immunol 2023;14():1264323 SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Puhl AC, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment Puhl AC, bioRxiv 2021 Dec;(): Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment Qin Z, Theranostics 2021;11(16):8076-8091 Pathology\|SARS-CoV-2_virus Radvak P, bioRxiv 2021 Jun;(): Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Infection\|SARS-CoV-2_virus Rizvi ZA, Commun Biol 2023 Sep 13;6(1):935 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Infection\|Pathology\|SARS-CoV-2_virus Robertson SJ, bioRxiv 2021 Sep;(): Infection\|SARS-CoV-2_virus Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 SARS-CoV-2_virus\|Treatment Salzer R, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Scaglione A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Scaglione A, Front Immunol 2021;12():719077 SARS-CoV-2_virus\|Treatment\|Vaccine Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 SARS-CoV-2_virus\|Treatment Seehusen F, bioRxiv 2021 Apr;(): Pathology\|SARS-CoV-2_virus Shapira T, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Silvas J, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus Sims JJ, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Treatment Slamanig S, EBioMedicine 2024 Jun 6;105():105185 SARS-CoV-2_virus\|Vaccine Smeyne RJ, bioRxiv 2022 Feb;(): PASC\|SARS-CoV-2_virus Sohn SY, mBio 2021 Nov 2;():e0275621 SARS-CoV-2_virus\|Treatment Song E, J Exp Med 2021 Mar 1;218(3): Infection\|SARS-CoV-2_virus Soni DK, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Suberi A, Sci Transl Med 2023 Aug 16;15(709):eabq0603 SARS-CoV-2_virus\|Vaccine Subramaniam S, bioRxiv 2021 Aug;(): Pathology\|SARS-CoV-2_virus Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 SARS-CoV-2_virus Su P, Mol Brain 2022 Aug 9;15(1):71 SARS-CoV-2_virus\|Treatment Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 SARS-CoV-2_virus\|Treatment Syenina A, PLoS Biol 2022 May;20(5):e3001643 SARS-CoV-2_virus\|Vaccine Tada T, Cell Rep 2020 Dec 22;33(12):108528 SARS-CoV-2_virus\|Treatment Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Tarres-Frexas F, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Tatham L, bioRxiv 2022;(): Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Turan RD, Sci Rep 2021 Aug 4;11(1):15799 SARS-CoV-2_virus\|Vaccine Ullah i, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Ullah I, iScience 2024 Mar 15;27(3):109049 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta van Bergen J, JCI Insight 2023 Nov 8;8(21): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.1.529_Omicron VanBlargan LA, Immunity 2021 Aug 19;(): SARS-CoV-2_virus\|Treatment\|Variant Van Dyke MC, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment van Huizen M, PLoS Pathog 2024 Mar;20(3):e1012100 Infection\|SARS-CoV-2_virus Venzon M, bioRxiv 2021 Jul;(): Pathology\|SARS-CoV-2_virus Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 Pathology\|SARS-CoV-2_virus\|Vaccine Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Weiss S, Int J Mol Sci 2023 May 5;24(9): SARS-CoV-2_virus\|Treatment Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta White KM, Science 2021 Feb 26;371(6532):926-931 SARS-CoV-2_virus\|Treatment Winkler ES, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Winkler ES, Nat Immunol 2020 Aug 24;(): Infection\|Pathology\|SARS-CoV-2_virus Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Pathology\|VOC_B.1.617.2_Delta Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta Ying B, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Zhang L, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Treatment\|Variant\|VOC_B.1.1.529_Omicron\|VOC_P.1_Gamma Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 SARS-CoV-2_virus Zheng J, bioRxiv 2020 Aug 10;(): Pathology\|SARS-CoV-2_virus\|Treatment Zheng J, Nature 2021 Jan;589(7843):603-607 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus\|Treatment Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 MERS-CoV_virus\|SARS-CoV_virus
B6.Cg-Tg(Syn1-ACE2)10Sig/LazarJ	MGI:6401204	congenic\|mutant strain\|transgenic										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6.Cg-Tg(Syn1-ACE2)10Sig/LazarJ congenic\|mutant strain\|transgenic			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6(Cg)-Tyr^c-2J/J	MGI:2163869	mutant strain\|spontaneous mutation										Scaglione A, Front Immunol 2021;12():719077	J:335910	SARS-CoV-2_virus\|Treatment\|Vaccine	B6(Cg)-Tyr^c-2J/J mutant strain\|spontaneous mutation			Scaglione A, Front Immunol 2021;12():719077 SARS-CoV-2_virus\|Treatment\|Vaccine
B6/JGpt-Ace2^em1Cd/Gpt	MGI:6424280	coisogenic\|endonuclease-mediated mutation\|mutant strain										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6/JGpt-Ace2^em1Cd/Gpt coisogenic\|endonuclease-mediated mutation\|mutant strain			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6/JGpt-Ace2^em1Cflox/Gpt	MGI:6424281	coisogenic\|endonuclease-mediated mutation\|mutant strain										Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	B6/JGpt-Ace2^em1Cflox/Gpt coisogenic\|endonuclease-mediated mutation\|mutant strain			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
B6N.129-Ccr9^tm1Lov/JmfJ	MGI:5644060	congenic\|mutant strain\|targeted mutation										Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:308730 J:327836	Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	B6N.129-Ccr9^tm1Lov/JmfJ congenic\|mutant strain\|targeted mutation			Schafer A, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
B6N.129-Ceacam1^tm2Bcn/J	MGI:5887126	congenic\|mutant strain\|targeted mutation										Hemmila E, J Virol 2004 Sep;78(18):10156-65	J:92376	Infection\|Mouse_Hepatitis_virus	B6N.129-Ceacam1^tm2Bcn/J congenic\|mutant strain\|targeted mutation			Hemmila E, J Virol 2004 Sep;78(18):10156-65 Infection\|Mouse_Hepatitis_virus
B6N.129S1-Tlr3^tm1Flv/J	MGI:4355732	congenic\|mutant strain\|targeted mutation	MGI:6433074	Tlr3^tm1Flv	MGI:2653138	Targeted	Null/knockout			immune system respiratory system	MP:0005387 MP:0005388	Totura AL, mBio 2015 May 26;6(3):e00638-15	J:288471	Infection\|SARS-CoV-MA_virus	B6N.129S1-Tlr3^tm1Flv/J congenic\|mutant strain\|targeted mutation	MGI:6433074	immune system respiratory system	Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection\|SARS-CoV-MA_virus
B6N.129S2-Casp1^tm1Flv/J	MGI:5004932	congenic\|mutant strain\|targeted mutation										Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yang J, Nature 2020 Jul 29;():	J:331762 J:323769 J:292665	Mouse_Hepatitis_virus Gene\|Pathology SARS-CoV-2_virus\|Vaccine	B6N.129S2-Casp1^tm1Flv/J congenic\|mutant strain\|targeted mutation			Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg	MGI:5521186	congenic\|mutant strain\|targeted mutation	MGI:5520923	Pla2g2d^tm1.1Mhg	MGI:5517549	Targeted	Null/knockout			cellular hematopoietic system homeostasis/metabolism immune system mortality/aging	MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0010768	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68	J:229035	Infection\|SARS-CoV-MA_virus	B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg congenic\|mutant strain\|targeted mutation	MGI:5520923	cellular hematopoietic system homeostasis/metabolism immune system mortality/aging	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 Infection\|SARS-CoV-MA_virus
B6NTac.129(FVB)-Muc4^tm1Unc/Rand	MGI:6423076	congenic\|mutant strain\|targeted mutation	MGI:6423102	Muc4^tm1Unc	MGI:6416171	Targeted	Null/knockout	Coronavirus infectious disease	DOID:0080599	growth/size/body immune system respiratory system mortality/aging	MP:0005378 MP:0005387 MP:0005388 MP:0010768	Plante JA, bioRxiv 2020;():	J:287566	Infection\|SARS-CoV-MA_virus\|Sex_bias	B6NTac.129(FVB)-Muc4^tm1Unc/Rand congenic\|mutant strain\|targeted mutation	MGI:6423102	growth/size/body immune system respiratory system mortality/aging Coronavirus infectious disease	Plante JA, bioRxiv 2020;(): Infection\|SARS-CoV-MA_virus\|Sex_bias
B6;SJL-Il6ra^tm1.1Drew/J	MGI:4461009	mutant stock\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	B6;SJL-Il6ra^tm1.1Drew/J mutant stock\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
B6.SJL-Ptprc^a Pepc^b/BoyJ	MGI:2164701	congenic\|mutant strain										Musiu C, Cell Death Differ 2021 Sep 13;():	J:313338	Pathology\|SARS-CoV-2_virus	B6.SJL-Ptprc^a Pepc^b/BoyJ congenic\|mutant strain			Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology\|SARS-CoV-2_virus
B6;SJL-Tg(KRT18-DPP4)3Pbmj/J	MGI:6455170	mutant stock\|transgenic										Li K, J Infect Dis 2016 Mar 1;213(5):712-22	J:285467	Infection\|MERS-CoV_virus\|Pathology	B6;SJL-Tg(KRT18-DPP4)3Pbmj/J mutant stock\|transgenic			Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Infection\|MERS-CoV_virus\|Pathology
B6;SJL-Tg(SFTPC-DPP4)3Pbmj/J	MGI:6455169	mutant stock\|transgenic										Li K, J Infect Dis 2016 Mar 1;213(5):712-22	J:285467	Infection\|MERS-CoV_virus\|Pathology	B6;SJL-Tg(SFTPC-DPP4)3Pbmj/J mutant stock\|transgenic			Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Infection\|MERS-CoV_virus\|Pathology
BALB/c	MGI:2161072	strain family										Abdoli A, bioRxiv 2021 Jun;(): Abdoli A, bioRxiv 2022 Feb;(): Agnihothram S, mBio 2014 Mar 25;5(2):e00047-14 Agostini ML, mBio 2018 Mar 6;9(2): Alimohammadi R, bioRxiv 2022 Mar;(): Amanat F, bioRxiv 2021 apr;(): Amanat F, bioRxiv 2021 Aug;(): An Y, bioRxiv 2021 Mar;(): Ao Z, bioRxiv 2021 Dec;(): Baray JC, bioRxiv 2020;(): Barreiro A, bioRxiv 2021 Dec;(): Baxter VK, bioRxiv 2022 Feb;(): Bellier B, bioRxiv 2021 Sep;(): Borriello F, bioRxiv 2021 Sep;(): Brentville VA, bioRxiv 2021 Jun;(): Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Capone S, bioRxiv 2020 Oct;(): Castano-Rodriguez C, mBio 2018 May 22;9(3): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chapman AP, bioRxiv 2020;(): Chen C, bioRxiv 2022 Feb;(): Chen J, bioRxiv 2021 Nov;(): Chen WH, Hum Vaccin Immunother 2014;10(3):648-58 Chen WH, Vaccine 2020 Nov 3;38(47):7533-7541 Chevillard C, bioRxiv 2021 Sep;(): Choque-Guevara R, bioRxiv 2021 Nov;(): Cohen AA, Science 2021 Feb 12;371(6530):735-741 Compton SR, Virology 1994 Aug 15;203(1):197-201 Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Dai L, Cell 2020 Jun 28;(): Dangi T, bioRxiv 2021 Jun;(): Davenport BJ, bioRxiv 2021 Nov;(): Day CW, Virology 2009 Dec 20;395(2):210-22 Deming D, PLoS Med 2006 Dec;3(12):e525 de Wilde AH, Virus Res 2017 Jan 15;228():7-13 Dey A, bioRxiv 2021 Jan;(): Dietert K, PLoS One 2017;12(11):e0188251 Du L, Nat Commun 2016 Nov 22;7():13473 Du L, PLoS One 2013;8(12):e81587 Elia U, bioRxiv 2020;(): Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Fehr AR, mBio 2016 Dec 13;7(6): Feng L, Nat Commun 2020 Aug 21;11(1):4207 Fernandez-Castaneda A, bioRxiv 2022;(): Ferrantelli F, bioRxiv 2020 Dec;(): Fett C, J Virol 2013 Jun;87(12):6551-9 Fu D, PLoS Biol 2021 May;19(5):e3001209 Gao J, bioRxiv 2021 Apr;(): Gao Q, Science 2020 Jul 3;369(6499):77-81 Gawish R, bioRxiv 2021 Aug;(): Gonzalez-Dominguez I, bioRxiv 2022 Mar;(): Graham RL, Commun Biol 2018;1():179 Gu H, bioRxiv 2020;(): Gu H, Science 2020 Jul 30;(): Guo X, Immunology 2015 Aug;145(4):476-84 Guo Y, J Biol Chem 2021 Jan 29;():100346 Haabeth OAW, bioRxiv 2021 Apr;(): He Z, bioRxiv 2020;(): Huang Q, Nat Commun 2021 Feb 3;12(1):776 Hua X, JCI Insight 2018 Jun 7;3(11): Hwang M, Immunology 2015 Mar;144(3):374-386 Jangra S, bioRxiv 2020 Oct 23;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Kalnin KV, bioRxiv 2020;(): Kandeil A, PLoS One 2020;15(10):e0241471 Kang YF, bioRxiv 2020 Nov;(): Kato H, PLoS One 2019;14(10):e0223684 Khan MS, bioRxiv 2022 May;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kibler KV, bioRxiv 2021 Dec;(): Kim E, EBioMedicine 2020 May;55():102743 Kim MH, PLoS One 2019;14(7):e0220196 Kobiyama K, bioRxiv 2021 Mar;(): Kozlovskaya L, bioRxiv 2022 Feb;(): Kumaki Y, Antiviral Res 2011 Jan;89(1):75-82 Lan J, PLoS One 2014;9(11):e112602 Lapp SA, bioRxiv 2021 Apr;(): Liang Y, bioRxiv 2021;(): Liao HY, bioRxiv 2021 May;(): Li D, bioRxiv 2021 Jan;(): Li K, mBio 2021 Aug 31;12(4):e0097021 Li L, bioRxiv 2020 Dec;(): Li L, bioRxiv 2021 Jul;(): Lin WS, bioRxiv 2021 Nov;(): Lin X, bioRxiv 2021 Sep;(): Li SW, Sci Rep 2016 May 13;6():25754 Liu H, bioRxiv 2021 Oct;(): Liu S, bioRxiv 2022 Feb;(): Liu WJ, J Immunol 2017 Jan 15;198(2):873-882 Liu X, bioRxiv 2021 Feb;(): Liu Y, bioRxiv 2022 Feb;(): Liu YM, Cell Rep 2020 Aug 11;32(6):108016 Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 Li Y, bioRxiv 2020 Oct;(): Li Z, bioRxiv 2021 Aug;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Luo S, bioRxiv 2020;(): Lu RM, bioRxiv 2022 Apr;(): Lu S, bioRxiv 2022 Feb;(): Lv H, Cell Rep 2020 Jun 2;31(9):107725 Mamedov T, bioRxiv 2022 Apr;(): Martinez DR, Science 2021 Aug 27;373(6558):991-998 Mazumder S, bioRxiv 2020 Oct;(): McMillan CL, bioRxiv 2021 May;(): Menachery VD, J Virol 2018 Sep 1;92(17): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Mudrick HE, bioRxiv 2021 Apr;(): Muruato A, bioRxiv 2021 May;(): Nagai M, bioRxiv 2020 Dec;(): Nanishi E, bioRxiv 2021 May;(): Narayan R, bioRxiv 2022 Feb;(): Nieto-Torres JL, PLoS Pathog 2014 May;10(5):e1004077 Niu J, Antiviral Res 2020 Jan;173():104646 Norheim G, bioRxiv 2020 Dec;(): O'Keefe BR, J Virol 2010 Mar;84(5):2511-21 Park JG, bioRxiv 2021 Jan;(): Paschall AV, bioRxiv 2021;(): Petras M, bioRxiv 2020 Nov;(): Phatarphekar A, bioRxiv 2022 Jan;(): Pitcovski J, bioRxiv 2021 Jun;(): Pollet J, bioRxiv 2020 Nov;(): Pollet J, bioRxiv 2021 Jul;(): Qu L, bioRxiv 2021 Mar;(): Rappaport AR, bioRxiv 2021 Nov;(): Rauch S, bioRxiv 2020 Oct;(): Reed CC, bioRxiv 2021 Aug;(): Roberts A, PLoS Pathog 2007 Jan;3(1):e5 Salah S, bioRxiv 2022 May;(): Schafer A, bioRxiv 2021 Sep;(): Scheiblhofer S, bioRxiv 2021 Feb;(): Seephetdee C, bioRxiv 2022 Mar;(): Sekimukai H, Microbiol Immunol 2020 Jan;64(1):33-51 Seo YB, bioRxiv 2020;(): Seo YB, bioRxiv 2021 Nov;(): Shen L, J Virol 2019 Jun 15;93(12): Shi Y, J Virol 2021 Jan 7;(): Shoemaker RH, bioRxiv 2021 Sep;(): Somogyi E, bioRxiv 2020;(): Staquicini DI, bioRxiv 2021 Mar;(): Stark FC, bioRxiv 2022 Mar;(): Su D, bioRxiv 2021 May;(): Su D, bioRxiv 2022 May;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Sun S, bioRxiv 2020 Nov;(): Sun W, bioRxiv 2021 Jul;(): Sun Y, bioRxiv 2021 Jun;(): Sun YJ, bioRxiv 2021 Jan;(): Swart M, bioRxiv 2022 Mar;(): Tostanoski LH, bioRxiv 2021 Jun;(): Tscherne A, bioRxiv 2021 Jan;(): Tseng CT, PLoS One 2012;7(4):e35421 Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Unoh Y, bioRxiv 2022;(): Valdes-Balbin Y, bioRxiv 2021 Feb;(): Vogel AB, bioRxiv 2020 Dec;(): Walls AC, bioRxiv 2021 Mar;(): Walls AC, bioRxiv 2022 Feb;(): Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Wang J, Protein Cell 2020 Aug 4;(): Wen HJ, bioRxiv 2021 Apr;(): Wentworth DE, Emerg Infect Dis 2004 Jul;10(7):1293-6 White KM, Science 2021 Feb 26;371(6532):926-931 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Wu K, bioRxiv 2021 Apr;(): Wu S, Nat Commun 2020 Aug 14;11(1):4081 Wu Y, bioRxiv 2022 Mar;(): Xu K, bioRxiv 2021 Feb;(): Yang R, EBioMedicine 2020 Jul 21;58():102890 Yang Y, bioRxiv 2021 Jun;(): Yuan Y, bioRxiv 2022 Feb;(): Yu J, bioRxiv 2021 Nov;(): Zabaleta N, bioRxiv 2021 Jan;(): Zang J, bioRxiv 2022 Feb;(): Zhang C, Nat Commun 2021 Jan 11;12(1):264 Zhang H, bioRxiv 2021-08;(): Zhang YN, bioRxiv 2021 Mar;(): Zhao H, Nat Commun 2020 Aug 25;11(1):4252 Zhao H, Sci Rep 2016 Feb 25;6():22008 Zhao S, bioRxiv 2021 May;(): Zhou R, bioRxiv 2021 Oct;(): Zhou Y, Antiviral Res 2015 Apr;116():76-84 Zhuang Z, J Exp Med 2021 Apr 5;218(4): Zhu L, bioRxiv 2020 Nov;():	J:308653 J:321881 J:288639 J:291893 J:321926 J:304606 J:308583 J:302915 J:316767 J:295383 J:315723 J:321901 J:310112 J:310116 J:308658 J:297122 J:296388 J:291880 J:291593 J:296213 J:321898 J:315718 J:302246 J:302247 J:310119 J:315730 J:302244 J:19444 J:308652 J:316771 J:290261 J:308670 J:315715 J:288585 J:291598 J:286954 J:300435 J:291595 J:291617 J:291630 J:296197 J:291885 J:291863 J:300090 J:321759 J:299089 J:286952 J:308893 J:304619 J:291884 J:308587 J:324918 J:291631 J:295389 J:291864 J:291591 J:309633 J:304646 J:296195 J:302315 J:291882 J:291592 J:296553 J:308668 J:308726 J:296200 J:296974 J:296698 J:292831 J:325024 J:161935 J:316772 J:291871 J:291633 J:302719 J:321880 J:288030 J:291637 J:308711 J:308659 J:308661 J:299105 J:313329 J:298266 J:308625 J:313449 J:310109 J:291621 J:313441 J:321875 J:291594 J:302147 J:321879 J:300093 J:299936 J:296372 J:309204 J:27269 J:295380 J:324952 J:321856 J:291886 J:325040 J:309691 J:296690 J:308889 J:291883 J:291897 J:303189 J:304681 J:308714 J:299071 J:308734 J:321883 J:291590 J:290254 J:298264 J:288029 J:299311 J:311912 J:296700 J:321755 J:308650 J:296705 J:308626 J:302934 J:315716 J:296387 J:308727 J:286408 J:324943 J:310117 J:302702 J:321929 J:291879 J:296069 J:313450 J:291875 J:300108 J:310120 J:296196 J:302940 J:321920 J:308731 J:324975 J:322631 J:298260 J:296709 J:308630 J:308645 J:299309 J:321921 J:308654 J:299308 J:291628 J:309630 J:321771 J:302155 J:298269 J:302930 J:321874 J:328107 J:291872 J:304675 J:286327 J:303457 J:25438 J:331760 J:304684 J:304623 J:300088 J:321907 J:302149 J:291894 J:308671 J:321891 J:313463 J:299310 J:321848 J:300884 J:308588 J:303460 J:300091 J:286403 J:308891 J:313436 J:288032 J:308898 J:298147	SARS-CoV-2_virus\|Vaccine Vaccine\|VOC_B.1.1.529_Omicron Infection SARS-CoV-MA_virus\|Treatment SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2-MA_virus\|Vaccine Infection\|SARS-CoV-2_virus Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus\|Sex_bias SARS-CoV-2_virus SARS-CoV-2-MA_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma SARS-CoV_virus\|Vaccine Vaccine SARS-CoV-2_virus\|Treatment Infection\|Mouse_Hepatitis_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Pathology\|SARS-CoV-MA_virus MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|Pathology MERS-CoV_virus\|Vaccine Pathology\|SARS-CoV-2_virus SARS-CoV-MA_virus\|Vaccine SARS-CoV-2-MA_virus SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Infection\|Pathology\|SARS-CoV-2-MA_virus Infection\|SARS-CoV-MA_virus\|Vaccine Infection\|Mouse_Hepatitis_virus\|SARS-CoV-MA_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta MERS-CoV-MA_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.617.2_Delta Infection\|VOC_B.1.1.529_Omicron SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2-MA_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Variant HCoV-OC43_virus\|Infection\|SARS-CoV-2_virus\|SARS-CoV_virus SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.351_Beta Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus\|SARS-CoV-MA_virus SARS-CoV-MA_virus HCoV-OC43_virus\|Infection HCoV-229E_virus\|SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta HCoV-OC43_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha Treatment\|VOC_P.1_Gamma Vaccine\|Variant SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Infection\|SARS-CoV_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Vaccine\|VOC_B.1.617.2_Delta MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|SARS-CoV_virus\|Treatment Infection\|MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	BALB/c strain family			Abdoli A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Abdoli A, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Agnihothram S, mBio 2014 Mar 25;5(2):e00047-14 Infection Agostini ML, mBio 2018 Mar 6;9(2): SARS-CoV-MA_virus\|Treatment Alimohammadi R, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine Amanat F, bioRxiv 2021 apr;(): SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Amanat F, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma An Y, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Ao Z, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Baray JC, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Barreiro A, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Baxter VK, bioRxiv 2022 Feb;(): SARS-CoV-2-MA_virus\|Vaccine Bellier B, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Borriello F, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Infection\|SARS-CoV-2_virus Capone S, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine Castano-Rodriguez C, mBio 2018 May 22;9(3): Infection\|SARS-CoV-MA_virus Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 SARS-CoV-MA_virus\|Sex_bias Chapman AP, bioRxiv 2020;(): SARS-CoV-2_virus Chen C, bioRxiv 2022 Feb;(): SARS-CoV-2-MA_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Chen J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Chen WH, Hum Vaccin Immunother 2014;10(3):648-58 SARS-CoV_virus\|Vaccine Chen WH, Vaccine 2020 Nov 3;38(47):7533-7541 SARS-CoV_virus\|Vaccine Chevillard C, bioRxiv 2021 Sep;(): Vaccine Choque-Guevara R, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Cohen AA, Science 2021 Feb 12;371(6530):735-741 SARS-CoV-2_virus\|Treatment Compton SR, Virology 1994 Aug 15;203(1):197-201 Infection\|Mouse_Hepatitis_virus Conforti A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Coria LM, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Dai L, Cell 2020 Jun 28;(): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Dangi T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Davenport BJ, bioRxiv 2021 Nov;(): MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Day CW, Virology 2009 Dec 20;395(2):210-22 Pathology\|SARS-CoV-MA_virus Deming D, PLoS Med 2006 Dec;3(12):e525 SARS-CoV_virus\|Vaccine de Wilde AH, Virus Res 2017 Jan 15;228():7-13 MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Dey A, bioRxiv 2021 Jan;(): Vaccine Dietert K, PLoS One 2017;12(11):e0188251 MERS-CoV_virus\|Pathology Du L, Nat Commun 2016 Nov 22;7():13473 MERS-CoV_virus\|Vaccine Du L, PLoS One 2013;8(12):e81587 MERS-CoV_virus\|Vaccine Elia U, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): SARS-CoV-2_virus\|Vaccine Fehr AR, mBio 2016 Dec 13;7(6): Infection\|SARS-CoV-MA_virus Feng L, Nat Commun 2020 Aug 21;11(1):4207 SARS-CoV-2_virus\|Vaccine Fernandez-Castaneda A, bioRxiv 2022;(): Pathology\|SARS-CoV-2_virus Ferrantelli F, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Fett C, J Virol 2013 Jun;87(12):6551-9 SARS-CoV-MA_virus\|Vaccine Fu D, PLoS Biol 2021 May;19(5):e3001209 SARS-CoV-2_virus\|Treatment Gao J, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Gao Q, Science 2020 Jul 3;369(6499):77-81 SARS-CoV-2_virus\|Vaccine Gawish R, bioRxiv 2021 Aug;(): SARS-CoV-2-MA_virus Gonzalez-Dominguez I, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Graham RL, Commun Biol 2018;1():179 SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Gu H, bioRxiv 2020;(): Infection\|Pathology\|SARS-CoV-2-MA_virus Gu H, Science 2020 Jul 30;(): Infection\|SARS-CoV-MA_virus\|Vaccine Guo X, Immunology 2015 Aug;145(4):476-84 MERS-CoV_virus\|Vaccine Guo Y, J Biol Chem 2021 Jan 29;():100346 SARS-CoV-2_virus\|Treatment Haabeth OAW, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine He Z, bioRxiv 2020;(): SARS-CoV-2_virus\|Treatment Huang Q, Nat Commun 2021 Feb 3;12(1):776 SARS-CoV-2_virus\|Vaccine Hua X, JCI Insight 2018 Jun 7;3(11): Infection\|Mouse_Hepatitis_virus\|SARS-CoV-MA_virus Hwang M, Immunology 2015 Mar;144(3):374-386 Mouse_Hepatitis_virus Jangra S, bioRxiv 2020 Oct 23;(): SARS-CoV-2_virus\|Vaccine Jiang S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Joyce MGl Chen WH, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Kalnin KV, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Kandeil A, PLoS One 2020;15(10):e0241471 SARS-CoV-2_virus Kang YF, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Kato H, PLoS One 2019;14(10):e0223684 MERS-CoV_virus\|Vaccine Khan MS, bioRxiv 2022 May;(): SARS-CoV-2_virus\|Vaccine Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology Kibler KV, bioRxiv 2021 Dec;(): SARS-CoV-2-MA_virus\|Vaccine Kim E, EBioMedicine 2020 May;55():102743 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Kim MH, PLoS One 2019;14(7):e0220196 MERS-CoV_virus\|Vaccine Kobiyama K, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Kozlovskaya L, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Kumaki Y, Antiviral Res 2011 Jan;89(1):75-82 MERS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Lan J, PLoS One 2014;9(11):e112602 MERS-CoV_virus\|Vaccine Lapp SA, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Liang Y, bioRxiv 2021;(): SARS-CoV-2_virus\|Vaccine Liao HY, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Li D, bioRxiv 2021 Jan;(): SARS-CoV-2_virus Li K, mBio 2021 Aug 31;12(4):e0097021 MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Li L, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Li L, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Lin WS, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Lin X, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Treatment Li SW, Sci Rep 2016 May 13;6():25754 SARS-CoV_virus Liu H, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.617.2_Delta Liu S, bioRxiv 2022 Feb;(): Infection\|VOC_B.1.1.529_Omicron Liu WJ, J Immunol 2017 Jan 15;198(2):873-882 MERS-CoV_virus\|Vaccine Liu X, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Liu Y, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Vaccine Liu YM, Cell Rep 2020 Aug 11;32(6):108016 SARS-CoV-2_virus Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Li Y, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Treatment Li Z, bioRxiv 2021 Aug;(): SARS-CoV-2-MA_virus\|Treatment Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Mouse_Hepatitis_virus Luo S, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Lu RM, bioRxiv 2022 Apr;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Lu S, bioRxiv 2022 Feb;(): Variant Lv H, Cell Rep 2020 Jun 2;31(9):107725 HCoV-OC43_virus\|Infection\|SARS-CoV-2_virus\|SARS-CoV_virus Mamedov T, bioRxiv 2022 Apr;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Martinez DR, Science 2021 Aug 27;373(6558):991-998 SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.351_Beta Mazumder S, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine McMillan CL, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Menachery VD, J Virol 2018 Sep 1;92(17): SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Infection\|SARS-CoV-2_virus Montagutelli X, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Mudrick HE, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Muruato A, bioRxiv 2021 May;(): SARS-CoV-2_virus\|SARS-CoV-MA_virus Nagai M, bioRxiv 2020 Dec;(): Infection\|SARS-CoV-2_virus Nanishi E, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Narayan R, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Treatment Nieto-Torres JL, PLoS Pathog 2014 May;10(5):e1004077 SARS-CoV-MA_virus Niu J, Antiviral Res 2020 Jan;173():104646 HCoV-OC43_virus\|Infection Norheim G, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine O'Keefe BR, J Virol 2010 Mar;84(5):2511-21 HCoV-229E_virus\|SARS-CoV_virus\|Treatment Park JG, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Paschall AV, bioRxiv 2021;(): SARS-CoV-2_virus\|Vaccine Petras M, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Phatarphekar A, bioRxiv 2022 Jan;(): SARS-CoV-2_virus\|Vaccine Pitcovski J, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Pollet J, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Pollet J, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Qu L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Rappaport AR, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Rauch S, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine Reed CC, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Roberts A, PLoS Pathog 2007 Jan;3(1):e5 Pathology\|SARS-CoV-MA_virus Salah S, bioRxiv 2022 May;(): SARS-CoV-2_virus\|Vaccine Schafer A, bioRxiv 2021 Sep;(): SARS-CoV-2-MA_virus\|Treatment Scheiblhofer S, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Seephetdee C, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Sekimukai H, Microbiol Immunol 2020 Jan;64(1):33-51 SARS-CoV-MA_virus\|Vaccine Seo YB, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Seo YB, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Shen L, J Virol 2019 Jun 15;93(12): HCoV-OC43_virus\|Treatment Shi Y, J Virol 2021 Jan 7;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Shoemaker RH, bioRxiv 2021 Sep;(): SARS-CoV-2-MA_virus\|Treatment Somogyi E, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Staquicini DI, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Stark FC, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Su D, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Su D, bioRxiv 2022 May;(): Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 SARS-CoV-2_virus Sun S, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Sun S, bioRxiv 2020 Nov;(): SARS-CoV-2-MA_virus Sun W, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Sun Y, bioRxiv 2021 Jun;(): Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha Sun YJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus Swart M, bioRxiv 2022 Mar;(): Vaccine\|VOC_B.1.1.529_Omicron Tostanoski LH, bioRxiv 2021 Jun;(): SARS-CoV-2-MA_virus\|Vaccine Tscherne A, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Tseng CT, PLoS One 2012;7(4):e35421 SARS-CoV_virus\|Vaccine Turan RD, Sci Rep 2021 Aug 4;11(1):15799 SARS-CoV-2_virus\|Vaccine Unoh Y, bioRxiv 2022;(): Treatment\|VOC_P.1_Gamma Valdes-Balbin Y, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Vogel AB, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Walls AC, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Walls AC, bioRxiv 2022 Feb;(): Vaccine\|Variant Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Wang J, Protein Cell 2020 Aug 4;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Wen HJ, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus\|Treatment Wentworth DE, Emerg Infect Dis 2004 Jul;10(7):1293-6 Infection\|SARS-CoV_virus White KM, Science 2021 Feb 26;371(6532):926-931 SARS-CoV-2_virus\|Treatment Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Infection\|Mouse_Hepatitis_virus Wong LR, Nature 2022 May;605(7908):146-151 SARS-CoV-2-MA_virus\|Treatment WOng LY, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus\|Treatment Wu K, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Wu S, Nat Commun 2020 Aug 14;11(1):4081 SARS-CoV-2_virus\|Vaccine Wu Y, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Xu K, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Yang R, EBioMedicine 2020 Jul 21;58():102890 SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Yang Y, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Yuan Y, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.617.2_Delta Yu J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Zabaleta N, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Zang J, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Zhang C, Nat Commun 2021 Jan 11;12(1):264 SARS-CoV-2_virus\|Treatment Zhang H, bioRxiv 2021-08;(): SARS-CoV-2_virus\|Treatment Zhang YN, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Zhao H, Nat Commun 2020 Aug 25;11(1):4252 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment Zhao H, Sci Rep 2016 Feb 25;6():22008 MERS-CoV_virus\|SARS-CoV_virus\|Treatment Zhao S, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Zhou R, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Vaccine Zhou Y, Antiviral Res 2015 Apr;116():76-84 Infection\|MERS-CoV_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Zhuang Z, J Exp Med 2021 Apr 5;218(4): Infection\|SARS-CoV-2_virus Zhu L, bioRxiv 2020 Nov;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment
BALB/cAnNCr	MGI:2160915	inbred strain										DeDiego ML, J Virol 2014 Jan;88(2):913-24 Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:286180 J:153918	Pathology\|SARS-CoV-MA_virus\|Treatment Mouse_Hepatitis_virus\|Pathology	BALB/cAnNCr inbred strain			DeDiego ML, J Virol 2014 Jan;88(2):913-24 Pathology\|SARS-CoV-MA_virus\|Treatment Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
BALB/cAnNCrl	MGI:2683685	inbred strain										Barnard DL, Antivir Chem Chemother 2006;17(5):275-84 Brouwer PJM, Cell 2021 Mar 4;184(5):1188-1200.e19 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Frieman M, J Virol 2012 Jan;86(2):884-97 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Polak K, bioRxiv 2020 Oct;(): Ying B, bioRxiv 2022 Feb;():	J:288314 J:303464 J:288107 J:288640 J:286329 J:296676 J:321873	SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Vaccine Infection\|MERS-CoV-MA_virus\|Treatment Infection\|SARS-CoV-MA_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Vaccine\|VOC_B.1.1.529_Omicron	BALB/cAnNCrl inbred strain			Barnard DL, Antivir Chem Chemother 2006;17(5):275-84 SARS-CoV_virus\|Treatment Brouwer PJM, Cell 2021 Mar 4;184(5):1188-1200.e19 SARS-CoV-2_virus\|Vaccine Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection\|MERS-CoV-MA_virus\|Treatment Frieman M, J Virol 2012 Jan;86(2):884-97 Infection\|SARS-CoV-MA_virus Jia W, Emerg Microbes Infect 2019;8(1):760-772 MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Polak K, bioRxiv 2020 Oct;(): SARS-CoV-2_virus\|Vaccine Ying B, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron
BALB/cAnNHsd	MGI:2161082	inbred strain										Adams LE, Cell Rep 2023 Mar 30;42(4):112326 Bolles M, J Virol 2011 Dec;85(23):12201-15 Leist SR, Cell 2020 Sep 23;(): Menachery VD, Nat Med 2015 Dec;21(12):1508-13 Roberts A, Virus Res 2008 Apr;133(1):20-32 Rockx B, J Virol 2009 Jul;83(14):7062-74 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8	J:349062 J:288593 J:296277 J:286371 J:286331 J:286406 J:286332 J:36900 J:64200	SARS-CoV-2-MA_virus\|Vaccine SARS-CoV_virus\|Vaccine Infection\|Pathology\|SARS-CoV-2-MA_virus Infection Infection\|SARS-CoV_virus\|Vaccine Pathology\|SARS-CoV_virus SARS-CoV_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	BALB/cAnNHsd inbred strain			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine Bolles M, J Virol 2011 Dec;85(23):12201-15 SARS-CoV_virus\|Vaccine Leist SR, Cell 2020 Sep 23;(): Infection\|Pathology\|SARS-CoV-2-MA_virus Menachery VD, Nat Med 2015 Dec;21(12):1508-13 Infection Roberts A, Virus Res 2008 Apr;133(1):20-32 Infection\|SARS-CoV_virus\|Vaccine Rockx B, J Virol 2009 Jul;83(14):7062-74 Pathology\|SARS-CoV_virus Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 SARS-CoV_virus Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Mouse_Hepatitis_virus Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 Mouse_Hepatitis_virus\|Pathology
BALB/cAnNTac	MGI:6200629	inbred strain										Adams LE, Cell Rep 2023 Mar 30;42(4):112326 Greenough TC, J Infect Dis 2005 Feb 15;191(4):507-14 Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Roberts A, J Virol 2005 May;79(9):5833-8 Subbarao K, J Virol 2004 Apr;78(7):3572-7	J:349062 J:288263 J:299104 J:303465 J:286301 J:286300	SARS-CoV-2-MA_virus\|Vaccine SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Vaccine Pathology\|SARS-CoV_virus SARS-CoV_virus	BALB/cAnNTac inbred strain			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine Greenough TC, J Infect Dis 2005 Feb 15;191(4):507-14 SARS-CoV_virus\|Treatment Liu R, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 SARS-CoV-2_virus\|Vaccine Roberts A, J Virol 2005 May;79(9):5833-8 Pathology\|SARS-CoV_virus Subbarao K, J Virol 2004 Apr;78(7):3572-7 SARS-CoV_virus
BALB/cBy	MGI:2159790	inbred strain										Bolles M, J Virol 2011 Dec;85(23):12201-15	J:288593	SARS-CoV_virus\|Vaccine	BALB/cBy inbred strain			Bolles M, J Virol 2011 Dec;85(23):12201-15 SARS-CoV_virus\|Vaccine
BALB/cByJ	MGI:2159771	inbred strain										Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Walls AC, Cell Rep 2022 Aug 30;40(9):111299	J:14457 J:328107	Infection\|Mouse_Hepatitis_virus SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta	BALB/cByJ inbred strain			Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Infection\|Mouse_Hepatitis_virus Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta
BALB/cCrl	MGI:2386653	inbred strain										Kumaki Y, Antiviral Res 2017 Mar;139():1-12	J:286953	SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	BALB/cCrl inbred strain			Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment
BALB/cCrSlc	MGI:2161019	inbred strain										Iwata-Yoshikawa N, J Virol 2014 Aug;88(15):8597-614 Nagai M, mBio 2021 Aug 31;12(4):e0159821	J:288033 J:313440	SARS-CoV-MA_virus\|Vaccine SARS-CoV-2_virus\|Vaccine	BALB/cCrSlc inbred strain			Iwata-Yoshikawa N, J Virol 2014 Aug;88(15):8597-614 SARS-CoV-MA_virus\|Vaccine Nagai M, mBio 2021 Aug 31;12(4):e0159821 SARS-CoV-2_virus\|Vaccine
BALB/cJ	MGI:2159737	inbred strain										Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Arevalo AP, bioRxiv 2020 Nov;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Dalvie NC, bioRxiv 2021 Mar;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gawish R, Elife 2022 Jan 13;11():e74623 Graham JB, iScience 2024 Mar 15;27(3):109103 Hassan AO, Cell 2020 Jun 10;(): Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hu Q, bioRxiv 2022 Mar;(): Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823 Rujas E, bioRxiv 2020;(): Slamanig S, EBioMedicine 2024 Jun 6;105():105185 Sourimant J, bioRxiv 2021 May;(): Tummino TA, bioRxiv 2021 Mar;(): Walls AC, Cell 2020 Nov 25;183(5):1367-1382.e17 Wang L, Nat Commun 2015 Jul 28;6():7712 Zost SJ, Nature 2020 Jul 15;():	J:308640 J:290255 J:296697 J:297398 J:302712 J:288204 J:318828 J:345413 J:290258 J:309629 J:321924 J:357765 J:296183 J:350298 J:308735 J:303456 J:298609 J:291618 J:291899	SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus\|Treatment MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology Pathology\|SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus Infection\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Gene\|Variant\|VOC_B.1.1.529_Omicron MERS-CoV_virus\|Vaccine SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment	BALB/cJ inbred strain			Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Alsoussi WB, J Immunol 2020 Jun 26;(): SARS-CoV-2_virus\|Treatment Arevalo AP, bioRxiv 2020 Nov;(): Mouse_Hepatitis_virus\|Treatment Corbett KS, Nature 2020 Oct;586(7830):567-571 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Dalvie NC, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 SARS-CoV-2_virus\|Vaccine Hu Q, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823 Gene\|Variant\|VOC_B.1.1.529_Omicron Rujas E, bioRxiv 2020;(): SARS-CoV-2_virus\|Treatment Slamanig S, EBioMedicine 2024 Jun 6;105():105185 SARS-CoV-2_virus\|Vaccine Sourimant J, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment Tummino TA, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Walls AC, Cell 2020 Nov 25;183(5):1367-1382.e17 SARS-CoV-2_virus\|Vaccine Wang L, Nat Commun 2015 Jul 28;6():7712 MERS-CoV_virus\|Vaccine Zost SJ, Nature 2020 Jul 15;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment
BALB/cJRj	MGI:6357755	inbred strain										Lapuente D, bioRxiv 2021 Aug;():	J:308581	SARS-CoV-2_virus\|Vaccine	BALB/cJRj inbred strain			Lapuente D, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine
(BALB/cJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865665	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(BALB/cJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
BALB/c-Kctd9^em1Beij	MGI:6382781	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6382782	Kctd9^em1Beij	MGI:6382731	Endonuclease-mediated	Null/knockout			hematopoietic system homeostasis/metabolism immune system mortality/aging	MP:0005397 MP:0005376 MP:0005387 MP:0010768	Zhang X, Front Immunol 2019;10():744	J:281803	Mouse_Hepatitis_virus	BALB/c-Kctd9^em1Beij coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6382782	hematopoietic system homeostasis/metabolism immune system mortality/aging	Zhang X, Front Immunol 2019;10():744 Mouse_Hepatitis_virus
BALB/cN	MGI:2161229	inbred strain										Kovacech B, bioRxiv 2021 Jun;():	J:308649	SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	BALB/cN inbred strain			Kovacech B, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
BALB/cOlaHsd	MGI:3047778	inbred strain										DeDiego ML, J Virol 2014 Jan;88(2):913-24 Hachim MY, Front Immunol 2020;11():1372 Jimenez-Guardeno JM, PLoS Pathog 2015 Oct;11(10):e1005215 Rothen DA, bioRxiv 2021 Sep;(): Spencer AJ, bioRxiv 2021 Jan;(): Spencer AJ, bioRxiv 2021 Jun;(): van der Ley PA, bioRxiv 2021 Aug;(): van Doremalen N, Nature 2020 Oct;586(7830):578-582	J:286180 J:291898 J:291656 J:310118 J:302146 J:308644 J:309194 J:297406	Pathology\|SARS-CoV-MA_virus\|Treatment Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-MA_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta	BALB/cOlaHsd inbred strain			DeDiego ML, J Virol 2014 Jan;88(2):913-24 Pathology\|SARS-CoV-MA_virus\|Treatment Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Jimenez-Guardeno JM, PLoS Pathog 2015 Oct;11(10):e1005215 SARS-CoV-MA_virus Rothen DA, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Spencer AJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Spencer AJ, bioRxiv 2021 Jun;(): Vaccine\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta van der Ley PA, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine van Doremalen N, Nature 2020 Oct;586(7830):578-582 SARS-CoV-2_virus\|Vaccine
BALB/c-Tg(Rela-luc)31Xen/Tac	MGI:6438428	coisogenic\|mutant strain\|transgenic										Samsudin F, bioRxiv 2021 Nov;():	J:313448	Pathology\|SARS-CoV-2_virus	BALB/c-Tg(Rela-luc)31Xen/Tac coisogenic\|mutant strain\|transgenic			Samsudin F, bioRxiv 2021 Nov;(): Pathology\|SARS-CoV-2_virus
BXSB.129S2(B6)-Ifnar1^tm1Agt/DcrJ	MGI:6159256	congenic\|mutant strain\|recombinant inbred (RI)\|targeted mutation										Miner JJ, Cell Rep 2020 Nov 3;33(5):108339	J:300094	SARS-CoV-2_virus	BXSB.129S2(B6)-Ifnar1^tm1Agt/DcrJ congenic\|mutant strain\|recombinant inbred (RI)\|targeted mutation			Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus
C.129P2(B6)-Fcer1g^tm1Rav/Tac	MGI:6438695	congenic\|mutant strain\|targeted mutation										Adams LE, Cell Rep 2023 Mar 30;42(4):112326	J:349062	SARS-CoV-2-MA_virus\|Vaccine	C.129P2(B6)-Fcer1g^tm1Rav/Tac congenic\|mutant strain\|targeted mutation			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine
C.129P2-Myd88^tm1Aki/Obs	MGI:5577109	congenic\|mutant strain\|targeted mutation										Nagai M, mBio 2021 Aug 31;12(4):e0159821	J:313440	SARS-CoV-2_virus\|Vaccine	C.129P2-Myd88^tm1Aki/Obs congenic\|mutant strain\|targeted mutation			Nagai M, mBio 2021 Aug 31;12(4):e0159821 SARS-CoV-2_virus\|Vaccine
C.129S2-Cd1^tm1Gru/J	MGI:2174232	congenic\|mutant strain\|targeted mutation										Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:92752	Infection\|SARS-CoV_virus	C.129S2-Cd1^tm1Gru/J congenic\|mutant strain\|targeted mutation			Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
C.129S7(B6)-Rag1^tm1Mom/J	MGI:2161492	congenic\|mutant strain\|targeted mutation										Mao T, bioRxiv 2021 Jun;():	J:308656	Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma	C.129S7(B6)-Rag1^tm1Mom/J congenic\|mutant strain\|targeted mutation			Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma
C.129X1-Ifng^tm1Yiw	MGI:6430486	congenic\|mutant strain\|targeted mutation	MGI:6430488	Ifng^tm1Yiw	MGI:3036127	Targeted	Null/knockout			homeostasis/metabolism immune system liver/biliary system mortality/aging	MP:0005376 MP:0005387 MP:0005370 MP:0010768	Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77	J:91691	Infection\|Mouse_Hepatitis_virus\|Pathology	C.129X1-Ifng^tm1Yiw congenic\|mutant strain\|targeted mutation	MGI:6430488	homeostasis/metabolism immune system liver/biliary system mortality/aging	Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 Infection\|Mouse_Hepatitis_virus\|Pathology
C3H/HeJ	MGI:2159741	inbred strain										Dhanyalayam D, bioRxiv 2021 Sep;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41	J:310121 J:161935	Comorbidity\|SARS-CoV-2_virus Mouse_Hepatitis_virus\|Pathology	C3H/HeJ inbred strain			Dhanyalayam D, bioRxiv 2021 Sep;(): Comorbidity\|SARS-CoV-2_virus Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology
C3H/HeJCr	MGI:2165380	inbred strain										Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:291635 J:153918	Mouse_Hepatitis_virus\|Pathology	C3H/HeJCr inbred strain			Hartwig SM, PLoS One 2014;9(3):e90720 Mouse_Hepatitis_virus\|Pathology Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C3H/HeNCr	MGI:2160592	inbred strain										Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:291635 J:153918	Mouse_Hepatitis_virus\|Pathology	C3H/HeNCr inbred strain			Hartwig SM, PLoS One 2014;9(3):e90720 Mouse_Hepatitis_virus\|Pathology Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C3H/St	MGI:2159861	inbred strain										De Albuquerque N, J Virol 2006 Nov;80(21):10382-94	J:288204	Mouse_Hepatitis_virus\|Pathology	C3H/St inbred strain			De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology
C57BL/10ScNJ	MGI:2165217	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Kumaki Y, Antiviral Res 2017 Mar;139():1-12	J:153918 J:286953	Mouse_Hepatitis_virus\|Pathology SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	C57BL/10ScNJ inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment
C57BL/10SnJ	MGI:2159909	inbred strain										Greer CD, bioRxiv 2021 Aug;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:308745 J:153918	SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology	C57BL/10SnJ inbred strain			Greer CD, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C57BL/6	MGI:2159769	strain family										Ahan RE, bioRxiv 2021 Jul;(): Alimohammadi R, bioRxiv 2022 Mar;(): Almanza G, bioRxiv 2021;(): An Y, bioRxiv 2021 Mar;(): Bleau C, J Virol 2015 Oct;89(19):9896-908 Brechbuhl J, bioRxiv 2021 Mar;(): Brentville VA, bioRxiv 2021 Jun;(): Cao L, bioRxiv 2021;(): Castro JT, bioRxiv 2021 Sep;(): Chandrasekar SS, Vaccines (Basel) 2021 Feb 6;9(2): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chen J, bioRxiv 2021 Nov;(): Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Counoupas C, bioRxiv 2020 Dec;(): Counoupas C, bioRxiv 2021;(): Dangi T, bioRxiv 2021 Jun;(): Dietert K, PLoS One 2017;12(11):e0188251 Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Ferrantelli F, bioRxiv 2020 Dec;(): Francis DM, bioRxiv 2021 Aug;(): Gale EC, bioRxiv 2021 Apr;(): Gale EC, bioRxiv 2021 Jul;(): Gawish R, bioRxiv 2021 Aug;(): Gerbre MS, bioRxiv 2021 Nov;(): Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Gray LT, bioRxiv 2021 May;(): Gu M, bioRxiv 2021 Apr;(): Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Hachim MY, Front Immunol 2020;11():1372 Hassler L, bioRxiv 2021 Mar;(): Hauser BM, bioRxiv 2021 Mar;(): Hawman DW, bioRxiv 2021 Dec;(): Heer CD, J Biol Chem 2020 Dec 25;295(52):17986-17996 He L, bioRxiv 2020;(): Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Huang Q, Nat Commun 2021 Feb 3;12(1):776 Jackson MR, bioRxiv 2021 Mar;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Keyaerts E, Antimicrob Agents Chemother 2009 Aug;53(8):3416-21 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kim E, EBioMedicine 2020 May;55():102743 Kobiyama K, bioRxiv 2021 Mar;(): Koester ST, PLoS One 2021;16(3):e0248730 Lam JH, bioRxiv 2021 Jan;(): Lapuente D, bioRxiv 2021 Aug;(): Lartey NL, bioRxiv 2021 Apr;(): Lei L, PLoS One 2013;8(4):e61166 Liang Y, Zool Res 2020 Oct 12;():1-29 Li JQ, bioRxiv 2020 Oct;(): Li L, bioRxiv 2021 Jul;(): Liu A, J Pathol 2021 Jan;253(1):17-30 Liu J, bioRxiv 2021 May;(): Long Y, bioRxiv 2021 Apr;(): Luo S, bioRxiv 2020;(): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Nicolai L, bioRxiv 2021 Jun;(): Niu J, Antiviral Res 2020 Jan;173():104646 Paidi RK, J Immunol 2021 Nov 15;207(10):2521-2533 Pan P, Nat Commun 2021 Aug 2;12(1):4664 Perez-Shibayama C, PLoS One 2013;8(11):e81442 Raha AA, Biosci Rep 2020 Dec 23;40(12): Ryu JK, bioRxiv 2021;(): Ryu S, bioRxiv 2020;(): Sanchez S, bioRxiv 2021 Apr;(): Seephetdee C, bioRxiv 2021 Mar;(): Soni S, PLoS One 2021;16(2):e0247510 Subramani J, bioRxiv 2021 Aug;(): Sun Y, bioRxiv 2021 Jun;(): Tong J, bioRxiv 2021 Feb;(): Tseng CT, PLoS One 2012;7(4):e35421 Volpatti LR, bioRxiv 2021 Apr;(): Vo T, bioRxiv 2020 Nov;(): Wang W, bioRxiv 2020 Dec;(): Wang Y, FASEB J 2021 Mar;35(3):e21419 Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Yang C, bioRxiv 2020;(): Yi C, Cell Mol Immunol 2020 Jun;17(6):621-630 Zabaleta N, bioRxiv 2021 Jan;(): Zhuang Z, J Exp Med 2021 Apr 5;218(4):	J:308572 J:321926 J:311920 J:302915 J:291878 J:303458 J:308658 J:311925 J:310123 J:302249 J:291593 J:315718 J:308652 J:316771 J:298265 J:308747 J:308670 J:291595 J:291885 J:299089 J:314179 J:303466 J:308622 J:308587 J:313462 J:88677 J:308736 J:303468 J:308901 J:291898 J:302921 J:302933 J:316766 J:300100 J:295372 J:297407 J:302315 J:302714 J:308668 J:308726 J:288028 J:161935 J:291871 J:302719 J:303461 J:300448 J:308581 J:304620 J:291629 J:296738 J:296674 J:308625 J:301197 J:308729 J:304618 J:295380 J:291897 J:303189 J:308623 J:290254 J:331805 J:313326 J:291632 J:313516 J:311923 J:295364 J:303470 J:302706 J:303459 J:308746 J:308645 J:302154 J:291628 J:304615 J:296710 J:299103 J:309535 J:291614 J:331760 J:304684 J:296070 J:291876 J:299310 J:308898	SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Infection\|Mouse_Hepatitis_virus Gene SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta SARS-CoV-MA_virus\|Sex_bias SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine MERS-CoV_virus\|Pathology SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta SARS-CoV-2-MA_virus Mouse_Hepatitis_virus Pathology\|SARS-CoV-2_virus Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus Pathology Treatment Mouse_Hepatitis_virus\|Pathology MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Infection\|Pathology\|SARS-CoV-2_virus Comorbidity\|Gene Vaccine Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma HCoV-OC43_virus\|Infection SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha SARS-CoV_virus\|Vaccine Infection SARS-CoV-2-MA_virus\|Treatment	C57BL/6 strain family			Ahan RE, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment Alimohammadi R, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine Almanza G, bioRxiv 2021;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta An Y, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Bleau C, J Virol 2015 Oct;89(19):9896-908 Infection\|Mouse_Hepatitis_virus Brechbuhl J, bioRxiv 2021 Mar;(): Gene Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Cao L, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Castro JT, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Chandrasekar SS, Vaccines (Basel) 2021 Feb 6;9(2): SARS-CoV-2_virus\|Vaccine Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 SARS-CoV-MA_virus\|Sex_bias Chen J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Conforti A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Coria LM, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Counoupas C, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Counoupas C, bioRxiv 2021;(): SARS-CoV-2_virus\|Vaccine Dangi T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Dietert K, PLoS One 2017;12(11):e0188251 MERS-CoV_virus\|Pathology Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): SARS-CoV-2_virus\|Vaccine Ferrantelli F, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Francis DM, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Gale EC, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Gale EC, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Gawish R, bioRxiv 2021 Aug;(): SARS-CoV-2-MA_virus Gerbre MS, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Mouse_Hepatitis_virus Gray LT, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Gu M, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Pathology\|SARS-CoV-2_virus Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Hassler L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Hauser BM, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Hawman DW, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Heer CD, J Biol Chem 2020 Dec 25;295(52):17986-17996 Infection\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus He L, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Gene Huang Q, Nat Commun 2021 Feb 3;12(1):776 SARS-CoV-2_virus\|Vaccine Jackson MR, bioRxiv 2021 Mar;(): Pathology Jiang S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Joyce MGl Chen WH, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Keyaerts E, Antimicrob Agents Chemother 2009 Aug;53(8):3416-21 Treatment Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology Kim E, EBioMedicine 2020 May;55():102743 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Kobiyama K, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Koester ST, PLoS One 2021;16(3):e0248730 Gene Lam JH, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Lapuente D, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Lartey NL, bioRxiv 2021 Apr;(): Treatment Lei L, PLoS One 2013;8(4):e61166 Mouse_Hepatitis_virus Liang Y, Zool Res 2020 Oct 12;():1-29 Infection\|Pathology\|SARS-CoV-2_virus Li JQ, bioRxiv 2020 Oct;(): Treatment Li L, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Liu A, J Pathol 2021 Jan;253(1):17-30 Comorbidity\|Gene Liu J, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Long Y, bioRxiv 2021 Apr;(): Vaccine Luo S, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Infection\|SARS-CoV-2_virus Montagutelli X, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Nicolai L, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Niu J, Antiviral Res 2020 Jan;173():104646 HCoV-OC43_virus\|Infection Paidi RK, J Immunol 2021 Nov 15;207(10):2521-2533 SARS-CoV-2_virus\|Treatment Pan P, Nat Commun 2021 Aug 2;12(1):4664 Pathology\|SARS-CoV-2_virus Perez-Shibayama C, PLoS One 2013;8(11):e81442 Mouse_Hepatitis_virus Raha AA, Biosci Rep 2020 Dec 23;40(12): Gene Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment Ryu S, bioRxiv 2020;(): Mouse_Hepatitis_virus\|Pathology Sanchez S, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Seephetdee C, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Soni S, PLoS One 2021;16(2):e0247510 Gene Subramani J, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Sun Y, bioRxiv 2021 Jun;(): Comorbidity\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha Tong J, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Tseng CT, PLoS One 2012;7(4):e35421 SARS-CoV_virus\|Vaccine Volpatti LR, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Vo T, bioRxiv 2020 Nov;(): Infection Wang W, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Vaccine Wang Y, FASEB J 2021 Mar;35(3):e21419 Gene Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Mouse_Hepatitis_virus Wong LR, Nature 2022 May;605(7908):146-151 SARS-CoV-2-MA_virus\|Treatment WOng LY, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus\|Treatment Yang C, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus Yi C, Cell Mol Immunol 2020 Jun;17(6):621-630 SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine Zabaleta N, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Zhuang Z, J Exp Med 2021 Apr 5;218(4): Infection\|SARS-CoV-2_virus
C57BL/6-Ace2^{em1(ACE2)Yowa}	MGI:6431338	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6431340	Ace2^{em1(ACE2)Yowa}	MGI:6431336	Endonuclease-mediated	Humanized sequence\|Null/knockout\|Reporter	COVID-19	DOID:0080600	cardiovascular system homeostasis/metabolism immune system respiratory system	MP:0005385 MP:0005376 MP:0005387 MP:0005388	Sun SH, Cell Host Microbe 2020;20():1-10	J:288243	Infection\|Pathology\|SARS-CoV-2_virus	C57BL/6-Ace2^{em1(ACE2)Yowa} coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6431340	cardiovascular system homeostasis/metabolism immune system respiratory system COVID-19	Sun SH, Cell Host Microbe 2020;20():1-10 Infection\|Pathology\|SARS-CoV-2_virus
C57BL/6(FVB)-Ceacam1^tm1.1Fta	MGI:5496838	mutant strain\|targeted mutation	MGI:5496535	Ceacam1^tm1.1Fta	MGI:5496530	Targeted	Inserted expressed sequence			immune system mortality/aging	MP:0005387 MP:0010768	Hirai A, J Virol 2010 Jul;84(13):6654-66	J:198335	Infection\|Mouse_Hepatitis_virus	C57BL/6(FVB)-Ceacam1^tm1.1Fta mutant strain\|targeted mutation	MGI:5496535	immune system mortality/aging	Hirai A, J Virol 2010 Jul;84(13):6654-66 Infection\|Mouse_Hepatitis_virus
C57BL/6-Gt(ROSA)26Sor^{em1(DPP4)Yowa}	MGI:6403445	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6403447	Gt(ROSA)26Sor^{em1(DPP4)Yowa}	MGI:6403442	Endonuclease-mediated	Humanized sequence\|Inserted expressed sequence\|Reporter	Middle East respiratory syndrome	DOID:0080642	immune system nervous system	MP:0005387 MP:0003631	Fan C, Viruses 2018 Aug 23;10(9):	J:279060	Infection\|MERS-CoV_virus\|Pathology\|Treatment	C57BL/6-Gt(ROSA)26Sor^{em1(DPP4)Yowa} coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6403447	immune system nervous system Middle East respiratory syndrome	Fan C, Viruses 2018 Aug 23;10(9): Infection\|MERS-CoV_virus\|Pathology\|Treatment
C57BL/6-Irf5^tm1Ppr/J	MGI:5291921	coisogenic\|mutant strain\|targeted mutation										Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	C57BL/6-Irf5^tm1Ppr/J coisogenic\|mutant strain\|targeted mutation			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
C57BL/6J	MGI:3028467	inbred strain	MGI:2166311							cardiovascular system endocrine/exocrine glands homeostasis/metabolism immune system muscle nervous system	MP:0005385 MP:0005379 MP:0005376 MP:0005387 MP:0005369 MP:0003631	Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Anand G, bioRxiv 2020 Dec;(): Benard A, Nat Commun 2021 Feb 18;12(1):1112 Biering SB, bioRxiv 2021 Dec;(): Bilinska K, bioRxiv 2021 Apr;(): Borriello F, bioRxiv 2021 Sep;(): Brady M, bioRxiv 2021 Aug;(): Brooks SD, bioRxiv 2021;(): Cao X, bioRxiv 2020 Dec;(): Chaparian RR, bioRxiv 2021 Apr;(): Chen JS, J Virol 2021 Jan 13;(): Chen Y, bioRxiv 2021 Nov;(): Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Das Sarma J, J Virol 2000 Oct;74(19):9206-13 De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Deng Q, bioRxiv 2020;(): Deng X, J Virol 2014 Oct 15;88(20):11886-98 dos Santos Pereira Andrade AC, bioRxiv 2021 May;(): Eldi P, bioRxiv 2021 Sep;(): Gawish R, Elife 2022 Jan 13;11():e74623 Geng T, bioRxiv 2021 Jun;(): Graham JB, iScience 2024 Mar 15;27(3):109103 Gralinski LE, mBio 2013 Aug 6;4(4): Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Hachim MY, Front Immunol 2020;11():1372 Han K, Am J Respir Cell Mol Biol 2021 Jan;64(1):79-88 Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Jia L, bioRxiv 2022 Feb;(): Joag V, J Immunol 2021 Mar 1;206(5):931-935 Josset L, RNA Biol 2014;11(7):875-90 Khaddaj-Mallat R, bioRxiv 2021 May;(): Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 Kim TY, bioRxiv 2020 Dec;(): King RG, bioRxiv 2020;(): Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Leist SR, Cell 2020 Sep 23;(): Li S, JCI Insight 2021 Jan 25;6(2): Madar-Balakirski N, bioRxiv 2021 Jul;(): Mandal P, PLoS One 2021;16(7):e0246270 Ngo VL, Cell Host Microbe 2024 Jan 23;(): Pewe L, J Virol 1997 Oct;71(10):7640-7 Radvak P, bioRxiv 2021 Jun;(): Roberts A, Virus Res 2008 Apr;133(1):20-32 Salvi V, bioRxiv 2021 Apr;(): Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 Salzer R, bioRxiv 2021 May;(): Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Satta S, Theranostics 2022;12(6):2639-2657 Schafer A, mBio 2022 Aug 30;13(4):e0145422 Sepe S, bioRxiv 2021 Jun;(): Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Shirato K, bioRxiv 2021 Jul;(): Sims JJ, bioRxiv 2021 Apr;(): Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Szurgot I, Sci Rep 2021 Feb 4;11(1):3125 Tsai SJ, bioRxiv 2020 Nov;(): Ullah I, iScience 2024 Mar 15;27(3):109049 Vanderheiden A, bioRxiv 2021 May;(): Vanderheiden A, mBio 2021 Nov 9;():e0274921 Wang H, bioRxiv 2021 Jul;(): Wang J, Protein Cell 2020 Aug 4;(): White KM, Science 2021 Feb 26;371(6532):926-931 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Xu H, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Zhuang X, iScience 2021 Oct 22;24(10):103144	J:308640 J:290255 J:298270 J:303473 J:316773 J:304622 J:310116 J:308577 J:311924 J:298259 J:308713 J:300110 J:315729 J:321761 J:325089 J:309512 J:297398 J:64499 J:288204 J:296182 J:214600 J:308662 J:310113 J:318828 J:308624 J:345413 J:288556 J:268979 J:291898 J:331824 J:33974 J:321887 J:303898 J:276026 J:308715 J:313327 J:299070 J:296068 J:286953 J:296277 J:302826 J:308635 J:308899 J:345954 J:42952 J:308643 J:286331 J:304651 J:313336 J:308749 J:309632 J:331825 J:327836 J:309195 J:286320 J:308576 J:304613 J:286332 J:322631 J:302250 J:296707 J:348954 J:308718 J:317454 J:308641 J:291872 J:303457 J:276183 J:295377 J:305777 J:341699	SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus Gene SARS-CoV-2_virus\|Vaccine Infection\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus\|Pathology SARS-CoV-2_virus\|Sex_bias Mouse_Hepatitis_virus Pathology\|SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus Infection\|Pathology\|SARS-CoV-MA_virus Infection\|SARS-CoV-MA_virus Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Infection\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron SARS-CoV-MA_virus SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Infection\|Pathology\|SARS-CoV-2-MA_virus Infection\|MERS-CoV-MA_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|SARS-CoV_virus\|Vaccine Comorbidity SARS-CoV-2_virus\|Variant SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus Comorbidity\|Gene MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment SARS-CoV_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Infection\|SARS-CoV-2-MA_virus\|VOC_B.1.351_Beta SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Treatment	C57BL/6J inbred strain	MGI:2166311	cardiovascular system endocrine/exocrine glands homeostasis/metabolism immune system muscle nervous system	Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Alsoussi WB, J Immunol 2020 Jun 26;(): SARS-CoV-2_virus\|Treatment Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus Benard A, Nat Commun 2021 Feb 18;12(1):1112 SARS-CoV-2_virus Biering SB, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Bilinska K, bioRxiv 2021 Apr;(): Gene Borriello F, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Brady M, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus Brooks SD, bioRxiv 2021;(): Gene Cao X, bioRxiv 2020 Dec;(): Infection\|SARS-CoV-2_virus Chaparian RR, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Chen JS, J Virol 2021 Jan 13;(): SARS-CoV-2_virus\|Treatment Chen Y, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Treatment Chong Z, bioRxiv 2022;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Pathology\|SARS-CoV-2_virus Corbett KS, Nature 2020 Oct;586(7830):567-571 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine Das Sarma J, J Virol 2000 Oct;74(19):9206-13 Mouse_Hepatitis_virus\|Pathology De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Mouse_Hepatitis_virus\|Pathology Deng Q, bioRxiv 2020;(): SARS-CoV-2_virus\|Sex_bias Deng X, J Virol 2014 Oct 15;88(20):11886-98 Mouse_Hepatitis_virus\|Pathology dos Santos Pereira Andrade AC, bioRxiv 2021 May;(): Mouse_Hepatitis_virus Eldi P, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus Geng T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Han K, Am J Respir Cell Mol Biol 2021 Jan;64(1):79-88 Infection\|Pathology\|SARS-CoV-2_virus Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus Jia L, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron Joag V, J Immunol 2021 Mar 1;206(5):931-935 SARS-CoV-2_virus\|Vaccine Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Khaddaj-Mallat R, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2_virus Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus\|Vaccine Kim TY, bioRxiv 2020 Dec;(): Infection\|SARS-CoV-2_virus King RG, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Leist SR, Cell 2020 Sep 23;(): Infection\|Pathology\|SARS-CoV-2-MA_virus Li S, JCI Insight 2021 Jan 25;6(2): Pathology\|SARS-CoV-2_virus Madar-Balakirski N, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Mandal P, PLoS One 2021;16(7):e0246270 Mouse_Hepatitis_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Pewe L, J Virol 1997 Oct;71(10):7640-7 Mouse_Hepatitis_virus Radvak P, bioRxiv 2021 Jun;(): Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Roberts A, Virus Res 2008 Apr;133(1):20-32 Infection\|SARS-CoV_virus\|Vaccine Salvi V, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 SARS-CoV-2_virus Salzer R, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Comorbidity Satta S, Theranostics 2022;12(6):2639-2657 SARS-CoV-2_virus\|Variant Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus Sepe S, bioRxiv 2021 Jun;(): Comorbidity\|Gene Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Shirato K, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment Sims JJ, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Treatment Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 SARS-CoV_virus Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 SARS-CoV-2_virus Szurgot I, Sci Rep 2021 Feb 4;11(1):3125 SARS-CoV-2_virus\|Vaccine Tsai SJ, bioRxiv 2020 Nov;(): SARS-CoV-2_virus\|Vaccine Ullah I, iScience 2024 Mar 15;27(3):109049 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Vanderheiden A, bioRxiv 2021 May;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Vanderheiden A, mBio 2021 Nov 9;():e0274921 Infection\|SARS-CoV-2-MA_virus\|VOC_B.1.351_Beta Wang H, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment Wang J, Protein Cell 2020 Aug 4;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus White KM, Science 2021 Feb 26;371(6532):926-931 SARS-CoV-2_virus\|Treatment Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus Xu H, bioRxiv 2020;(): Treatment Zhou B, Nature 2021 Apr;592(7852):122-127 Infection\|SARS-CoV-2_virus Zhuang X, iScience 2021 Oct 22;24(10):103144 SARS-CoV-2_virus
C57BL/6J-Ace2^em1Cya/Cya	MGI:6500741	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6500742	Ace2^em1Cya	MGI:6500740	Endonuclease-mediated	Null/knockout			cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282	J:299383	Gene	C57BL/6J-Ace2^em1Cya/Cya coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6500742	cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 Gene
C57BL/6J-Ace2^em1Guru/Mmjax	MGI:6763024	coisogenic\|endonuclease-mediated mutation\|mutant strain										Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	C57BL/6J-Ace2^em1Guru/Mmjax coisogenic\|endonuclease-mediated mutation\|mutant strain			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
C57BL/6J-Ace2^em2Guru/Mmjax	MGI:6763026	coisogenic\|endonuclease-mediated mutation\|mutant strain										Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	C57BL/6J-Ace2^em2Guru/Mmjax coisogenic\|endonuclease-mediated mutation\|mutant strain			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
C57BL/6J-Dpp4^em1Rba	MGI:6400424	coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6400425 MGI:6400427	Dpp4^em1Rba	MGI:6400423	Endonuclease-mediated	Humanized sequence	Middle East respiratory syndrome	DOID:0080642	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, PLoS One 2019;14(7):e0220126 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541):	J:279834 J:279723 J:286320	MERS-CoV_virus MERS-CoV_virus\|Pathology MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment	C57BL/6J-Dpp4^em1Rba coisogenic\|endonuclease-mediated mutation\|mutant strain	MGI:6400425 MGI:6400427	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome	Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 MERS-CoV_virus Leist SR, PLoS One 2019;14(7):e0220126 MERS-CoV_virus\|Pathology Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment
C57BL/6JJcl	MGI:3055581	inbred strain										Nagai M, Nat Commun 2023 Jun 30;14(1):3863	J:337953	SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha	C57BL/6JJcl inbred strain			Nagai M, Nat Commun 2023 Jun 30;14(1):3863 SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha
C57BL/6J-Lyst^bg-J/J	MGI:2163994	coisogenic\|mutant strain\|spontaneous mutation										Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:92752	Infection\|SARS-CoV_virus	C57BL/6J-Lyst^bg-J/J coisogenic\|mutant strain\|spontaneous mutation			Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
C57BL/6J-Sting1^gt/J	MGI:5292744	chemically induced mutation\|coisogenic\|mutant strain										Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	C57BL/6J-Sting1^gt/J chemically induced mutation\|coisogenic\|mutant strain			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
C57BL/6J-Tg(CAG-ACE2)GT5-027Cyt/J	MGI:6711187	coisogenic\|mutant strain\|transgenic										Tsai C-Y, bioRxiv 2021;():	J:305559	SARS-CoV-2_virus	C57BL/6J-Tg(CAG-ACE2)GT5-027Cyt/J coisogenic\|mutant strain\|transgenic			Tsai C-Y, bioRxiv 2021;(): SARS-CoV-2_virus
C57BL/6J-Ticam1^Lps2/J	MGI:3051113	chemically induced mutation\|coisogenic\|mutant strain	MGI:5520919	Ticam1^Lps2	MGI:2679794	Chemically induced (ENU)	Not Specified			cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Totura AL, mBio 2015 May 26;6(3):e00638-15	J:288471	Infection\|SARS-CoV-MA_virus	C57BL/6J-Ticam1^Lps2/J chemically induced mutation\|coisogenic\|mutant strain	MGI:5520919	cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection\|SARS-CoV-MA_virus
(C57BL/6J x C3H/HeJ)F1/J	MGI:5654213	F1 hybrid										Corbett KS, Nature 2020 Oct;586(7830):567-571	J:297398	MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine	(C57BL/6J x C3H/HeJ)F1/J F1 hybrid			Corbett KS, Nature 2020 Oct;586(7830):567-571 MERS-CoV_virus\|SARS-CoV-2_virus\|Vaccine
C57BL/6-Mcph1^{Tg(HLA-A2.1)1Enge}/J	MGI:2164434	mutant strain\|transgenic										Carter B, bioRxiv 2021 May;():	J:308712	SARS-CoV-2_virus\|Vaccine	C57BL/6-Mcph1^{Tg(HLA-A2.1)1Enge}/J mutant strain\|transgenic			Carter B, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine
C57BL/6N	MGI:2159965	inbred strain										Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Rai P, bioRxiv 2021 Jun;():	J:297122 J:308665	Infection\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus	C57BL/6N inbred strain			Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Infection\|SARS-CoV-2_virus Rai P, bioRxiv 2021 Jun;(): Pathology\|SARS-CoV-2_virus
C57BL/6NCr	MGI:2160593	inbred strain										Fang Z, bioRxiv 2022 Mar;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:324933 J:153918	Vaccine\|VOC_B.1.1.529_Omicron Mouse_Hepatitis_virus\|Pathology	C57BL/6NCr inbred strain			Fang Z, bioRxiv 2022 Mar;(): Vaccine\|VOC_B.1.1.529_Omicron Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C57BL/6NCrl	MGI:2683688	inbred strain										De Gasparo R, bioRxiv 2021 Jan;(): Rujas E, bioRxiv 2020;(): Sariol A, Proc Natl Acad Sci U S A 2020 Sep 29;117(39):24464-24474	J:300432 J:296183 J:298608	SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus	C57BL/6NCrl inbred strain			De Gasparo R, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Treatment Rujas E, bioRxiv 2020;(): SARS-CoV-2_virus\|Treatment Sariol A, Proc Natl Acad Sci U S A 2020 Sep 29;117(39):24464-24474 Mouse_Hepatitis_virus
C57BL/6NCrSlc	MGI:5295404	inbred strain										Nishikawa T, bioRxiv 2021 Jan;():	J:300443	SARS-CoV-2-MA_virus\|Vaccine	C57BL/6NCrSlc inbred strain			Nishikawa T, bioRxiv 2021 Jan;(): SARS-CoV-2-MA_virus\|Vaccine
C57BL/6N-Gsdmd^em4Fcw/J	MGI:6196335	coisogenic\|endonuclease-mediated mutation\|mutant strain										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	C57BL/6N-Gsdmd^em4Fcw/J coisogenic\|endonuclease-mediated mutation\|mutant strain			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
C57BL/6NJ	MGI:3056279	inbred strain										Hachim MY, Front Immunol 2020;11():1372 Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:291898 J:308730 J:327836	Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	C57BL/6NJ inbred strain			Hachim MY, Front Immunol 2020;11():1372 Gene\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
C57BL/6N-Parp12^{tm1.1(KOMP)Vlcg}/MbpMmucd	MGI:6346855	coisogenic\|mutant strain\|targeted mutation										Kerr CM, J Virol 2023 Sep 28;97(9):e0088523	J:340885	Gene\|Infection\|Mouse_Hepatitis_virus	C57BL/6N-Parp12^{tm1.1(KOMP)Vlcg}/MbpMmucd coisogenic\|mutant strain\|targeted mutation			Kerr CM, J Virol 2023 Sep 28;97(9):e0088523 Gene\|Infection\|Mouse_Hepatitis_virus
C57BL/6NTac	MGI:2164831	inbred strain										Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	C57BL/6NTac inbred strain			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
C57BL/6-Tg(Aicda/EGFP)1Rcas/J	MGI:5318090	coisogenic\|mutant strain\|transgenic										Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	C57BL/6-Tg(Aicda/EGFP)1Rcas/J coisogenic\|mutant strain\|transgenic			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
C57BL/6-Tg(CAG-ACE2,-luc)1Smoc/Smoc	MGI:6476454	coisogenic\|mutant strain\|transgenic										Yang S, J Med Virol 2022 Aug;94(8):3605-3612	J:339218	Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta	C57BL/6-Tg(CAG-ACE2,-luc)1Smoc/Smoc coisogenic\|mutant strain\|transgenic			Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta
C57BL/6-Tg(CAG-DPP4)4Yuzh	MGI:6402444	coisogenic\|mutant strain\|transgenic	MGI:6402445	Tg(CAG-DPP4)4Yuzh	MGI:6402443	Transgenic	Humanized sequence\|Inserted expressed sequence	Middle East respiratory syndrome	DOID:0080642	behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging	MP:0005386 MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005367 MP:0005388 MP:0010768	Zhao G, PLoS One 2015;10(12):e0145561	J:286175	Infection\|MERS-CoV_virus	C57BL/6-Tg(CAG-DPP4)4Yuzh coisogenic\|mutant strain\|transgenic	MGI:6402445	behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging Middle East respiratory syndrome	Zhao G, PLoS One 2015;10(12):e0145561 Infection\|MERS-CoV_virus
C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ	MGI:3706817	coisogenic\|mutant strain\|transgenic										Hohsfield LA, Glia 2022 May;70(5):875-891	J:324342	Mouse_Hepatitis_virus	C57BL/6-Tg(CAG-EGFP)131Osb/LeySopJ coisogenic\|mutant strain\|transgenic			Hohsfield LA, Glia 2022 May;70(5):875-891 Mouse_Hepatitis_virus
CAST/EiJ	MGI:2159793	inbred strain\|wild-derived	MGI:2659102							cellular immune system nervous system mortality/aging	MP:0005384 MP:0005387 MP:0003631 MP:0010768	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	CAST/EiJ inbred strain\|wild-derived	MGI:2659102	cellular immune system nervous system mortality/aging	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(CAST/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865669	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(CAST/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
C.B10-H2^b/LilMcdJ	MGI:2161599	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	C.B10-H2^b/LilMcdJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
CBA/J	MGI:2159756	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	CBA/J inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
CC001/Unc	MGI:6202009	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC001/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC001/UncJ	MGI:5649079	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC001/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC001/Unc x CC055/TauUnc)F1	MGI:7596177	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC001/Unc x CC055/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC001/Unc x CC074/Unc)F1	MGI:7596178	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC001/Unc x CC074/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC002/Unc	MGI:6188584	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC002/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC002/Unc x CC011/Unc)F1	MGI:7596179											Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC002/Unc x CC011/Unc)F1			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC002/Unc x CC021/Unc)F1	MGI:7596180	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC002/Unc x CC021/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC003/Unc	MGI:6188583	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103 Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:345413 J:270045	SARS-CoV-2-MA_virus Pathology\|SARS-CoV-MA_virus	CC003/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
(CC003/Unc x CC051/TauUnc)F1	MGI:7596181	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC003/Unc x CC051/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC003/Unc x CC062/Unc)F1	MGI:7596182	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC003/Unc x CC062/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC004/TauUnc	MGI:6188582	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC004/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC004/TauUncJ	MGI:5649082	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC004/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC004/TauUnc x CC011/Unc)F1	MGI:6307729	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC004/TauUnc x CC011/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC004/TauUnc x CC012/GeniUnc)F1	MGI:7596183	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC004/TauUnc x CC012/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC005/TauUnc	MGI:6188581	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC005/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC005/TauUnc x CC001/Unc)F1	MGI:6307730	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC005/TauUnc x CC001/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC005/TauUnc x CC038/GeniUnc)F1	MGI:7596184	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC005/TauUnc x CC038/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC005/TauUnc x CC040/TauUnc)F1	MGI:6307737	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC005/TauUnc x CC040/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC006/TauUnc	MGI:6188580	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC006/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC006/TauUncJ	MGI:5649237	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC006/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC006/TauUnc x CC007/Unc)F1	MGI:7596185	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC006/TauUnc x CC007/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC006/TauUnc x CC039/Unc)F1	MGI:7596186	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC006/TauUnc x CC039/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC007/Unc	MGI:6188579	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC007/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC007/Unc x CC070/TauUnc)F1	MGI:7596187	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC007/Unc x CC070/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC007/Unc x CC075/Unc)F1	MGI:7596188	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC007/Unc x CC075/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC008/GeniUnc	MGI:6188578	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC008/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC008/GeniUnc x CC009/Unc)F1	MGI:7596189	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC008/GeniUnc x CC009/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC008/GeniUnc x CC010/GeniUnc)F1	MGI:7596190	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC008/GeniUnc x CC010/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC008/GeniUnc x CC018/Unc)F1	MGI:7596191	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC008/GeniUnc x CC018/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC009/Unc	MGI:6188577	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC009/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC009/Unc x CC040/TauUnc)F1	MGI:7596192	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC009/Unc x CC040/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC010/GeniUnc	MGI:6188576	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC010/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC010/GeniUncJ	MGI:5649239	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC010/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC010/GeniUnc x CC015/Unc)F1	MGI:7596193	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC010/GeniUnc x CC015/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC010/GeniUnc x CC060/Unc)F1	MGI:7596194	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC010/GeniUnc x CC060/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC011/Unc	MGI:5749398	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103 Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:345413 J:327836	SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	CC011/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
CC011/UncJ	MGI:5649240	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC011/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC011/Unc x CC032/GeniUnc)F1	MGI:7596195	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC011/Unc x CC032/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC011/Unc x CC042/GeniUnc)F1	MGI:7596196	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC011/Unc x CC042/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC012/GeniUnc	MGI:6188575	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC012/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC012/GeniUncJ	MGI:5694080	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC012/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC012/GeniUnc x CC004/TauUnc)F1	MGI:7596198	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC012/GeniUnc x CC004/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC012/GeniUnc x CC032/GeniUnc)F1	MGI:7596200											Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC012/GeniUnc x CC032/GeniUnc)F1			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC012/GeniUnc x CC038/GeniUnc)F1	MGI:7596202	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC012/GeniUnc x CC038/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC013/GeniUnc	MGI:6188574	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC013/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC013/GeniUncJ	MGI:5649241	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC013/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC013/GeniUnc x CC026/GeniUnc)F1	MGI:7596203	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC013/GeniUnc x CC026/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC013/GeniUnc x CC041/TauUnc)F1	MGI:7596204	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC013/GeniUnc x CC041/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC014/UncJ	MGI:5659477	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC014/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC014/Unc x CC059/TauUnc)F1	MGI:7596205	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC014/Unc x CC059/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC015/Unc	MGI:6188573	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC015/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC015/UncJ	MGI:5659478	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC015/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC015/Unc x CC018/Unc)F1	MGI:7596206	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC015/Unc x CC018/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC015/Unc x CC059/TauUnc)F1	MGI:7596207	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC015/Unc x CC059/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC016/GeniUnc	MGI:6188572	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC016/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC016/GeniUncJ	MGI:5659479	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC016/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC016/GeniUnc x CC038/GeniUnc)F1	MGI:7596208	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC016/GeniUnc x CC038/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC016/GeniUnc x CC061/GeniUnc)F1	MGI:7596209	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC016/GeniUnc x CC061/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC017/Unc	MGI:6188571	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103 Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:345413 J:327836	SARS-CoV-2-MA_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	CC017/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
(CC017/Unc x CC004/TauUnc)F1	MGI:6307731	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC017/Unc x CC004/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC017/Unc x CC041/TauUnc)F1	MGI:7596210	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC017/Unc x CC041/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC018/Unc	MGI:6188570	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC018/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC018/UncJ	MGI:5649243	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC018/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC018/Unc x CC009/Unc)F1	MGI:7596211	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC018/Unc x CC009/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC018/Unc x CC065/Unc)F1	MGI:7596212	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC018/Unc x CC065/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC019/TauUnc	MGI:6188569	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC019/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC019/TauUncJ	MGI:5649244	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC019/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC019/TauUnc x CC002/Unc)F1	MGI:7596213	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC019/TauUnc x CC002/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC019/TauUnc x CC004/TauUnc)F1	MGI:7596214	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC019/TauUnc x CC004/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC019/TauUnc x CC027/GeniUnc)F1	MGI:7596215	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC019/TauUnc x CC027/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC020/GeniUnc x CC008/GeniUnc)F1	MGI:7596216	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC020/GeniUnc x CC008/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC021/Unc	MGI:6188567	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC021/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC021/Unc x CC023/GeniUnc)F1	MGI:7596217	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC021/Unc x CC023/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC022/GeniUnc x CC024/GeniUnc)F1	MGI:7596218	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC022/GeniUnc x CC024/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC022/GeniUnc x CC044/Unc)F1	MGI:7596219	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC022/GeniUnc x CC044/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC023/GeniUnc	MGI:6188565	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC023/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC023/GeniUncJ	MGI:5659483	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC023/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC023/GeniUnc x CC025/GeniUnc)F1	MGI:7596220	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC023/GeniUnc x CC025/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC024/GeniUnc	MGI:6188564	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC024/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC024/GeniUncJ	MGI:5649245	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC024/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC024/GeniUnc x CC023/GeniUnc)F1	MGI:6307732	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC024/GeniUnc x CC023/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC025/GeniUnc	MGI:6188563	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC025/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC025/GeniUncJ	MGI:5649246	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC025/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC025/GeniUnc x CC028/GeniUnc)F1	MGI:7596222	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC025/GeniUnc x CC028/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC026/GeniUnc	MGI:6188562	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC026/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC026/GeniUncJ	MGI:5649247	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC026/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC026/GeniUnc x CC034/Unc)F1	MGI:7596223	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC026/GeniUnc x CC034/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC027/GeniUnc	MGI:6188561	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC027/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC027/GeniUnc x CC036/Unc)F1	MGI:7596224	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC027/GeniUnc x CC036/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC027/GeniUnc x CC045/GeniUnc)F1	MGI:7596225	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC027/GeniUnc x CC045/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC028/GeniUnc	MGI:6188560	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC028/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC028/GeniUncJ	MGI:5659485	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC028/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC028/GeniUnc x CC024/GeniUnc)F1	MGI:7596226	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC028/GeniUnc x CC024/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC028/GeniUnc x CC030/GeniUnc)F1	MGI:7596227	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC028/GeniUnc x CC030/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC029/Unc	MGI:6188559	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC029/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC029/UncJ	MGI:5659486	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC029/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC029/Unc x CC027/GeniUnc)F1	MGI:7596228	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC029/Unc x CC027/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC029/Unc x CC071/TauUnc)F1	MGI:7596229	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC029/Unc x CC071/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC030/GeniUnc	MGI:6188558	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC030/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC030/GeniUncJ	MGI:5659487	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC030/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC030/GeniUnc x CC023/GeniUnc)F1	MGI:7596230	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC030/GeniUnc x CC023/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC030/GeniUnc x CC042/GeniUnc)F1	MGI:7596231	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC030/GeniUnc x CC042/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC030/GeniUnc x CC061/GeniUnc)F1	MGI:7596232	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC030/GeniUnc x CC061/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC031/GeniUnc	MGI:6188557	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC031/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC032/GeniUnc	MGI:6188556	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC032/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC032/GeniUncJ	MGI:5649248	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC032/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC032/GeniUnc x CC013/GeniUnc)F1	MGI:7596233	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC032/GeniUnc x CC013/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC032/GeniUnc x CC017/Unc)F1	MGI:7596234	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC032/GeniUnc x CC017/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC033/GeniUnc	MGI:6188555	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC033/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC033/GeniUncJ	MGI:5659488	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC033/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC033/GeniUnc x CC046/Unc)F1	MGI:7596235	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC033/GeniUnc x CC046/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC033/GeniUnc x CC068/TauUnc)F1	MGI:7596236	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC033/GeniUnc x CC068/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC034/Unc	MGI:6188554	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC034/Unc recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC034/Unc x CC016/GeniUnc)F1	MGI:7596237	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC034/Unc x CC016/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC035/Unc	MGI:6188553	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC035/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC035/Unc x CC020/GeniUnc)F1	MGI:7596238	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC035/Unc x CC020/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC035/Unc x CC071/TauUnc)F1	MGI:7596239	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC035/Unc x CC071/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC036/Unc	MGI:6188552	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC036/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC036/Unc x CC051/TauUnc)F1	MGI:7596240	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC036/Unc x CC051/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC037/TauUnc	MGI:6188551	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC037/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC037/TauUncJ	MGI:5649249	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC037/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC037/TauUnc x CC046/Unc)F1	MGI:7596242	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC037/TauUnc x CC046/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC037/TauUnc x CC057/Unc)F1	MGI:7596243	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC037/TauUnc x CC057/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC038/GeniUnc	MGI:6188550	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC038/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC038/GeniUncJ	MGI:5659491	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC038/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC038/GeniUnc x CC013/GeniUnc)F1	MGI:7596244	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC038/GeniUnc x CC013/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC039/Unc	MGI:6188549	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC039/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC039/UncJ	MGI:5659492	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC039/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
CC040/TauUnc	MGI:6188548	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC040/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC040/TauUnc x CC003/Unc)F1	MGI:7596247	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC040/TauUnc x CC003/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC040/TauUnc x CC015/Unc)F1	MGI:7596248	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC040/TauUnc x CC015/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC041/TauUnc	MGI:6188547	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC041/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC041/TauUncJ	MGI:5649251	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC041/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC041/TauUnc x CC012/GeniUnc)F1	MGI:6307733	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC041/TauUnc x CC012/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC041/TauUnc x CC016/GeniUnc)F1	MGI:7596249	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC041/TauUnc x CC016/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC042/GeniUnc	MGI:6188546	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC042/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC042/GeniUncJ	MGI:5649255	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC042/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC042/GeniUnc x CC017/Unc)F1	MGI:7596250	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC042/GeniUnc x CC017/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC042/GeniUnc x CC019/TauUnc)F1	MGI:7596251	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC042/GeniUnc x CC019/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC042/GeniUnc x CC025/GeniUnc)F1	MGI:7596316	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC042/GeniUnc x CC025/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC043/GeniUnc	MGI:6188545	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC043/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC043/GeniUncJ	MGI:5649256	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC043/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC043/GeniUnc x CC033/GeniUnc)F1	MGI:7596254	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC043/GeniUnc x CC033/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC043/GeniUnc x CC037/TauUnc)F1	MGI:7596257	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC043/GeniUnc x CC037/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC044/Unc	MGI:6188544	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC044/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC044/Unc x CC060/Unc)F1	MGI:7596258	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC044/Unc x CC060/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC045/GeniUnc	MGI:6188543	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC045/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC045/GeniUnc x CC044/Unc)F1	MGI:7596260	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC045/GeniUnc x CC044/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC046/Unc	MGI:6188542	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC046/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC046/UncJ	MGI:5659495	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC046/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC046/Unc x CC068/TauUnc)F1	MGI:7596262	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC046/Unc x CC068/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC049/TauUnc	MGI:6188540	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC049/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC049/TauUnc x CC036/Unc)F1	MGI:7596264	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC049/TauUnc x CC036/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC051/TauUnc	MGI:6188538	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC051/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC051/TauUnc x CC005/TauUnc)F1	MGI:7596265	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC051/TauUnc x CC005/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC051/TauUnc x CC009/Unc)F1	MGI:7596267	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC051/TauUnc x CC009/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC052/GeniUncJ	MGI:5659498	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC052/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC052/GeniUnc x CC007/Unc)F1	MGI:7596268	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC052/GeniUnc x CC007/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC052/GeniUnc x CC014/Unc)F1	MGI:7596269	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC052/GeniUnc x CC014/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC053/Unc	MGI:6188536	recombinant inbred (RI)	MGI:6402903					severe acute respiratory syndrome	DOID:2945	immune system mortality/aging	MP:0005387 MP:0010768	Graham JB, iScience 2024 Mar 15;27(3):109103 Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:345413 J:270045	SARS-CoV-2-MA_virus Pathology\|SARS-CoV-MA_virus	CC053/Unc recombinant inbred (RI)	MGI:6402903	immune system mortality/aging severe acute respiratory syndrome	Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
CC055/TauUncJ	MGI:5659644	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC055/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC055/TauUnc x CC006/TauUnc)F1	MGI:7596270	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC055/TauUnc x CC006/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC055/TauUnc x CC028/GeniUnc)F1	MGI:7596271	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC055/TauUnc x CC028/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC056/GeniUncJ	MGI:5816616	mutant strain\|recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC056/GeniUncJ mutant strain\|recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC056/GeniUnc x CC033/GeniUnc)F1	MGI:7596272	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC056/GeniUnc x CC033/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC057/Unc	MGI:6188533	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC057/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC057/UncJ	MGI:5659646	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC057/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC057/Unc x CC052/GeniUnc)F1	MGI:7596273	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC057/Unc x CC052/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC058/Unc	MGI:6188532	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC058/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC058/UncJ	MGI:5659649	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC058/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC058/Unc x CC022/GeniUnc)F1	MGI:7596274	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC058/Unc x CC022/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC059/TauUnc	MGI:6188531	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC059/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC059/TauUncJ	MGI:5659650	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC059/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC059/TauUnc x CC065/Unc)F1	MGI:7596275	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC059/TauUnc x CC065/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC060/Unc	MGI:6188530	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC060/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC060/UncJ	MGI:5659652	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC060/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC060/Unc x CC006/TauUnc)F1	MGI:7596276	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC060/Unc x CC006/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC060/Unc x CC037/TauUnc)F1	MGI:7596277	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC060/Unc x CC037/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC061/GeniUnc	MGI:6188529	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC061/GeniUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC061/GeniUncJ	MGI:5649258	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC061/GeniUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC061/GeniUnc x CC025/GeniUnc)F1	MGI:7596278	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC061/GeniUnc x CC025/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC061/GeniUnc x CC026/GeniUnc)F1	MGI:7596279	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC061/GeniUnc x CC026/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC061/GeniUnc x CC039/Unc)F1	MGI:7596280	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC061/GeniUnc x CC039/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC062/Unc	MGI:6188528	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC062/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC062/UncJ	MGI:5906018	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC062/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC062/Unc x CC046/Unc)F1	MGI:7596281	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC062/Unc x CC046/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC062/Unc x CC072/TauUnc)F1	MGI:7596282	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC062/Unc x CC072/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC063/Unc x CC001/Unc)F1	MGI:7596283	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC063/Unc x CC001/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC063/Unc x CC002/Unc)F1	MGI:7596284	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC063/Unc x CC002/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC065/Unc	MGI:6188526	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC065/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC065/UncJ	MGI:5659659	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC065/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC065/Unc x CC010/GeniUnc)F1	MGI:7596285	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC065/Unc x CC010/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC065/Unc x CC018/Unc)F1	MGI:7596286	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC065/Unc x CC018/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC065/Unc x CC072/TauUnc)F1	MGI:7596287	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC065/Unc x CC072/TauUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC068/TauUnc	MGI:6188525	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC068/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC068/TauUncJ	MGI:5649259	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC068/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC068/TauUnc x CC035/Unc)F1	MGI:7596288	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC068/TauUnc x CC035/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC068/TauUnc x CC043/GeniUnc)F1	MGI:7596289	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC068/TauUnc x CC043/GeniUnc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC070/TauUnc x CC003/Unc)F1	MGI:7596290	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC070/TauUnc x CC003/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC071/TauUnc	MGI:6188523	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC071/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC071/TauUncJ	MGI:5659663	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC071/TauUncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC071/TauUnc x CC053/Unc)F1	MGI:7596291	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC071/TauUnc x CC053/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC071/TauUnc x CC058/Unc)F1	MGI:7596292	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC071/TauUnc x CC058/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC072/TauUnc	MGI:6188522	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC072/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC072/TauUnc x CC063/Unc)F1	MGI:7596293	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC072/TauUnc x CC063/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC072/TauUnc x CC075/Unc)F1	MGI:7596294	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC072/TauUnc x CC075/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC074/Unc	MGI:6188520	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC074/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC074/UncJ	MGI:5659666	recombinant inbred (RI)										Graham JB, bioRxiv 2020 Sep 21;():	J:296262	SARS-CoV-MA_virus	CC074/UncJ recombinant inbred (RI)			Graham JB, bioRxiv 2020 Sep 21;(): SARS-CoV-MA_virus
(CC074/Unc x CC002/Unc)F1	MGI:7596295	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC074/Unc x CC002/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC074/Unc x CC058/Unc)F1	MGI:7596296	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC074/Unc x CC058/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC074/Unc x CC062/Unc)F1	MGI:7596297	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC074/Unc x CC062/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC075/Unc	MGI:6188519	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC075/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
(CC075/Unc x CC021/Unc)F1	MGI:7596298	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC075/Unc x CC021/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
(CC075/Unc x CC035/Unc)F1	MGI:7596299	F1 hybrid										Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287	J:303526	Infection\|SARS-CoV-2-MA_virus	(CC075/Unc x CC035/Unc)F1 F1 hybrid			Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Infection\|SARS-CoV-2-MA_virus
CC078/TauUnc	MGI:6188517	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC078/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC079/TauUnc	MGI:6188516	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC079/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC080/TauUnc	MGI:6188515	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC080/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC081/Unc	MGI:6188514	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC081/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC083/Unc	MGI:6188512	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC083/Unc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
CC084/TauUnc	MGI:7596534	recombinant inbred (RI)										Graham JB, iScience 2024 Mar 15;27(3):109103	J:345413	SARS-CoV-2-MA_virus	CC084/TauUnc recombinant inbred (RI)			Graham JB, iScience 2024 Mar 15;27(3):109103 SARS-CoV-2-MA_virus
C.C3-H2^k/LilMcdJ	MGI:2163605	congenic\|major histocompatibility congenic\|mutant strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	C.C3-H2^k/LilMcdJ congenic\|major histocompatibility congenic\|mutant strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
C.Cg-Cd19^tm1(cre)Cgn Igh^b/J	MGI:2174231	congenic\|mutant strain\|targeted mutation										Kotagiri P, EBioMedicine 2022 Feb 18;77():103878	J:322643	SARS-CoV-2_virus	C.Cg-Cd19^tm1(cre)Cgn Igh^b/J congenic\|mutant strain\|targeted mutation			Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus
C.Cg-Tg(K18-ACE2)2Prlmn/J	MGI:6479852	congenic\|mutant strain\|transgenic										McCray PB Jr, J Virol 2007 Jan;81(2):813-21	J:283648	Infection\|SARS-CoV_virus	C.Cg-Tg(K18-ACE2)2Prlmn/J congenic\|mutant strain\|transgenic			McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Infection\|SARS-CoV_virus
CD-1	MGI:5649524	outbred stock										Borriello F, bioRxiv 2021 Sep;(): Chadchan SB, Biol Reprod 2021 Feb 11;104(2):336-343 Dai W, Science 2020 Jun 19;368(6497):1331-1335 Duty JA, Med 2022 Oct 14;3(10):705-721.e11 Falach R, bioRxiv 2020 Nov;(): Fernandez-Castaneda A, bioRxiv 2022;(): Grandi A, bioRxiv 2021 Jul;(): Hassler L, bioRxiv 2021 Mar;(): King RG, bioRxiv 2020;(): Rice A, bioRxiv 2021 Mar;(): Rice A, bioRxiv 2021 Nov;(): Rice A, Sci Rep 2021 Jul 21;11(1):14917 Spencer AJ, bioRxiv 2021 Jan;(): Tummino TA, bioRxiv 2021 Mar;():	J:310116 J:302245 J:290792 J:349963 J:296678 J:321759 J:308639 J:302921 J:296068 J:303210 J:315738 J:308902 J:302146 J:303456	SARS-CoV-2_virus\|Vaccine Gene SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Comorbidity\|Infection\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment	CD-1 outbred stock			Borriello F, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Chadchan SB, Biol Reprod 2021 Feb 11;104(2):336-343 Gene Dai W, Science 2020 Jun 19;368(6497):1331-1335 SARS-CoV_virus\|Treatment Duty JA, Med 2022 Oct 14;3(10):705-721.e11 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Falach R, bioRxiv 2020 Nov;(): Comorbidity\|Infection\|SARS-CoV-2_virus Fernandez-Castaneda A, bioRxiv 2022;(): Pathology\|SARS-CoV-2_virus Grandi A, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Hassler L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment King RG, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine Rice A, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Rice A, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine Rice A, Sci Rep 2021 Jul 21;11(1):14917 SARS-CoV-2_virus\|Vaccine Spencer AJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Tummino TA, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment
CD1.129S-Stat1⁺/Cnbc	MGI:6119400	congenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.129S-Stat1⁺/Cnbc congenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1(129S)-Tg(ANPEP)270Mmul/Cnbc	MGI:6119398	congenic\|mutant strain\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1(129S)-Tg(ANPEP)270Mmul/Cnbc congenic\|mutant strain\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1(129S)-Tg(ANPEP)861Mmul/Cnbc	MGI:6119399	congenic\|mutant strain\|targeted mutation										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1(129S)-Tg(ANPEP)861Mmul/Cnbc congenic\|mutant strain\|targeted mutation			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1.Cg-Stat1^tm1Dlv/Cnbc	MGI:6119401	congenic\|mutant strain\|targeted mutation\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.Cg-Stat1^tm1Dlv/Cnbc congenic\|mutant strain\|targeted mutation\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)270Mmul/Cnbc	MGI:6120539	congenic\|mutant strain\|targeted mutation\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)270Mmul/Cnbc congenic\|mutant strain\|targeted mutation\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)861Mmul/Cnbc	MGI:6120528	congenic\|mutant strain\|targeted mutation\|transgenic										Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	CD1.Cg-Stat1^tm1Dlv Tg(ANPEP)861Mmul/Cnbc congenic\|mutant strain\|targeted mutation\|transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
Crl:CD-1	MGI:5652673	outbred stock										Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8	J:36900 J:64200	Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	Crl:CD-1 outbred stock			Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Mouse_Hepatitis_virus Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 Mouse_Hepatitis_virus\|Pathology
DBA/1J	MGI:2159759	inbred strain										Shen ZT, Sci Rep 2016 Jun 28;6():28672	J:291625	SARS-CoV_virus	DBA/1J inbred strain			Shen ZT, Sci Rep 2016 Jun 28;6():28672 SARS-CoV_virus
DBA/2J	MGI:2684695	inbred strain										Hassan AO, Cell 2020 Jun 10;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:290258 J:153918	Infection\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus\|Pathology	DBA/2J inbred strain			Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
(DBA/2J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865662	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(DBA/2J x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
FVB-Tg(Cdh5-tTA)D5Lbjn/J	MGI:4839338	coisogenic\|mutant strain\|transgenic										Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	FVB-Tg(Cdh5-tTA)D5Lbjn/J coisogenic\|mutant strain\|transgenic			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
ICR	MGI:2160272	strain family										Rao L, Proc Natl Acad Sci U S A 2020 Nov 3;117(44):27141-27147 Sagawa T, Environ Res 2021 Apr;195():110722 Spencer AJ, bioRxiv 2021 Jan;():	J:297098 J:305462 J:302146	SARS-CoV-2_virus\|Treatment Comorbidity\|Gene SARS-CoV-2_virus\|Vaccine	ICR strain family			Rao L, Proc Natl Acad Sci U S A 2020 Nov 3;117(44):27141-27147 SARS-CoV-2_virus\|Treatment Sagawa T, Environ Res 2021 Apr;195():110722 Comorbidity\|Gene Spencer AJ, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine
ICR-Tg(Ace2-ACE2)1Cqin/J	MGI:6401293	mutant stock\|transgenic										Yang XH, Comp Med 2007 Oct;57(5):450-9	J:141460	Infection\|SARS-CoV_virus	ICR-Tg(Ace2-ACE2)1Cqin/J mutant stock\|transgenic			Yang XH, Comp Med 2007 Oct;57(5):450-9 Infection\|SARS-CoV_virus
NOD.Cg-Prkdc^scid Il2rg^tm1Wjl Ace2^{tm1(ACE2)Dwnt}/J	MGI:6865656	congenic\|mutant strain\|spontaneous mutation\|targeted mutation										Zhou B, bioRxiv 2020;():	J:296356	Infection\|SARS-CoV-2_virus	NOD.Cg-Prkdc^scid Il2rg^tm1Wjl Ace2^{tm1(ACE2)Dwnt}/J congenic\|mutant strain\|spontaneous mutation\|targeted mutation			Zhou B, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus
NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/SzJ	MGI:3577020	congenic\|mutant strain\|spontaneous mutation\|targeted mutation										Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/SzJ congenic\|mutant strain\|spontaneous mutation\|targeted mutation			Harb H, Immunity 2021 Apr 22;(): Infection
NOD.Cg-Rag1^tm1Mom Il2rg^tm1Wjl/SzJ	MGI:3804477	congenic\|targeted mutation										Halwe S, bioRxiv 2021 Jun;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:308648 J:345954	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|MERS-CoV-MA_virus	NOD.Cg-Rag1^tm1Mom Il2rg^tm1Wjl/SzJ congenic\|targeted mutation			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
NOD/ShiLtJ	MGI:2162056	inbred strain										Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	NOD/ShiLtJ inbred strain			Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(NOD/ShiLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865671	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(NOD/ShiLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
NZB/BlNJ	MGI:2180844	inbred strain										Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:153918	Mouse_Hepatitis_virus\|Pathology	NZB/BlNJ inbred strain			Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
NZO/HlLtJ	MGI:2173835	inbred strain	MGI:5902927							immune system	MP:0005387	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	NZO/HlLtJ inbred strain	MGI:5902927	immune system	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(NZO/HlLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865670	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(NZO/HlLtJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
PWK/PhJ	MGI:2160654	inbred strain\|wild-derived	MGI:5902923							immune system mortality/aging	MP:0005387 MP:0010768	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	PWK/PhJ inbred strain\|wild-derived	MGI:5902923	immune system mortality/aging	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(PWK/PhJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865668	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(PWK/PhJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus
SJL	MGI:2159833	strain family										Compton SR, Virology 1994 Aug 15;203(1):197-201	J:19444	Infection\|Mouse_Hepatitis_virus	SJL strain family			Compton SR, Virology 1994 Aug 15;203(1):197-201 Infection\|Mouse_Hepatitis_virus
SJL/J	MGI:2159739	inbred strain	MGI:3719417	Ceacam1^Hv2-r	MGI:3053078	Spontaneous				immune system	MP:0005387	Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Dveksler GS, J Virol 1993 Jan;67(1):1-8 Stohlman SA, J Immunol 1980 Apr;124(4):1733-9 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Yokomori K, J Virol 1992 Dec;66(12):6931-8	J:14457 J:92495 J:25384 J:25438 J:3241	Infection\|Mouse_Hepatitis_virus Mouse_Hepatitis_virus	SJL/J inbred strain	MGI:3719417	immune system	Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Infection\|Mouse_Hepatitis_virus Dveksler GS, J Virol 1993 Jan;67(1):1-8 Infection\|Mouse_Hepatitis_virus Stohlman SA, J Immunol 1980 Apr;124(4):1733-9 Mouse_Hepatitis_virus Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Infection\|Mouse_Hepatitis_virus Yokomori K, J Virol 1992 Dec;66(12):6931-8 Mouse_Hepatitis_virus
STOCK Hopx^{tm2.1(cre/ERT2)Joe}/J	MGI:5320285	mutant stock\|targeted mutation										Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	STOCK Hopx^{tm2.1(cre/ERT2)Joe}/J mutant stock\|targeted mutation			Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
STOCK Tg(Actl6b-Cre)4092Jiwu/J	MGI:5699265	mutant stock\|transgenic										Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	STOCK Tg(Actl6b-Cre)4092Jiwu/J mutant stock\|transgenic			Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
STOCK Tg(Mx1-cre)1Cgn/J	MGI:2162199	mutant stock\|transgenic										Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226	J:331827	SARS-CoV-2_virus	STOCK Tg(Mx1-cre)1Cgn/J mutant stock\|transgenic			Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 SARS-CoV-2_virus
Swiss albino	MGI:5652853	outbred stock										Saleh AA, bioRxiv 2021 Mar;():	J:302705	SARS-CoV-2_virus\|Vaccine	Swiss albino outbred stock			Saleh AA, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine
Swiss Webster	MGI:2160840	outbred stock										Lai CY, bioRxiv 2021 Mar;(): Ngo VL, Cell Host Microbe 2024 Jan 23;(): Staquicini DI, bioRxiv 2021 Mar;():	J:302709 J:345954 J:302940	SARS-CoV-2_virus\|Vaccine Infection\|MERS-CoV-MA_virus	Swiss Webster outbred stock			Lai CY, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Staquicini DI, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine
WSB/EiJ	MGI:2160667	inbred strain\|wild-derived	MGI:5818477							immune system mortality/aging	MP:0005387 MP:0010768	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44	J:268979 J:276026 J:276986 J:276989 J:276183	Infection\|SARS-CoV-MA_virus SARS-CoV-MA_virus	WSB/EiJ inbred strain\|wild-derived	MGI:5818477	immune system mortality/aging	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus Josset L, RNA Biol 2014;11(7):875-90 SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Peng X, mBio 2011;2(6): SARS-CoV-MA_virus Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Infection\|SARS-CoV-MA_virus
(WSB/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J	MGI:6865667	F1 hybrid\|mutant strain\|transgenic										Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481	J:338561	Infection\|SARS-CoV-2_virus	(WSB/EiJ x B6.Cg-Tg(K18-ACE2)2Prlmn/J)F1/J F1 hybrid\|mutant strain\|transgenic			Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus

Alleles for Laboratory Mouse Strains Used in Coronavirus Research

Alleles for laboratory mouse strains used in coronavirus research along with mouse phenotype categories and human disease terms and relevant references. Under each reference is a list of keywords for the research areas and the viruses mentioned in the publication. A virus name appended with ‘MA’ indicates that the virus is a mouse adapted strain.

Mouse alleles names are linked to allele detail pages at MGI. Human disease terms are linked to the Disease Ontology Browser at MGI. References are linked to the reference detail pages at MGI.

1-allele	2-mgi	3-type	4-subtypes	5-geno-id	6-do-term	7-do-id	8-mp-term	9-mp-id	10-cite	11-jnum	12-tags	Allele	Genotype Details	Human Disease and Mouse Phenotype Categories	References \| Keywords
Ace2^em1(ACE2)Gpt	MGI:6452437	Endonuclease-mediated	Inserted expressed sequence						Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120	J:324335 J:340364	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron SARS-CoV-2_virus\|VOC_B.1.351_Beta	Ace2^em1(ACE2)Gpt Endonuclease-mediated			Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120 SARS-CoV-2_virus\|VOC_B.1.351_Beta
Ace2^{em1(ACE2)Mlkn}	MGI:6842318	Endonuclease-mediated	Conditional ready\|Humanized sequence\|Inserted expressed sequence\|Null/knockout						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Gao S, Front Cardiovasc Med 2023;10():1266276	J:315719 J:337814 J:346048	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus	Ace2^{em1(ACE2)Mlkn} Endonuclease-mediated			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Gao S, Front Cardiovasc Med 2023;10():1266276 Infection\|SARS-CoV-2_virus
Ace2^em1(ACE2)Rlu	MGI:7524682	Endonuclease-mediated	Humanized sequence\|Inserted expressed sequence						Romero MJ, Front Immunol 2023;14():1241448	J:339692	SARS-CoV-2_virus	Ace2^em1(ACE2)Rlu Endonuclease-mediated			Romero MJ, Front Immunol 2023;14():1241448 SARS-CoV-2_virus
Ace2^{em1(ACE2)Yowa}	MGI:6431336	Endonuclease-mediated	Humanized sequence\|Null/knockout\|Reporter	MGI:6431340	COVID-19	DOID:0080600	cardiovascular system homeostasis/metabolism immune system respiratory system	MP:0005385 MP:0005376 MP:0005387 MP:0005388	Sun SH, Cell Host Microbe 2020;20():1-10 Wu Y, Science 2020 Jun 12;368(6496):1274-1278 Yang J, Nature 2020 Jul 29;(): Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Ye Q, bioRxiv 2020 Nov;(): Pinto D, bioRxiv 2020 Apr 9;(): Zhu L, bioRxiv 2020 Nov;(): Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 Chen J, bioRxiv 2021 Nov;():	J:288243 J:290802 J:292665 J:295349 J:295350 J:295351 J:296708 J:297123 J:298147 J:298750 J:315718	Infection\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Pathology\|SARS-CoV-2_virus SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus	Ace2^{em1(ACE2)Yowa} Endonuclease-mediated	MGI:6431340	cardiovascular system homeostasis/metabolism immune system respiratory system COVID-19	Sun SH, Cell Host Microbe 2020;20():1-10 Infection\|Pathology\|SARS-CoV-2_virus Wu Y, Science 2020 Jun 12;368(6496):1274-1278 SARS-CoV-2_virus\|Treatment Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Munoz-Fontela C, Nature 2020 Sep 23;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Ye Q, bioRxiv 2020 Nov;(): Pathology\|SARS-CoV-2_virus Pinto D, bioRxiv 2020 Apr 9;(): SARS-CoV-2_virus\|Treatment Zhu L, bioRxiv 2020 Nov;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus Chen J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Vaccine
Ace2^em1Cya	MGI:6500740	Endonuclease-mediated	Null/knockout	MGI:6500742			cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282	J:299383	Gene	Ace2^em1Cya Endonuclease-mediated	MGI:6500742	cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system	Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 Gene
Ace2^em1Diam	MGI:7398548	Endonuclease-mediated	Null/knockout						Winkler ES, J Virol 2022 Jan 12;96(1):e0151121	J:331773	Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	Ace2^em1Diam Endonuclease-mediated			Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
Ace2^em1Guru	MGI:6763023	Endonuclease-mediated	Humanized sequence						Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	Ace2^em1Guru Endonuclease-mediated			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
Ace2^em1Mccc	MGI:7468713	Endonuclease-mediated	Humanized sequence						Nakandakari-Higa S, Front Immunol 2022;13():1007080	J:335150	Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Ace2^em1Mccc Endonuclease-mediated			Nakandakari-Higa S, Front Immunol 2022;13():1007080 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Ace2^em1Qhs	MGI:6415670	Endonuclease-mediated	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^em1Qhs Endonuclease-mediated			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^em1Smoc	MGI:6415213	Endonuclease-mediated	Null/knockout						Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 Li D, J Med Virol 2022 Oct;94(10):4878-4889	J:319435 J:339217	Gene\|Infection Infection\|SARS-CoV-2_virus	Ace2^em1Smoc Endonuclease-mediated			Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 Gene\|Infection Li D, J Med Virol 2022 Oct;94(10):4878-4889 Infection\|SARS-CoV-2_virus
Ace2^{em2(ACE2/GFP)Mlkn}	MGI:6842319	Endonuclease-mediated	Conditional ready\|Humanized sequence\|Inserted expressed sequence\|Null/knockout\|Reporter						Tang AT, bioRxiv 2021 Dec;():	J:315719	Pathology\|SARS-CoV-2_virus	Ace2^{em2(ACE2/GFP)Mlkn} Endonuclease-mediated			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus
Ace2^em2(ACE2)Gpt	MGI:6452442	Endonuclease-mediated	Inserted expressed sequence	MGI:6514876			growth/size/body immune system respiratory system	MP:0005378 MP:0005387 MP:0005388	Wu X, bioRxiv 2021 Feb;():	J:302150	SARS-CoV-2_virus\|Treatment	Ace2^em2(ACE2)Gpt Endonuclease-mediated	MGI:6514876	growth/size/body immune system respiratory system	Wu X, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Treatment
Ace2^{em2(ACE2)Mlkn}	MGI:7507528	Endonuclease-mediated	Conditional ready\|Humanized sequence\|Inserted expressed sequence\|Null/knockout						Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Ace2^{em2(ACE2)Mlkn} Endonuclease-mediated			Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Ace2^em2Guru	MGI:6763025	Endonuclease-mediated	Humanized sequence						Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787	J:298750	SARS-CoV-2_virus	Ace2^em2Guru Endonuclease-mediated			Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus
Ace2^em2Mccc	MGI:7468714	Endonuclease-mediated	Humanized sequence						Nakandakari-Higa S, Front Immunol 2022;13():1007080	J:335150	Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Ace2^em2Mccc Endonuclease-mediated			Nakandakari-Higa S, Front Immunol 2022;13():1007080 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Ace2^em2Shyy	MGI:6406965	Endonuclease-mediated	Not Specified						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^em2Shyy Endonuclease-mediated			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^em#Yngh	MGI:5752578	Endonuclease-mediated	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^em#Yngh Endonuclease-mediated			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^{tm1(ACE2)Dwnt}	MGI:6469881	Targeted	Humanized sequence\|Inserted expressed sequence						Zhou B, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Ulrich L, bioRxiv 2021 Jun;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Perico L, Sci Rep 2023 Jul 14;13(1):11392 Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120	J:296356 J:305777 J:308620 J:331773 J:338324 J:338414	Infection\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron	Ace2^{tm1(ACE2)Dwnt} Targeted			Zhou B, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus Zhou B, Nature 2021 Apr;592(7852):122-127 Infection\|SARS-CoV-2_virus Ulrich L, bioRxiv 2021 Jun;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Perico L, Sci Rep 2023 Jul 14;13(1):11392 Pathology\|SARS-CoV-2_virus\|Treatment Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron
Ace2^{tm1a(KOMP)Wtsi}	MGI:4820112	Targeted	Conditional ready\|Null/knockout\|Reporter						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^{tm1a(KOMP)Wtsi} Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^{tm1c(KOMP)Wtsi}	MGI:6415205	Targeted	Conditional ready						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Ace2^{tm1c(KOMP)Wtsi} Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^tm1Cof	MGI:3665270	Targeted	Null/knockout						Ji H, Hypertension 2020 Aug;76(2):478-487 Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:290256 J:296535	Gene SARS-CoV-2_virus	Ace2^tm1Cof Targeted			Ji H, Hypertension 2020 Aug;76(2):478-487 Gene Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Ace2^tm1Hira	MGI:3794966	Targeted	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165 Wang Y, FASEB J 2021 Mar;35(3):e21419	J:296535 J:309535	SARS-CoV-2_virus Gene	Ace2^tm1Hira Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Wang Y, FASEB J 2021 Mar;35(3):e21419 Gene
Ace2^tm1Lex	MGI:5007005	Targeted	Null/knockout						Jia H, Nat Commun 2020 Oct 14;11(1):5165 Bilinska K, bioRxiv 2021 Apr;():	J:296535 J:304622	SARS-CoV-2_virus Gene	Ace2^tm1Lex Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Bilinska K, bioRxiv 2021 Apr;(): Gene
Ace2^tm1Pngr	MGI:2661723	Targeted	Null/knockout	MGI:5912243 MGI:6402915			cardiovascular system immune system	MP:0005385 MP:0005387	Kuba K, Nat Med 2005 Aug;11(8):875-9 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Gawish R, Elife 2022 Jan 13;11():e74623	J:286299 J:294026 J:296535 J:318828	Infection\|SARS-CoV_virus SARS-CoV-2_virus\|SARS-CoV_virus SARS-CoV-2_virus Pathology\|SARS-CoV-2-MA_virus	Ace2^tm1Pngr Targeted	MGI:5912243 MGI:6402915	cardiovascular system immune system	Kuba K, Nat Med 2005 Aug;11(8):875-9 Infection\|SARS-CoV_virus Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus\|SARS-CoV_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus
Ace^tm4Keb	MGI:2665017	Targeted	Null/knockout						Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943	J:294060	SARS-CoV-2_virus	Ace^tm4Keb Targeted			Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 SARS-CoV-2_virus
Ace^tm7Keb	MGI:3783350	Targeted	Modified isoform(s)						Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943	J:294060	SARS-CoV-2_virus	Ace^tm7Keb Targeted			Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 SARS-CoV-2_virus
Adar^tm1.1Phs	MGI:3828307	Targeted	Conditional ready\|No functional change						Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038	J:333092	Gene\|VOC_B.1.351_Beta	Adar^tm1.1Phs Targeted			Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 Gene\|VOC_B.1.351_Beta
Adh5^{Gt(IST12290F1)Tigm}	MGI:4065198	Gene trapped	Null/knockout\|Reporter						Kim J, Front Pharmacol 2023;14():1304697	J:343781	SARS-CoV-2_virus\|Treatment	Adh5^{Gt(IST12290F1)Tigm} Gene trapped			Kim J, Front Pharmacol 2023;14():1304697 SARS-CoV-2_virus\|Treatment
Aicda^{tm1.1(cre/ERT2)Crey}	MGI:4437052	Targeted	Inducible\|Null/knockout\|Recombinase						Gregoire C, bioRxiv 2021 Dec;():	J:316768	SARS-CoV-2_virus	Aicda^{tm1.1(cre/ERT2)Crey} Targeted			Gregoire C, bioRxiv 2021 Dec;(): SARS-CoV-2_virus
Aicda^tm1Hon	MGI:2156156	Targeted	Null/knockout						Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	Aicda^tm1Hon Targeted			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
Aim2^tm1.1Vmd	MGI:5428935	Targeted	Null/knockout						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Aim2^tm1.1Vmd Targeted			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Apaf1^tm1Her	MGI:1860245	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Apaf1^tm1Her Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Apoe^{tm1(APOE*2)Mae}	MGI:2158396	Targeted	Humanized sequence\|Inserted expressed sequence						Ostendorf BN, Nature 2022 Nov;611(7935):346-351	J:340480	Gene\|SARS-CoV-2-MA_virus	Apoe^{tm1(APOE*2)Mae} Targeted			Ostendorf BN, Nature 2022 Nov;611(7935):346-351 Gene\|SARS-CoV-2-MA_virus
Apoe^{tm2(APOE*3)Mae}	MGI:2157240	Targeted	Humanized sequence\|Inserted expressed sequence\|Modified isoform(s)\|Null/knockout						Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378	J:305558	SARS-CoV-2_virus	Apoe^{tm2(APOE*3)Mae} Targeted			Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 SARS-CoV-2_virus
Apoe^{tm3(APOE*4)Mae}	MGI:2158398	Targeted	Humanized sequence\|Inserted expressed sequence						Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 Ostendorf BN, Nature 2022 Nov;611(7935):346-351	J:305558 J:340480	SARS-CoV-2_virus Gene\|SARS-CoV-2-MA_virus	Apoe^{tm3(APOE*4)Mae} Targeted			Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 SARS-CoV-2_virus Ostendorf BN, Nature 2022 Nov;611(7935):346-351 Gene\|SARS-CoV-2-MA_virus
App^tm3.1Tcs	MGI:5637817	Targeted	Humanized sequence						Magusali N, bioRxiv 2021 Mar;():	J:303205	Comorbidity	App^tm3.1Tcs Targeted			Magusali N, bioRxiv 2021 Mar;(): Comorbidity
Atg5^tm1Myok	MGI:3663625	Targeted	Conditional ready\|No functional change						Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5	J:282479	Mouse_Hepatitis_virus	Atg5^tm1Myok Targeted			Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Mouse_Hepatitis_virus
B2m^tm1Unc	MGI:1857133	Targeted	Null/knockout						Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83	J:308658 J:33974 J:54035	SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	B2m^tm1Unc Targeted			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83 Mouse_Hepatitis_virus\|Pathology
Batf3^tm1Kmm	MGI:3817232	Targeted	Null/knockout						Ndeupen S, bioRxiv 2021 Aug;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:308580 J:345954	SARS-CoV-2_virus\|Vaccine Infection\|MERS-CoV-MA_virus	Batf3^tm1Kmm Targeted			Ndeupen S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
Bcl6^tm1.1Dent	MGI:5518542	Targeted	Conditional ready\|No functional change						Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	Bcl6^tm1.1Dent Targeted			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
Bsg^tm1(BSG)Smoc	MGI:6430241	Targeted	Humanized sequence\|Inserted expressed sequence						Geng J, bioRxiv 2021 May;():	J:308748	SARS-CoV-2_virus	Bsg^tm1(BSG)Smoc Targeted			Geng J, bioRxiv 2021 May;(): SARS-CoV-2_virus
C1qa^{tm1d(EUCOMM)Wtsi}	MGI:6151469	Targeted	Null/knockout						Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	C1qa^{tm1d(EUCOMM)Wtsi} Targeted			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
C3^tm1Crr	MGI:1861799	Targeted	Null/knockout	MGI:3799624			homeostasis/metabolism immune system nervous system vision/eye	MP:0005376 MP:0005387 MP:0003631 MP:0005391	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	C3^tm1Crr Targeted	MGI:3799624	homeostasis/metabolism immune system nervous system vision/eye	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
C4b^tm1Crr	MGI:1889070	Targeted	Null/knockout	MGI:5296003			homeostasis/metabolism immune system renal/urinary system	MP:0005376 MP:0005387 MP:0005367	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	C4b^tm1Crr Targeted	MGI:5296003	homeostasis/metabolism immune system renal/urinary system	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
C5ar1^{tm1.1(C5AR1)Cmac}	MGI:6449073	Targeted	Humanized sequence\|Inserted expressed sequence\|Null/knockout						Carvelli J, Nature 2020 Jul 29;():	J:291890	Pathology\|SARS-CoV-2_virus\|Treatment	C5ar1^{tm1.1(C5AR1)Cmac} Targeted			Carvelli J, Nature 2020 Jul 29;(): Pathology\|SARS-CoV-2_virus\|Treatment
Casp1^tm1Flv	MGI:2158744	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;(): Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854	J:292665 J:298138 J:323769 J:331762 J:331829	SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus Gene\|Pathology	Casp1^tm1Flv Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus
Casp1^tm1Gne	MGI:5882087	Targeted	Null/knockout						Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118	J:313327	SARS-CoV-2_virus\|Vaccine	Casp1^tm1Gne Targeted			Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus\|Vaccine
Casp1^tm1Sesh	MGI:1927822	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp1^tm1Sesh Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp3^tm1Flv	MGI:2158753	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp3^tm1Flv Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp4^del	MGI:5473345	Spontaneous	Null/knockout						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Casp4^del Spontaneous			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Casp4^tm1.1Vmd	MGI:5468949	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp4^tm1.1Vmd Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp4^tm1Yuan	MGI:2159366	Targeted	Null/knockout						Eltobgy M, bioRxiv 2021;(): Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119	J:311911 J:331823	Gene\|SARS-CoV-2-MA_virus Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	Casp4^tm1Yuan Targeted			Eltobgy M, bioRxiv 2021;(): Gene\|SARS-CoV-2-MA_virus Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Casp7^tm1Flv	MGI:3603317	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Casp7^tm1Flv Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Casp8^tm1.1Raz	MGI:5546196	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:296686 J:298138	Pathology\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus	Casp8^tm1.1Raz Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Ccl2^tm1Rol	MGI:2175911	Targeted	Null/knockout						Held KS, Virology 2004 Nov 24;329(2):251-60	J:102446	Infection\|Mouse_Hepatitis_virus	Ccl2^tm1Rol Targeted			Held KS, Virology 2004 Nov 24;329(2):251-60 Infection\|Mouse_Hepatitis_virus
Ccr1^tm1Gao	MGI:1931850	Targeted	Null/knockout	MGI:3614443	Coronavirus infectious disease	DOID:0080599	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	Ccr1^tm1Gao Targeted	MGI:3614443	cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
Ccr2^tm1Ifc	MGI:2158213	Targeted	Null/knockout	MGI:3580323			cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging	MP:0005384 MP:0005397 MP:0005387 MP:0003631 MP:0005390 MP:0002006 MP:0010768	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92	J:106738	Mouse_Hepatitis_virus\|Pathology	Ccr2^tm1Ifc Targeted	MGI:3580323	cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Mouse_Hepatitis_virus\|Pathology
Ccr2^tm1Mae	MGI:2158345	Targeted	Null/knockout	MGI:3841005	age related macular degeneration Coronavirus infectious disease	DOID:10871 DOID:0080599	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye	MP:0005386 MP:0005385 MP:0005397 MP:0005387 MP:0003631 MP:0001186 MP:0005388 MP:0005391	Held KS, Virology 2004 Nov 24;329(2):251-60 Glass WG, Virology 2001 Sep 15;288(1):8-17 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:102446 J:102561 J:162707	Infection\|Mouse_Hepatitis_virus Mouse_Hepatitis_virus Pathology\|SARS-CoV-MA_virus	Ccr2^tm1Mae Targeted	MGI:3841005	behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye age related macular degeneration Coronavirus infectious disease	Held KS, Virology 2004 Nov 24;329(2):251-60 Infection\|Mouse_Hepatitis_virus Glass WG, Virology 2001 Sep 15;288(1):8-17 Mouse_Hepatitis_virus Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
Ccr5^tm1Kuz	MGI:1861911	Targeted	Null/knockout	MGI:4418655	Coronavirus infectious disease	DOID:0080599	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging	MP:0005386 MP:0005385 MP:0005387 MP:0003631 MP:0005388 MP:0005391 MP:0010768	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology\|SARS-CoV-MA_virus	Ccr5^tm1Kuz Targeted	MGI:4418655	behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging Coronavirus infectious disease	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus
Ccr9^tm1Lov	MGI:3654108	Targeted	Null/knockout						Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:308730 J:327836	Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	Ccr9^tm1Lov Targeted			Schafer A, bioRxiv 2021 May;(): Pathology\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
Cd19^tm1(cre)Cgn	MGI:1931143	Targeted	Recombinase						Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Atkinson JR, J Virol 2017 Dec 1;91(23): Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682	J:143484 J:253411 J:322643 J:333746 J:336666	Mouse_Hepatitis_virus SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine Comorbidity\|SARS-CoV-2_virus	Cd19^tm1(cre)Cgn Targeted			Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus Atkinson JR, J Virol 2017 Dec 1;91(23): Mouse_Hepatitis_virus Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Comorbidity\|SARS-CoV-2_virus
Cd1^tm1Gru	MGI:1857482	Targeted	Null/knockout						Johansen MD, Mucosal Immunol 2020 Aug 20;(): Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:295350 J:92752	MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Infection\|SARS-CoV_virus	Cd1^tm1Gru Targeted			Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
Cd274^tm1Lpc	MGI:3043876	Targeted	Null/knockout						Phares TW, J Immunol 2009 May 1;182(9):5430-8 Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Phares TW, J Neuroinflammation 2012 Dec 14;9():269	J:147948 J:165192 J:331800	Mouse_Hepatitis_virus Gene\|Mouse_Hepatitis_virus	Cd274^tm1Lpc Targeted			Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Mouse_Hepatitis_virus Phares TW, J Neuroinflammation 2012 Dec 14;9():269 Gene\|Mouse_Hepatitis_virus
Cd47^tm1Fpl	MGI:1861955	Targeted	Null/knockout						Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	Cd47^tm1Fpl Targeted			Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
Cd4^tm1Knw	MGI:1857143	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	Cd4^tm1Knw Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
Cd4^tm1Litt	MGI:1857281	Targeted	Null/knockout						Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	Cd4^tm1Litt Targeted			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
Cd4^tm1Mak	MGI:1857144	Targeted	Null/knockout						Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Chakravarty D, J Virol 2020 Jul 1;94(14):	J:112983 J:290222	Mouse_Hepatitis_virus Mouse_Hepatitis_virus\|Pathology	Cd4^tm1Mak Targeted			Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Mouse_Hepatitis_virus Chakravarty D, J Virol 2020 Jul 1;94(14): Mouse_Hepatitis_virus\|Pathology
Cd79a^tm1(cre)Reth	MGI:3687451	Targeted	Null/knockout\|Recombinase						Kotagiri P, EBioMedicine 2022 Feb 18;77():103878	J:322643	SARS-CoV-2_virus	Cd79a^tm1(cre)Reth Targeted			Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus
Cd8a^tm1Mak	MGI:1857149	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	Cd8a^tm1Mak Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
Ceacam1^Hv2-r	MGI:3053078	Spontaneous		MGI:3719417			immune system	MP:0005387	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8	J:240703 J:3241 J:701 J:92495	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Ceacam1^Hv2-r Spontaneous	MGI:3719417	immune system	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Mouse_Hepatitis_virus Yokomori K, J Virol 1992 Dec;66(12):6931-8 Mouse_Hepatitis_virus Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Mouse_Hepatitis_virus Dveksler GS, J Virol 1993 Jan;67(1):1-8 Infection\|Mouse_Hepatitis_virus
Ceacam1^Hv2-s	MGI:3027072	Spontaneous		MGI:3719418			immune system	MP:0005387	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8	J:240703 J:3241 J:701 J:92495	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Ceacam1^Hv2-s Spontaneous	MGI:3719418	immune system	Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Mouse_Hepatitis_virus Yokomori K, J Virol 1992 Dec;66(12):6931-8 Mouse_Hepatitis_virus Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Mouse_Hepatitis_virus Dveksler GS, J Virol 1993 Jan;67(1):1-8 Infection\|Mouse_Hepatitis_virus
Ceacam1^tm1.1Fta	MGI:5496530	Targeted	Inserted expressed sequence	MGI:5496535			immune system mortality/aging	MP:0005387 MP:0010768	Hirai A, J Virol 2010 Jul;84(13):6654-66	J:198335	Infection\|Mouse_Hepatitis_virus	Ceacam1^tm1.1Fta Targeted	MGI:5496535	immune system mortality/aging	Hirai A, J Virol 2010 Jul;84(13):6654-66 Infection\|Mouse_Hepatitis_virus
Ceacam1^tm1Bcn	MGI:2180785	Targeted	Null/knockout	MGI:2656211			immune system mortality/aging	MP:0005387 MP:0010768	Blau DM, J Virol 2001 Sep;75(17):8173-86 Hemmila E, J Virol 2004 Sep;78(18):10156-65	J:70815 J:92376	Infection\|Mouse_Hepatitis_virus	Ceacam1^tm1Bcn Targeted	MGI:2656211	immune system mortality/aging	Blau DM, J Virol 2001 Sep;75(17):8173-86 Infection\|Mouse_Hepatitis_virus Hemmila E, J Virol 2004 Sep;78(18):10156-65 Infection\|Mouse_Hepatitis_virus
Ceacam1^tm2Bcn	MGI:3053071	Targeted	Null/knockout	MGI:3053437			digestive/alimentary system homeostasis/metabolism immune system neoplasm	MP:0005381 MP:0005376 MP:0005387 MP:0002006	Miura TA, J Virol 2008 Jan;82(2):755-63 Hemmila E, J Virol 2004 Sep;78(18):10156-65	J:130131 J:92376	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Ceacam1^tm2Bcn Targeted	MGI:3053437	digestive/alimentary system homeostasis/metabolism immune system neoplasm	Miura TA, J Virol 2008 Jan;82(2):755-63 Mouse_Hepatitis_virus Hemmila E, J Virol 2004 Sep;78(18):10156-65 Infection\|Mouse_Hepatitis_virus
Ces1c^tm1.1Loc	MGI:4938302	Targeted	Null/knockout						Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 Martinez DR, bioRxiv 2021 Jan;(): Zhu C, Nat Commun 2022 Aug 3;13(1):4503	J:286362 J:286402 J:298752 J:302135 J:335969	MERS-CoV_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|Treatment SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment	Ces1c^tm1.1Loc Targeted			Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): MERS-CoV_virus\|SARS-CoV_virus\|Treatment Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 MERS-CoV_virus\|Treatment Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Martinez DR, bioRxiv 2021 Jan;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus\|Treatment
Cfb^tm1Hrc	MGI:1861129	Targeted	Null/knockout	MGI:3771614			immune system	MP:0005387	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology\|SARS-CoV-MA_virus	Cfb^tm1Hrc Targeted	MGI:3771614	immune system	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology\|SARS-CoV-MA_virus
Ch25h^tm1Rus	MGI:4947407	Targeted	Null/knockout						Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648	J:343658	SARS-CoV-2_virus	Ch25h^tm1Rus Targeted			Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus
Ciita^tm1Ccum	MGI:1857456	Targeted	Null/knockout						Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus\|VOC_B.1.351_Beta	Ciita^tm1Ccum Targeted			Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta
Cmpk2^{tm1c(KOMP)Wtsi}	MGI:6753388	Targeted	Conditional ready						Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11	J:308159	Pathology\|SARS-CoV-2_virus\|Treatment	Cmpk2^{tm1c(KOMP)Wtsi} Targeted			Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 Pathology\|SARS-CoV-2_virus\|Treatment
Col1a1^{tm1(tetO-Cpt1a,-GFP)Slms}	MGI:7564295	Targeted	Inducible\|Inserted expressed sequence						Miguel V, Redox Biol 2023 Dec;68():102957	J:343262	Treatment	Col1a1^{tm1(tetO-Cpt1a,-GFP)Slms} Targeted			Miguel V, Redox Biol 2023 Dec;68():102957 Treatment
Commd10^{Tg(Vav1-icre)A2Kio}	MGI:2449949	Transgenic	Null/knockout\|Recombinase						Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Commd10^{Tg(Vav1-icre)A2Kio} Transgenic			Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Csf1^{tm1.1(CSF1)Flv}	MGI:5296679	Targeted	Humanized sequence\|Inserted expressed sequence						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Csf1^{tm1.1(CSF1)Flv} Targeted			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Csf2/Il3^{tm1.1(CSF2,IL3)Flv}	MGI:4887881	Targeted	Humanized sequence\|Inserted expressed sequence						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Targeted			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Csf2^tm1Mlg	MGI:1930996	Targeted	Null/knockout						Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection\|MERS-CoV-MA_virus	Csf2^tm1Mlg Targeted			Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
Ctnnb1^tm1Knw	MGI:3767601	Targeted	Conditional ready						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Ctnnb1^tm1Knw Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Cx3cr1^tm1Litt	MGI:2670351	Targeted	Null/knockout\|Reporter						Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943	J:291614	Mouse_Hepatitis_virus	Cx3cr1^tm1Litt Targeted			Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Mouse_Hepatitis_virus
Cx3cr1^{tm2.1(cre/ERT2)Litt}	MGI:5450813	Targeted	Inducible\|Recombinase\|Reporter						Verma AK, mBio 2021 Oct 26;12(5):e0196921	J:313438	Mouse_Hepatitis_virus	Cx3cr1^{tm2.1(cre/ERT2)Litt} Targeted			Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus
Cxcl10^tm1Adl	MGI:2180678	Targeted	Null/knockout						Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80	J:140673	Mouse_Hepatitis_virus	Cxcl10^tm1Adl Targeted			Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80 Mouse_Hepatitis_virus
Cxcl13^tm1Cys	MGI:2384500	Targeted	Null/knockout\|Reporter						Phares TW, Brain Behav Immun 2016 May;54():128-139	J:316468	Mouse_Hepatitis_virus	Cxcl13^tm1Cys Targeted			Phares TW, Brain Behav Immun 2016 May;54():128-139 Mouse_Hepatitis_virus
Cxcl5^tm1Gscw	MGI:4819800	Targeted	Null/knockout						Liang Y, Zool Res 2020 Oct 12;():1-29	J:296738	Infection\|Pathology\|SARS-CoV-2_virus	Cxcl5^tm1Gscw Targeted			Liang Y, Zool Res 2020 Oct 12;():1-29 Infection\|Pathology\|SARS-CoV-2_virus
Cxcr3^tm1Dgen	MGI:3604545	Targeted	Null/knockout\|Reporter						McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	Cxcr3^tm1Dgen Targeted			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
Cxcr6^tm1Litt	MGI:3613526	Targeted	Null/knockout\|Reporter						Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:327836	SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus	Cxcr6^tm1Litt Targeted			Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus\|SARS-CoV-MA_virus
Dpp4^em1Rba	MGI:6400423	Endonuclease-mediated	Humanized sequence	MGI:6400425	Middle East respiratory syndrome	DOID:0080642	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Leist SR, PLoS One 2019;14(7):e0220126 Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, Methods Mol Biol 2020;2099():137-159 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Menachery VD, mBio 2017 Aug 22;8(4): Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3):	J:279723 J:279834 J:285962 J:286320 J:286402 J:287147 J:295349 J:295350 J:300138	MERS-CoV_virus\|Pathology MERS-CoV_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|Treatment Infection\|MERS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus	Dpp4^em1Rba Endonuclease-mediated	MGI:6400425	cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome	Leist SR, PLoS One 2019;14(7):e0220126 MERS-CoV_virus\|Pathology Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 MERS-CoV_virus Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 MERS-CoV_virus\|Treatment Menachery VD, mBio 2017 Aug 22;8(4): Infection\|MERS-CoV_virus Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): MERS-CoV_virus
Dpp4^{em2(DPP4)Smoc}	MGI:6415291	Endonuclease-mediated	Inserted expressed sequence						Xia LY, Nat Commun 2024 Feb 5;15(1):1048	J:353426	Infection	Dpp4^{em2(DPP4)Smoc} Endonuclease-mediated			Xia LY, Nat Commun 2024 Feb 5;15(1):1048 Infection
Dpp4^{tm1.1(DPP4)Pbmj}	MGI:6400999	Targeted	Humanized sequence\|Inserted expressed sequence	MGI:6401000	Middle East respiratory syndrome	DOID:0080642	cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Leist SR, Methods Mol Biol 2020;2099():137-159 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Li K, mBio 2020 Apr 7;11(2): Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): Zheng J, J Clin Invest 2021 Jun 1;131(11): Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 Wong L-YR, mBio 2023 Oct 26;14(6):e0247623	J:242025 J:285962 J:286329 J:287921 J:288107 J:295349 J:295350 J:300104 J:300138 J:311966 J:315826 J:343780	Infection\|MERS-CoV-MA_virus\|Pathology MERS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Infection\|MERS-CoV-MA_virus\|Treatment MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Comorbidity\|MERS-CoV_virus MERS-CoV_virus\|Vaccine MERS-CoV-MA_virus\|Pathology\|SARS-CoV-2_virus	Dpp4^{tm1.1(DPP4)Pbmj} Targeted	MGI:6401000	cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome	Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Infection\|MERS-CoV-MA_virus\|Pathology Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Jia W, Emerg Microbes Infect 2019;8(1):760-772 MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Li K, mBio 2020 Apr 7;11(2): MERS-CoV-MA_virus\|MERS-CoV_virus\|Vaccine Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection\|MERS-CoV-MA_virus\|Treatment Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): MERS-CoV_virus Zheng J, J Clin Invest 2021 Jun 1;131(11): Comorbidity\|MERS-CoV_virus Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 MERS-CoV_virus\|Vaccine Wong L-YR, mBio 2023 Oct 26;14(6):e0247623 MERS-CoV-MA_virus\|Pathology\|SARS-CoV-2_virus
Dpp4^{tm1(DPP4)Vlcg}	MGI:5788094	Targeted	Inserted expressed sequence\|Null/knockout	MGI:6400455 MGI:6435210	Middle East respiratory syndrome	DOID:0080642	immune system respiratory system hematopoietic system homeostasis/metabolism	MP:0005387 MP:0005388 MP:0005397 MP:0005376	Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Coleman CM, J Virol 2017 Jan 01;91(1): Leist SR, Methods Mol Biol 2020;2099():137-159 Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Singh A, Virol Sin 2020 Jun;35(3):290-304	J:223728 J:238079 J:285962 J:286238 J:295349	Infection\|MERS-CoV_virus\|Treatment MERS-CoV_virus\|Pathology MERS-CoV_virus Comorbidity\|MERS-CoV_virus\|Pathology MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Dpp4^{tm1(DPP4)Vlcg} Targeted	MGI:6400455 MGI:6435210	immune system respiratory system Middle East respiratory syndrome hematopoietic system homeostasis/metabolism	Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Infection\|MERS-CoV_virus\|Treatment Coleman CM, J Virol 2017 Jan 01;91(1): MERS-CoV_virus\|Pathology Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Comorbidity\|MERS-CoV_virus\|Pathology Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Dyrk1a^tm1Jdc	MGI:5648391	Targeted	Conditional ready\|No functional change						Strine MS, PLoS Biol 2023 Jun;21(6):e3002097	J:341033	Gene\|MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Dyrk1a^tm1Jdc Targeted			Strine MS, PLoS Biol 2023 Jun;21(6):e3002097 Gene\|MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Ebi3^Gt716Lex	MGI:3793965	Gene trapped	Null/knockout\|Reporter	MGI:6442003			hematopoietic system immune system nervous system mortality/aging	MP:0005397 MP:0005387 MP:0003631 MP:0010768	Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6	J:286951	Infection\|Mouse_Hepatitis_virus	Ebi3^Gt716Lex Gene trapped	MGI:6442003	hematopoietic system immune system nervous system mortality/aging	Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6 Infection\|Mouse_Hepatitis_virus
Edil3^{Tg(Sox2-cre)1Amc}	MGI:2656539	Transgenic	Null/knockout\|Recombinase						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Edil3^{Tg(Sox2-cre)1Amc} Transgenic			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Egfr^Mhdadsk5	MGI:2682255	Chemically induced (ENU)							Venkataraman T, J Virol 2017 Jun 15;91(12):	J:243599	Pathology\|SARS-CoV-MA_virus	Egfr^Mhdadsk5 Chemically induced (ENU)			Venkataraman T, J Virol 2017 Jun 15;91(12): Pathology\|SARS-CoV-MA_virus
Eif2ak2^tm1Cwe	MGI:2182566	Targeted	Null/knockout						Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195	J:291588	HCoV-229E_virus\|Mouse_Hepatitis_virus	Eif2ak2^tm1Cwe Targeted			Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus\|Mouse_Hepatitis_virus
Elane^tm1Sds	MGI:2182771	Targeted	Null/knockout						Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118	J:313327	SARS-CoV-2_virus\|Vaccine	Elane^tm1Sds Targeted			Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus\|Vaccine
Epor^{tm1.1(EGFP/icre)Uk}	MGI:3052727	Targeted	Null/knockout\|Recombinase\|Reporter						Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008	J:325468	SARS-CoV-2_virus	Epor^{tm1.1(EGFP/icre)Uk} Targeted			Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008 SARS-CoV-2_virus
Fadd^tm1Mak	MGI:2159360	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Fadd^tm1Mak Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Fadd^tm1Mpa	MGI:3700154	Targeted	Conditional ready\|No functional change						Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533	J:323957	Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta	Fadd^tm1Mpa Targeted			Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta
Fcer1g^tm1Rav	MGI:1857165	Targeted	Null/knockout						Adams LE, Cell Rep 2023 Mar 30;42(4):112326	J:349062	SARS-CoV-2-MA_virus\|Vaccine	Fcer1g^tm1Rav Targeted			Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus\|Vaccine
Fcgrt^tm1Dcr	MGI:3511510	Targeted	Null/knockout						Halwe S, bioRxiv 2021 Jun;():	J:308648	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	Fcgrt^tm1Dcr Targeted			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
Fga^tm1Jld	MGI:2152976	Targeted	Null/knockout						Ryu JK, bioRxiv 2021;():	J:311923	SARS-CoV-2_virus\|Treatment	Fga^tm1Jld Targeted			Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment
Fgg^tm2Jld	MGI:3046446	Targeted							Ryu JK, bioRxiv 2021;():	J:311923	SARS-CoV-2_virus\|Treatment	Fgg^tm2Jld Targeted			Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment
Fgl2^tm1Pam	MGI:3582343	Targeted	Null/knockout\|Reporter	MGI:3583696 MGI:3583697	autoimmune glomerulonephritis	DOID:0040094	cardiovascular system homeostasis/metabolism immune system mortality/aging cellular growth/size/body hematopoietic system renal/urinary system	MP:0005385 MP:0005376 MP:0005387 MP:0010768 MP:0005384 MP:0005378 MP:0005397 MP:0005367	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66	J:99453	Mouse_Hepatitis_virus	Fgl2^tm1Pam Targeted	MGI:3583696 MGI:3583697	cardiovascular system homeostasis/metabolism immune system mortality/aging cellular growth/size/body hematopoietic system renal/urinary system autoimmune glomerulonephritis	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 Mouse_Hepatitis_virus
Foxg1^{tm1.1(cre)Ddmo}	MGI:5818697	Targeted	Recombinase						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Foxg1^{tm1.1(cre)Ddmo} Targeted			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Foxp3^tm2Ayr	MGI:3574964	Targeted	No functional change\|Reporter						Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7	J:177608	Mouse_Hepatitis_virus	Foxp3^tm2Ayr Targeted			Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7 Mouse_Hepatitis_virus
Foxp3^tm2Tch	MGI:3699400	Targeted	Reporter						Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279 Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997	J:247329 J:324704	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus	Foxp3^tm2Tch Targeted			Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279 Mouse_Hepatitis_virus Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 Infection\|Mouse_Hepatitis_virus
Foxp3^{tm3(HBEGF/GFP)Ayr}	MGI:3698131	Targeted	Inserted expressed sequence\|Reporter						Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085	J:327784	SARS-CoV-2_virus	Foxp3^{tm3(HBEGF/GFP)Ayr} Targeted			Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085 SARS-CoV-2_virus
Foxp3^{tm4(YFP/icre)Ayr}	MGI:3790499	Targeted	Recombinase						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Foxp3^{tm4(YFP/icre)Ayr} Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Foxp3^{tm9(EGFP/cre/ERT2)Ayr}	MGI:4950935	Targeted	Inducible\|Recombinase\|Reporter						Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997	J:324704	Infection\|Mouse_Hepatitis_virus	Foxp3^{tm9(EGFP/cre/ERT2)Ayr} Targeted			Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 Infection\|Mouse_Hepatitis_virus
G3bp1^em1Gpt	MGI:7299354	Endonuclease-mediated	Conditional ready\|No functional change						Liu H, J Virol 2022 Jun 22;96(12):e0041222	J:342298	Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	G3bp1^em1Gpt Endonuclease-mediated			Liu H, J Virol 2022 Jun 22;96(12):e0041222 Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Gbp2^tm1.1Kpf	MGI:5475104	Targeted	Null/knockout\|Reporter						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Gbp2^tm1.1Kpf Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Gpr183^{tm1.1(KOMP)Vlcg}	MGI:5617257	Targeted	Null/knockout\|Reporter						Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648	J:343658	SARS-CoV-2_virus	Gpr183^{tm1.1(KOMP)Vlcg} Targeted			Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus
Gsdmd^em1Tdk	MGI:6342025	Endonuclease-mediated	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119	J:296686 J:298138 J:331823	Pathology\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	Gsdmd^em1Tdk Endonuclease-mediated			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Gsdmd^em4Fcw	MGI:6196334	Endonuclease-mediated	Null/knockout						Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	Gsdmd^em4Fcw Endonuclease-mediated			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
Gsdme^{tm1a(KOMP)Wtsi}	MGI:4363231	Targeted	Conditional ready\|Null/knockout\|Reporter						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Gsdme^{tm1a(KOMP)Wtsi} Targeted			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Gt(ROSA)26Sor^{em1(CAG-ACE2)Mlkn}	MGI:6842323	Endonuclease-mediated	Conditional ready\|Humanized sequence\|Inserted expressed sequence						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Gao S, Front Cardiovasc Med 2023;10():1266276	J:315719 J:337814 J:346048	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus	Gt(ROSA)26Sor^{em1(CAG-ACE2)Mlkn} Endonuclease-mediated			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Gao S, Front Cardiovasc Med 2023;10():1266276 Infection\|SARS-CoV-2_virus
Gt(ROSA)26Sor^{em1(CAG-N,CAG-ACE2)Liwe}	MGI:7570165	Endonuclease-mediated	Conditional ready\|Epitope tag\|Humanized sequence\|Inserted expressed sequence						Yang B, Cell Discov 2023 Apr 20;9(1):43	J:338826	Infection\|Pathology\|SARS-CoV-2_virus	Gt(ROSA)26Sor^{em1(CAG-N,CAG-ACE2)Liwe} Endonuclease-mediated			Yang B, Cell Discov 2023 Apr 20;9(1):43 Infection\|Pathology\|SARS-CoV-2_virus
Gt(ROSA)26Sor^{em1(DPP4)Yowa}	MGI:6403442	Endonuclease-mediated	Humanized sequence\|Inserted expressed sequence\|Reporter	MGI:6403447	Middle East respiratory syndrome	DOID:0080642	immune system nervous system	MP:0005387 MP:0003631	Fan C, Viruses 2018 Aug 23;10(9): Zhou H, Nat Commun 2019 Jul 11;10(1):3068 Singh A, Virol Sin 2020 Jun;35(3):290-304	J:279060 J:279324 J:295349	Infection\|MERS-CoV_virus\|Pathology\|Treatment MERS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Gt(ROSA)26Sor^{em1(DPP4)Yowa} Endonuclease-mediated	MGI:6403447	immune system nervous system Middle East respiratory syndrome	Fan C, Viruses 2018 Aug 23;10(9): Infection\|MERS-CoV_virus\|Pathology\|Treatment Zhou H, Nat Commun 2019 Jul 11;10(1):3068 MERS-CoV_virus Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Gt(ROSA)26Sor^{tm1.1(Ace2)Spo}	MGI:6406372	Targeted	Inserted expressed sequence						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Gt(ROSA)26Sor^{tm1.1(Ace2)Spo} Targeted			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}	MGI:3809524	Targeted	Conditional ready\|Reporter						Pan R, Proc Natl Acad Sci U S A 2020 Jul 7;117(27):15902-15910 Tang AT, bioRxiv 2021 Dec;(): Nakandakari-Higa S, Front Immunol 2022;13():1007080 Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:291543 J:315719 J:335150 J:337814	Infection\|Mouse_Hepatitis_virus Pathology\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze} Targeted			Pan R, Proc Natl Acad Sci U S A 2020 Jul 7;117(27):15902-15910 Infection\|Mouse_Hepatitis_virus Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Nakandakari-Higa S, Front Immunol 2022;13():1007080 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}	MGI:2669525	Targeted	Inducible\|Recombinase						Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658	J:326929	Gene	Gt(ROSA)26Sor^{tm1(cre/ERT)Nat} Targeted			Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene
Gt(ROSA)26Sor^tm1(EYFP)Cos	MGI:2449038	Targeted	Conditional ready\|Reporter						Gregoire C, bioRxiv 2021 Dec;():	J:316768	SARS-CoV-2_virus	Gt(ROSA)26Sor^tm1(EYFP)Cos Targeted			Gregoire C, bioRxiv 2021 Dec;(): SARS-CoV-2_virus
Gt(ROSA)26Sor^tm1(FLP1)Dym	MGI:2429412	Targeted	Recombinase						Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Gt(ROSA)26Sor^tm1(FLP1)Dym Targeted			Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces}	MGI:5004724	Targeted	Conditional ready\|Inserted expressed sequence\|Reporter						Musiu C, Cell Death Differ 2021 Sep 13;():	J:313338	Pathology\|SARS-CoV-2_virus	Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces} Targeted			Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology\|SARS-CoV-2_virus
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}	MGI:3583817	Targeted	Conditional ready\|Reporter\|Transactivator						Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy} Targeted			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
Gt(ROSA)26Sor^{tm9(CAG-tdTomato)Hze}	MGI:3809523	Targeted	Conditional ready\|Reporter						Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997	J:324704	Infection\|Mouse_Hepatitis_virus	Gt(ROSA)26Sor^{tm9(CAG-tdTomato)Hze} Targeted			Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 Infection\|Mouse_Hepatitis_virus
H2-Ab1^b-tm1Doi	MGI:1927483	Targeted	Null/knockout						Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110	J:308658 J:33974	SARS-CoV-2_virus\|Vaccine Mouse_Hepatitis_virus	H2-Ab1^b-tm1Doi Targeted			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus
H2^b	MGI:3579319	Not Applicable							Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83	J:120484	Mouse_Hepatitis_virus	H2^b Not Applicable			Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 Mouse_Hepatitis_virus
H2-K^bm1	MGI:3618114	Spontaneous							Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41	J:161935	Mouse_Hepatitis_virus\|Pathology	H2-K^bm1 Spontaneous			Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology
Hopx^{tm2.1(cre/ERT2)Joe}	MGI:5300731	Targeted	Inducible\|Recombinase						Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Hopx^{tm2.1(cre/ERT2)Joe} Targeted			Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Hrsq10^C57BL/6J	MGI:6404145	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq10^C57BL/6J QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq10^PWK/PhJ	MGI:6404144	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq10^PWK/PhJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq11^C57BL/6J	MGI:6404147	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq11^C57BL/6J QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq11^PWK/PhJ	MGI:6404146	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq11^PWK/PhJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq12^C57BL/6J	MGI:6404149	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq12^C57BL/6J QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq12^PWK/PhJ	MGI:6404148	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq12^PWK/PhJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq1^C57BL/6J	MGI:6403775	QTL							Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504	J:268979	Infection\|SARS-CoV-MA_virus	Hrsq1^C57BL/6J QTL			Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus
Hrsq1^WSB/EiJ	MGI:6403776	QTL							Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504	J:268979	Infection\|SARS-CoV-MA_virus	Hrsq1^WSB/EiJ QTL			Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus
Hrsq2^PWK/PhJ	MGI:6403777	QTL							Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504	J:268979	Infection\|SARS-CoV-MA_virus	Hrsq2^PWK/PhJ QTL			Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus
Hrsq3^A/J	MGI:6403778	QTL							Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504	J:268979	Infection\|SARS-CoV-MA_virus	Hrsq3^A/J QTL			Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus
Hrsq4^CAST/EiJ	MGI:6403779	QTL							Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504	J:268979	Infection\|SARS-CoV-MA_virus	Hrsq4^CAST/EiJ QTL			Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus
Hrsq5^C57BL/6J	MGI:6404143	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq5^C57BL/6J QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq5^PWK/PhJ	MGI:6404142	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq5^PWK/PhJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq6^C57BL/6J	MGI:6404175	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq6^C57BL/6J QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq6^WSB/EiJ	MGI:6404176	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq6^WSB/EiJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq7^129S1/SvImJ	MGI:6404180	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq7^129S1/SvImJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq7^C57BL/6J	MGI:6404178	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq7^C57BL/6J QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq7^PWK/PhJ	MGI:6404177	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq7^PWK/PhJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq7^WSB/EiJ	MGI:6404182	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq7^WSB/EiJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq8^CAST/EiJ	MGI:6404186	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq8^CAST/EiJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq8^NOD/ShiLtJ	MGI:6404183	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq8^NOD/ShiLtJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq8^WSB/EiJ	MGI:6404185	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq8^WSB/EiJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq9^129S1/SvImJ	MGI:6404194	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq9^129S1/SvImJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq9^CAST/EiJ	MGI:6404195	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq9^CAST/EiJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq9^NOD/ShiLtJ	MGI:6404192	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq9^NOD/ShiLtJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq9^NZO/HlLtJ	MGI:6404190	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq9^NZO/HlLtJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Hrsq9^PWK/PhJ	MGI:6404189	QTL							Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Hrsq9^PWK/PhJ QTL			Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Ido1^tm1.1Mkks	MGI:5775113	Targeted	Null/knockout						Grunewald ME, J Virol 2020 Jan 17;94(3):	J:290586	Infection\|Mouse_Hepatitis_virus	Ido1^tm1.1Mkks Targeted			Grunewald ME, J Virol 2020 Jan 17;94(3): Infection\|Mouse_Hepatitis_virus
Ido1^tm1Alm	MGI:3505776	Targeted	Null/knockout						McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	Ido1^tm1Alm Targeted			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
Ifih1^tm1.1Cln	MGI:3663677	Targeted	Null/knockout						Menachery VD, J Virol 2014 Apr;88(8):4251-64 Zalinger ZB, J Virol 2015 Dec 15;89(24):12330-40 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72	J:213001 J:227926 J:242293 J:308903 J:318622	SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment\|Vaccine Infection\|Mouse_Hepatitis_virus Pathology\|SARS-CoV-2_virus Mouse_Hepatitis_virus	Ifih1^tm1.1Cln Targeted			Menachery VD, J Virol 2014 Apr;88(8):4251-64 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment\|Vaccine Zalinger ZB, J Virol 2015 Dec 15;89(24):12330-40 Infection\|Mouse_Hepatitis_virus Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Infection\|Mouse_Hepatitis_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Mouse_Hepatitis_virus
Ifih1^tm1Aki	MGI:3801032	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Ifih1^tm1Aki Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Ifit1^{tm1(KOMP)Vlcg}	MGI:3808310	Targeted	Null/knockout\|Reporter	MGI:6436931			growth/size/body hematopoietic system homeostasis/metabolism immune system nervous system mortality/aging	MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0003631 MP:0010768	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Butchi NB, J Virol 2014 Jan;88(2):1051-64 Menachery VD, J Virol 2014 Apr;88(8):4251-64	J:187561 J:205203 J:213001	Mouse_Hepatitis_virus SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment\|Vaccine	Ifit1^{tm1(KOMP)Vlcg} Targeted	MGI:6436931	growth/size/body hematopoietic system homeostasis/metabolism immune system nervous system mortality/aging	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Butchi NB, J Virol 2014 Jan;88(2):1051-64 Mouse_Hepatitis_virus Menachery VD, J Virol 2014 Apr;88(8):4251-64 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment\|Vaccine
Ifit2^{tm1(KOMP)Vlcg}	MGI:3799963	Targeted	Null/knockout\|Reporter						Das Sarma J, PLoS Pathog 2020 Nov;16(11):e1009034	J:313166	Mouse_Hepatitis_virus	Ifit2^{tm1(KOMP)Vlcg} Targeted			Das Sarma J, PLoS Pathog 2020 Nov;16(11):e1009034 Mouse_Hepatitis_virus
Ifitm3^em1Jsy	MGI:6362958	Endonuclease-mediated	Null/knockout						Zani A, bioRxiv 2021Dec;():	J:316764	Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	Ifitm3^em1Jsy Endonuclease-mediated			Zani A, bioRxiv 2021Dec;(): Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Ifnar1^tm1.1Ees	MGI:5692160	Targeted	Conditional ready\|No functional change						Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	Ifnar1^tm1.1Ees Targeted			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
Ifnar1^tm1.2Ees	MGI:5692167	Targeted	Null/knockout						Israelow B, J Exp Med 2020 Dec 7;217(12): Sun J, Cell 2020 Jun 10;(): Yang J, Nature 2020 Jul 29;(): Mao T, bioRxiv 2021 Jun;(): Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229	J:291862 J:291881 J:292665 J:308656 J:338414 J:343550	Infection\|Pathology\|SARS-CoV-2_virus Infection\|Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus\|Treatment	Ifnar1^tm1.2Ees Targeted			Israelow B, J Exp Med 2020 Dec 7;217(12): Infection\|Pathology\|SARS-CoV-2_virus Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment
Ifnar1^tm1Agt	MGI:1930950	Targeted	Null/knockout	MGI:2654514 MGI:3575517 MGI:6449667			behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system vision/eye mortality/aging cellular	MP:0005386 MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0005391 MP:0010768 MP:0005384	Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Ireland DD, J Virol 2008 Jan;82(1):300-10 Phares TW, J Immunol 2009 May 1;182(9):5430-8 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Menachery VD, J Virol 2014 Apr;88(8):4251-64 Deng X, J Virol 2014 Oct 15;88(20):11886-98 Fehr AR, J Virol 2015 Feb;89(3):1523-36 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Peng X, mBio 2010 Oct 26;1(5): Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Hassan AO, Cell 2020 Jun 10;(): Channappanavar R, Cell Host Microbe 2016 Feb 10;19(2):181-93 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 Malczyk AH, J Virol 2015 Nov;89(22):11654-67 Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:143484 J:144400 J:145215 J:147948 J:187561 J:207380 J:213001 J:214600 J:221981 J:242293 J:276986 J:286237 J:290258 J:291874 J:296686 J:300094 J:300105 J:312515 J:317125 J:318622 J:319459 J:345954	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus Infection\|Mouse_Hepatitis_virus MERS-CoV_virus SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment\|Vaccine Mouse_Hepatitis_virus\|Pathology Infection\|SARS-CoV-MA_virus Pathology\|SARS-CoV-MA_virus Infection\|SARS-CoV-2_virus\|Treatment Gene\|Infection\|Pathology\|SARS-CoV-MA_virus Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine MERS-CoV_virus\|Vaccine SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Infection\|SARS-CoV-2_virus Infection\|MERS-CoV-MA_virus	Ifnar1^tm1Agt Targeted	MGI:2654514 MGI:3575517 MGI:6449667	behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system vision/eye mortality/aging cellular	Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus Ireland DD, J Virol 2008 Jan;82(1):300-10 Infection\|Mouse_Hepatitis_virus Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus Menachery VD, J Virol 2014 Apr;88(8):4251-64 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment\|Vaccine Deng X, J Virol 2014 Oct 15;88(20):11886-98 Mouse_Hepatitis_virus\|Pathology Fehr AR, J Virol 2015 Feb;89(3):1523-36 Mouse_Hepatitis_virus Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Infection\|Mouse_Hepatitis_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Channappanavar R, Cell Host Microbe 2016 Feb 10;19(2):181-93 Gene\|Infection\|Pathology\|SARS-CoV-MA_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 SARS-CoV-2_virus\|Vaccine Malczyk AH, J Virol 2015 Nov;89(22):11654-67 MERS-CoV_virus\|Vaccine Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Mouse_Hepatitis_virus Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Infection\|SARS-CoV-2_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
Ifnar1^tm1Pjh	MGI:2667975	Targeted	Null/knockout						Rawle DJ, bioRxiv 2021 Feb;(): Ogger PP, Eur J Immunol 2022 Nov;52(11):1768-1775	J:302157 J:333792	SARS-CoV-2_virus Infection\|SARS-CoV-2_virus	Ifnar1^tm1Pjh Targeted			Rawle DJ, bioRxiv 2021 Feb;(): SARS-CoV-2_virus Ogger PP, Eur J Immunol 2022 Nov;52(11):1768-1775 Infection\|SARS-CoV-2_virus
Ifnar1^tm1Uka	MGI:2655303	Targeted	Conditional ready\|No functional change						Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106	J:143484	Mouse_Hepatitis_virus	Ifnar1^tm1Uka Targeted			Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus
Ifnar2^tm1Pjh	MGI:2680693	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Rawle DJ, bioRxiv 2021 Feb;():	J:296686 J:302157	Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus	Ifnar2^tm1Pjh Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Rawle DJ, bioRxiv 2021 Feb;(): SARS-CoV-2_virus
Ifngr1^tm1Agt	MGI:1857286	Targeted	Null/knockout	MGI:3575517 MGI:6403197			hematopoietic system immune system mortality/aging	MP:0005397 MP:0005387 MP:0010768	Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Hassan AO, Cell 2020 Jun 10;(): Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Schijns VE, J Immunol 1996 Jul 15;157(2):815-21 Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229	J:131907 J:286237 J:290258 J:300094 J:34040 J:343550	Mouse_Hepatitis_virus Pathology\|SARS-CoV-MA_virus Infection\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus	Ifngr1^tm1Agt Targeted	MGI:3575517 MGI:6403197	hematopoietic system immune system mortality/aging	Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Mouse_Hepatitis_virus Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus Schijns VE, J Immunol 1996 Jul 15;157(2):815-21 Mouse_Hepatitis_virus Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment
Ifng^tm1Ts	MGI:1857184	Targeted	Null/knockout	MGI:4365971			endocrine/exocrine glands hematopoietic system immune system neoplasm mortality/aging	MP:0005379 MP:0005397 MP:0005387 MP:0002006 MP:0010768	Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Phares TW, J Immunol 2009 May 1;182(9):5430-8 Malone KE, Glia 2008 Mar;56(4):426-35 Sun J, Cell 2020 Jun 10;(): Savarin C, J Neuroinflammation 2012 May 29;9():104 France MP, Aust Vet J 1999 Sep;77(9):600-4 Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9	J:112048 J:147948 J:156284 J:291881 J:331807 J:59661 J:88552	Infection\|Mouse_Hepatitis_virus Mouse_Hepatitis_virus Infection\|Pathology\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus\|Pathology	Ifng^tm1Ts Targeted	MGI:4365971	endocrine/exocrine glands hematopoietic system immune system neoplasm mortality/aging	Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Infection\|Mouse_Hepatitis_virus Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus Malone KE, Glia 2008 Mar;56(4):426-35 Mouse_Hepatitis_virus Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment Savarin C, J Neuroinflammation 2012 May 29;9():104 Mouse_Hepatitis_virus France MP, Aust Vet J 1999 Sep;77(9):600-4 Mouse_Hepatitis_virus\|Pathology Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Mouse_Hepatitis_virus
Ifng^tm1Yiw	MGI:3036127	Targeted	Null/knockout	MGI:6430478 MGI:6430488			behavior/neurological digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging	MP:0005386 MP:0005381 MP:0005378 MP:0005376 MP:0005387 MP:0005370 MP:0010768	Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77	J:50405 J:91691	Mouse_Hepatitis_virus\|Pathology Infection\|Mouse_Hepatitis_virus\|Pathology	Ifng^tm1Yiw Targeted	MGI:6430478 MGI:6430488	behavior/neurological digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging	Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Mouse_Hepatitis_virus\|Pathology Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 Infection\|Mouse_Hepatitis_virus\|Pathology
Ifnl2^tm1.1Arte	MGI:7493919	Targeted	No functional change\|Reporter						Chong Z, Cell Rep 2022 May 10;39(6):110799	J:325089	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta	Ifnl2^tm1.1Arte Targeted			Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta
Ifnlr1^tm1Palu	MGI:3775762	Targeted	Null/knockout	MGI:6403849			immune system	MP:0005387	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799	J:286237 J:300094 J:321761 J:325089	Pathology\|SARS-CoV-MA_virus SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta	Ifnlr1^tm1Palu Targeted	MGI:6403849	immune system	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus Chong Z, bioRxiv 2022;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta
Igh^em1Rcas	MGI:6725128	Endonuclease-mediated	Inserted expressed sequence						Xu J, Nature 2021 Jun 7;():	J:307753	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma	Igh^em1Rcas Endonuclease-mediated			Xu J, Nature 2021 Jun 7;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma
Igh-J^tm1Dhu	MGI:2158307	Targeted	Null/knockout						Afkhami S, bioRxiv 2021 Jul;():	J:308640	SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	Igh-J^tm1Dhu Targeted			Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
Ighm^tm1Cgn	MGI:1857187	Targeted	Null/knockout						Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Israelow B, bioRxiv 2021 May;(): Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682	J:120484 J:207380 J:308733 J:336666	Mouse_Hepatitis_virus MERS-CoV_virus Infection\|SARS-CoV-2_virus Comorbidity\|SARS-CoV-2_virus	Ighm^tm1Cgn Targeted			Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 Mouse_Hepatitis_virus Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Comorbidity\|SARS-CoV-2_virus
Igh^{tm3.1(VRC01)Nemz}	MGI:5779356	Targeted	Inserted expressed sequence						Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	Igh^{tm3.1(VRC01)Nemz} Targeted			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
Igs2^{em1(KRT18-ACE2)Gpt}	MGI:6452440	Endonuclease-mediated	Inserted expressed sequence						Yu S, Proc Natl Acad Sci U S A 2022 Jan 4;119(1):e2111199119 Yuan Y, bioRxiv 2022 Feb;():	J:318831 J:321891	Infection\|SARS-CoV-2_virus Vaccine\|VOC_B.1.617.2_Delta	Igs2^{em1(KRT18-ACE2)Gpt} Endonuclease-mediated			Yu S, Proc Natl Acad Sci U S A 2022 Jan 4;119(1):e2111199119 Infection\|SARS-CoV-2_virus Yuan Y, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.617.2_Delta
Ikbkb^tm2Mka	MGI:2445462	Targeted	Conditional ready\|No functional change						Satta S, Theranostics 2022;12(6):2639-2657	J:331825	SARS-CoV-2_virus\|Variant	Ikbkb^tm2Mka Targeted			Satta S, Theranostics 2022;12(6):2639-2657 SARS-CoV-2_virus\|Variant
Ikbkg^tm1.1Mpa	MGI:2679024	Targeted	Conditional ready\|No functional change						Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533	J:323957	Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta	Ikbkg^tm1.1Mpa Targeted			Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta
Il10^tm1.1Karp	MGI:4355198	Targeted	Reporter						Trandem K, J Immunol 2011 Mar 15;186(6):3642-52	J:169759	Mouse_Hepatitis_virus\|Pathology	Il10^tm1.1Karp Targeted			Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 Mouse_Hepatitis_virus\|Pathology
Il10^tm1Cgn	MGI:1857199	Targeted	Null/knockout						Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 Puntambekar SS, Glia 2015 Jun 30;():	J:169759 J:225834	Mouse_Hepatitis_virus\|Pathology Mouse_Hepatitis_virus	Il10^tm1Cgn Targeted			Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 Mouse_Hepatitis_virus\|Pathology Puntambekar SS, Glia 2015 Jun 30;(): Mouse_Hepatitis_virus
Il17a^em1Cya	MGI:6695195	Endonuclease-mediated	Null/knockout						Lin X, iScience 2021 Apr 23;24(4):102293	J:304178	Pathology\|SARS-CoV-2_virus\|Treatment	Il17a^em1Cya Endonuclease-mediated			Lin X, iScience 2021 Apr 23;24(4):102293 Pathology\|SARS-CoV-2_virus\|Treatment
Il18r1^tm1Aki	MGI:2136765	Targeted	Null/knockout						Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854	J:162707 J:331829	Pathology\|SARS-CoV-MA_virus Mouse_Hepatitis_virus	Il18r1^tm1Aki Targeted			Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus
Il1b^tm1Yiw	MGI:2157396	Targeted	Null/knockout\|Reporter						Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	Il1b^tm1Yiw Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
Il1r1^tm1Imx	MGI:1861112	Targeted	Null/knockout						Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854	J:162707 J:331829	Pathology\|SARS-CoV-MA_virus Mouse_Hepatitis_virus	Il1r1^tm1Imx Targeted			Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus
Il2rg^em26Gpt	MGI:5827573	Endonuclease-mediated	Not Specified						Hu Z, bioRxiv 2021 Nov;():	J:313461	Infection\|SARS-CoV-2_virus	Il2rg^em26Gpt Endonuclease-mediated			Hu Z, bioRxiv 2021 Nov;(): Infection\|SARS-CoV-2_virus
Il2rg^tm1.1Flv	MGI:4887837	Targeted	Null/knockout						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Il2rg^tm1.1Flv Targeted			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Il2rg^tm1Wjl	MGI:1857455	Targeted	Null/knockout						Halwe S, bioRxiv 2021 Jun;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:308648 J:345954	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Infection\|MERS-CoV-MA_virus	Il2rg^tm1Wjl Targeted			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus
Il6ra^tm1.1Drew	MGI:4456449	Targeted	Conditional ready\|No functional change						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Il6ra^tm1.1Drew Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Il6^tm1Kopf	MGI:1857197	Targeted	Null/knockout	MGI:3837132			hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system mortality/aging	MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0010768	Imai Y, Cell 2008 Apr 18;133(2):235-49 Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Ndeupen S, bioRxiv 2021 Aug;(): Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7	J:145306 J:286953 J:308580 J:337329	SARS-CoV_virus SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment SARS-CoV-2_virus\|Vaccine	Il6^tm1Kopf Targeted	MGI:3837132	hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system mortality/aging	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus\|SARS-CoV_virus\|Treatment Ndeupen S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 SARS-CoV-2_virus\|Vaccine
Il6^tm2(IL6)Flv	MGI:6405713	Targeted	Humanized sequence\|Inserted expressed sequence\|Null/knockout						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Il6^tm2(IL6)Flv Targeted			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Irf1^tm1Mak	MGI:1857205	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Irf1^tm1Mak Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Irf3^tm1Ttg	MGI:3577601	Targeted	Null/knockout						Imai Y, Cell 2008 Apr 18;133(2):235-49 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:145306 J:187561 J:291862 J:296686	SARS-CoV_virus Mouse_Hepatitis_virus Infection\|Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|Treatment	Irf3^tm1Ttg Targeted			Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Israelow B, J Exp Med 2020 Dec 7;217(12): Infection\|Pathology\|SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Irf5^tm1Ppr	MGI:5291913	Targeted	Conditional ready\|No functional change						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Irf5^tm1Ppr Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Irf7^tm1Ttg	MGI:3577089	Targeted	Null/knockout						Daffis S, Nature 2010 Nov 18;468(7322):452-6 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:187561 J:291862 J:296686	Mouse_Hepatitis_virus Infection\|Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|Treatment	Irf7^tm1Ttg Targeted			Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Israelow B, J Exp Med 2020 Dec 7;217(12): Infection\|Pathology\|SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Irf9^tm1Ttg	MGI:2446102	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Irf9^tm1Ttg Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Kctd9^em1Beij	MGI:6382731	Endonuclease-mediated	Null/knockout	MGI:6382782			hematopoietic system homeostasis/metabolism immune system mortality/aging	MP:0005397 MP:0005376 MP:0005387 MP:0010768	Zhang X, Front Immunol 2019;10():744	J:281803	Mouse_Hepatitis_virus	Kctd9^em1Beij Endonuclease-mediated	MGI:6382782	hematopoietic system homeostasis/metabolism immune system mortality/aging	Zhang X, Front Immunol 2019;10():744 Mouse_Hepatitis_virus
Ldlr^tm1Her	MGI:1857212	Targeted	Null/knockout						Ensor CM, bioRxiv 2021-09;():	J:310122	SARS-CoV-2_virus	Ldlr^tm1Her Targeted			Ensor CM, bioRxiv 2021-09;(): SARS-CoV-2_virus
Lepr^db	MGI:1856009	Spontaneous							Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263	J:292007 J:308897	Gene Comorbidity	Lepr^db Spontaneous			Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Gene Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263 Comorbidity
Ltb4r1^tm1Adl	MGI:2385786	Targeted	Null/knockout						Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682	J:336666	Comorbidity\|SARS-CoV-2_virus	Ltb4r1^tm1Adl Targeted			Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Comorbidity\|SARS-CoV-2_virus
Ly6e^{tm1a(EUCOMM)Hmgu}	MGI:5428615	Targeted	Conditional ready\|Null/knockout\|Reporter						Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Ly6e^{tm1a(EUCOMM)Hmgu} Targeted			Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Ly6e^{tm1c(EUCOMM)Hmgu}	MGI:6448980	Targeted	Conditional ready						Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Ly6e^{tm1c(EUCOMM)Hmgu} Targeted			Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene\|HCoV-229E_virus\|HCoV-OC43_virus\|MERS-CoV_virus\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Lyst^bg-J	MGI:1855969	Spontaneous							Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:92752	Infection\|SARS-CoV_virus	Lyst^bg-J Spontaneous			Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
Lyz2^tm1(cre)Ifo	MGI:1934631	Targeted	Recombinase						Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Imai Y, Cell 2008 Apr 18;133(2):235-49 Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Page C, J Virol 2012 Dec;86(24):13334-49 Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Musiu C, Cell Death Differ 2021 Sep 13;(): Verma AK, mBio 2021 Oct 26;12(5):e0196921 Wang Y, Sci Adv 2021 Jan;7(1): de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Satta S, Theranostics 2022;12(6):2639-2657	J:143484 J:145306 J:282479 J:286337 J:311033 J:313338 J:313438 J:314537 J:331763 J:331825	Mouse_Hepatitis_virus SARS-CoV_virus Pathology\|SARS-CoV_virus Comorbidity\|Gene\|Mouse_Hepatitis_virus Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus SARS-CoV-2_virus\|Variant	Lyz2^tm1(cre)Ifo Targeted			Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Mouse_Hepatitis_virus Page C, J Virol 2012 Dec;86(24):13334-49 Pathology\|SARS-CoV_virus Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Comorbidity\|Gene\|Mouse_Hepatitis_virus Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology\|SARS-CoV-2_virus Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus Wang Y, Sci Adv 2021 Jan;7(1): SARS-CoV-2_virus de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 SARS-CoV-2_virus Satta S, Theranostics 2022;12(6):2639-2657 SARS-CoV-2_virus\|Variant
Mavs^tm1Aki	MGI:3773161	Targeted	Null/knockout						Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:207380 J:288107 J:296686 J:308903	MERS-CoV_virus Infection\|MERS-CoV-MA_virus\|Treatment Pathology\|SARS-CoV-2_virus\|Treatment Pathology\|SARS-CoV-2_virus	Mavs^tm1Aki Targeted			Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection\|MERS-CoV-MA_virus\|Treatment Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus
Mavs^tm1Zjc	MGI:3654145	Targeted	Null/knockout						Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7	J:337329	SARS-CoV-2_virus\|Vaccine	Mavs^tm1Zjc Targeted			Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 SARS-CoV-2_virus\|Vaccine
Mbd2^em1Wgcy	MGI:6825813	Endonuclease-mediated	Conditional ready\|No functional change						Wang Y, Sci Adv 2021 Jan;7(1):	J:314537	SARS-CoV-2_virus	Mbd2^em1Wgcy Endonuclease-mediated			Wang Y, Sci Adv 2021 Jan;7(1): SARS-CoV-2_virus
Mcph1^{Tg(HLA-A2.1)1Enge}	MGI:3056375	Transgenic	Humanized sequence\|Inserted expressed sequence\|Null/knockout						Carter B, bioRxiv 2021 May;():	J:308712	SARS-CoV-2_virus\|Vaccine	Mcph1^{Tg(HLA-A2.1)1Enge} Transgenic			Carter B, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine
Mlkl^tm1.2Wsa	MGI:5614464	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:296686 J:298138	Pathology\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus	Mlkl^tm1.2Wsa Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Mmp14^tm1Ktry	MGI:2386246	Targeted	Null/knockout						Guo X, Nat Commun 2022 Dec 23;13(1):7907	J:333743	SARS-CoV-2_virus	Mmp14^tm1Ktry Targeted			Guo X, Nat Commun 2022 Dec 23;13(1):7907 SARS-CoV-2_virus
Muc16^tm1Bhr	MGI:3840843	Targeted	Null/knockout						Biering SB, Nat Genet 2022 Aug;54(8):1078-1089	J:331758	SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	Muc16^tm1Bhr Targeted			Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Muc1^tm1Gend	MGI:2447730	Targeted	Null/knockout						Biering SB, Nat Genet 2022 Aug;54(8):1078-1089	J:331758	SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	Muc1^tm1Gend Targeted			Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Muc4^PWK/PhJ	MGI:6423091	Not Applicable	Hypomorph	MGI:6423103			immune system	MP:0005387	Plante JA, bioRxiv 2020;():	J:287566	Infection\|SARS-CoV-MA_virus\|Sex_bias	Muc4^PWK/PhJ Not Applicable	MGI:6423103	immune system	Plante JA, bioRxiv 2020;(): Infection\|SARS-CoV-MA_virus\|Sex_bias
Muc4^tm1Unc	MGI:6416171	Targeted	Null/knockout	MGI:6423102	Coronavirus infectious disease	DOID:0080599	growth/size/body immune system respiratory system mortality/aging	MP:0005378 MP:0005387 MP:0005388 MP:0010768	Plante JA, bioRxiv 2020;(): Biering SB, Nat Genet 2022 Aug;54(8):1078-1089	J:287566 J:331758	Infection\|SARS-CoV-MA_virus\|Sex_bias SARS-CoV-2-MA_virus\|SARS-CoV-2_virus	Muc4^tm1Unc Targeted	MGI:6423102	growth/size/body immune system respiratory system mortality/aging Coronavirus infectious disease	Plante JA, bioRxiv 2020;(): Infection\|SARS-CoV-MA_virus\|Sex_bias Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus
Mx1^tm1.1Agsa	MGI:6275981	Targeted	Inducible\|Inserted expressed sequence\|Null/knockout\|Reporter						Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	Mx1^tm1.1Agsa Targeted			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
Myd88^tm1.1Defr	MGI:4421295	Targeted	Null/knockout	MGI:6272304			behavior/neurological hematopoietic system immune system nervous system mortality/aging	MP:0005386 MP:0005397 MP:0005387 MP:0003631 MP:0010768	Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Khan S, bioRxiv 2021 Mar;(): Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7	J:224849 J:303202 J:337329	Infection\|Mouse_Hepatitis_virus\|Pathology Infection\|SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine	Myd88^tm1.1Defr Targeted	MGI:6272304	behavior/neurological hematopoietic system immune system nervous system mortality/aging	Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Infection\|Mouse_Hepatitis_virus\|Pathology Khan S, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 SARS-CoV-2_virus\|Vaccine
Myd88^tm1Aki	MGI:2385681	Targeted	Null/knockout	MGI:3694811 MGI:3577712	Coronavirus infectious disease	DOID:0080599	digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system liver/biliary system respiratory system vision/eye neoplasm cardiovascular system cellular hearing/vestibular/ear nervous system renal/urinary system mortality/aging	MP:0005381 MP:0005379 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0005388 MP:0005391 MP:0002006 MP:0005385 MP:0005384 MP:0005377 MP:0003631 MP:0005367 MP:0010768	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Imai Y, Cell 2008 Apr 18;133(2):235-49 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Salvi V, bioRxiv 2021 Apr;(): Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 Nagai M, mBio 2021 Aug 31;12(4):e0159821	J:144400 J:145306 J:162707 J:207380 J:298138 J:304651 J:308903 J:313336 J:313440	Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus SARS-CoV_virus Pathology\|SARS-CoV-MA_virus MERS-CoV_virus Mouse_Hepatitis_virus Infection\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine	Myd88^tm1Aki Targeted	MGI:3694811 MGI:3577712	digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system liver/biliary system respiratory system vision/eye neoplasm cardiovascular system cellular hearing/vestibular/ear nervous system renal/urinary system mortality/aging Coronavirus infectious disease	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology\|SARS-CoV-MA_virus Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus Salvi V, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 SARS-CoV-2_virus Nagai M, mBio 2021 Aug 31;12(4):e0159821 SARS-CoV-2_virus\|Vaccine
Ncf1^m1J	MGI:2661962	Spontaneous		MGI:2661972	chronic granulomatous disease	DOID:3265	hematopoietic system immune system	MP:0005397 MP:0005387	Imai Y, Cell 2008 Apr 18;133(2):235-49	J:145306	SARS-CoV_virus	Ncf1^m1J Spontaneous	MGI:2661972	hematopoietic system immune system chronic granulomatous disease	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus
Nfe2l2^tm1Ywk	MGI:2385926	Targeted	Null/knockout						Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823	J:357765	Gene\|Variant\|VOC_B.1.1.529_Omicron	Nfe2l2^tm1Ywk Targeted			Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823 Gene\|Variant\|VOC_B.1.1.529_Omicron
Nlrc4^tm1Vmd	MGI:3046934	Targeted	Null/knockout						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Nlrc4^tm1Vmd Targeted			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Nlrp3^tm1Bhk	MGI:5465108	Targeted	Null/knockout						Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yalcinkaya M, Sci Rep 2021 Dec 24;11(1):24432 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545	J:323769 J:329139 J:331762	Gene\|Pathology Pathology\|SARS-CoV-2_virus Mouse_Hepatitis_virus	Nlrp3^tm1Bhk Targeted			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology Yalcinkaya M, Sci Rep 2021 Dec 24;11(1):24432 Pathology\|SARS-CoV-2_virus Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus
Nlrp3^tm1Flv	MGI:3686871	Targeted	Null/knockout						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:298138 J:308903	Mouse_Hepatitis_virus Pathology\|SARS-CoV-2_virus	Nlrp3^tm1Flv Targeted			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus
Nlrp3^tm1Tsc	MGI:3721141	Targeted	Null/knockout\|Reporter						Zeng J, EBioMedicine 2021 Dec 31;75():103803	J:319443	Pathology\|SARS-CoV-2_virus	Nlrp3^tm1Tsc Targeted			Zeng J, EBioMedicine 2021 Dec 31;75():103803 Pathology\|SARS-CoV-2_virus
Nlrp3^tm1Vmd	MGI:3622094	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	Nlrp3^tm1Vmd Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
Nos2^tm1Lau	MGI:1857228	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology\|SARS-CoV-2_virus\|Treatment	Nos2^tm1Lau Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Notch1^tm2Rko	MGI:3044585	Targeted	Conditional ready\|No functional change						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch1^tm2Rko Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Notch2^tm3Grid	MGI:3617328	Targeted	Conditional ready\|No functional change						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch2^tm3Grid Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Notch3^em1Tch	MGI:7624470	Endonuclease-mediated	Conditional ready						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch3^em1Tch Endonuclease-mediated			Harb H, Immunity 2021 Apr 22;(): Infection
Notch4^{tm1c(NCOM)Mfgc}	MGI:6316296	Targeted	Conditional ready						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch4^{tm1c(NCOM)Mfgc} Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Omp^tm3Mom	MGI:3692201	Targeted	Null/knockout\|Reporter						Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880	J:319436	Gene	Omp^tm3Mom Targeted			Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880 Gene
Parp12^{tm1.1(KOMP)Vlcg}	MGI:5548746	Targeted	Null/knockout\|Reporter						Kerr CM, J Virol 2023 Sep 28;97(9):e0088523	J:340885	Gene\|Infection\|Mouse_Hepatitis_virus	Parp12^{tm1.1(KOMP)Vlcg} Targeted			Kerr CM, J Virol 2023 Sep 28;97(9):e0088523 Gene\|Infection\|Mouse_Hepatitis_virus
Pdgfb^tm3.1Cbet	MGI:2670574	Targeted	Null/knockout						He L, bioRxiv 2020;():	J:295372	Infection\|SARS-CoV-2_virus	Pdgfb^tm3.1Cbet Targeted			He L, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus
Pj1^BALB/cHeA	MGI:3613181	QTL							Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104	J:1357	Mouse_Hepatitis_virus	Pj1^BALB/cHeA QTL			Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 Mouse_Hepatitis_virus
Pj1^STS/A	MGI:3613177	QTL							Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104	J:1357	Mouse_Hepatitis_virus	Pj1^STS/A QTL			Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 Mouse_Hepatitis_virus
Pla2g2d^tm1.1Mhg	MGI:5517549	Targeted	Null/knockout	MGI:5520923			cellular hematopoietic system homeostasis/metabolism immune system mortality/aging	MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0010768	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 Zheng J, J Clin Invest 2021 Jun 1;131(11):	J:229035 J:311966	Infection\|SARS-CoV-MA_virus Comorbidity\|MERS-CoV_virus	Pla2g2d^tm1.1Mhg Targeted	MGI:5520923	cellular hematopoietic system homeostasis/metabolism immune system mortality/aging	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 Infection\|SARS-CoV-MA_virus Zheng J, J Clin Invest 2021 Jun 1;131(11): Comorbidity\|MERS-CoV_virus
Plat^tm1Mlg	MGI:1857288	Targeted	Null/knockout	MGI:6433845			immune system mortality/aging	MP:0005387 MP:0010768	Gralinski LE, mBio 2013 Aug 6;4(4):	J:288556	Infection\|Pathology\|SARS-CoV-MA_virus	Plat^tm1Mlg Targeted	MGI:6433845	immune system mortality/aging	Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus
Ppp1r14c^tm1Uhl	MGI:4450989	Targeted	Null/knockout	MGI:6433773	Coronavirus infectious disease	DOID:0080599	immune system	MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	Ppp1r14c^tm1Uhl Targeted	MGI:6433773	immune system Coronavirus infectious disease	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
Prkdc^em26Gpt	MGI:5827572	Endonuclease-mediated	Not Specified						Hu Z, bioRxiv 2021 Nov;():	J:313461	Infection\|SARS-CoV-2_virus	Prkdc^em26Gpt Endonuclease-mediated			Hu Z, bioRxiv 2021 Nov;(): Infection\|SARS-CoV-2_virus
Prkdc^scid	MGI:1857113	Spontaneous							Graham RL, Nat Med 2012 Dec;18(12):1820-6 Halwe S, bioRxiv 2021 Jun;(): Abdelnabi R, J Virol 2022 Aug 24;96(16):e0075822 Pewe L, J Virol 1997 Oct;71(10):7640-7	J:286309 J:308648 J:331764 J:42952	SARS-CoV_virus\|Vaccine SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Treatment\|VOC_B.1.351_Beta Mouse_Hepatitis_virus	Prkdc^scid Spontaneous			Graham RL, Nat Med 2012 Dec;18(12):1820-6 SARS-CoV_virus\|Vaccine Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Abdelnabi R, J Virol 2022 Aug 24;96(16):e0075822 Treatment\|VOC_B.1.351_Beta Pewe L, J Virol 1997 Oct;71(10):7640-7 Mouse_Hepatitis_virus
Ptgdr^tm1.1Brey	MGI:6802150	Targeted	Conditional ready\|No functional change						Verma AK, mBio 2021 Oct 26;12(5):e0196921	J:313438	Mouse_Hepatitis_virus	Ptgdr^tm1.1Brey Targeted			Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus
Ptgdr^tm1Sna	MGI:2386956	Targeted	Null/knockout	MGI:3057193			hematopoietic system immune system nervous system respiratory system mortality/aging	MP:0005397 MP:0005387 MP:0003631 MP:0005388 MP:0010768	Vijay R, Proc Natl Acad Sci U S A 2017 Jul 03;114(27):E5444-E5453 Verma AK, mBio 2021 Oct 26;12(5):e0196921	J:243958 J:313438	Mouse_Hepatitis_virus	Ptgdr^tm1Sna Targeted	MGI:3057193	hematopoietic system immune system nervous system respiratory system mortality/aging	Vijay R, Proc Natl Acad Sci U S A 2017 Jul 03;114(27):E5444-E5453 Mouse_Hepatitis_virus Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus
Ptges2^tm1Bhk	MGI:3620552	Targeted	Null/knockout						McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	Ptges2^tm1Bhk Targeted			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
Ptpn2^{tm1c(EUCOMM)Wtsi}	MGI:5902694	Targeted	Conditional ready						Spalinger MR, bioRxiv 2020 Dec 9;():	J:300213	SARS-CoV-2_virus\|Treatment	Ptpn2^{tm1c(EUCOMM)Wtsi} Targeted			Spalinger MR, bioRxiv 2020 Dec 9;(): SARS-CoV-2_virus\|Treatment
Ptpn2^tm1Mtr	MGI:3044910	Targeted	Null/knockout						Spalinger MR, bioRxiv 2020 Dec 9;():	J:300213	SARS-CoV-2_virus\|Treatment	Ptpn2^tm1Mtr Targeted			Spalinger MR, bioRxiv 2020 Dec 9;(): SARS-CoV-2_virus\|Treatment
Ptx3^tm1Zuk	MGI:2670952	Targeted	Null/knockout	MGI:2670955			endocrine/exocrine glands immune system reproductive system	MP:0005379 MP:0005387 MP:0005389	Han B, Lab Invest 2012 Sep;92(9):1285-96	J:188421	Mouse_Hepatitis_virus	Ptx3^tm1Zuk Targeted	MGI:2670955	endocrine/exocrine glands immune system reproductive system	Han B, Lab Invest 2012 Sep;92(9):1285-96 Mouse_Hepatitis_virus
Pycard^tm1Nnz	MGI:3771030	Targeted	Null/knockout						Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Pycard^tm1Nnz Targeted			Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Rag1^tm1Mom	MGI:1857241	Targeted	Null/knockout						Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Channappanavar R, J Infect Dis 2015 Dec 15;212(12):1894-903 Hassan AO, Cell 2020 Jun 10;(): Johansen MD, Mucosal Immunol 2020 Aug 20;(): Halwe S, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2021 Jun;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Ngo VL, Cell Host Microbe 2024 Jan 23;(): Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:106738 J:131907 J:286309 J:287959 J:290258 J:295350 J:308648 J:308656 J:308733 J:331753 J:345954 J:92752	Mouse_Hepatitis_virus\|Pathology Mouse_Hepatitis_virus SARS-CoV_virus\|Vaccine MERS-CoV_virus\|Treatment Infection\|SARS-CoV-2_virus\|Treatment MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Infection\|SARS-CoV-2_virus Infection\|MERS-CoV-MA_virus Infection\|SARS-CoV_virus	Rag1^tm1Mom Targeted			Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Mouse_Hepatitis_virus\|Pathology Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Mouse_Hepatitis_virus Graham RL, Nat Med 2012 Dec;18(12):1820-6 SARS-CoV_virus\|Vaccine Channappanavar R, J Infect Dis 2015 Dec 15;212(12):1894-903 MERS-CoV_virus\|Treatment Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Infection\|SARS-CoV-2_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection\|SARS-CoV_virus
Rag2^tm1.1Flv	MGI:4887836	Targeted	Null/knockout						Mao T, bioRxiv 2021 Jun;(): Sefik E, bioRxiv 2021;():	J:308656 J:311907	Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus	Rag2^tm1.1Flv Targeted			Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Rapgef3^tm1.1Chen	MGI:5559594	Targeted	Null/knockout						Xiao J, J Biol Chem 2021 Oct 19;():101315	J:313334	Pathology	Rapgef3^tm1.1Chen Targeted			Xiao J, J Biol Chem 2021 Oct 19;():101315 Pathology
Rbpj^tm1Hon	MGI:3583755	Targeted	Conditional ready\|No functional change						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Rbpj^tm1Hon Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Ripk3^tm1.1Vmd	MGI:7256694	Targeted	Null/knockout						Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533	J:323957	Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta	Ripk3^tm1.1Vmd Targeted			Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta
Ripk3^tm1Vmd	MGI:3028853	Targeted	Null/knockout						Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:296686 J:298138	Pathology\|SARS-CoV-2_virus\|Treatment Mouse_Hepatitis_virus	Ripk3^tm1Vmd Targeted			Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Rnasel^tm1Slvm	MGI:2182763	Targeted	Null/knockout						Zhang R, Proc Natl Acad Sci U S A 2013 Aug 6;110(32):13114-9 Goldstein SA, J Virol 2017 Mar 01;91(5): Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 Thornbrough JM, mBio 2016 Mar 29;7(2):e00258 Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Zhao L, J Virol 2013 Aug;87(15):8408-18	J:200706 J:239306 J:291588 J:292006 J:318622 J:346257	Mouse_Hepatitis_virus Infection\|Mouse_Hepatitis_virus HCoV-229E_virus\|Mouse_Hepatitis_virus MERS-CoV_virus\|Mouse_Hepatitis_virus	Rnasel^tm1Slvm Targeted			Zhang R, Proc Natl Acad Sci U S A 2013 Aug 6;110(32):13114-9 Mouse_Hepatitis_virus Goldstein SA, J Virol 2017 Mar 01;91(5): Infection\|Mouse_Hepatitis_virus Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus\|Mouse_Hepatitis_virus Thornbrough JM, mBio 2016 Mar 29;7(2):e00258 MERS-CoV_virus\|Mouse_Hepatitis_virus Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Mouse_Hepatitis_virus Zhao L, J Virol 2013 Aug;87(15):8408-18 Infection\|Mouse_Hepatitis_virus
Rnh1^tm2.1Rall	MGI:7407148	Targeted	Conditional ready						Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226	J:331827	SARS-CoV-2_virus	Rnh1^tm2.1Rall Targeted			Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 SARS-CoV-2_virus
Samhd1^{tm1d(EUCOMM)Wtsi}	MGI:5551758	Targeted	Null/knockout						Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120	J:338414	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron	Samhd1^{tm1d(EUCOMM)Wtsi} Targeted			Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron
Serpine1^tm1Mlg	MGI:1857287	Targeted	Null/knockout	MGI:3690223	Coronavirus infectious disease	DOID:0080599	cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging	MP:0005385 MP:0005376 MP:0005387 MP:0005370 MP:0005388 MP:0010768	Gralinski LE, mBio 2013 Aug 6;4(4):	J:288556	Infection\|Pathology\|SARS-CoV-MA_virus	Serpine1^tm1Mlg Targeted	MGI:3690223	cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging Coronavirus infectious disease	Gralinski LE, mBio 2013 Aug 6;4(4): Infection\|Pathology\|SARS-CoV-MA_virus
Setdb2^{tm1c(KOMP)Wtsi}	MGI:5816257	Targeted	Conditional ready						Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118	J:311033	Comorbidity\|Gene\|Mouse_Hepatitis_virus	Setdb2^{tm1c(KOMP)Wtsi} Targeted			Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Comorbidity\|Gene\|Mouse_Hepatitis_virus
Sftpc^{tm1(cre/ERT2)Blh}	MGI:5305340	Targeted	Inducible\|Recombinase						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Sftpc^{tm1(cre/ERT2)Blh} Targeted			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Shh^{tm1(EGFP/cre)Cjt}	MGI:3053959	Targeted	Null/knockout\|Recombinase						Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron	Shh^{tm1(EGFP/cre)Cjt} Targeted			Tang AT, bioRxiv 2021 Dec;(): Pathology\|SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron
Shh^{tm2(cre/ERT2)Cjt}	MGI:3053960	Targeted	Inducible\|Recombinase						Anand G, bioRxiv 2020 Dec;():	J:298270	Pathology\|SARS-CoV-2_virus	Shh^{tm2(cre/ERT2)Cjt} Targeted			Anand G, bioRxiv 2020 Dec;(): Pathology\|SARS-CoV-2_virus
Sirpa^tm1Nog	MGI:2388979	Targeted	Null/knockout						Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	Sirpa^tm1Nog Targeted			Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
Smad3^tm1Cxd	MGI:1857695	Targeted	Null/knockout						Wang W, Adv Sci (Weinh) 2022 Jan;9(3):e2103248	J:333753	Pathology\|SARS-CoV-2_virus	Smad3^tm1Cxd Targeted			Wang W, Adv Sci (Weinh) 2022 Jan;9(3):e2103248 Pathology\|SARS-CoV-2_virus
Sry^dl1Rlb	MGI:1857786	Spontaneous							Ensor CM, bioRxiv 2021-09;():	J:310122	SARS-CoV-2_virus	Sry^dl1Rlb Spontaneous			Ensor CM, bioRxiv 2021-09;(): SARS-CoV-2_virus
Stat1^tm1Dlv	MGI:1930947	Targeted	Null/knockout	MGI:3806318 MGI:6403902 MGI:6403905	Coronavirus infectious disease	DOID:0080599	hematopoietic system homeostasis/metabolism immune system vision/eye cardiovascular system digestive/alimentary system respiratory system	MP:0005397 MP:0005376 MP:0005387 MP:0005391 MP:0005385 MP:0005381 MP:0005388	Lassnig C, Transgenic Res 2005 Dec;14(6):803-6 Venkataraman T, J Virol 2017 Jun 15;91(12): Page C, J Virol 2012 Dec;86(24):13334-49 Hassan AO, Cell 2020 Jun 10;(): Sun J, Cell 2020 Jun 10;(): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Ngo VL, Cell Host Microbe 2024 Jan 23;(): Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:103578 J:243599 J:286337 J:290258 J:291881 J:296686 J:345954 J:99728	HCoV-229E_virus Pathology\|SARS-CoV-MA_virus Pathology\|SARS-CoV_virus Infection\|SARS-CoV-2_virus\|Treatment Infection\|Pathology\|SARS-CoV-2_virus\|Treatment Pathology\|SARS-CoV-2_virus\|Treatment Infection\|MERS-CoV-MA_virus	Stat1^tm1Dlv Targeted	MGI:3806318 MGI:6403902 MGI:6403905	hematopoietic system homeostasis/metabolism immune system vision/eye cardiovascular system digestive/alimentary system respiratory system Coronavirus infectious disease	Lassnig C, Transgenic Res 2005 Dec;14(6):803-6 HCoV-229E_virus Venkataraman T, J Virol 2017 Jun 15;91(12): Pathology\|SARS-CoV-MA_virus Page C, J Virol 2012 Dec;86(24):13334-49 Pathology\|SARS-CoV_virus Hassan AO, Cell 2020 Jun 10;(): Infection\|SARS-CoV-2_virus\|Treatment Sun J, Cell 2020 Jun 10;(): Infection\|Pathology\|SARS-CoV-2_virus\|Treatment Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection\|MERS-CoV-MA_virus Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
Stat1^tm1Mam	MGI:4821871	Targeted	Conditional ready\|No functional change						Page C, J Virol 2012 Dec;86(24):13334-49	J:286337	Pathology\|SARS-CoV_virus	Stat1^tm1Mam Targeted			Page C, J Virol 2012 Dec;86(24):13334-49 Pathology\|SARS-CoV_virus
Stat1^tm1Rds	MGI:1861949	Targeted	Null/knockout	MGI:3771372	breast cancer severe acute respiratory syndrome	DOID:1612 DOID:2945	cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging	MP:0005385 MP:0005384 MP:0005381 MP:0005379 MP:0005397 MP:0005376 MP:0005387 MP:0010771 MP:0005370 MP:0005369 MP:0003631 MP:0005388 MP:0005390 MP:0002006 MP:0010768	Zornetzer GA, J Virol 2010 Nov;84(21):11297-309 Peng X, mBio 2010 Oct 26;1(5): Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;():	J:164586 J:276986 J:286237 J:286309 J:295349 J:295350	Pathology\|SARS-CoV-MA_virus Infection\|SARS-CoV-MA_virus SARS-CoV_virus\|Vaccine MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus	Stat1^tm1Rds Targeted	MGI:3771372	cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging breast cancer severe acute respiratory syndrome	Zornetzer GA, J Virol 2010 Nov;84(21):11297-309 Pathology\|SARS-CoV-MA_virus Peng X, mBio 2010 Oct 26;1(5): Infection\|SARS-CoV-MA_virus Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology\|SARS-CoV-MA_virus Graham RL, Nat Med 2012 Dec;18(12):1820-6 SARS-CoV_virus\|Vaccine Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus
Stat6^tm1Gru	MGI:1888385	Targeted	Null/knockout						Page C, J Virol 2012 Dec;86(24):13334-49	J:286337	Pathology\|SARS-CoV_virus	Stat6^tm1Gru Targeted			Page C, J Virol 2012 Dec;86(24):13334-49 Pathology\|SARS-CoV_virus
Sting1^gt	MGI:4939597	Chemically induced (ENU)							Yang J, Nature 2020 Jul 29;(): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:292665 J:296686	SARS-CoV-2_virus\|Vaccine Pathology\|SARS-CoV-2_virus\|Treatment	Sting1^gt Chemically induced (ENU)			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment
Sting1^tm1.2Camb	MGI:5639232	Targeted	Null/knockout						Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	Sting1^tm1.2Camb Targeted			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
Sting1^tm1Gnb	MGI:3817418	Targeted	Null/knockout						Humphries F, Sci Immunol 2021 May 18;6(59):	J:333769	SARS-CoV-2_virus\|Treatment	Sting1^tm1Gnb Targeted			Humphries F, Sci Immunol 2021 May 18;6(59): SARS-CoV-2_virus\|Treatment
Tcra^tm1Mom	MGI:1857255	Targeted	Null/knockout						Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229	J:343550	Infection\|SARS-CoV-2_virus\|Treatment	Tcra^tm1Mom Targeted			Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment
Tcrb^tm1Mom	MGI:1857256	Targeted	Null/knockout						Dandekar AA, J Virol 2005 Aug;79(15):9388-96	J:153339	Mouse_Hepatitis_virus	Tcrb^tm1Mom Targeted			Dandekar AA, J Virol 2005 Aug;79(15):9388-96 Mouse_Hepatitis_virus
Terc^tm1Rdp	MGI:1857930	Targeted	Null/knockout						Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658	J:309195 J:326929	Comorbidity\|Gene Gene	Terc^tm1Rdp Targeted			Sepe S, bioRxiv 2021 Jun;(): Comorbidity\|Gene Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene
Terf2^tm1Tdl	MGI:3619524	Targeted	Conditional ready\|No functional change						Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658	J:309195 J:326929	Comorbidity\|Gene Gene	Terf2^tm1Tdl Targeted			Sepe S, bioRxiv 2021 Jun;(): Comorbidity\|Gene Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene
Tg(Ace2-ACE2)1Cqin	MGI:6401292	Transgenic	Humanized sequence\|Inserted expressed sequence	MGI:6402641	COVID-19 severe acute respiratory syndrome	DOID:0080600 DOID:2945	cardiovascular system digestive/alimentary system endocrine/exocrine glands growth/size/body homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system	MP:0005385 MP:0005381 MP:0005379 MP:0005378 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005367 MP:0005388	Yang XH, Comp Med 2007 Oct;57(5):450-9 Bao L, Nature 2020 May 7;(): Natoli S, Eur J Neurol 2020 Apr 25;(): Bao L, J Infect Dis 2020 May 23;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Yang J, Nature 2020 Jul 29;(): Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Jia H, Nat Commun 2020 Oct 14;11(1):5165 Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Shang C, J Virol 2021 Nov 23;95(24):e0153721	J:141460 J:287631 J:287925 J:288244 J:288402 J:292665 J:294026 J:295328 J:295349 J:295350 J:295351 J:296535 J:308901 J:331770	Infection\|SARS-CoV_virus Infection\|Pathology\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment	Tg(Ace2-ACE2)1Cqin Transgenic	MGI:6402641	cardiovascular system digestive/alimentary system endocrine/exocrine glands growth/size/body homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system COVID-19 severe acute respiratory syndrome	Yang XH, Comp Med 2007 Oct;57(5):450-9 Infection\|SARS-CoV_virus Bao L, Nature 2020 May 7;(): Infection\|Pathology\|SARS-CoV-2_virus Natoli S, Eur J Neurol 2020 Apr 25;(): Infection\|SARS-CoV-2_virus Bao L, J Infect Dis 2020 May 23;(): Infection\|SARS-CoV-2_virus Lutz C, Hum Genomics 2020 Jun 4;14(1):20 SARS-CoV-2_virus Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus\|SARS-CoV_virus Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Infection\|SARS-CoV-2_virus Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Munoz-Fontela C, Nature 2020 Sep 23;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Pathology\|SARS-CoV-2_virus Shang C, J Virol 2021 Nov 23;95(24):e0153721 SARS-CoV-2_virus\|Treatment
Tg(Acta2-GFP)1Pfk	MGI:5805225	Transgenic	Inserted expressed sequence\|Reporter						He L, bioRxiv 2020;():	J:295372	Infection\|SARS-CoV-2_virus	Tg(Acta2-GFP)1Pfk Transgenic			He L, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus
Tg(ANPEP)270Mmul	MGI:5645778	Transgenic	Inserted expressed sequence	MGI:6403902 MGI:6403906	Coronavirus infectious disease	DOID:0080599	cardiovascular system immune system	MP:0005385 MP:0005387	Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	Tg(ANPEP)270Mmul Transgenic	MGI:6403902 MGI:6403906	cardiovascular system immune system Coronavirus infectious disease	Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
Tg(ANPEP)861Mmul	MGI:5645779	Transgenic	Inserted expressed sequence	MGI:6403905 MGI:6403907	Coronavirus infectious disease	DOID:0080599	cardiovascular system digestive/alimentary system immune system respiratory system	MP:0005385 MP:0005381 MP:0005387 MP:0005388	Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	Tg(ANPEP)861Mmul Transgenic	MGI:6403905 MGI:6403907	cardiovascular system digestive/alimentary system immune system respiratory system Coronavirus infectious disease	Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
Tg(ANPEP)#Mmul	MGI:5582782	Transgenic	Inserted expressed sequence						Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80	J:99728	HCoV-229E_virus	Tg(ANPEP)#Mmul Transgenic			Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus
Tg(APP695)3Dbo	MGI:2447334	Transgenic	Humanized sequence\|Inserted expressed sequence						Chen J, Transl Psychiatry 2023 Dec 16;13(1):396	J:348471	Gene\|Infection\|SARS-CoV-2_virus	Tg(APP695)3Dbo Transgenic			Chen J, Transl Psychiatry 2023 Dec 16;13(1):396 Gene\|Infection\|SARS-CoV-2_virus
Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas	MGI:3693208	Transgenic	Humanized sequence\|Inserted expressed sequence						Lim KH, Front Genet 2021;12():741175 Hohsfield LA, Glia 2022 May;70(5):875-891	J:319460 J:324342	Gene\|SARS-CoV-2_virus Mouse_Hepatitis_virus	Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas Transgenic			Lim KH, Front Genet 2021;12():741175 Gene\|SARS-CoV-2_virus Hohsfield LA, Glia 2022 May;70(5):875-891 Mouse_Hepatitis_virus
Tg(CAG-ACE2)AC22Ctkt	MGI:6402929	Transgenic	Humanized sequence\|Inserted expressed sequence						Tseng CT, J Virol 2007 Feb;81(3):1162-73 Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Lutz C, Hum Genomics 2020 Jun 4;14(1):20	J:117824 J:148946 J:288402	Infection\|SARS-CoV_virus Pathology\|SARS-CoV_virus SARS-CoV-2_virus	Tg(CAG-ACE2)AC22Ctkt Transgenic			Tseng CT, J Virol 2007 Feb;81(3):1162-73 Infection\|SARS-CoV_virus Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Pathology\|SARS-CoV_virus Lutz C, Hum Genomics 2020 Jun 4;14(1):20 SARS-CoV-2_virus
Tg(CAG-ACE2)AC63Ctkt	MGI:6402829	Transgenic	Humanized sequence\|Inserted expressed sequence	MGI:6402831			immune system	MP:0005387	Tseng CT, J Virol 2007 Feb;81(3):1162-73 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11	J:117824 J:284000 J:288402 J:294026	Infection\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV_virus SARS-CoV-2_virus SARS-CoV-2_virus\|SARS-CoV_virus	Tg(CAG-ACE2)AC63Ctkt Transgenic	MGI:6402831	immune system	Tseng CT, J Virol 2007 Feb;81(3):1162-73 Infection\|SARS-CoV_virus Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 MERS-CoV_virus\|SARS-CoV_virus Lutz C, Hum Genomics 2020 Jun 4;14(1):20 SARS-CoV-2_virus Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus\|SARS-CoV_virus
Tg(CAG-ACE2)AC70Ctkt	MGI:6402828	Transgenic	Humanized sequence\|Inserted expressed sequence	MGI:6402832	severe acute respiratory syndrome	DOID:2945	cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Tseng CT, J Virol 2007 Feb;81(3):1162-73 Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Ma H, bioRxiv 2021;():	J:117824 J:148946 J:283999 J:284000 J:288402 J:294026 J:296535 J:300104 J:311906	Infection\|SARS-CoV_virus Pathology\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV_virus SARS-CoV-2_virus SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma	Tg(CAG-ACE2)AC70Ctkt Transgenic	MGI:6402832	cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging severe acute respiratory syndrome	Tseng CT, J Virol 2007 Feb;81(3):1162-73 Infection\|SARS-CoV_virus Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Pathology\|SARS-CoV_virus Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 MERS-CoV_virus\|SARS-CoV_virus Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 MERS-CoV_virus\|SARS-CoV_virus Lutz C, Hum Genomics 2020 Jun 4;14(1):20 SARS-CoV-2_virus Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus\|SARS-CoV_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Ma H, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma
Tg(CAG-ACE2)GT5-027Cyt	MGI:6711183	Transgenic	Epitope tag\|Humanized sequence\|Inserted expressed sequence						Tsai C-Y, bioRxiv 2021;(): Liao HY, bioRxiv 2021 May;():	J:305559 J:308661	SARS-CoV-2_virus SARS-CoV-2_virus\|Vaccine	Tg(CAG-ACE2)GT5-027Cyt Transgenic			Tsai C-Y, bioRxiv 2021;(): SARS-CoV-2_virus Liao HY, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine
Tg(CAG-ACE2,-luc)1Smoc	MGI:7279190	Transgenic	Humanized sequence\|Inserted expressed sequence\|Reporter						Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 Li D, J Med Virol 2022 Oct;94(10):4878-4889 Yang S, J Med Virol 2022 Aug;94(8):3605-3612	J:324335 J:339217 J:339218	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Infection\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta	Tg(CAG-ACE2,-luc)1Smoc Transgenic			Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Li D, J Med Virol 2022 Oct;94(10):4878-4889 Infection\|SARS-CoV-2_virus Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta
Tg(CAG-DPP4)4Yuzh	MGI:6402443	Transgenic	Humanized sequence\|Inserted expressed sequence	MGI:6402445	Middle East respiratory syndrome	DOID:0080642	behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging	MP:0005386 MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005367 MP:0005388 MP:0010768	Zhao G, PLoS One 2015;10(12):e0145561 Jiang Y, Viruses 2019 Jan 9;11(1): Singh A, Virol Sin 2020 Jun;35(3):290-304 Tai W, Virology 2016 Dec;499():375-382	J:286175 J:295108 J:295349 J:331809	Infection\|MERS-CoV_virus MERS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV_virus\|Treatment	Tg(CAG-DPP4)4Yuzh Transgenic	MGI:6402445	behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging Middle East respiratory syndrome	Zhao G, PLoS One 2015;10(12):e0145561 Infection\|MERS-CoV_virus Jiang Y, Viruses 2019 Jan 9;11(1): MERS-CoV_virus Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Tai W, Virology 2016 Dec;499():375-382 MERS-CoV_virus\|Treatment
Tg(CAG-DPP4)52Ctkt	MGI:6402051	Transgenic	Humanized sequence\|Inserted expressed sequence	MGI:6402055	Middle East respiratory syndrome	DOID:0080642	growth/size/body hematopoietic system immune system nervous system respiratory system mortality/aging	MP:0005378 MP:0005397 MP:0005387 MP:0003631 MP:0005388 MP:0010768	Tao X, J Virol 2015;90(1):57-67 Agrawal AS, J Virol 2015 Apr;89(7):3659-70 Agrawal AS, Sci Rep 2016 Aug 19;6():31629 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Leist SR, Methods Mol Biol 2020;2099():137-159 Algaissi A, J Infect Dis 2019 Feb 15;219(5):829-835 Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 Natoli S, Eur J Neurol 2020 Apr 25;(): Choi JH, PLoS One 2020;15(5):e0232757 Agrawal AS, Hum Vaccin Immunother 2016 Sep;12(9):2351-6 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961	J:227925 J:258199 J:266753 J:284000 J:285962 J:286197 J:286454 J:287925 J:288262 J:291895 J:295349 J:295350 J:300104	Infection\|MERS-CoV_virus\|Vaccine Infection\|MERS-CoV_virus MERS-CoV_virus\|Treatment MERS-CoV_virus\|SARS-CoV_virus MERS-CoV_virus Infection\|MERS-CoV_virus\|Pathology MERS-CoV_virus\|Pathology Infection\|SARS-CoV-2_virus MERS-CoV_virus\|Vaccine MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Tg(CAG-DPP4)52Ctkt Transgenic	MGI:6402055	growth/size/body hematopoietic system immune system nervous system respiratory system mortality/aging Middle East respiratory syndrome	Tao X, J Virol 2015;90(1):57-67 Infection\|MERS-CoV_virus\|Vaccine Agrawal AS, J Virol 2015 Apr;89(7):3659-70 Infection\|MERS-CoV_virus Agrawal AS, Sci Rep 2016 Aug 19;6():31629 MERS-CoV_virus\|Treatment Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 MERS-CoV_virus\|SARS-CoV_virus Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Algaissi A, J Infect Dis 2019 Feb 15;219(5):829-835 Infection\|MERS-CoV_virus\|Pathology Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 MERS-CoV_virus\|Pathology Natoli S, Eur J Neurol 2020 Apr 25;(): Infection\|SARS-CoV-2_virus Choi JH, PLoS One 2020;15(5):e0232757 MERS-CoV_virus\|Treatment Agrawal AS, Hum Vaccin Immunother 2016 Sep;12(9):2351-6 MERS-CoV_virus\|Vaccine Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Tg(CAG-EGFP/Map1lc3b)53Nmz	MGI:3759813	Transgenic	Inserted expressed sequence\|Reporter						Zhu H, FASEB J 2023 May;37(5):e22919	J:341982	Pathology\|SARS-CoV-2_virus	Tg(CAG-EGFP/Map1lc3b)53Nmz Transgenic			Zhu H, FASEB J 2023 May;37(5):e22919 Pathology\|SARS-CoV-2_virus
Tg(CAG-OVAL)916Jen	MGI:3050829	Transgenic	Inserted expressed sequence						Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41	J:161935	Mouse_Hepatitis_virus\|Pathology	Tg(CAG-OVAL)916Jen Transgenic			Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Mouse_Hepatitis_virus\|Pathology
Tg(CAG-Serpine1)1Dgi	MGI:3763900	Transgenic	Inserted expressed sequence						Jain KG, Am J Physiol Lung Cell Mol Physiol 2022 Nov 1;323(5):L515-L524	J:329972	Gene	Tg(CAG-Serpine1)1Dgi Transgenic			Jain KG, Am J Physiol Lung Cell Mol Physiol 2022 Nov 1;323(5):L515-L524 Gene
Tg(CD207-Dta)312Dhka	MGI:3762048	Transgenic	Inserted expressed sequence						Ndeupen S, bioRxiv 2021 Aug;():	J:308580	SARS-CoV-2_virus\|Vaccine	Tg(CD207-Dta)312Dhka Transgenic			Ndeupen S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine
Tg(CD46)373Zbz	MGI:6501992	Transgenic	Humanized sequence\|Inserted expressed sequence						Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 Malczyk AH, J Virol 2015 Nov;89(22):11654-67	J:300105 J:312515	SARS-CoV-2_virus\|Vaccine MERS-CoV_virus\|Vaccine	Tg(CD46)373Zbz Transgenic			Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 SARS-CoV-2_virus\|Vaccine Malczyk AH, J Virol 2015 Nov;89(22):11654-67 MERS-CoV_virus\|Vaccine
Tg(Cd4-CD4)2362Litt	MGI:3702083	Transgenic	Humanized sequence\|Inserted expressed sequence						Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	Tg(Cd4-CD4)2362Litt Transgenic			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
Tg(DPP4)2Nnag	MGI:6403115	Transgenic	Humanized sequence\|Inserted expressed sequence	MGI:6403636 MGI:6403118	Middle East respiratory syndrome	DOID:0080642	immune system homeostasis/metabolism respiratory system	MP:0005387 MP:0005376 MP:0005388	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 Singh A, Virol Sin 2020 Jun;35(3):290-304 Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961	J:283077 J:286321 J:286454 J:295349 J:300104	MERS-CoV-MA_virus\|MERS-CoV_virus\|Pathology Infection\|MERS-CoV_virus MERS-CoV_virus\|Pathology MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus	Tg(DPP4)2Nnag Transgenic	MGI:6403636 MGI:6403118	immune system homeostasis/metabolism respiratory system Middle East respiratory syndrome	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): MERS-CoV-MA_virus\|MERS-CoV_virus\|Pathology Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Infection\|MERS-CoV_virus Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 MERS-CoV_virus\|Pathology Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus
Tg(FCGRT)32Dcr	MGI:4944199	Transgenic	Humanized sequence\|Inserted expressed sequence						Halwe S, bioRxiv 2021 Jun;():	J:308648	SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta	Tg(FCGRT)32Dcr Transgenic			Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta
Tg(FOXJ1-ACE2)1Rba	MGI:6415223	Transgenic	Inserted expressed sequence	MGI:6415340	Coronavirus infectious disease COVID-19 severe acute respiratory syndrome	DOID:0080599 DOID:0080600 DOID:2945	cardiovascular system hematopoietic system homeostasis/metabolism immune system muscle respiratory system mortality/aging	MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005369 MP:0005388 MP:0010768	Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 Jiang RD, Cell 2020 May 21;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Dinnon KH 3rd, Nature 2020 Aug 27;(): Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Hou Y, bioRxiv 2020;(): Jia H, Nat Commun 2020 Oct 14;11(1):5165 Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 Huang Q, Nat Commun 2021 Feb 3;12(1):776 Li D, Cell 2021 Aug 5;184(16):4203-4219.e32	J:287092 J:288386 J:288402 J:294063 J:295328 J:295349 J:295350 J:295381 J:296535 J:299936 J:302315 J:313328	Infection Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus Infection\|SARS-CoV-2-MA_virus\|Treatment Infection\|SARS-CoV-2_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Vaccine SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment	Tg(FOXJ1-ACE2)1Rba Transgenic	MGI:6415340	cardiovascular system hematopoietic system homeostasis/metabolism immune system muscle respiratory system mortality/aging Coronavirus infectious disease COVID-19 severe acute respiratory syndrome	Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 Infection Jiang RD, Cell 2020 May 21;(): Pathology\|SARS-CoV-2_virus Lutz C, Hum Genomics 2020 Jun 4;14(1):20 SARS-CoV-2_virus Dinnon KH 3rd, Nature 2020 Aug 27;(): Infection\|SARS-CoV-2-MA_virus\|Treatment Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Infection\|SARS-CoV-2_virus Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Hou Y, bioRxiv 2020;(): Infection\|SARS-CoV-2_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Treatment Huang Q, Nat Commun 2021 Feb 3;12(1):776 SARS-CoV-2_virus\|Vaccine Li D, Cell 2021 Aug 5;184(16):4203-4219.e32 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment
Tg(H2-Aa-HLA-DPA1)1Lone	MGI:5494673	Transgenic	Inserted expressed sequence						Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	Tg(H2-Aa-HLA-DPA1)1Lone Transgenic			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
Tg(H2-Ab1-HLA-DPB1)1Lone	MGI:5494677	Transgenic	Inserted expressed sequence						Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	Tg(H2-Ab1-HLA-DPB1)1Lone Transgenic			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
Tg(HLA-A2*/H2-Kb)273Rtct	MGI:3851006	Transgenic	Inserted expressed sequence						Prakash S, bioRxiv 2020;():	J:295374	SARS-CoV-2_virus\|Vaccine	Tg(HLA-A2*/H2-Kb)273Rtct Transgenic			Prakash S, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine
Tg(HLA-A/H2-D/B2M)1Bpe	MGI:3711164	Transgenic	Inserted expressed sequence						Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	Tg(HLA-A/H2-D/B2M)1Bpe Transgenic			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
Tg(HLA-DRA0101,HLA-DRB10101)1Dma	MGI:5312109	Transgenic	Inserted expressed sequence						Brentville VA, bioRxiv 2021 Jun;():	J:308658	SARS-CoV-2_virus\|Vaccine	Tg(HLA-DRA0101,HLA-DRB10101)1Dma Transgenic			Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine
Tg(HLA-DRA0101,HLA-DRB10101)1Dmz	MGI:3809457	Transgenic	Humanized sequence\|Inserted expressed sequence						Prakash S, bioRxiv 2020;():	J:295374	SARS-CoV-2_virus\|Vaccine	Tg(HLA-DRA0101,HLA-DRB10101)1Dmz Transgenic			Prakash S, bioRxiv 2020;(): SARS-CoV-2_virus\|Vaccine
Tg(K18-ACE2)2Prlmn	MGI:6389235	Transgenic	Humanized sequence\|Inserted expressed sequence	MGI:6399965 MGI:6455041	severe acute respiratory syndrome COVID-19	DOID:2945 DOID:0080600	cardiovascular system immune system respiratory system mortality/aging behavior/neurological cellular growth/size/body hematopoietic system homeostasis/metabolism liver/biliary system nervous system vision/eye	MP:0005385 MP:0005387 MP:0005388 MP:0010768 MP:0005386 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005370 MP:0003631 MP:0005391	Netland J, J Virol 2008 Aug;82(15):7264-75 McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Zhao J, J Virol 2009 Mar;83(5):2368-73 Dediego ML, Virology 2008 Jul 5;376(2):379-89 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Netland J, Virology 2010 Mar 30;399(1):120-128 Natoli S, Eur J Neurol 2020 Apr 25;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Moreau GB, Am J Trop Med Hyg 2020 Jul 28;(): Cleary SJ, Br J Pharmacol 2020 May 27;(): Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 Winkler ES, Nat Immunol 2020 Aug 24;(): Golden JW, JCI Insight 2020 Aug 25;(): Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Clark JJ, bioRxiv 2020;(): Bai L, bioRxiv 2020;(): Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Ho JSY , bioRxiv 2020 Dec;(): Zhang H, bioRxiv 2020 Dec;(): Kumari P, bioRxiv 2020 Dec;(): Chen JS, bioRxiv 2020 Sep 25;(): Winkler ES, bioRxiv 2020 Dec;(): Soni DK, bioRxiv 2020 Dec;(): Liu R, bioRxiv 2021 Jan;(): Garcia-Arriaza J, J Virol 2021 Jan 7;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Chen JS, J Virol 2021 Jan 13;(): Carossino M, bioRxiv 2021 Jan;(): Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Ku MW, bioRxiv 2021 Feb;(): Dampalla CS, bioRxiv 2021 Feb;(): Noy-Porat T, bioRxiv 2021 Feb;(): Biswas R, bioRxiv 2021 Feb;(): Brunaugh AD, PLoS One 2021;16(2):e0246803 Yinda CK, PLoS Pathog 2021 Jan;17(1):e1009195 Song E, J Exp Med 2021 Mar 1;218(3): Arce VM, Cell Mol Immunol 2021 Jan 14;(): Case JB, bioRxiv 2021 Mar;(): Silvas J, bioRxiv 2021 Mar;(): Zhai C, bioRxiv 2021 Mar;(): Hassler L, bioRxiv 2021 Mar;(): Napolitano V, bioRxiv 2021 Mar;(): Hanke L, bioRxiv 2021 Mar;(): Hoffmann D, bioRxiv 2021 Mar;(): Ullah i, bioRxiv 2021 Mar;(): Zheng J, Nature 2021 Jan;589(7843):603-607 White KM, Science 2021 Feb 26;371(6532):926-931 Elia U, bioRxiv 2021 Mar;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 Joag V, J Immunol 2021 Mar 1;206(5):931-935 Sims JJ, bioRxiv 2021 Apr;(): Cao H, bioRxiv 2021 Apr;(): Seehusen F, bioRxiv 2021 Apr;(): Idris A, bioRxiv 2021 Apr;(): Matchett WE, bioRxiv 2021 Apr;(): Seibert B, bioRxiv 2021 Apr;(): Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 Johnson BA, Nature 2021 Mar;591(7849):293-299 Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 Marx S, bioRxiv 2021 Aug;(): Ryu DK, bioRxiv 2021 Jul;(): Alvaradov DM, bioRxiv 2021 Aug;(): Li W, bioRxiv 2021 Aug;(): Tarres-Frexas F, bioRxiv 2021 Aug;(): Ndeupen S, bioRxiv 2021 Aug;(): Fumagalli V, bioRxiv 2021 Aug;(): Wagner TR, bioRxiv 2021 Aug;(): Ulrich L, bioRxiv 2021 Jun;(): Belouzard S, bioRxiv 2021 Jun;(): Madar-Balakirski N, bioRxiv 2021 Jul;(): Hunt AC, bioRxiv 2021 Jul;(): Grandi A, bioRxiv 2021 Jul;(): Afkhami S, bioRxiv 2021 Jul;(): Venzon M, bioRxiv 2021 Jul;(): Radvak P, bioRxiv 2021 Jun;(): Dong W, bioRxiv 2021 Jun;(): Melamed S, bioRxiv 2021 Jun;(): Conforti A, bioRxiv 2021 Jun;(): Chen JS, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2021 Jun;(): Scaglione A, bioRxiv 2021 Jun;(): Visualization of SARS-CoV-2 infection dynamic., bioRxiv 2021 Jun;(): Chaparian RR, bioRxiv 2021 Apr;(): Shapira T, bioRxiv 2021 May;(): Horspool AM, bioRxiv 2021 May;(): Van Dyke MC, bioRxiv 2021 May;(): Stefan MA, bioRxiv 2021 May;(): Amruta N, bioRxiv 2021 May;(): Dong W, bioRxiv 2021 May;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Israelow B, bioRxiv 2021 May;(): Greer CD, bioRxiv 2021 Aug;(): Salzer R, bioRxiv 2021 May;(): McMillan CL, bioRxiv 2021 May;(): Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 Caceres CJ, Sci Rep 2021 May 5;11(1):9609 Noy-Porat T, iScience 2021 May 21;24(5):102479 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Subramaniam S, bioRxiv 2021 Aug;(): Hilligan KL, bioRxiv 2021 Aug;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Chan CEZ, PLoS One 2021;16(6):e0253487 Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): Dhanyalayam D, bioRxiv 2021 Sep;(): Castro JT, bioRxiv 2021 Sep;(): Robertson SJ, bioRxiv 2021 Sep;(): Eltobgy M, bioRxiv 2021;(): Puhl AC, bioRxiv 2021;(): Sohn SY, mBio 2021 Nov 2;():e0275621 Li K, mBio 2021 Aug 31;12(4):e0097021 Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Zhou R, bioRxiv 2021 Oct;(): Tada T, Cell Rep 2020 Dec 22;33(12):108528 Hong J, bioRxiv 2021 Oct;(): Mejia OR, bioRxiv 2021 Nov;(): Olivarria GM, bioRxiv 2021 Nov;(): Barreiro A, bioRxiv 2021 Dec;(): Chen Y, bioRxiv 2021 Nov;(): Chaves OA, bioRxiv 2021 Nov;(): Ng KW, bioRxiv 2021 Dec;(): Lin X, bioRxiv 2021 Dec;(): Zhao Y, bioRxiv 2021 Dec;(): Zani A, bioRxiv 2021Dec;(): Zhang L, bioRxiv 2021 Dec;(): Gregoire C, bioRxiv 2021 Dec;(): Puhl AC, bioRxiv 2021 Dec;(): Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Liu X, mBio 2021 Apr 20;12(2): Gawish R, Elife 2022 Jan 13;11():e74623 Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Awosanya OD, Bone 2022 Jan;154():116227 Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 Qin Z, Theranostics 2021;11(16):8076-8091 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Ceon E, bioRxiv 2022 Jan;(): Jeong GU, bioRxiv 2022;(): Chong Z, bioRxiv 2022;(): Lee KS, bioRxiv 2022;(): Duty A, bioRxiv 2022;(): Tatham L, bioRxiv 2022;(): Mao T, bioRxiv 2022;(): Ying B, bioRxiv 2022 Feb;(): Liu Y, bioRxiv 2022 Feb;(): Bishop CR, bioRxiv 2022 Feb;(): Mann BJ, bioRxiv 2022 Feb;(): Ye C, bioRxiv 2022 Mar;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Smeyne RJ, bioRxiv 2022 Feb;(): Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Cohen AA, bioRxiv 2022 Mar;(): Zhang L, bioRxiv 2022 Mar;(): Natekar JP, bioRxiv 2022 Apr;(): Jeong GU, bioRxiv 2022 Apr;(): Rizvi ZA, bioRxiv 2022 Apr;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Bishop CR, PLoS Pathog 2022 Sep;18(9):e1010867 Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Kim SH, Front Immunol 2022;13():1055811 de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Manangeeswaran M, Front Immunol 2022;13():919815 Su P, Mol Brain 2022 Aug 9;15(1):71 Chen IP, Cell Rep 2022 Jul 19;40(3):111088 Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Pan R, mBio 2022 Jan 25;():e0366221 Qin C, Proc Natl Acad Sci U S A 2022 Jun 28;119(26):e2122897119 Solopov PA, Am J Pathol 2022 Jul;192(7):990-1000 Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Dhanyalayam D, Front Cardiovasc Med 2022;9():783974 Parray HA, PLoS Pathog 2022 Dec;18(12):e1010994 Humphries F, Sci Immunol 2021 May 18;6(59): Lee S, Nature 2021 Nov;599(7884):283-289 Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Li M, Sci Immunol 2021 May 18;6(59): Callahan V, Viruses 2021 Jun 3;13(6): Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Scaglione A, Front Immunol 2021;12():719077 Vitner EB, Life Sci Alliance 2022 Jan;5(1): Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 Chen EC, Cell Rep 2021 Aug 24;36(8):109604 Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 Li W, Cell Rep 2022 Jan 11;38(2):110210 Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 Syenina A, PLoS Biol 2022 May;20(5):e3001643 Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 Dubuc I, Front Immunol 2022;13():893792 Zhu C, Nat Commun 2022 Aug 3;13(1):4503 Perez P, Front Immunol 2022;13():995235 Mao T, Science 2022 Nov 25;378(6622):eabo2523 Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Oktay E, Commun Biol 2023 Mar 23;6(1):308 Weiss S, Int J Mol Sci 2023 May 5;24(9): Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 Dampalla CS, Proc Natl Acad Sci U S A 2021 Jul 20;118(29): Zhao S, Nat Commun 2021 Aug 9;12(1):4887 Drayman N, Science 2021 Aug 20;373(6557):931-936 VanBlargan LA, Immunity 2021 Aug 19;(): van Oosten L, mBio 2021 Oct 26;12(5):e0181321 Dong W, J Virol 2022 Jan 12;96(1):e0096421 Kim EH, J Virol 2022 Mar 23;96(6):e0187321 Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 Nagai M, Nat Commun 2023 Jun 30;14(1):3863 Hastie KM, Cell Rep 2023 May 30;42(5):112421 Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Wei WC, Front Pharmacol 2023;14():1125414 Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Gioia U, Nat Cell Biol 2023 Apr;25(4):550-564 Rizvi ZA, Commun Biol 2023 Sep 13;6(1):935 Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 Perez P, Front Immunol 2023;14():1264323 Lee YJ, Am J Pathol 2023 Jul;193(7):866-882 Ewart G, PLoS Pathog 2023 Aug;19(8):e1011328 Wong L-YR, mBio 2023 Oct 26;14(6):e0247623 Suberi A, Sci Transl Med 2023 Aug 16;15(709):eabq0603 Oliveira VLS, Front Immunol 2024;15():1378591 Matchett WE, J Immunol 2021 Jun 30;(): Jeong H, Dis Model Mech 2022 Nov 1;15(11):dmm049632 Dangi T, J Clin Invest 2022 Dec 1;132(23): Goncalves R, iScience 2023 Feb 17;26(2):105972 Cao L, Sci Transl Med 2022 Sep 7;14(661):eabm7621 Jaki L, Nat Commun 2023 Apr 10;14(1):1999 Ullah I, iScience 2024 Mar 15;27(3):109049 Avila-Nieto C, Nat Commun 2024 Mar 21;15(1):2349 Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Duty JA, Med 2022 Oct 14;3(10):705-721.e11 Do MH, PLoS One 2023;18(9):e0291537 Kim JW, Front Immunol 2023;14():1271508 Kehrer T, Cell Host Microbe 2023 Oct 11;31(10):1668-1684.e12 van Bergen J, JCI Insight 2023 Nov 8;8(21): Lu A, Int J Mol Sci 2024 Feb 8;25(4): van Huizen M, PLoS Pathog 2024 Mar;20(3):e1012100 Mao T, Proc Natl Acad Sci U S A 2024 Apr 30;121(18):e2319566121 Mei M, Proc Natl Acad Sci U S A 2024 May 28;121(22):e2314166121 Slamanig S, EBioMedicine 2024 Jun 6;105():105185	J:138136 J:283648 J:283997 J:283998 J:283999 J:284000 J:286214 J:287925 J:288402 J:291888 J:292835 J:294026 J:294058 J:294083 J:294084 J:295350 J:295351 J:296067 J:296212 J:296397 J:296535 J:296686 J:298250 J:298262 J:298267 J:298866 J:299082 J:299096 J:299104 J:300041 J:300104 J:300110 J:300428 J:300960 J:302144 J:302145 J:302148 J:302158 J:302248 J:302313 J:302314 J:302316 J:302703 J:302912 J:302918 J:302921 J:303204 J:303206 J:303207 J:303209 J:303220 J:303457 J:303462 J:303465 J:303472 J:303898 J:304613 J:304616 J:304647 J:304677 J:304678 J:304698 J:305460 J:307033 J:308159 J:308571 J:308573 J:308575 J:308578 J:308579 J:308580 J:308584 J:308585 J:308620 J:308621 J:308635 J:308636 J:308637 J:308639 J:308640 J:308642 J:308643 J:308647 J:308651 J:308652 J:308655 J:308656 J:308666 J:308672 J:308713 J:308716 J:308719 J:308721 J:308723 J:308724 J:308725 J:308726 J:308733 J:308745 J:308749 J:308889 J:308894 J:308895 J:308896 J:308903 J:309192 J:309197 J:309512 J:309629 J:309630 J:309634 J:310110 J:310121 J:310123 J:310124 J:311911 J:311915 J:312952 J:313329 J:313337 J:313436 J:313439 J:313447 J:315717 J:315722 J:315723 J:315729 J:315731 J:315739 J:315744 J:316763 J:316764 J:316765 J:316768 J:316769 J:317125 J:317455 J:318828 J:319366 J:319440 J:319441 J:319447 J:319458 J:319459 J:321756 J:321757 J:321761 J:321763 J:321764 J:321766 J:321770 J:321873 J:321879 J:321906 J:321910 J:321927 J:322631 J:322638 J:323957 J:324935 J:324936 J:324941 J:324951 J:325034 J:325089 J:328107 J:330016 J:330045 J:331753 J:331754 J:331763 J:331765 J:331766 J:331767 J:331773 J:331808 J:331821 J:331822 J:331823 J:331826 J:333745 J:333769 J:334872 J:335892 J:335897 J:335898 J:335899 J:335902 J:335904 J:335906 J:335907 J:335910 J:335914 J:335918 J:335919 J:335924 J:335928 J:335929 J:335930 J:335931 J:335933 J:335935 J:335939 J:335943 J:335945 J:335947 J:335949 J:335952 J:335960 J:335961 J:335969 J:335976 J:335986 J:335996 J:335997 J:336005 J:336008 J:336014 J:336016 J:336017 J:336018 J:336021 J:336025 J:336026 J:336189 J:337953 J:338412 J:338414 J:338420 J:338561 J:339218 J:339694 J:340506 J:343550 J:343658 J:343770 J:343773 J:343775 J:343780 J:343790 J:348063 J:348320 J:348325 J:348326 J:348327 J:348328 J:348329 J:348954 J:349496 J:349938 J:349963 J:349970 J:349971 J:349972 J:349973 J:349976 J:349977 J:349979 J:349980 J:350298	Infection\|SARS-CoV_virus Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus MERS-CoV_virus\|SARS-CoV_virus SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Infection\|SARS-CoV-2_virus SARS-CoV-2_virus Infection\|Pathology\|SARS-CoV-2_virus SARS-CoV-2_virus\|SARS-CoV_virus SARS-CoV-2_virus\|Vaccine Infection\|Pathology\|SARS-CoV-2_virus\|Sex_bias MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Comorbidity\|Pathology\|SARS-CoV-2_virus Comorbidity\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment Vaccine MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Pathology\|SARS-CoV-2_virus Gene\|SARS-CoV-2_virus MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.429\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha SARS-CoV-2_virus\|VOC_B.1.351_Beta Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Gene\|SARS-CoV-2-MA_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Comorbidity\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Gene\|Pathology\|SARS-CoV-2_virus Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Pathology\|SARS-CoV-2-MA_virus SARS-CoV-2_virus\|Vaccine\|VOC_P.1_Gamma SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Pathology\|VOC_B.1.617.2_Delta Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Vaccine\|VOC_B.1.1.529_Omicron Pathology PASC\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta SARS-CoV-2_virus\|Treatment\|Variant\|VOC_B.1.1.529_Omicron\|VOC_P.1_Gamma Infection\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Infection\|Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta SARS-CoV-2-MA_virus\|SARS-CoV-2_virus SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Infection\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus Infection\|SARS-CoV-2_virus\|Treatment Comorbidity\|SARS-CoV-2_virus\|Sex_bias SARS-CoV-2_virus\|Treatment\|Variant SARS-CoV-2_virus\|Treatment\|Vaccine SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|Variant SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Comorbidity\|Infection\|SARS-CoV-2_virus Pathology\|SARS-CoV-2_virus\|Vaccine SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta MERS-CoV-MA_virus\|Pathology\|SARS-CoV-2_virus Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.617.2_Delta SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Infection\|Pathology\|SARS-CoV-2_virus\|Variant SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.1.529_Omicron	Tg(K18-ACE2)2Prlmn Transgenic	MGI:6399965 MGI:6455041	cardiovascular system immune system respiratory system mortality/aging severe acute respiratory syndrome behavior/neurological cellular growth/size/body hematopoietic system homeostasis/metabolism liver/biliary system nervous system vision/eye COVID-19	Netland J, J Virol 2008 Aug;82(15):7264-75 Infection\|SARS-CoV_virus McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Infection\|SARS-CoV_virus Zhao J, J Virol 2009 Mar;83(5):2368-73 Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus Dediego ML, Virology 2008 Jul 5;376(2):379-89 Infection\|SARS-CoV_virus Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 MERS-CoV_virus\|SARS-CoV_virus Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 MERS-CoV_virus\|SARS-CoV_virus Netland J, Virology 2010 Mar 30;399(1):120-128 SARS-CoV-MA_virus\|SARS-CoV_virus\|Vaccine Natoli S, Eur J Neurol 2020 Apr 25;(): Infection\|SARS-CoV-2_virus Lutz C, Hum Genomics 2020 Jun 4;14(1):20 SARS-CoV-2_virus Moreau GB, Am J Trop Med Hyg 2020 Jul 28;(): Infection\|Pathology\|SARS-CoV-2_virus Cleary SJ, Br J Pharmacol 2020 May 27;(): SARS-CoV-2_virus Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus\|SARS-CoV_virus Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 SARS-CoV-2_virus\|Vaccine Winkler ES, Nat Immunol 2020 Aug 24;(): Infection\|Pathology\|SARS-CoV-2_virus Golden JW, JCI Insight 2020 Aug 25;(): Infection\|Pathology\|SARS-CoV-2_virus\|Sex_bias Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus\|MERS-CoV_virus\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV-MA_virus\|SARS-CoV_virus Munoz-Fontela C, Nature 2020 Sep 23;(): SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Clark JJ, bioRxiv 2020;(): Comorbidity\|Pathology\|SARS-CoV-2_virus Bai L, bioRxiv 2020;(): Comorbidity\|SARS-CoV-2_virus Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Infection\|SARS-CoV-2_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Ho JSY , bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Zhang H, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Kumari P, bioRxiv 2020 Dec;(): Infection\|Pathology\|SARS-CoV-2_virus Chen JS, bioRxiv 2020 Sep 25;(): SARS-CoV-2_virus\|Treatment Winkler ES, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Soni DK, bioRxiv 2020 Dec;(): SARS-CoV-2_virus\|Treatment Liu R, bioRxiv 2021 Jan;(): SARS-CoV-2_virus\|Vaccine Garcia-Arriaza J, J Virol 2021 Jan 7;(): Vaccine Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus Chen JS, J Virol 2021 Jan 13;(): SARS-CoV-2_virus\|Treatment Carossino M, bioRxiv 2021 Jan;(): Pathology\|SARS-CoV-2_virus Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Pathology\|SARS-CoV-2_virus Ku MW, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Vaccine Dampalla CS, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Treatment Noy-Porat T, bioRxiv 2021 Feb;(): SARS-CoV-2_virus\|Treatment Biswas R, bioRxiv 2021 Feb;(): Gene\|SARS-CoV-2_virus Brunaugh AD, PLoS One 2021;16(2):e0246803 MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Yinda CK, PLoS Pathog 2021 Jan;17(1):e1009195 Pathology\|SARS-CoV-2_virus Song E, J Exp Med 2021 Mar 1;218(3): Infection\|SARS-CoV-2_virus Arce VM, Cell Mol Immunol 2021 Jan 14;(): Pathology\|SARS-CoV-2_virus Case JB, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Silvas J, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus Zhai C, bioRxiv 2021 Mar;(): SARS-CoV-2_virus Hassler L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Napolitano V, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Hanke L, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta Hoffmann D, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Ullah i, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Treatment Zheng J, Nature 2021 Jan;589(7843):603-607 Pathology\|SARS-CoV-2_virus\|Treatment White KM, Science 2021 Feb 26;371(6532):926-931 SARS-CoV-2_virus\|Treatment Elia U, bioRxiv 2021 Mar;(): SARS-CoV-2_virus\|Vaccine Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 SARS-CoV-2_virus\|Vaccine Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 SARS-CoV-2_virus\|Treatment Joag V, J Immunol 2021 Mar 1;206(5):931-935 SARS-CoV-2_virus\|Vaccine Sims JJ, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Treatment Cao H, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Seehusen F, bioRxiv 2021 Apr;(): Pathology\|SARS-CoV-2_virus Idris A, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Treatment Matchett WE, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Seibert B, bioRxiv 2021 Apr;(): Infection\|SARS-CoV-2_virus Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 SARS-CoV-2_virus Johnson BA, Nature 2021 Mar;591(7849):293-299 SARS-CoV-2_virus Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 Pathology\|SARS-CoV-2_virus\|Treatment Marx S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Treatment Ryu DK, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Alvaradov DM, bioRxiv 2021 Aug;(): SARS-CoV-2_virus Li W, bioRxiv 2021 Aug;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.429\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Tarres-Frexas F, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Ndeupen S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Fumagalli V, bioRxiv 2021 Aug;(): Infection\|SARS-CoV-2_virus Wagner TR, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta Ulrich L, bioRxiv 2021 Jun;(): Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Belouzard S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment Madar-Balakirski N, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Ryu DK, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma Hunt AC, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Grandi A, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine Afkhami S, bioRxiv 2021 Jul;(): SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Venzon M, bioRxiv 2021 Jul;(): Pathology\|SARS-CoV-2_virus Radvak P, bioRxiv 2021 Jun;(): Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Dong W, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha Melamed S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Conforti A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|VOC_B.1.351_Beta Mao T, bioRxiv 2021 Jun;(): Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_P.1_Gamma Scaglione A, bioRxiv 2021 Jun;(): SARS-CoV-2_virus\|Vaccine Visualization of SARS-CoV-2 infection dynamic., bioRxiv 2021 Jun;(): Infection\|SARS-CoV-2_virus Chaparian RR, bioRxiv 2021 Apr;(): SARS-CoV-2_virus\|Vaccine Shapira T, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Horspool AM, bioRxiv 2021 May;(): SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Van Dyke MC, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment Stefan MA, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment Amruta N, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Treatment Dong W, bioRxiv 2021 May;(): SARS-CoV-2_virus Joyce MGl Chen WH, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Israelow B, bioRxiv 2021 May;(): Infection\|SARS-CoV-2_virus Greer CD, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Vaccine Salzer R, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine McMillan CL, bioRxiv 2021 May;(): SARS-CoV-2_virus\|Vaccine Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 SARS-CoV-2_virus\|Treatment Caceres CJ, Sci Rep 2021 May 5;11(1):9609 SARS-CoV-2_virus\|Treatment Noy-Porat T, iScience 2021 May 21;24(5):102479 SARS-CoV-2_virus\|Treatment Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus Subramaniam S, bioRxiv 2021 Aug;(): Pathology\|SARS-CoV-2_virus Hilligan KL, bioRxiv 2021 Aug;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Pathology\|SARS-CoV-2_virus Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 SARS-CoV-2_virus\|Vaccine Turan RD, Sci Rep 2021 Aug 4;11(1):15799 SARS-CoV-2_virus\|Vaccine Chan CEZ, PLoS One 2021;16(6):e0253487 SARS-CoV-2_virus\|Treatment Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): SARS-CoV-2_virus Dhanyalayam D, bioRxiv 2021 Sep;(): Comorbidity\|SARS-CoV-2_virus Castro JT, bioRxiv 2021 Sep;(): SARS-CoV-2_virus\|Vaccine Robertson SJ, bioRxiv 2021 Sep;(): Infection\|SARS-CoV-2_virus Eltobgy M, bioRxiv 2021;(): Gene\|SARS-CoV-2-MA_virus Puhl AC, bioRxiv 2021;(): SARS-CoV-2_virus\|Treatment Sohn SY, mBio 2021 Nov 2;():e0275621 SARS-CoV-2_virus\|Treatment Li K, mBio 2021 Aug 31;12(4):e0097021 MERS-CoV_virus\|SARS-CoV-2_virus\|Treatment Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Pathology\|SARS-CoV-2_virus Zhou R, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Vaccine Tada T, Cell Rep 2020 Dec 22;33(12):108528 SARS-CoV-2_virus\|Treatment Hong J, bioRxiv 2021 Oct;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Mejia OR, bioRxiv 2021 Nov;(): Comorbidity\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Olivarria GM, bioRxiv 2021 Nov;(): Pathology\|SARS-CoV-2_virus Barreiro A, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Chen Y, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Treatment Chaves OA, bioRxiv 2021 Nov;(): SARS-CoV-2_virus\|Treatment Ng KW, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Vaccine Lin X, bioRxiv 2021 Dec;(): Gene\|Pathology\|SARS-CoV-2_virus Zhao Y, bioRxiv 2021 Dec;(): Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Zani A, bioRxiv 2021Dec;(): Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Zhang L, bioRxiv 2021 Dec;(): SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma Gregoire C, bioRxiv 2021 Dec;(): SARS-CoV-2_virus Puhl AC, bioRxiv 2021 Dec;(): Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.427\|VOC_B.1.617.2_Delta Liu X, mBio 2021 Apr 20;12(2): SARS-CoV-2_virus Gawish R, Elife 2022 Jan 13;11():e74623 Pathology\|SARS-CoV-2-MA_virus Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 SARS-CoV-2_virus\|Vaccine\|VOC_P.1_Gamma Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Pathology\|SARS-CoV-2_virus Awosanya OD, Bone 2022 Jan;154():116227 Pathology\|SARS-CoV-2_virus Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 SARS-CoV-2_virus\|Vaccine Qin Z, Theranostics 2021;11(16):8076-8091 Pathology\|SARS-CoV-2_virus Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Infection\|SARS-CoV-2_virus Ceon E, bioRxiv 2022 Jan;(): SARS-CoV-2_virus\|Treatment Jeong GU, bioRxiv 2022;(): Pathology\|SARS-CoV-2_virus Chong Z, bioRxiv 2022;(): SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Lee KS, bioRxiv 2022;(): Pathology\|VOC_B.1.617.2_Delta Duty A, bioRxiv 2022;(): Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Tatham L, bioRxiv 2022;(): Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Mao T, bioRxiv 2022;(): SARS-CoV-2_virus\|Vaccine Ying B, bioRxiv 2022 Feb;(): Vaccine\|VOC_B.1.1.529_Omicron Liu Y, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Vaccine Bishop CR, bioRxiv 2022 Feb;(): Pathology Mann BJ, bioRxiv 2022 Feb;(): SARS-CoV-2_virus\|Treatment Ye C, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Vaccine Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 SARS-CoV-2_virus Smeyne RJ, bioRxiv 2022 Feb;(): PASC\|SARS-CoV-2_virus Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology\|SARS-CoV-2_virus\|VOC_B.1.351_Beta Cohen AA, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Treatment Zhang L, bioRxiv 2022 Mar;(): SARS-CoV-2_virus\|Treatment\|Variant\|VOC_B.1.1.529_Omicron\|VOC_P.1_Gamma Natekar JP, bioRxiv 2022 Apr;(): Infection\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Jeong GU, bioRxiv 2022 Apr;(): Pathology\|SARS-CoV-2_virus Rizvi ZA, bioRxiv 2022 Apr;(): Infection\|Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Walls AC, Cell Rep 2022 Aug 30;40(9):111299 SARS-CoV-2_virus\|Vaccine\|Variant\|VOC_B.1.351_Beta Bishop CR, PLoS Pathog 2022 Sep;18(9):e1010867 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Infection\|SARS-CoV-2_virus Kim SH, Front Immunol 2022;13():1055811 SARS-CoV-2_virus de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 SARS-CoV-2_virus Manangeeswaran M, Front Immunol 2022;13():919815 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta\|VOC_P.1_Gamma Su P, Mol Brain 2022 Aug 9;15(1):71 SARS-CoV-2_virus\|Treatment Chen IP, Cell Rep 2022 Jul 19;40(3):111088 SARS-CoV-2_virus Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection\|SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Pan R, mBio 2022 Jan 25;():e0366221 Infection\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus Qin C, Proc Natl Acad Sci U S A 2022 Jun 28;119(26):e2122897119 Infection\|SARS-CoV-2_virus\|Treatment Solopov PA, Am J Pathol 2022 Jul;192(7):990-1000 Comorbidity\|SARS-CoV-2_virus Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Gene\|SARS-CoV-2-MA_virus\|SARS-CoV-2_virus Dhanyalayam D, Front Cardiovasc Med 2022;9():783974 Comorbidity\|SARS-CoV-2_virus\|Sex_bias Parray HA, PLoS Pathog 2022 Dec;18(12):e1010994 SARS-CoV-2_virus\|Treatment\|Variant Humphries F, Sci Immunol 2021 May 18;6(59): SARS-CoV-2_virus\|Treatment Lee S, Nature 2021 Nov;599(7884):283-289 SARS-CoV-2_virus\|Treatment Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 SARS-CoV-2_virus\|Vaccine Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Pathology\|SARS-CoV-2_virus Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 SARS-CoV-2_virus Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Gene\|SARS-CoV-2_virus Li M, Sci Immunol 2021 May 18;6(59): SARS-CoV-2_virus\|Treatment Callahan V, Viruses 2021 Jun 3;13(6): Infection\|Pathology\|SARS-CoV-2_virus Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Comorbidity\|SARS-CoV-2_virus Scaglione A, Front Immunol 2021;12():719077 SARS-CoV-2_virus\|Treatment\|Vaccine Vitner EB, Life Sci Alliance 2022 Jan;5(1): Infection\|Pathology\|SARS-CoV-2_virus Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Infection\|Pathology\|SARS-CoV-2_virus Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 SARS-CoV-2_virus\|Treatment El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 SARS-CoV-2_virus\|Treatment Chen EC, Cell Rep 2021 Aug 24;36(8):109604 SARS-CoV-2_virus\|Treatment Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 SARS-CoV-2_virus\|Treatment Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta Li W, Cell Rep 2022 Jan 11;38(2):110210 SARS-CoV-2_virus\|Treatment\|Variant Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 SARS-CoV-2_virus\|Vaccine Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 SARS-CoV-2_virus\|Vaccine Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 SARS-CoV-2_virus\|Treatment Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 SARS-CoV-2_virus Syenina A, PLoS Biol 2022 May;20(5):e3001643 SARS-CoV-2_virus\|Vaccine Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 SARS-CoV-2_virus\|Treatment Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 SARS-CoV-2_virus\|Treatment\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 SARS-CoV-2_virus\|Vaccine\|Variant Dubuc I, Front Immunol 2022;13():893792 Pathology\|SARS-CoV-2_virus Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus\|Treatment Perez P, Front Immunol 2022;13():995235 SARS-CoV-2_virus\|Vaccine Mao T, Science 2022 Nov 25;378(6622):eabo2523 SARS-CoV-2_virus\|Vaccine Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Pathology\|VOC_B.1.617.2_Delta Oktay E, Commun Biol 2023 Mar 23;6(1):308 SARS-CoV-2_virus\|Vaccine Weiss S, Int J Mol Sci 2023 May 5;24(9): SARS-CoV-2_virus\|Treatment Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 SARS-CoV-2-MA_virus\|SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.7_Alpha\|VOC_B.1.351_Beta\|VOC_B.1.617.2_Delta Dampalla CS, Proc Natl Acad Sci U S A 2021 Jul 20;118(29): SARS-CoV-2_virus\|Treatment Zhao S, Nat Commun 2021 Aug 9;12(1):4887 SARS-CoV-2_virus\|Treatment Drayman N, Science 2021 Aug 20;373(6557):931-936 SARS-CoV-2_virus\|Treatment VanBlargan LA, Immunity 2021 Aug 19;(): SARS-CoV-2_virus\|Treatment\|Variant van Oosten L, mBio 2021 Oct 26;12(5):e0181321 SARS-CoV-2_virus\|Vaccine Dong W, J Virol 2022 Jan 12;96(1):e0096421 Infection\|Pathology\|SARS-CoV-2_virus Kim EH, J Virol 2022 Mar 23;96(6):e0187321 Comorbidity\|Infection\|SARS-CoV-2_virus Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 Pathology\|SARS-CoV-2_virus\|Vaccine Nagai M, Nat Commun 2023 Jun 30;14(1):3863 SARS-CoV-2_virus\|VOC_B.1.1.7_Alpha Hastie KM, Cell Rep 2023 May 30;42(5):112421 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Wei WC, Front Pharmacol 2023;14():1125414 SARS-CoV-2_virus\|Treatment Robertson SJ, Nat Commun 2023 Jul 25;14(1):4481 Infection\|SARS-CoV-2_virus Yang S, J Med Virol 2022 Aug;94(8):3605-3612 Pathology\|SARS-CoV-2_virus\|VOC_B.1.617.2_Delta Gioia U, Nat Cell Biol 2023 Apr;25(4):550-564 SARS-CoV-2_virus Rizvi ZA, Commun Biol 2023 Sep 13;6(1):935 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection\|SARS-CoV-2_virus\|Treatment Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus Perez P, Front Immunol 2023;14():1264323 SARS-CoV-2_virus\|Vaccine\|VOC_B.1.351_Beta Lee YJ, Am J Pathol 2023 Jul;193(7):866-882 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Ewart G, PLoS Pathog 2023 Aug;19(8):e1011328 SARS-CoV-2_virus\|Treatment Wong L-YR, mBio 2023 Oct 26;14(6):e0247623 MERS-CoV-MA_virus\|Pathology\|SARS-CoV-2_virus Suberi A, Sci Transl Med 2023 Aug 16;15(709):eabq0603 SARS-CoV-2_virus\|Vaccine Oliveira VLS, Front Immunol 2024;15():1378591 Mouse_Hepatitis_virus\|SARS-CoV-2_virus\|Treatment\|VOC_P.1_Gamma Matchett WE, J Immunol 2021 Jun 30;(): SARS-CoV-2_virus\|Vaccine Jeong H, Dis Model Mech 2022 Nov 1;15(11):dmm049632 Pathology\|SARS-CoV-2_virus Dangi T, J Clin Invest 2022 Dec 1;132(23): SARS-CoV-2_virus\|Treatment Goncalves R, iScience 2023 Feb 17;26(2):105972 Pathology\|SARS-CoV-2_virus\|VOC_B.1.1.529_Omicron\|VOC_B.1.1.7_Alpha\|VOC_B.1.617.2_Delta Cao L, Sci Transl Med 2022 Sep 7;14(661):eabm7621 SARS-CoV-2_virus\|Treatment\|Variant Jaki L, Nat Commun 2023 Apr 10;14(1):1999 SARS-CoV-2_virus\|Treatment Ullah I, iScience 2024 Mar 15;27(3):109049 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron\|VOC_B.1.617.2_Delta Avila-Nieto C, Nat Commun 2024 Mar 21;15(1):2349 SARS-CoV-2_virus\|Vaccine\|VOC_B.1.1.529_Omicron\|VOC_B.1.351_Beta Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Pathology\|SARS-CoV-2_virus Duty JA, Med 2022 Oct 14;3(10):705-721.e11 SARS-CoV-2_virus\|Treatment\|VOC_B.1.1.529_Omicron Do MH, PLoS One 2023;18(9):e0291537 SARS-CoV-2_virus\|Treatment Kim JW, Front Immunol 2023;14():1271508 SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta Kehrer T, Cell Host Microbe 2023 Oct 11;31(10):1668-1684.e12 Infection\|Pathology\|SARS-CoV-2_virus\|Variant van Bergen J, JCI Insight 2023 Nov 8;8(21): SARS-CoV-2_virus\|SARS-CoV_virus\|Vaccine\|VOC_B.1.1.529_Omicron Lu A, Int J Mol Sci 2024 Feb 8;25(4): SARS-CoV-2_virus\|Treatment\|VOC_B.1.617.2_Delta van Huizen M, PLoS Pathog 2024 Mar;20(3):e1012100 Infection\|SARS-CoV-2_virus Mao T, Proc Natl Acad Sci U S A 2024 Apr 30;121(18):e2319566121 SARS-CoV-2_virus\|Treatment Mei M, Proc Natl Acad Sci U S A 2024 May 28;121(22):e2314166121 Infection\|SARS-CoV-2_virus Slamanig S, EBioMedicine 2024 Jun 6;105():105185 SARS-CoV-2_virus\|Vaccine
Tg(KRT18-DPP4)3Pbmj	MGI:6402178	Transgenic	Epitope tag\|Humanized sequence\|Inserted expressed sequence	MGI:6402203	Middle East respiratory syndrome	DOID:0080642	cardiovascular system digestive/alimentary system hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging	MP:0005385 MP:0005381 MP:0005397 MP:0005376 MP:0005387 MP:0003631 MP:0005367 MP:0005388 MP:0010768	Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Leist SR, Methods Mol Biol 2020;2099():137-159 Zhou J, Sci Adv 2017 Nov;3(11):eaao4966 Yuan S, Nat Commun 2019 Jan 10;10(1):120 Rathnayake AD, Sci Transl Med 2020 Aug 3;(): Knaap RC, bioRxiv 2019;(): Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118	J:285467 J:285962 J:286231 J:291634 J:291887 J:295365 J:315826	Infection\|MERS-CoV_virus\|Pathology MERS-CoV_virus Infection\|MERS-CoV_virus MERS-CoV_virus\|Treatment MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment MERS-CoV_virus\|Vaccine	Tg(KRT18-DPP4)3Pbmj Transgenic	MGI:6402203	cardiovascular system digestive/alimentary system hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging Middle East respiratory syndrome	Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Infection\|MERS-CoV_virus\|Pathology Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Zhou J, Sci Adv 2017 Nov;3(11):eaao4966 Infection\|MERS-CoV_virus Yuan S, Nat Commun 2019 Jan 10;10(1):120 MERS-CoV_virus\|Treatment Rathnayake AD, Sci Transl Med 2020 Aug 3;(): MERS-CoV_virus\|SARS-CoV-2_virus\|SARS-CoV_virus\|Treatment Knaap RC, bioRxiv 2019;(): Infection\|MERS-CoV_virus Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 MERS-CoV_virus\|Vaccine
Tg(Myh6-ACE2)1Rbre	MGI:6459902	Transgenic	Humanized sequence\|Inserted expressed sequence						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Tg(Myh6-ACE2)1Rbre Transgenic			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Tg(Myh6-ACE2)2Rbre	MGI:6459903	Transgenic	Humanized sequence\|Inserted expressed sequence						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Tg(Myh6-ACE2)2Rbre Transgenic			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Tg(PSEN1)5Dbo	MGI:2447335	Transgenic	Humanized sequence\|Inserted expressed sequence						Chen J, Transl Psychiatry 2023 Dec 16;13(1):396	J:348471	Gene\|Infection\|SARS-CoV-2_virus	Tg(PSEN1)5Dbo Transgenic			Chen J, Transl Psychiatry 2023 Dec 16;13(1):396 Gene\|Infection\|SARS-CoV-2_virus
Tg(SFTPC-DPP4)3Pbmj	MGI:6402180	Transgenic	Epitope tag\|Humanized sequence\|Inserted expressed sequence	MGI:6402208			immune system	MP:0005387	Li K, J Infect Dis 2016 Mar 1;213(5):712-22	J:285467	Infection\|MERS-CoV_virus\|Pathology	Tg(SFTPC-DPP4)3Pbmj Transgenic	MGI:6402208	immune system	Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Infection\|MERS-CoV_virus\|Pathology
Tg(SIRPA)1Flv	MGI:5300383	Transgenic	Humanized sequence\|Inserted expressed sequence						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Tg(SIRPA)1Flv Transgenic			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Tg(Sry)2Ei	MGI:3041982	Transgenic	Inserted expressed sequence						Ensor CM, bioRxiv 2021-09;():	J:310122	SARS-CoV-2_virus	Tg(Sry)2Ei Transgenic			Ensor CM, bioRxiv 2021-09;(): SARS-CoV-2_virus
Tg(Syn1-ACE2)10Sig	MGI:6401191	Transgenic	Humanized sequence\|Inserted expressed sequence						Jia H, Nat Commun 2020 Oct 14;11(1):5165	J:296535	SARS-CoV-2_virus	Tg(Syn1-ACE2)10Sig Transgenic			Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus
Tg(TcraTcrb)425Cbn	MGI:3046083	Transgenic	Inserted expressed sequence						Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7	J:177608	Mouse_Hepatitis_virus	Tg(TcraTcrb)425Cbn Transgenic			Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7 Mouse_Hepatitis_virus
Tg(TcrLCMV)#Sdz	MGI:4838215	Transgenic	Inserted expressed sequence						Perez-Shibayama C, PLoS One 2013;8(11):e81442	J:291632	Mouse_Hepatitis_virus	Tg(TcrLCMV)#Sdz Transgenic			Perez-Shibayama C, PLoS One 2013;8(11):e81442 Mouse_Hepatitis_virus
Tg(Tek-cre)1Ywa	MGI:2450311	Transgenic	Hypomorph\|Recombinase						Gao S, Front Cardiovasc Med 2023;10():1266276	J:346048	Infection\|SARS-CoV-2_virus	Tg(Tek-cre)1Ywa Transgenic			Gao S, Front Cardiovasc Med 2023;10():1266276 Infection\|SARS-CoV-2_virus
Tg(tetO-GFP,-APOL1)#Susz	MGI:6331297	Transgenic	Humanized sequence\|Inducible\|Inserted expressed sequence\|Reporter						Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	Tg(tetO-GFP,-APOL1)#Susz Transgenic			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
Tg(tetO-GFP,-APOL1*)#Susz	MGI:6331300	Transgenic	Humanized sequence\|Inducible\|Inserted expressed sequence\|Reporter						Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6	J:323769	Gene\|Pathology	Tg(tetO-GFP,-APOL1*)#Susz Transgenic			Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene\|Pathology
Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz	MGI:4412048	Transgenic	Humanized sequence\|Inserted expressed sequence						Magusali N, bioRxiv 2021 Mar;():	J:303205	Comorbidity	Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz Transgenic			Magusali N, bioRxiv 2021 Mar;(): Comorbidity
Tg(Tk1-DPP4)27Ysj	MGI:6443611	Transgenic	Epitope tag\|Humanized sequence\|Inserted expressed sequence	MGI:6443613	Middle East respiratory syndrome	DOID:0080642	behavior/neurological cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system integument nervous system respiratory system mortality/aging	MP:0005386 MP:0005385 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0010771 MP:0003631 MP:0005388 MP:0010768	Kim J, J Microbiol Biotechnol 2020 Mar 28;30(3):427-438	J:290259	Infection\|MERS-CoV_virus\|Pathology	Tg(Tk1-DPP4)27Ysj Transgenic	MGI:6443613	behavior/neurological cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system integument nervous system respiratory system mortality/aging Middle East respiratory syndrome	Kim J, J Microbiol Biotechnol 2020 Mar 28;30(3):427-438 Infection\|MERS-CoV_virus\|Pathology
Thpo^{tm1.1(TPO)Flv}	MGI:4887867	Targeted	Humanized sequence\|Inserted expressed sequence						Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Thpo^{tm1.1(TPO)Flv} Targeted			Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Ticam1^Lps2	MGI:2679794	Chemically induced (ENU)	Not Specified	MGI:5520919			cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768	Totura AL, mBio 2015 May 26;6(3):e00638-15	J:288471	Infection\|SARS-CoV-MA_virus	Ticam1^Lps2 Chemically induced (ENU)	MGI:5520919	cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging	Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection\|SARS-CoV-MA_virus
Ticam1^tm1Aki	MGI:3029019	Targeted	Null/knockout	MGI:3029024			cellular hematopoietic system homeostasis/metabolism immune system nervous system	MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0003631	Imai Y, Cell 2008 Apr 18;133(2):235-49 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:145306 J:296686 J:308903	SARS-CoV_virus Pathology\|SARS-CoV-2_virus\|Treatment Pathology\|SARS-CoV-2_virus	Ticam1^tm1Aki Targeted	MGI:3029024	cellular hematopoietic system homeostasis/metabolism immune system nervous system	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology\|SARS-CoV-2_virus\|Treatment Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus
Ticam2^tm1Aki	MGI:3040182	Targeted	Null/knockout	MGI:3040184	Coronavirus infectious disease	DOID:0080599	immune system	MP:0005387	Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663	J:270045	Pathology\|SARS-CoV-MA_virus	Ticam2^tm1Aki Targeted	MGI:3040184	immune system Coronavirus infectious disease	Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology\|SARS-CoV-MA_virus
Timp1^tm1Pds	MGI:3512125	Targeted	Null/knockout						Savarin C, ASN Neuro 2013 Nov 26;5(5):e00127	J:331803	Mouse_Hepatitis_virus	Timp1^tm1Pds Targeted			Savarin C, ASN Neuro 2013 Nov 26;5(5):e00127 Mouse_Hepatitis_virus
Tlr2^tm1Aki	MGI:2178675	Targeted	Null/knockout						Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:308903	Pathology\|SARS-CoV-2_virus	Tlr2^tm1Aki Targeted			Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus
Tlr2^tm1Kir	MGI:2674036	Targeted	Null/knockout						Yang J, Nature 2020 Jul 29;(): Khan S, bioRxiv 2021 Mar;():	J:292665 J:303202	SARS-CoV-2_virus\|Vaccine Infection\|SARS-CoV-2_virus	Tlr2^tm1Kir Targeted			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine Khan S, bioRxiv 2021 Mar;(): Infection\|SARS-CoV-2_virus
Tlr3^tm1Aki	MGI:3690535	Targeted	Null/knockout	MGI:3698173 MGI:6403489			cardiovascular system immune system muscle	MP:0005385 MP:0005387 MP:0005369	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Imai Y, Cell 2008 Apr 18;133(2):235-49	J:144400 J:145306	Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus SARS-CoV_virus	Tlr3^tm1Aki Targeted	MGI:3698173 MGI:6403489	cardiovascular system immune system muscle	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus
Tlr3^tm1Flv	MGI:2653138	Targeted	Null/knockout	MGI:6433074			immune system respiratory system	MP:0005387 MP:0005388	Totura AL, mBio 2015 May 26;6(3):e00638-15	J:288471	Infection\|SARS-CoV-MA_virus	Tlr3^tm1Flv Targeted	MGI:6433074	immune system respiratory system	Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection\|SARS-CoV-MA_virus
Tlr4^Lps-d	MGI:1857718	Spontaneous							Imai Y, Cell 2008 Apr 18;133(2):235-49 Khanolkar A, J Virol 2009 Sep;83(17):8946-56	J:145306 J:153918	SARS-CoV_virus Mouse_Hepatitis_virus\|Pathology	Tlr4^Lps-d Spontaneous			Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus\|Pathology
Tlr4^lps-del	MGI:1860755	Spontaneous	Null/knockout						Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus\|Vaccine	Tlr4^lps-del Spontaneous			Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus\|Vaccine
Tlr4^tm1Aki	MGI:1860885	Targeted	Null/knockout	MGI:3588775			homeostasis/metabolism immune system	MP:0005376 MP:0005387	Imai Y, Cell 2008 Apr 18;133(2):235-49 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:145306 J:308903	SARS-CoV_virus Pathology\|SARS-CoV-2_virus	Tlr4^tm1Aki Targeted	MGI:3588775	homeostasis/metabolism immune system	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus
Tlr7^tm1Aki	MGI:3045662	Targeted	Null/knockout	MGI:6403489 MGI:6403490			immune system	MP:0005387	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:144400 J:288107 J:308903	Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus Infection\|MERS-CoV-MA_virus\|Treatment Pathology\|SARS-CoV-2_virus	Tlr7^tm1Aki Targeted	MGI:6403489 MGI:6403490	immune system	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection\|Mouse_Hepatitis_virus\|SARS-CoV_virus Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection\|MERS-CoV-MA_virus\|Treatment Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology\|SARS-CoV-2_virus
Tlr9^tm1Aki	MGI:2660562	Targeted	Null/knockout						Imai Y, Cell 2008 Apr 18;133(2):235-49 Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008	J:145306 J:325468	SARS-CoV_virus SARS-CoV-2_virus	Tlr9^tm1Aki Targeted			Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008 SARS-CoV-2_virus
Tmem41b^em1Cya	MGI:6838393	Endonuclease-mediated	Null/knockout	MGI:6838394			mortality/aging	MP:0010768	Sun L, PLoS Pathog 2021 Dec;17(12):e1010113	J:316472	Gene\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus	Tmem41b^em1Cya Endonuclease-mediated	MGI:6838394	mortality/aging	Sun L, PLoS Pathog 2021 Dec;17(12):e1010113 Gene\|Mouse_Hepatitis_virus\|SARS-CoV-2_virus
Tmprss2^{tm1(KOMP)Vlcg}	MGI:4399580	Targeted	Null/knockout\|Reporter	MGI:5705124 MGI:6403636			embryo growth/size/body immune system reproductive system respiratory system mortality/aging	MP:0005380 MP:0005378 MP:0005387 MP:0005389 MP:0005388 MP:0010768	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11	J:283077 J:294026	MERS-CoV-MA_virus\|MERS-CoV_virus\|Pathology SARS-CoV-2_virus\|SARS-CoV_virus	Tmprss2^{tm1(KOMP)Vlcg} Targeted	MGI:5705124 MGI:6403636	embryo growth/size/body immune system reproductive system respiratory system mortality/aging	Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): MERS-CoV-MA_virus\|MERS-CoV_virus\|Pathology Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus\|SARS-CoV_virus
Tnfrsf1a^tm1Imx	MGI:1857468	Targeted	Null/knockout	MGI:6433775			immune system	MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32	J:288523 J:315532	Pathology\|SARS-CoV-MA_virus Mouse_Hepatitis_virus	Tnfrsf1a^tm1Imx Targeted	MGI:6433775	immune system	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32 Mouse_Hepatitis_virus
Tnfrsf1a^tm1Mak	MGI:1857261	Targeted	Null/knockout						McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	Tnfrsf1a^tm1Mak Targeted			McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
Tnfrsf1b^tm1Imx	MGI:1860087	Targeted	Null/knockout	MGI:6433775			immune system	MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32	J:288523 J:315532	Pathology\|SARS-CoV-MA_virus Mouse_Hepatitis_virus	Tnfrsf1b^tm1Imx Targeted	MGI:6433775	immune system	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32 Mouse_Hepatitis_virus
Tnfrsf1b^tm1Mwm	MGI:1857262	Targeted	Null/knockout	MGI:3580520			cellular hematopoietic system immune system	MP:0005384 MP:0005397 MP:0005387	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology\|SARS-CoV-MA_virus	Tnfrsf1b^tm1Mwm Targeted	MGI:3580520	cellular hematopoietic system immune system	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology\|SARS-CoV-MA_virus
Tnf^tm1Gkl	MGI:2149024	Targeted	Null/knockout						Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32	J:315532	Mouse_Hepatitis_virus	Tnf^tm1Gkl Targeted			Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32 Mouse_Hepatitis_virus
Traf6^tm1.1Mpa	MGI:3836555	Targeted	Conditional ready\|No functional change						Imai Y, Cell 2008 Apr 18;133(2):235-49	J:145306	SARS-CoV_virus	Traf6^tm1.1Mpa Targeted			Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus
Trem2^{tm1(KOMP)Vlcg}	MGI:3797897	Targeted	Null/knockout\|Reporter						Hwang M, J Neuroinflammation 2022 Nov 4;19(1):267	J:331755	Mouse_Hepatitis_virus	Trem2^{tm1(KOMP)Vlcg} Targeted			Hwang M, J Neuroinflammation 2022 Nov 4;19(1):267 Mouse_Hepatitis_virus
Trim55^tm1Slbt	MGI:3773035	Targeted	Null/knockout	MGI:3773039			cardiovascular system growth/size/body immune system limbs/digits/tail muscle	MP:0005385 MP:0005378 MP:0005387 MP:0005371 MP:0005369	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504	J:268979	Infection\|SARS-CoV-MA_virus	Trim55^tm1Slbt Targeted	MGI:3773039	cardiovascular system growth/size/body immune system limbs/digits/tail muscle	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection\|SARS-CoV-MA_virus
Tyr^c-2J	MGI:1855985	Spontaneous	Null/knockout						Scaglione A, Front Immunol 2021;12():719077	J:335910	SARS-CoV-2_virus\|Treatment\|Vaccine	Tyr^c-2J Spontaneous			Scaglione A, Front Immunol 2021;12():719077 SARS-CoV-2_virus\|Treatment\|Vaccine
Usp10^em2Smoc	MGI:7442004	Endonuclease-mediated	Conditional ready						Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus\|Vaccine	Usp10^em2Smoc Endonuclease-mediated			Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus\|Vaccine
Usp18^tm1Dez	MGI:2387336	Targeted	Null/knockout\|Reporter	MGI:5908648			homeostasis/metabolism immune system	MP:0005376 MP:0005387	Ma XZ, J Virol 2014 Jun;88(11):6195-204	J:214425	Mouse_Hepatitis_virus	Usp18^tm1Dez Targeted	MGI:5908648	homeostasis/metabolism immune system	Ma XZ, J Virol 2014 Jun;88(11):6195-204 Mouse_Hepatitis_virus
Vhl^tm1Jae	MGI:2136645	Targeted	Conditional ready\|No functional change						Kotagiri P, EBioMedicine 2022 Feb 18;77():103878	J:322643	SARS-CoV-2_virus	Vhl^tm1Jae Targeted			Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus
Wwtr1^tm1.2Hmc	MGI:7581994	Targeted	Conditional ready						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Wwtr1^tm1.2Hmc Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Yap1^tm1.1Dupa	MGI:4819826	Targeted	Conditional ready\|No functional change						Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Yap1^tm1.1Dupa Targeted			Harb H, Immunity 2021 Apr 22;(): Infection
Yif1b^em1Hawu	MGI:7408565	Endonuclease-mediated	Null/knockout						Lin X, bioRxiv 2021 Dec;():	J:315744	Gene\|Pathology\|SARS-CoV-2_virus	Yif1b^em1Hawu Endonuclease-mediated			Lin X, bioRxiv 2021 Dec;(): Gene\|Pathology\|SARS-CoV-2_virus

Mouse Genes Associated with Coronavirus Infection and Pathology

Curated set of mouse genes associated with coronavirus infectious disease and pathology with links to the relevant reference(s). Under each reference is a list of keywords for the research areas and the viruses mentioned in the publication. A virus name appended with ‘MA’ indicates that the virus is a mouse adapted strain.

Genes are linked to the gene detail pages at the Mouse Genome Informatics (MGI) database and to the mouse gene page at the Alliance of Genome Resources. References are linked to the reference detail pages at MGI.

1-gene-symbol	2-gene-name	3-feature-type	4-mgi-id	5-short-citation	6-jnum-id	7-covid-tags	Gene	Gene Details	References \| Keywords
Abl2	ABL proto-oncogene 2, non-receptor tyrosine kinase	protein coding gene	MGI:87860	Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6	J:25438	Infection \| Mouse_Hepatitis_virus	Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase protein coding gene	MGI \| Alliance	Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Infection \| Mouse_Hepatitis_virus
Ace	angiotensin I converting enzyme	protein coding gene	MGI:87874	Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943	J:294060	SARS-CoV-2_virus	Ace angiotensin I converting enzyme protein coding gene	MGI \| Alliance	Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 SARS-CoV-2_virus
Ace2	angiotensin converting enzyme 2	protein coding gene	MGI:1917258	Adams LE, mBio 2021 Mar 16;12(2): Bao L, Nature 2020 May 7;(): Biagioli M, bioRxiv 2021 Feb;(): Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Bilinska K, bioRxiv 2021 Apr;(): Bourgonje AR, J Pathol 2020 Jul;251(3):228-248 Brechbuhl J, bioRxiv 2021 Mar;(): Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880 Chen J, Aging Cell 2020 Jun 19;(): Chen J, bioRxiv 2021 Nov;(): Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Deng Q, bioRxiv 2020;(): Gao S, Front Cardiovasc Med 2023;10():1266276 Gawish R, Elife 2022 Jan 13;11():e74623 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Israelow B, J Exp Med 2020 Dec 7;217(12): Jia H, Nat Commun 2020 Oct 14;11(1):5165 Jiang S, bioRxiv 2021 Aug;(): Ji H, Hypertension 2020 Aug;76(2):478-487 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Koester ST, PLoS One 2021;16(3):e0248730 Kuba K, Nat Med 2005 Aug;11(8):875-9 Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 Li D, J Med Virol 2022 Oct;94(10):4878-4889 Li F, Nat Commun 2021 Feb 8;12(1):866 Liu A, J Pathol 2021 Jan;253(1):17-30 Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120 Liu Y, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2025373118 Li Y, bioRxiv 2020 Oct;(): Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Munoz-Fontela C, Nature 2020 Sep 23;(): Nakandakari-Higa S, Front Immunol 2022;13():1007080 Perico L, Sci Rep 2023 Jul 14;13(1):11392 Pinto D, bioRxiv 2020 Apr 9;(): Qiao J, Biochem Biophys Res Commun 2020 Dec 17;533(4):867-871 Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 Romero MJ, Front Immunol 2023;14():1241448 Sagawa T, Environ Res 2021 Apr;195():110722 Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Singh A, Virol Sin 2020 Jun;35(3):290-304 Song J, J Med Virol 2020 Nov;92(11):2556-2566 Soni S, PLoS One 2021;16(2):e0247510 Sun SH, Cell Host Microbe 2020;20():1-10 Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Tang X, bioRxiv 2020 Oct;(): Ulrich L, bioRxiv 2021 Jun;(): van de Veerdonk FL, Elife 2020 Apr 27;9():e57555 Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263 Viveiros A, Am J Physiol Heart Circ Physiol 2021 Jan 1;320(1):H296-H304 Vo T, bioRxiv 2020 Nov;(): Wang Q, Cell 2020 May 14;181(4):894-904.e9 Wang Y, FASEB J 2021 Mar;35(3):e21419 Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Wu X, bioRxiv 2021 Feb;(): Wu Y, Science 2020 Jun 12;368(6496):1274-1278 Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 Xu J, Theranostics 2021;11(15):7379-7390 Yang J, Nature 2020 Jul 29;(): Ye Q, bioRxiv 2020 Nov;(): Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 Zhou B, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Zhou P, Nature 2020 Mar;579(7798):270-273 Zhu L, bioRxiv 2020 Nov;(): Ziegler CGK, Cell 2020 May 28;181(5):1016-1035.e19	J:305729 J:287631 J:302704 J:288137 J:304622 J:300087 J:303458 J:319436 J:291430 J:315718 J:292007 J:296182 J:346048 J:318828 J:92752 J:298750 J:297407 J:291862 J:296535 J:308668 J:290256 J:295350 J:303461 J:286299 J:324335 J:339217 J:303471 J:301197 J:340364 J:303469 J:296372 J:349938 J:294026 J:295351 J:335150 J:338324 J:297123 J:299392 J:319435 J:339692 J:305462 J:309632 J:309195 J:326929 J:295349 J:300096 J:303459 J:288243 J:338414 J:315719 J:337814 J:296386 J:308620 J:291465 J:308897 J:303463 J:296710 J:291441 J:309535 J:331773 J:302150 J:290802 J:294060 J:314372 J:292665 J:296708 J:299383 J:296356 J:305777 J:291451 J:298147 J:291435	SARS-CoV-2-MA_virus Infection \| Pathology \| SARS-CoV-2_virus Infection \| Treatment Infection \| SARS-CoV-2_virus Gene SARS-CoV-2_virus SARS-CoV-2_virus \| Sex_bias SARS-CoV-2_virus \| Vaccine Pathology \| SARS-CoV-2-MA_virus Infection \| SARS-CoV_virus MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron SARS-CoV-2_virus \| Treatment Comorbidity \| Gene SARS-CoV-2_virus \| VOC_B.1.351_Beta Pathology \| SARS-CoV-2_virus SARS-CoV-2_virus \| SARS-CoV_virus SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Infection \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron Pathology \| SARS-CoV-2_virus \| Treatment Gene \| Infection Comorbidity MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron Infection \| SARS-CoV-2_virus \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Infection SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| Treatment	Ace2 angiotensin converting enzyme 2 protein coding gene	MGI \| Alliance	Adams LE, mBio 2021 Mar 16;12(2): SARS-CoV-2-MA_virus Bao L, Nature 2020 May 7;(): Infection \| Pathology \| SARS-CoV-2_virus Biagioli M, bioRxiv 2021 Feb;(): Infection \| Treatment Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Infection \| SARS-CoV-2_virus Bilinska K, bioRxiv 2021 Apr;(): Gene Bourgonje AR, J Pathol 2020 Jul;251(3):228-248 SARS-CoV-2_virus Brechbuhl J, bioRxiv 2021 Mar;(): Gene Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880 Gene Chen J, Aging Cell 2020 Jun 19;(): SARS-CoV-2_virus \| Sex_bias Chen J, bioRxiv 2021 Nov;(): SARS-CoV-2_virus \| Vaccine Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Gene Deng Q, bioRxiv 2020;(): SARS-CoV-2_virus \| Sex_bias Gao S, Front Cardiovasc Med 2023;10():1266276 Infection \| SARS-CoV-2_virus Gawish R, Elife 2022 Jan 13;11():e74623 Pathology \| SARS-CoV-2-MA_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 SARS-CoV-2_virus Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Gene Israelow B, J Exp Med 2020 Dec 7;217(12): Infection \| Pathology \| SARS-CoV-2_virus Jia H, Nat Commun 2020 Oct 14;11(1):5165 SARS-CoV-2_virus Jiang S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus \| Vaccine Ji H, Hypertension 2020 Aug;76(2):478-487 Gene Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Koester ST, PLoS One 2021;16(3):e0248730 Gene Kuba K, Nat Med 2005 Aug;11(8):875-9 Infection \| SARS-CoV_virus Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron Li D, J Med Virol 2022 Oct;94(10):4878-4889 Infection \| SARS-CoV-2_virus Li F, Nat Commun 2021 Feb 8;12(1):866 SARS-CoV-2_virus \| Treatment Liu A, J Pathol 2021 Jan;253(1):17-30 Comorbidity \| Gene Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120 SARS-CoV-2_virus \| VOC_B.1.351_Beta Liu Y, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2025373118 Gene Li Y, bioRxiv 2020 Oct;(): SARS-CoV-2_virus \| Treatment Martin-Lopez E, eNeuro 2024 Jun;11(6):ENEURO.0106-24.2024 Pathology \| SARS-CoV-2_virus Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus \| SARS-CoV_virus Munoz-Fontela C, Nature 2020 Sep 23;(): SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Nakandakari-Higa S, Front Immunol 2022;13():1007080 Infection \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron Perico L, Sci Rep 2023 Jul 14;13(1):11392 Pathology \| SARS-CoV-2_virus \| Treatment Pinto D, bioRxiv 2020 Apr 9;(): SARS-CoV-2_virus \| Treatment Qiao J, Biochem Biophys Res Commun 2020 Dec 17;533(4):867-871 Gene Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 Gene \| Infection Romero MJ, Front Immunol 2023;14():1241448 SARS-CoV-2_virus Sagawa T, Environ Res 2021 Apr;195():110722 Comorbidity \| Gene Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Comorbidity Sepe S, bioRxiv 2021 Jun;(): Comorbidity \| Gene Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Song J, J Med Virol 2020 Nov;92(11):2556-2566 Infection \| SARS-CoV-2_virus Soni S, PLoS One 2021;16(2):e0247510 Gene Sun SH, Cell Host Microbe 2020;20():1-10 Infection \| Pathology \| SARS-CoV-2_virus Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron Tang AT, bioRxiv 2021 Dec;(): Pathology \| SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron Tang X, bioRxiv 2020 Oct;(): Infection \| SARS-CoV-2_virus Ulrich L, bioRxiv 2021 Jun;(): Infection \| SARS-CoV-2_virus \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta van de Veerdonk FL, Elife 2020 Apr 27;9():e57555 SARS-CoV-2_virus \| Treatment Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263 Comorbidity Viveiros A, Am J Physiol Heart Circ Physiol 2021 Jan 1;320(1):H296-H304 Gene Vo T, bioRxiv 2020 Nov;(): Infection Wang Q, Cell 2020 May 14;181(4):894-904.e9 SARS-CoV-2_virus Wang Y, FASEB J 2021 Mar;35(3):e21419 Gene Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Infection \| SARS-CoV-2_virus \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Wu X, bioRxiv 2021 Feb;(): SARS-CoV-2_virus \| Treatment Wu Y, Science 2020 Jun 12;368(6496):1274-1278 SARS-CoV-2_virus \| Treatment Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 SARS-CoV-2_virus Xu J, Theranostics 2021;11(15):7379-7390 Infection Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine Ye Q, bioRxiv 2020 Nov;(): Pathology \| SARS-CoV-2_virus Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 Gene Zhou B, bioRxiv 2020;(): Infection \| SARS-CoV-2_virus Zhou B, Nature 2021 Apr;592(7852):122-127 Infection \| SARS-CoV-2_virus Zhou P, Nature 2020 Mar;579(7798):270-273 SARS-CoV-2_virus Zhu L, bioRxiv 2020 Nov;(): SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| Treatment Ziegler CGK, Cell 2020 May 28;181(5):1016-1035.e19 Pathology \| SARS-CoV-2_virus
Adar	adenosine deaminase, RNA-specific	protein coding gene	MGI:1889575	Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038	J:333092	Gene \| VOC_B.1.351_Beta	Adar adenosine deaminase, RNA-specific protein coding gene	MGI \| Alliance	Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 Gene \| VOC_B.1.351_Beta
Adh5	alcohol dehydrogenase 5 (class III), chi polypeptide	protein coding gene	MGI:87929	Kim J, Front Pharmacol 2023;14():1304697	J:343781	SARS-CoV-2_virus \| Treatment	Adh5 alcohol dehydrogenase 5 (class III), chi polypeptide protein coding gene	MGI \| Alliance	Kim J, Front Pharmacol 2023;14():1304697 SARS-CoV-2_virus \| Treatment
Ahr	aryl-hydrocarbon receptor	protein coding gene	MGI:105043	Biagioli M, bioRxiv 2021 Feb;(): Grunewald ME, J Virol 2020 Jan 17;94(3):	J:302704 J:290586	Infection \| Treatment Infection \| Mouse_Hepatitis_virus	Ahr aryl-hydrocarbon receptor protein coding gene	MGI \| Alliance	Biagioli M, bioRxiv 2021 Feb;(): Infection \| Treatment Grunewald ME, J Virol 2020 Jan 17;94(3): Infection \| Mouse_Hepatitis_virus
Aicda	activation-induced cytidine deaminase	protein coding gene	MGI:1342279	Gregoire C, bioRxiv 2021 Dec;(): Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:316768 J:333746	SARS-CoV-2_virus SARS-CoV-2_virus \| Vaccine	Aicda activation-induced cytidine deaminase protein coding gene	MGI \| Alliance	Gregoire C, bioRxiv 2021 Dec;(): SARS-CoV-2_virus Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus \| Vaccine
Aim2	absent in melanoma 2	protein coding gene	MGI:2686159	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Aim2 absent in melanoma 2 protein coding gene	MGI \| Alliance	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Apaf1	apoptotic peptidase activating factor 1	protein coding gene	MGI:1306796	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology \| SARS-CoV-2_virus \| Treatment	Apaf1 apoptotic peptidase activating factor 1 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment
Apoe	apolipoprotein E	protein coding gene	MGI:88057	Ostendorf BN, Nature 2022 Nov;611(7935):346-351 Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378	J:340480 J:305558	Gene \| SARS-CoV-2-MA_virus SARS-CoV-2_virus	Apoe apolipoprotein E protein coding gene	MGI \| Alliance	Ostendorf BN, Nature 2022 Nov;611(7935):346-351 Gene \| SARS-CoV-2-MA_virus Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 SARS-CoV-2_virus
App	amyloid beta precursor protein	protein coding gene	MGI:88059	Magusali N, bioRxiv 2021 Mar;():	J:303205	Comorbidity	App amyloid beta precursor protein protein coding gene	MGI \| Alliance	Magusali N, bioRxiv 2021 Mar;(): Comorbidity
Arl8b	ADP-ribosylation factor-like 8B	protein coding gene	MGI:1914416	Ghosh S, Cell 2020 Dec 10;183(6):1520-1535.e14	J:302472	Infection \| Mouse_Hepatitis_virus	Arl8b ADP-ribosylation factor-like 8B protein coding gene	MGI \| Alliance	Ghosh S, Cell 2020 Dec 10;183(6):1520-1535.e14 Infection \| Mouse_Hepatitis_virus
Atg5	autophagy related 5	protein coding gene	MGI:1277186	de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5	J:331763 J:282479	SARS-CoV-2_virus Mouse_Hepatitis_virus	Atg5 autophagy related 5 protein coding gene	MGI \| Alliance	de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 SARS-CoV-2_virus Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Mouse_Hepatitis_virus
B2m	beta-2 microglobulin	protein coding gene	MGI:88127	Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83	J:308658 J:33974 J:54035	SARS-CoV-2_virus \| Vaccine Mouse_Hepatitis_virus Mouse_Hepatitis_virus \| Pathology	B2m beta-2 microglobulin protein coding gene	MGI \| Alliance	Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| Vaccine Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83 Mouse_Hepatitis_virus \| Pathology
Batf3	basic leucine zipper transcription factor, ATF-like 3	protein coding gene	MGI:1925491	Ndeupen S, bioRxiv 2021 Aug;(): Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:308580 J:345954	SARS-CoV-2_virus \| Vaccine Infection \| MERS-CoV-MA_virus	Batf3 basic leucine zipper transcription factor, ATF-like 3 protein coding gene	MGI \| Alliance	Ndeupen S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus \| Vaccine Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection \| MERS-CoV-MA_virus
Bcl2l1	BCL2-like 1	protein coding gene	MGI:88139	Yang Y, Biochem J 2005 Nov 15;392(Pt 1):135-43	J:287050	SARS-CoV_virus	Bcl2l1 BCL2-like 1 protein coding gene	MGI \| Alliance	Yang Y, Biochem J 2005 Nov 15;392(Pt 1):135-43 SARS-CoV_virus
Bcl2l12	BCL2 like 12	protein coding gene	MGI:1922986	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Imai Y, Cell 2008 Apr 18;133(2):235-49	J:187561 J:145306	Mouse_Hepatitis_virus SARS-CoV_virus	Bcl2l12 BCL2 like 12 protein coding gene	MGI \| Alliance	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus
Bcl6	B cell leukemia/lymphoma 6	protein coding gene	MGI:107187	Chen JS, bioRxiv 2021 Jun;():	J:308655	SARS-CoV-2_virus \| VOC_B.1.351_Beta	Bcl6 B cell leukemia/lymphoma 6 protein coding gene	MGI \| Alliance	Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| VOC_B.1.351_Beta
Bsg	basigin	protein coding gene	MGI:88208	Geng J, bioRxiv 2021 May;(): Qiao J, Biochem Biophys Res Commun 2020 Dec 17;533(4):867-871	J:308748 J:299392	SARS-CoV-2_virus Gene	Bsg basigin protein coding gene	MGI \| Alliance	Geng J, bioRxiv 2021 May;(): SARS-CoV-2_virus Qiao J, Biochem Biophys Res Commun 2020 Dec 17;533(4):867-871 Gene
C1qa	complement component 1, q subcomponent, alpha polypeptide	protein coding gene	MGI:88223	Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection \| MERS-CoV-MA_virus	C1qa complement component 1, q subcomponent, alpha polypeptide protein coding gene	MGI \| Alliance	Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection \| MERS-CoV-MA_virus
C3	complement component 3	protein coding gene	MGI:88227	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology \| SARS-CoV-MA_virus	C3 complement component 3 protein coding gene	MGI \| Alliance	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology \| SARS-CoV-MA_virus
C4b	complement C4B (Chido blood group)	protein coding gene	MGI:88228	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology \| SARS-CoV-MA_virus	C4b complement C4B (Chido blood group) protein coding gene	MGI \| Alliance	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology \| SARS-CoV-MA_virus
C5ar1	complement component 5a receptor 1	protein coding gene	MGI:88232	Carvelli J, Nature 2020 Jul 29;(): Jiang Y, Viruses 2019 Jan 9;11(1):	J:291890 J:295108	Pathology \| SARS-CoV-2_virus \| Treatment MERS-CoV_virus	C5ar1 complement component 5a receptor 1 protein coding gene	MGI \| Alliance	Carvelli J, Nature 2020 Jul 29;(): Pathology \| SARS-CoV-2_virus \| Treatment Jiang Y, Viruses 2019 Jan 9;11(1): MERS-CoV_virus
Casp1	caspase 1	protein coding gene	MGI:96544	Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yang J, Nature 2020 Jul 29;(): Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:331762 J:296686 J:313327 J:323769 J:292665 J:331829 J:298138	Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus \| Treatment SARS-CoV-2_virus \| Vaccine Gene \| Pathology	Casp1 caspase 1 protein coding gene	MGI \| Alliance	Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus \| Vaccine Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene \| Pathology Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Casp3	caspase 3	protein coding gene	MGI:107739	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology \| SARS-CoV-2_virus \| Treatment	Casp3 caspase 3 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment
Casp4	caspase 4, apoptosis-related cysteine peptidase	protein coding gene	MGI:107700	Eltobgy M, bioRxiv 2021;(): Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:311911 J:331823 J:296686 J:298138	Gene \| SARS-CoV-2-MA_virus Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| Treatment Mouse_Hepatitis_virus	Casp4 caspase 4, apoptosis-related cysteine peptidase protein coding gene	MGI \| Alliance	Eltobgy M, bioRxiv 2021;(): Gene \| SARS-CoV-2-MA_virus Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Casp7	caspase 7	protein coding gene	MGI:109383	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology \| SARS-CoV-2_virus \| Treatment	Casp7 caspase 7 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment
Casp8	caspase 8	protein coding gene	MGI:1261423	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:296686 J:298138	Pathology \| SARS-CoV-2_virus \| Treatment Mouse_Hepatitis_virus	Casp8 caspase 8 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Ccl2	C-C motif chemokine ligand 2	protein coding gene	MGI:98259	Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Held KS, Virology 2004 Nov 24;329(2):251-60	J:92752 J:102446	Infection \| SARS-CoV_virus Infection \| Mouse_Hepatitis_virus	Ccl2 C-C motif chemokine ligand 2 protein coding gene	MGI \| Alliance	Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus Held KS, Virology 2004 Nov 24;329(2):251-60 Infection \| Mouse_Hepatitis_virus
Ccl3	C-C motif chemokine ligand 3	protein coding gene	MGI:98260	Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:92752	Infection \| SARS-CoV_virus	Ccl3 C-C motif chemokine ligand 3 protein coding gene	MGI \| Alliance	Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus
Ccl5	C-C motif chemokine ligand 5	protein coding gene	MGI:98262	Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:88677 J:92752	Mouse_Hepatitis_virus Infection \| SARS-CoV_virus	Ccl5 C-C motif chemokine ligand 5 protein coding gene	MGI \| Alliance	Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Mouse_Hepatitis_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus
Ccr1	C-C motif chemokine receptor 1	protein coding gene	MGI:104618	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology \| SARS-CoV-MA_virus	Ccr1 C-C motif chemokine receptor 1 protein coding gene	MGI \| Alliance	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology \| SARS-CoV-MA_virus
Ccr2	C-C motif chemokine receptor 2	protein coding gene	MGI:106185	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Glass WG, Virology 2001 Sep 15;288(1):8-17 Held KS, Virology 2004 Nov 24;329(2):251-60 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Vanderheiden A, bioRxiv 2021 May;(): Vanderheiden A, mBio 2021 Nov 9;():e0274921	J:106738 J:102561 J:102446 J:162707 J:308718 J:317454	Mouse_Hepatitis_virus \| Pathology Mouse_Hepatitis_virus Infection \| Mouse_Hepatitis_virus Pathology \| SARS-CoV-MA_virus SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| VOC_B.1.351_Beta Infection \| SARS-CoV-2-MA_virus \| VOC_B.1.351_Beta	Ccr2 C-C motif chemokine receptor 2 protein coding gene	MGI \| Alliance	Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Mouse_Hepatitis_virus \| Pathology Glass WG, Virology 2001 Sep 15;288(1):8-17 Mouse_Hepatitis_virus Held KS, Virology 2004 Nov 24;329(2):251-60 Infection \| Mouse_Hepatitis_virus Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology \| SARS-CoV-MA_virus Vanderheiden A, bioRxiv 2021 May;(): SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| VOC_B.1.351_Beta Vanderheiden A, mBio 2021 Nov 9;():e0274921 Infection \| SARS-CoV-2-MA_virus \| VOC_B.1.351_Beta
Ccr5	C-C motif chemokine receptor 5	protein coding gene	MGI:107182	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240	J:162707	Pathology \| SARS-CoV-MA_virus	Ccr5 C-C motif chemokine receptor 5 protein coding gene	MGI \| Alliance	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology \| SARS-CoV-MA_virus
Ccr9	C-C motif chemokine receptor 9	protein coding gene	MGI:1341902	Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:308730 J:327836	Pathology \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus SARS-CoV-2-MA_virus \| SARS-CoV-MA_virus	Ccr9 C-C motif chemokine receptor 9 protein coding gene	MGI \| Alliance	Schafer A, bioRxiv 2021 May;(): Pathology \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus \| SARS-CoV-MA_virus
Cd19	CD19 antigen	protein coding gene	MGI:88319	Atkinson JR, J Virol 2017 Dec 1;91(23): Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682	J:253411 J:143484 J:322643 J:333746 J:336666	Mouse_Hepatitis_virus SARS-CoV-2_virus SARS-CoV-2_virus \| Vaccine Comorbidity \| SARS-CoV-2_virus	Cd19 CD19 antigen protein coding gene	MGI \| Alliance	Atkinson JR, J Virol 2017 Dec 1;91(23): Mouse_Hepatitis_virus Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus \| Vaccine Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Comorbidity \| SARS-CoV-2_virus
Cd274	CD274 antigen	protein coding gene	MGI:1926446	Phares TW, J Immunol 2009 May 1;182(9):5430-8 Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Phares TW, J Neuroinflammation 2012 Dec 14;9():269	J:147948 J:165192 J:331800	Mouse_Hepatitis_virus Gene \| Mouse_Hepatitis_virus	Cd274 CD274 antigen protein coding gene	MGI \| Alliance	Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Mouse_Hepatitis_virus Phares TW, J Neuroinflammation 2012 Dec 14;9():269 Gene \| Mouse_Hepatitis_virus
Cd4	CD4 antigen	protein coding gene	MGI:88335	Brentville VA, bioRxiv 2021 Jun;(): Chakravarty D, J Virol 2020 Jul 1;94(14): Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Yang J, Nature 2020 Jul 29;():	J:308658 J:290222 J:112983 J:292665	SARS-CoV-2_virus \| Vaccine Mouse_Hepatitis_virus \| Pathology Mouse_Hepatitis_virus	Cd4 CD4 antigen protein coding gene	MGI \| Alliance	Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| Vaccine Chakravarty D, J Virol 2020 Jul 1;94(14): Mouse_Hepatitis_virus \| Pathology Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Mouse_Hepatitis_virus Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine
Cd46	CD46 antigen, complement regulatory protein	protein coding gene	MGI:1203290	Lu M, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026153118	J:303467	SARS-CoV-2_virus \| Vaccine	Cd46 CD46 antigen, complement regulatory protein protein coding gene	MGI \| Alliance	Lu M, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026153118 SARS-CoV-2_virus \| Vaccine
Cd47	CD47 antigen (Rh-related antigen, integrin-associated signal transducer)	protein coding gene	MGI:96617	Tal MC, mBio 2020 Jun 23;11(3): Wenzek C, iScience 2022 Dec 22;25(12):105540	J:291450 J:331693	SARS-CoV-2_virus	Cd47 CD47 antigen (Rh-related antigen, integrin-associated signal transducer) protein coding gene	MGI \| Alliance	Tal MC, mBio 2020 Jun 23;11(3): SARS-CoV-2_virus Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
Cd74	CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)	protein coding gene	MGI:96534	Bruchez A, Science 2020 Oct 9;370(6513):241-247	J:297334	Gene	Cd74 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) protein coding gene	MGI \| Alliance	Bruchez A, Science 2020 Oct 9;370(6513):241-247 Gene
Cd79a	CD79A antigen (immunoglobulin-associated alpha)	protein coding gene	MGI:101774	Kotagiri P, EBioMedicine 2022 Feb 18;77():103878	J:322643	SARS-CoV-2_virus	Cd79a CD79A antigen (immunoglobulin-associated alpha) protein coding gene	MGI \| Alliance	Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus
Cd8a	CD8 subunit alpha	protein coding gene	MGI:88346	Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus \| Vaccine	Cd8a CD8 subunit alpha protein coding gene	MGI \| Alliance	Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine
Cd9	CD9 antigen	protein coding gene	MGI:88348	Earnest JT, PLoS Pathog 2017 Jul;13(7):e1006546	J:246218	Infection \| MERS-CoV_virus	Cd9 CD9 antigen protein coding gene	MGI \| Alliance	Earnest JT, PLoS Pathog 2017 Jul;13(7):e1006546 Infection \| MERS-CoV_virus
Ceacam1	CEA cell adhesion molecule 1	protein coding gene	MGI:1347245	Blau DM, J Virol 2001 Sep;75(17):8173-86 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8 Hemmila E, J Virol 2004 Sep;78(18):10156-65 Hirai A, J Virol 2010 Jul;84(13):6654-66 Miura TA, J Virol 2008 Jan;82(2):755-63 Nedellec P, J Virol 1994 Jul;68(7):4525-37 Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Peng G, Proc Natl Acad Sci U S A 2011 Jun 28;108(26):10696-701 Shang J, PLoS Pathog 2020 Mar;16(3):e1008392 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Yokomori K, J Virol 1992 Dec;66(12):6931-8	J:70815 J:701 J:92495 J:92376 J:198335 J:130131 J:18755 J:240703 J:173546 J:296119 J:25438 J:3241	Infection \| Mouse_Hepatitis_virus Mouse_Hepatitis_virus	Ceacam1 CEA cell adhesion molecule 1 protein coding gene	MGI \| Alliance	Blau DM, J Virol 2001 Sep;75(17):8173-86 Infection \| Mouse_Hepatitis_virus Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Mouse_Hepatitis_virus Dveksler GS, J Virol 1993 Jan;67(1):1-8 Infection \| Mouse_Hepatitis_virus Hemmila E, J Virol 2004 Sep;78(18):10156-65 Infection \| Mouse_Hepatitis_virus Hirai A, J Virol 2010 Jul;84(13):6654-66 Infection \| Mouse_Hepatitis_virus Miura TA, J Virol 2008 Jan;82(2):755-63 Mouse_Hepatitis_virus Nedellec P, J Virol 1994 Jul;68(7):4525-37 Infection \| Mouse_Hepatitis_virus Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Mouse_Hepatitis_virus Peng G, Proc Natl Acad Sci U S A 2011 Jun 28;108(26):10696-701 Mouse_Hepatitis_virus Shang J, PLoS Pathog 2020 Mar;16(3):e1008392 Infection \| Mouse_Hepatitis_virus Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Infection \| Mouse_Hepatitis_virus Yokomori K, J Virol 1992 Dec;66(12):6931-8 Mouse_Hepatitis_virus
Ceacam2	CEA cell adhesion molecule 2	protein coding gene	MGI:1347246	Hirai A, J Virol 2010 Jul;84(13):6654-66 Nedellec P, J Virol 1994 Jul;68(7):4525-37	J:198335 J:18755	Infection \| Mouse_Hepatitis_virus	Ceacam2 CEA cell adhesion molecule 2 protein coding gene	MGI \| Alliance	Hirai A, J Virol 2010 Jul;84(13):6654-66 Infection \| Mouse_Hepatitis_virus Nedellec P, J Virol 1994 Jul;68(7):4525-37 Infection \| Mouse_Hepatitis_virus
Ces1c	carboxylesterase 1C	protein coding gene	MGI:95420	Martinez DR, bioRxiv 2021 Jan;(): Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): Zhu C, Nat Commun 2022 Aug 3;13(1):4503	J:302135 J:298752 J:286402 J:286362 J:335969	SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| Treatment MERS-CoV_virus \| Treatment MERS-CoV_virus \| SARS-CoV_virus \| Treatment SARS-CoV-2_virus \| Treatment	Ces1c carboxylesterase 1C protein coding gene	MGI \| Alliance	Martinez DR, bioRxiv 2021 Jan;(): SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| Treatment Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| Treatment Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 MERS-CoV_virus \| Treatment Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): MERS-CoV_virus \| SARS-CoV_virus \| Treatment Zhu C, Nat Commun 2022 Aug 3;13(1):4503 SARS-CoV-2_virus \| Treatment
Cfb	complement factor B	protein coding gene	MGI:105975	Gralinski LE, mBio 2018 Oct 9;9(5):	J:286325	Pathology \| SARS-CoV-MA_virus	Cfb complement factor B protein coding gene	MGI \| Alliance	Gralinski LE, mBio 2018 Oct 9;9(5): Pathology \| SARS-CoV-MA_virus
Ch25h	cholesterol 25-hydroxylase	protein coding gene	MGI:1333869	Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648	J:343658	SARS-CoV-2_virus	Ch25h cholesterol 25-hydroxylase protein coding gene	MGI \| Alliance	Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus
Ciita	class II transactivator	protein coding gene	MGI:108445	Bruchez A, Science 2020 Oct 9;370(6513):241-247 Chen JS, bioRxiv 2021 Jun;():	J:297334 J:308655	Gene SARS-CoV-2_virus \| VOC_B.1.351_Beta	Ciita class II transactivator protein coding gene	MGI \| Alliance	Bruchez A, Science 2020 Oct 9;370(6513):241-247 Gene Chen JS, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| VOC_B.1.351_Beta
Cmpk2	cytidine/uridine monophosphate kinase 2	protein coding gene	MGI:99830	Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11	J:308159	Pathology \| SARS-CoV-2_virus \| Treatment	Cmpk2 cytidine/uridine monophosphate kinase 2 protein coding gene	MGI \| Alliance	Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 Pathology \| SARS-CoV-2_virus \| Treatment
Col1a1	collagen, type I, alpha 1	protein coding gene	MGI:88467	Miguel V, Redox Biol 2023 Dec;68():102957	J:343262	Treatment	Col1a1 collagen, type I, alpha 1 protein coding gene	MGI \| Alliance	Miguel V, Redox Biol 2023 Dec;68():102957 Treatment
Commd10	COMM domain containing 10	protein coding gene	MGI:1916706	Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene \| HCoV-229E_virus \| HCoV-OC43_virus \| MERS-CoV_virus \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus \| SARS-CoV_virus	Commd10 COMM domain containing 10 protein coding gene	MGI \| Alliance	Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene \| HCoV-229E_virus \| HCoV-OC43_virus \| MERS-CoV_virus \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus \| SARS-CoV_virus
Csf1	colony stimulating factor 1 (macrophage)	protein coding gene	MGI:1339753	Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Csf1 colony stimulating factor 1 (macrophage) protein coding gene	MGI \| Alliance	Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Csf2	colony stimulating factor 2 (granulocyte-macrophage)	protein coding gene	MGI:1339752	Ngo VL, Cell Host Microbe 2024 Jan 23;():	J:345954	Infection \| MERS-CoV-MA_virus	Csf2 colony stimulating factor 2 (granulocyte-macrophage) protein coding gene	MGI \| Alliance	Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection \| MERS-CoV-MA_virus
Ctnnb1	catenin beta 1	protein coding gene	MGI:88276	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Ctnnb1 catenin beta 1 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Cx3cr1	C-X3-C motif chemokine receptor 1	protein coding gene	MGI:1333815	Verma AK, mBio 2021 Oct 26;12(5):e0196921 Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943	J:313438 J:291614	Mouse_Hepatitis_virus	Cx3cr1 C-X3-C motif chemokine receptor 1 protein coding gene	MGI \| Alliance	Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Mouse_Hepatitis_virus
Cxcl10	C-X-C motif chemokine ligand 10	protein coding gene	MGI:1352450	Callahan V, Viruses 2021 Jun 3;13(6): Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80	J:335906 J:92752 J:140673	Infection \| Pathology \| SARS-CoV-2_virus Infection \| SARS-CoV_virus Mouse_Hepatitis_virus	Cxcl10 C-X-C motif chemokine ligand 10 protein coding gene	MGI \| Alliance	Callahan V, Viruses 2021 Jun 3;13(6): Infection \| Pathology \| SARS-CoV-2_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80 Mouse_Hepatitis_virus
Cxcl13	C-X-C motif chemokine ligand 13	protein coding gene	MGI:1888499	Phares TW, Brain Behav Immun 2016 May;54():128-139	J:316468	Mouse_Hepatitis_virus	Cxcl13 C-X-C motif chemokine ligand 13 protein coding gene	MGI \| Alliance	Phares TW, Brain Behav Immun 2016 May;54():128-139 Mouse_Hepatitis_virus
Cxcl5	C-X-C motif chemokine ligand 5	protein coding gene	MGI:1096868	Liang Y, Zool Res 2020 Oct 12;():1-29	J:296738	Infection \| Pathology \| SARS-CoV-2_virus	Cxcl5 C-X-C motif chemokine ligand 5 protein coding gene	MGI \| Alliance	Liang Y, Zool Res 2020 Oct 12;():1-29 Infection \| Pathology \| SARS-CoV-2_virus
Cxcl9	C-X-C motif chemokine ligand 9	protein coding gene	MGI:1352449	Callahan V, Viruses 2021 Jun 3;13(6): Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:335906 J:92752	Infection \| Pathology \| SARS-CoV-2_virus Infection \| SARS-CoV_virus	Cxcl9 C-X-C motif chemokine ligand 9 protein coding gene	MGI \| Alliance	Callahan V, Viruses 2021 Jun 3;13(6): Infection \| Pathology \| SARS-CoV-2_virus Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus
Cxcr3	C-X-C motif chemokine receptor 3	protein coding gene	MGI:1277207	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology \| SARS-CoV-MA_virus	Cxcr3 C-X-C motif chemokine receptor 3 protein coding gene	MGI \| Alliance	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology \| SARS-CoV-MA_virus
Cxcr6	C-X-C motif chemokine receptor 6	protein coding gene	MGI:1934582	Schafer A, mBio 2022 Aug 30;13(4):e0145422	J:327836	SARS-CoV-2-MA_virus \| SARS-CoV-MA_virus	Cxcr6 C-X-C motif chemokine receptor 6 protein coding gene	MGI \| Alliance	Schafer A, mBio 2022 Aug 30;13(4):e0145422 SARS-CoV-2-MA_virus \| SARS-CoV-MA_virus
Dpp4	dipeptidylpeptidase 4	protein coding gene	MGI:94919	Brunaugh AD, PLoS One 2021;16(2):e0246803 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Coleman CM, J Virol 2017 Jan 01;91(1): Du L, Nat Commun 2016 Nov 22;7():13473 Earnest JT, PLoS Pathog 2017 Jul;13(7):e1006546 Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Jia W, Emerg Microbes Infect 2019;8(1):760-772 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Leist SR, Methods Mol Biol 2020;2099():137-159 Leist SR, PLoS One 2019;14(7):e0220126 Li K, mBio 2020 Apr 7;11(2): Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Menachery VD, mBio 2017 Aug 22;8(4): Munster VJ, NPJ Vaccines 2017;2():28 Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Raha AA, Biosci Rep 2020 Dec 23;40(12): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Singh A, Virol Sin 2020 Jun;35(3):290-304 Tai W, Virology 2016 Dec;499():375-382 Wong L-YR, mBio 2023 Oct 26;14(6):e0247623 Xia LY, Nat Commun 2024 Feb 5;15(1):1048 Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Zheng J, J Clin Invest 2021 Jun 1;131(11):	J:302248 J:288107 J:279834 J:238079 J:291617 J:246218 J:300138 J:315826 J:286321 J:286329 J:295350 J:286238 J:285962 J:279723 J:287921 J:242025 J:287147 J:292834 J:223728 J:313516 J:286402 J:286320 J:295349 J:331809 J:343780 J:353426 J:300104 J:311966	MERS-CoV_virus \| SARS-CoV-2_virus \| Treatment Infection \| MERS-CoV-MA_virus \| Treatment MERS-CoV_virus MERS-CoV_virus \| Pathology MERS-CoV_virus \| Vaccine Infection \| MERS-CoV_virus MERS-CoV-MA_virus \| MERS-CoV_virus \| Vaccine MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Comorbidity \| MERS-CoV_virus \| Pathology Infection \| MERS-CoV-MA_virus \| Pathology Infection \| MERS-CoV_virus \| Treatment Gene MERS-CoV_virus \| Treatment MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus MERS-CoV-MA_virus \| Pathology \| SARS-CoV-2_virus Infection MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Comorbidity \| MERS-CoV_virus	Dpp4 dipeptidylpeptidase 4 protein coding gene	MGI \| Alliance	Brunaugh AD, PLoS One 2021;16(2):e0246803 MERS-CoV_virus \| SARS-CoV-2_virus \| Treatment Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection \| MERS-CoV-MA_virus \| Treatment Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 MERS-CoV_virus Coleman CM, J Virol 2017 Jan 01;91(1): MERS-CoV_virus \| Pathology Du L, Nat Commun 2016 Nov 22;7():13473 MERS-CoV_virus \| Vaccine Earnest JT, PLoS Pathog 2017 Jul;13(7):e1006546 Infection \| MERS-CoV_virus Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): MERS-CoV_virus Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 MERS-CoV_virus \| Vaccine Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Infection \| MERS-CoV_virus Jia W, Emerg Microbes Infect 2019;8(1):760-772 MERS-CoV-MA_virus \| MERS-CoV_virus \| Vaccine Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Comorbidity \| MERS-CoV_virus \| Pathology Leist SR, Methods Mol Biol 2020;2099():137-159 MERS-CoV_virus Leist SR, PLoS One 2019;14(7):e0220126 MERS-CoV_virus \| Pathology Li K, mBio 2020 Apr 7;11(2): MERS-CoV-MA_virus \| MERS-CoV_virus \| Vaccine Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Infection \| MERS-CoV-MA_virus \| Pathology Menachery VD, mBio 2017 Aug 22;8(4): Infection \| MERS-CoV_virus Munster VJ, NPJ Vaccines 2017;2():28 MERS-CoV_virus \| Vaccine Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Infection \| MERS-CoV_virus \| Treatment Raha AA, Biosci Rep 2020 Dec 23;40(12): Gene Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 MERS-CoV_virus \| Treatment Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Tai W, Virology 2016 Dec;499():375-382 MERS-CoV_virus \| Treatment Wong L-YR, mBio 2023 Oct 26;14(6):e0247623 MERS-CoV-MA_virus \| Pathology \| SARS-CoV-2_virus Xia LY, Nat Commun 2024 Feb 5;15(1):1048 Infection Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Zheng J, J Clin Invest 2021 Jun 1;131(11): Comorbidity \| MERS-CoV_virus
Dyrk1a	dual-specificity tyrosine phosphorylation regulated kinase 1a	protein coding gene	MGI:1330299	Strine MS, PLoS Biol 2023 Jun;21(6):e3002097	J:341033	Gene \| MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV_virus	Dyrk1a dual-specificity tyrosine phosphorylation regulated kinase 1a protein coding gene	MGI \| Alliance	Strine MS, PLoS Biol 2023 Jun;21(6):e3002097 Gene \| MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV_virus
Ebi3	Epstein-Barr virus induced gene 3	protein coding gene	MGI:1354171	Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6	J:286951	Infection \| Mouse_Hepatitis_virus	Ebi3 Epstein-Barr virus induced gene 3 protein coding gene	MGI \| Alliance	Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6 Infection \| Mouse_Hepatitis_virus
Edil3	EGF-like repeats and discoidin I-like domains 3	protein coding gene	MGI:1329025	Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron	Edil3 EGF-like repeats and discoidin I-like domains 3 protein coding gene	MGI \| Alliance	Tang AT, bioRxiv 2021 Dec;(): Pathology \| SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron
Egfr	epidermal growth factor receptor	protein coding gene	MGI:95294	Venkataraman T, J Virol 2017 Jun 15;91(12):	J:243599	Pathology \| SARS-CoV-MA_virus	Egfr epidermal growth factor receptor protein coding gene	MGI \| Alliance	Venkataraman T, J Virol 2017 Jun 15;91(12): Pathology \| SARS-CoV-MA_virus
Egr1	early growth response 1	protein coding gene	MGI:95295	Li SW, Sci Rep 2016 May 13;6():25754	J:291621	SARS-CoV_virus	Egr1 early growth response 1 protein coding gene	MGI \| Alliance	Li SW, Sci Rep 2016 May 13;6():25754 SARS-CoV_virus
Eif2ak2	eukaryotic translation initiation factor 2-alpha kinase 2	protein coding gene	MGI:1353449	Kapil P, J Neuroimmunol 2014 May 15;270(1-2):1-12 Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195	J:318208 J:291588	Mouse_Hepatitis_virus HCoV-229E_virus \| Mouse_Hepatitis_virus	Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 protein coding gene	MGI \| Alliance	Kapil P, J Neuroimmunol 2014 May 15;270(1-2):1-12 Mouse_Hepatitis_virus Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus
Elane	elastase, neutrophil expressed	protein coding gene	MGI:2679229	Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118	J:313327	SARS-CoV-2_virus \| Vaccine	Elane elastase, neutrophil expressed protein coding gene	MGI \| Alliance	Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 SARS-CoV-2_virus \| Vaccine
Epor	erythropoietin receptor	protein coding gene	MGI:95408	Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008	J:325468	SARS-CoV-2_virus	Epor erythropoietin receptor protein coding gene	MGI \| Alliance	Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008 SARS-CoV-2_virus
Fadd	Fas associated via death domain	protein coding gene	MGI:109324	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533	J:296686 J:323957	Pathology \| SARS-CoV-2_virus \| Treatment Pathology \| SARS-CoV-2_virus \| VOC_B.1.351_Beta	Fadd Fas associated via death domain protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology \| SARS-CoV-2_virus \| VOC_B.1.351_Beta
Fcer1g	Fc receptor, IgE, high affinity I, gamma polypeptide	protein coding gene	MGI:95496	Adams LE, Cell Rep 2023 Mar 30;42(4):112326	J:349062	SARS-CoV-2-MA_virus \| Vaccine	Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide protein coding gene	MGI \| Alliance	Adams LE, Cell Rep 2023 Mar 30;42(4):112326 SARS-CoV-2-MA_virus \| Vaccine
Fcgrt	Fc fragment of IgG receptor and transporter	protein coding gene	MGI:103017	Halwe S, bioRxiv 2021 Jun;():	J:308648	SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta	Fcgrt Fc fragment of IgG receptor and transporter protein coding gene	MGI \| Alliance	Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta
Fga	fibrinogen alpha chain	protein coding gene	MGI:1316726	Ryu JK, bioRxiv 2021;():	J:311923	SARS-CoV-2_virus \| Treatment	Fga fibrinogen alpha chain protein coding gene	MGI \| Alliance	Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus \| Treatment
Fgg	fibrinogen gamma chain	protein coding gene	MGI:95526	Ryu JK, bioRxiv 2021;():	J:311923	SARS-CoV-2_virus \| Treatment	Fgg fibrinogen gamma chain protein coding gene	MGI \| Alliance	Ryu JK, bioRxiv 2021;(): SARS-CoV-2_virus \| Treatment
Fgl2	fibrinogen-like protein 2	protein coding gene	MGI:103266	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66	J:99453	Mouse_Hepatitis_virus	Fgl2 fibrinogen-like protein 2 protein coding gene	MGI \| Alliance	Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 Mouse_Hepatitis_virus
Foxg1	forkhead box G1	protein coding gene	MGI:1347464	Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron	Foxg1 forkhead box G1 protein coding gene	MGI \| Alliance	Tang AT, bioRxiv 2021 Dec;(): Pathology \| SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron
Foxp3	forkhead box P3	protein coding gene	MGI:1891436	Harb H, Immunity 2021 Apr 22;(): Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085 Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7 Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279	J:347529 J:324704 J:327784 J:177608 J:247329	Infection Infection \| Mouse_Hepatitis_virus SARS-CoV-2_virus Mouse_Hepatitis_virus	Foxp3 forkhead box P3 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 Infection \| Mouse_Hepatitis_virus Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085 SARS-CoV-2_virus Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7 Mouse_Hepatitis_virus Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279 Mouse_Hepatitis_virus
G3bp1	G3BP stress granule assembly factor 1	protein coding gene	MGI:1351465	Liu H, J Virol 2022 Jun 22;96(12):e0041222	J:342298	Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus	G3bp1 G3BP stress granule assembly factor 1 protein coding gene	MGI \| Alliance	Liu H, J Virol 2022 Jun 22;96(12):e0041222 Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus
Gbp2	guanylate binding protein 2	protein coding gene	MGI:102772	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology \| SARS-CoV-2_virus \| Treatment	Gbp2 guanylate binding protein 2 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment
Golm1	golgi membrane protein 1	protein coding gene	MGI:1917329	Wan L, Nat Metab 2022 Jan;4(1):29-43	J:335014	Pathology \| SARS-CoV-2-MA_virus	Golm1 golgi membrane protein 1 protein coding gene	MGI \| Alliance	Wan L, Nat Metab 2022 Jan;4(1):29-43 Pathology \| SARS-CoV-2-MA_virus
Gpi1	glucose-6-phosphate isomerase 1	protein coding gene	MGI:95797	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104	J:1357	Mouse_Hepatitis_virus	Gpi1 glucose-6-phosphate isomerase 1 protein coding gene	MGI \| Alliance	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 Mouse_Hepatitis_virus
Gpr183	G protein-coupled receptor 183	protein coding gene	MGI:2442034	Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648	J:343658	SARS-CoV-2_virus	Gpr183 G protein-coupled receptor 183 protein coding gene	MGI \| Alliance	Fessler MB, Am J Respir Cell Mol Biol 2023 Dec;69(6):638-648 SARS-CoV-2_virus
Gsdmd	gasdermin D	protein coding gene	MGI:1916396	Eltobgy M, bioRxiv 2021;(): Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:311911 J:331823 J:296686 J:323769 J:298138	Gene \| SARS-CoV-2-MA_virus Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| Treatment Gene \| Pathology Mouse_Hepatitis_virus	Gsdmd gasdermin D protein coding gene	MGI \| Alliance	Eltobgy M, bioRxiv 2021;(): Gene \| SARS-CoV-2-MA_virus Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene \| Pathology Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Gsdme	gasdermin E	protein coding gene	MGI:1889850	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Gsdme gasdermin E protein coding gene	MGI \| Alliance	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
H2-Ab1	histocompatibility 2, class II antigen A, beta 1	protein coding gene	MGI:103070	Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110	J:308658 J:33974	SARS-CoV-2_virus \| Vaccine Mouse_Hepatitis_virus	H2-Ab1 histocompatibility 2, class II antigen A, beta 1 protein coding gene	MGI \| Alliance	Brentville VA, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| Vaccine Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Mouse_Hepatitis_virus
Havcr1	hepatitis A virus cellular receptor 1	protein coding gene	MGI:2159680	Yang C, bioRxiv 2020;():	J:296070	Infection \| SARS-CoV-2_virus	Havcr1 hepatitis A virus cellular receptor 1 protein coding gene	MGI \| Alliance	Yang C, bioRxiv 2020;(): Infection \| SARS-CoV-2_virus
Hey2	hairy/enhancer-of-split related with YRPW motif 2	protein coding gene	MGI:1341884	Hassan AO, Cell Rep 2021 Jul 27;36(4):109452	J:309629	SARS-CoV-2_virus \| Vaccine	Hey2 hairy/enhancer-of-split related with YRPW motif 2 protein coding gene	MGI \| Alliance	Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 SARS-CoV-2_virus \| Vaccine
Hopx	HOP homeobox	protein coding gene	MGI:1916782	Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:337814	Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron	Hopx HOP homeobox protein coding gene	MGI \| Alliance	Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron
Hspb1	heat shock protein 1	protein coding gene	MGI:96240	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562	J:288137	Infection \| SARS-CoV-2_virus	Hspb1 heat shock protein 1 protein coding gene	MGI \| Alliance	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Infection \| SARS-CoV-2_virus
Ido1	indoleamine 2,3-dioxygenase 1	protein coding gene	MGI:96416	Grunewald ME, J Virol 2020 Jan 17;94(3): McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:290586 J:288523	Infection \| Mouse_Hepatitis_virus Pathology \| SARS-CoV-MA_virus	Ido1 indoleamine 2,3-dioxygenase 1 protein coding gene	MGI \| Alliance	Grunewald ME, J Virol 2020 Jan 17;94(3): Infection \| Mouse_Hepatitis_virus McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology \| SARS-CoV-MA_virus
Ifih1	interferon induced with helicase C domain 1	protein coding gene	MGI:1918836	Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 Menachery VD, J Virol 2014 Apr;88(8):4251-64 Zalinger ZB, J Virol 2015 Dec 15;89(24):12330-40 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Zust R, Nat Immunol 2011 Feb;12(2):137-43	J:318622 J:242293 J:296686 J:291588 J:213001 J:227926 J:308903 J:168254	Mouse_Hepatitis_virus Infection \| Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus \| Treatment HCoV-229E_virus \| Mouse_Hepatitis_virus SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment \| Vaccine Pathology \| SARS-CoV-2_virus	Ifih1 interferon induced with helicase C domain 1 protein coding gene	MGI \| Alliance	Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Mouse_Hepatitis_virus Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Infection \| Mouse_Hepatitis_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus Menachery VD, J Virol 2014 Apr;88(8):4251-64 SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment \| Vaccine Zalinger ZB, J Virol 2015 Dec 15;89(24):12330-40 Infection \| Mouse_Hepatitis_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus Zust R, Nat Immunol 2011 Feb;12(2):137-43 HCoV-229E_virus \| Mouse_Hepatitis_virus
Ifit1	interferon-induced protein with tetratricopeptide repeats 1	protein coding gene	MGI:99450	Butchi NB, J Virol 2014 Jan;88(2):1051-64 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mears HV, J Biol Chem 2020 Dec 18;295(51):17781-17801 Menachery VD, J Virol 2014 Apr;88(8):4251-64	J:205203 J:187561 J:302651 J:213001	Mouse_Hepatitis_virus SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment \| Vaccine	Ifit1 interferon-induced protein with tetratricopeptide repeats 1 protein coding gene	MGI \| Alliance	Butchi NB, J Virol 2014 Jan;88(2):1051-64 Mouse_Hepatitis_virus Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Mears HV, J Biol Chem 2020 Dec 18;295(51):17781-17801 Mouse_Hepatitis_virus Menachery VD, J Virol 2014 Apr;88(8):4251-64 SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment \| Vaccine
Ifit1bl1	interferon induced protein with tetratricpeptide repeats 1B like 1	protein coding gene	MGI:3650685	Mears HV, J Biol Chem 2020 Dec 18;295(51):17781-17801	J:302651	Mouse_Hepatitis_virus	Ifit1bl1 interferon induced protein with tetratricpeptide repeats 1B like 1 protein coding gene	MGI \| Alliance	Mears HV, J Biol Chem 2020 Dec 18;295(51):17781-17801 Mouse_Hepatitis_virus
Ifit1bl2	interferon induced protein with tetratricopeptide repeats 1B like 2	protein coding gene	MGI:2148249	Mears HV, J Biol Chem 2020 Dec 18;295(51):17781-17801	J:302651	Mouse_Hepatitis_virus	Ifit1bl2 interferon induced protein with tetratricopeptide repeats 1B like 2 protein coding gene	MGI \| Alliance	Mears HV, J Biol Chem 2020 Dec 18;295(51):17781-17801 Mouse_Hepatitis_virus
Ifit2	interferon-induced protein with tetratricopeptide repeats 2	protein coding gene	MGI:99449	Butchi NB, J Virol 2014 Jan;88(2):1051-64 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Das Sarma J, PLoS Pathog 2020 Nov;16(11):e1009034	J:205203 J:187561 J:313166	Mouse_Hepatitis_virus	Ifit2 interferon-induced protein with tetratricopeptide repeats 2 protein coding gene	MGI \| Alliance	Butchi NB, J Virol 2014 Jan;88(2):1051-64 Mouse_Hepatitis_virus Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Das Sarma J, PLoS Pathog 2020 Nov;16(11):e1009034 Mouse_Hepatitis_virus
Ifitm1	interferon induced transmembrane protein 1	protein coding gene	MGI:1915963	Huang IC, PLoS Pathog 2011;7(1):e1001258	J:187558	SARS-CoV_virus	Ifitm1 interferon induced transmembrane protein 1 protein coding gene	MGI \| Alliance	Huang IC, PLoS Pathog 2011;7(1):e1001258 SARS-CoV_virus
Ifitm2	interferon induced transmembrane protein 2	protein coding gene	MGI:1933382	Huang IC, PLoS Pathog 2011;7(1):e1001258	J:187558	SARS-CoV_virus	Ifitm2 interferon induced transmembrane protein 2 protein coding gene	MGI \| Alliance	Huang IC, PLoS Pathog 2011;7(1):e1001258 SARS-CoV_virus
Ifitm3	interferon induced transmembrane protein 3	protein coding gene	MGI:1913391	Huang IC, PLoS Pathog 2011;7(1):e1001258 Zani A, bioRxiv 2021Dec;():	J:187558 J:316764	SARS-CoV_virus Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus	Ifitm3 interferon induced transmembrane protein 3 protein coding gene	MGI \| Alliance	Huang IC, PLoS Pathog 2011;7(1):e1001258 SARS-CoV_virus Zani A, bioRxiv 2021Dec;(): Gene \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus
Ifnar1	interferon (alpha and beta) receptor 1	protein coding gene	MGI:107658	Ahan RE, bioRxiv 2021 Jul;(): Anand G, bioRxiv 2020 Dec;(): Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Channappanavar R, Cell Host Microbe 2016 Feb 10;19(2):181-93 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Dangi T, bioRxiv 2021 Jun;(): Deng X, J Virol 2014 Oct 15;88(20):11886-98 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Fehr AR, J Virol 2015 Feb;89(3):1523-36 Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Grunewald ME, J Virol 2020 Jan 17;94(3): Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Hassan AO, Cell 2020 Jun 10;(): Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 Ireland DD, J Virol 2008 Jan;82(1):300-10 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Lu M, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026153118 Madar-Balakirski N, bioRxiv 2021 Jul;(): Malczyk AH, J Virol 2015 Nov;89(22):11654-67 Mao T, bioRxiv 2021 Jun;(): Menachery VD, J Virol 2014 Apr;88(8):4251-64 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Ngo VL, Cell Host Microbe 2024 Jan 23;(): Ogger PP, Eur J Immunol 2022 Nov;52(11):1768-1775 Peng X, mBio 2010 Oct 26;1(5): Phares TW, J Immunol 2009 May 1;182(9):5430-8 Rawle DJ, bioRxiv 2021 Feb;(): Sun J, Cell 2020 Jun 10;(): Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Yang J, Nature 2020 Jul 29;(): Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5	J:308572 J:298270 J:318622 J:144400 J:143484 J:291874 J:187561 J:308670 J:214600 J:242293 J:221981 J:286237 J:290586 J:308901 J:290258 J:319459 J:343550 J:300105 J:145215 J:291862 J:296686 J:303467 J:308635 J:312515 J:308656 J:213001 J:300094 J:345954 J:333792 J:276986 J:147948 J:302157 J:291881 J:338414 J:317125 J:292665 J:207380	SARS-CoV-2_virus \| Treatment Pathology \| SARS-CoV-2_virus Mouse_Hepatitis_virus Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus Gene \| Infection \| Pathology \| SARS-CoV-MA_virus SARS-CoV-2_virus \| SARS-CoV_virus \| Vaccine Mouse_Hepatitis_virus \| Pathology Infection \| Mouse_Hepatitis_virus Pathology \| SARS-CoV-MA_virus Infection \| SARS-CoV-2_virus \| Treatment Infection \| SARS-CoV-2_virus SARS-CoV-2_virus \| Vaccine Infection \| Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| Treatment MERS-CoV_virus \| Vaccine Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta \| VOC_P.1_Gamma SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment \| Vaccine SARS-CoV-2_virus Infection \| MERS-CoV-MA_virus Infection \| SARS-CoV-MA_virus Infection \| Pathology \| SARS-CoV-2_virus \| Treatment SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.427 \| VOC_B.1.617.2_Delta MERS-CoV_virus	Ifnar1 interferon (alpha and beta) receptor 1 protein coding gene	MGI \| Alliance	Ahan RE, bioRxiv 2021 Jul;(): SARS-CoV-2_virus \| Treatment Anand G, bioRxiv 2020 Dec;(): Pathology \| SARS-CoV-2_virus Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Mouse_Hepatitis_virus Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus Channappanavar R, Cell Host Microbe 2016 Feb 10;19(2):181-93 Gene \| Infection \| Pathology \| SARS-CoV-MA_virus Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Dangi T, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| SARS-CoV_virus \| Vaccine Deng X, J Virol 2014 Oct 15;88(20):11886-98 Mouse_Hepatitis_virus \| Pathology Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Infection \| Mouse_Hepatitis_virus Fehr AR, J Virol 2015 Feb;89(3):1523-36 Mouse_Hepatitis_virus Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology \| SARS-CoV-MA_virus Grunewald ME, J Virol 2020 Jan 17;94(3): Infection \| Mouse_Hepatitis_virus Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Pathology \| SARS-CoV-2_virus Hassan AO, Cell 2020 Jun 10;(): Infection \| SARS-CoV-2_virus \| Treatment Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Infection \| SARS-CoV-2_virus Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection \| SARS-CoV-2_virus \| Treatment Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 SARS-CoV-2_virus \| Vaccine Ireland DD, J Virol 2008 Jan;82(1):300-10 Infection \| Mouse_Hepatitis_virus Israelow B, J Exp Med 2020 Dec 7;217(12): Infection \| Pathology \| SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Lu M, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026153118 SARS-CoV-2_virus \| Vaccine Madar-Balakirski N, bioRxiv 2021 Jul;(): SARS-CoV-2_virus \| Vaccine Malczyk AH, J Virol 2015 Nov;89(22):11654-67 MERS-CoV_virus \| Vaccine Mao T, bioRxiv 2021 Jun;(): Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta \| VOC_P.1_Gamma Menachery VD, J Virol 2014 Apr;88(8):4251-64 SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment \| Vaccine Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection \| MERS-CoV-MA_virus Ogger PP, Eur J Immunol 2022 Nov;52(11):1768-1775 Infection \| SARS-CoV-2_virus Peng X, mBio 2010 Oct 26;1(5): Infection \| SARS-CoV-MA_virus Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus Rawle DJ, bioRxiv 2021 Feb;(): SARS-CoV-2_virus Sun J, Cell 2020 Jun 10;(): Infection \| Pathology \| SARS-CoV-2_virus \| Treatment Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.427 \| VOC_B.1.617.2_Delta Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus
Ifnar2	interferon (alpha and beta) receptor 2	protein coding gene	MGI:1098243	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Rawle DJ, bioRxiv 2021 Feb;():	J:296686 J:302157	Pathology \| SARS-CoV-2_virus \| Treatment SARS-CoV-2_virus	Ifnar2 interferon (alpha and beta) receptor 2 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Rawle DJ, bioRxiv 2021 Feb;(): SARS-CoV-2_virus
Ifnb1	interferon beta 1, fibroblast	protein coding gene	MGI:107657	Butchi NB, J Virol 2014 Jan;88(2):1051-64	J:205203	Mouse_Hepatitis_virus	Ifnb1 interferon beta 1, fibroblast protein coding gene	MGI \| Alliance	Butchi NB, J Virol 2014 Jan;88(2):1051-64 Mouse_Hepatitis_virus
Ifng	interferon gamma	protein coding gene	MGI:107656	Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 France MP, Aust Vet J 1999 Sep;77(9):600-4 Gonzalez JM, Am J Pathol 2006 Mar;168(3):796-804 Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 Malone KE, Glia 2008 Mar;56(4):426-35 Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Phares TW, J Immunol 2009 May 1;182(9):5430-8 Savarin C, J Neuroinflammation 2012 May 29;9():104 Sun J, Cell 2020 Jun 10;(): Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26	J:88552 J:59661 J:106482 J:50405 J:91691 J:156284 J:112048 J:147948 J:331807 J:291881 J:131907	Mouse_Hepatitis_virus Mouse_Hepatitis_virus \| Pathology Infection \| Mouse_Hepatitis_virus Infection \| Mouse_Hepatitis_virus \| Pathology Infection \| Pathology \| SARS-CoV-2_virus \| Treatment	Ifng interferon gamma protein coding gene	MGI \| Alliance	Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Mouse_Hepatitis_virus France MP, Aust Vet J 1999 Sep;77(9):600-4 Mouse_Hepatitis_virus \| Pathology Gonzalez JM, Am J Pathol 2006 Mar;168(3):796-804 Infection \| Mouse_Hepatitis_virus Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Mouse_Hepatitis_virus \| Pathology Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 Infection \| Mouse_Hepatitis_virus \| Pathology Malone KE, Glia 2008 Mar;56(4):426-35 Mouse_Hepatitis_virus Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Infection \| Mouse_Hepatitis_virus Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus Savarin C, J Neuroinflammation 2012 May 29;9():104 Mouse_Hepatitis_virus Sun J, Cell 2020 Jun 10;(): Infection \| Pathology \| SARS-CoV-2_virus \| Treatment Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Mouse_Hepatitis_virus
Ifngr1	interferon gamma receptor 1	protein coding gene	MGI:107655	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Hassan AO, Cell 2020 Jun 10;(): Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Schijns VE, J Immunol 1996 Jul 15;157(2):815-21 Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26	J:286237 J:290258 J:343550 J:300094 J:34040 J:131907	Pathology \| SARS-CoV-MA_virus Infection \| SARS-CoV-2_virus \| Treatment SARS-CoV-2_virus Mouse_Hepatitis_virus	Ifngr1 interferon gamma receptor 1 protein coding gene	MGI \| Alliance	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology \| SARS-CoV-MA_virus Hassan AO, Cell 2020 Jun 10;(): Infection \| SARS-CoV-2_virus \| Treatment Hilligan KL, Nat Commun 2023 Dec 12;14(1):8229 Infection \| SARS-CoV-2_virus \| Treatment Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus Schijns VE, J Immunol 1996 Jul 15;157(2):815-21 Mouse_Hepatitis_virus Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Mouse_Hepatitis_virus
Ifnl2	interferon lambda 2	protein coding gene	MGI:3647279	Chong Z, Cell Rep 2022 May 10;39(6):110799	J:325089	SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron \| VOC_B.1.351_Beta	Ifnl2 interferon lambda 2 protein coding gene	MGI \| Alliance	Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron \| VOC_B.1.351_Beta
Ifnlr1	interferon lambda receptor 1	protein coding gene	MGI:2429859	Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339	J:321761 J:325089 J:286237 J:300094	SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron \| VOC_B.1.351_Beta Pathology \| SARS-CoV-MA_virus SARS-CoV-2_virus	Ifnlr1 interferon lambda receptor 1 protein coding gene	MGI \| Alliance	Chong Z, bioRxiv 2022;(): SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron \| VOC_B.1.351_Beta Chong Z, Cell Rep 2022 May 10;39(6):110799 SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron \| VOC_B.1.351_Beta Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology \| SARS-CoV-MA_virus Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 SARS-CoV-2_virus
Ighm	immunoglobulin heavy constant mu	gene segment	MGI:96448	Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 Israelow B, bioRxiv 2021 May;(): Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5	J:120484 J:308733 J:336666 J:207380	Mouse_Hepatitis_virus Infection \| SARS-CoV-2_virus Comorbidity \| SARS-CoV-2_virus MERS-CoV_virus	Ighm immunoglobulin heavy constant mu gene segment	MGI \| Alliance	Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 Mouse_Hepatitis_virus Israelow B, bioRxiv 2021 May;(): Infection \| SARS-CoV-2_virus Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Comorbidity \| SARS-CoV-2_virus Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus
Ikbkb	inhibitor of kappaB kinase beta	protein coding gene	MGI:1338071	Satta S, Theranostics 2022;12(6):2639-2657	J:331825	SARS-CoV-2_virus \| Variant	Ikbkb inhibitor of kappaB kinase beta protein coding gene	MGI \| Alliance	Satta S, Theranostics 2022;12(6):2639-2657 SARS-CoV-2_virus \| Variant
Ikbkg	inhibitor of kappaB kinase gamma	protein coding gene	MGI:1338074	Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533	J:323957	Pathology \| SARS-CoV-2_virus \| VOC_B.1.351_Beta	Ikbkg inhibitor of kappaB kinase gamma protein coding gene	MGI \| Alliance	Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology \| SARS-CoV-2_virus \| VOC_B.1.351_Beta
Il10	interleukin 10	protein coding gene	MGI:96537	Kapil P, J Neuroimmunol 2014 May 15;270(1-2):1-12 Puntambekar SS, Glia 2015 Jun 30;(): Trandem K, J Immunol 2011 Mar 15;186(6):3642-52	J:318208 J:225834 J:169759	Mouse_Hepatitis_virus Mouse_Hepatitis_virus \| Pathology	Il10 interleukin 10 protein coding gene	MGI \| Alliance	Kapil P, J Neuroimmunol 2014 May 15;270(1-2):1-12 Mouse_Hepatitis_virus Puntambekar SS, Glia 2015 Jun 30;(): Mouse_Hepatitis_virus Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 Mouse_Hepatitis_virus \| Pathology
Il12b	interleukin 12b	protein coding gene	MGI:96540	Schijns VE, J Immunol 1996 Jul 15;157(2):815-21	J:34040	Mouse_Hepatitis_virus	Il12b interleukin 12b protein coding gene	MGI \| Alliance	Schijns VE, J Immunol 1996 Jul 15;157(2):815-21 Mouse_Hepatitis_virus
Il17a	interleukin 17A	protein coding gene	MGI:107364	Lin X, iScience 2021 Apr 23;24(4):102293 Savarin C, J Neuroinflammation 2012 May 29;9():104	J:304178 J:331807	Pathology \| SARS-CoV-2_virus \| Treatment Mouse_Hepatitis_virus	Il17a interleukin 17A protein coding gene	MGI \| Alliance	Lin X, iScience 2021 Apr 23;24(4):102293 Pathology \| SARS-CoV-2_virus \| Treatment Savarin C, J Neuroinflammation 2012 May 29;9():104 Mouse_Hepatitis_virus
Il17ra	interleukin 17 receptor A	protein coding gene	MGI:107399	Lin X, iScience 2021 Apr 23;24(4):102293	J:304178	Pathology \| SARS-CoV-2_virus \| Treatment	Il17ra interleukin 17 receptor A protein coding gene	MGI \| Alliance	Lin X, iScience 2021 Apr 23;24(4):102293 Pathology \| SARS-CoV-2_virus \| Treatment
Il18	interleukin 18	protein coding gene	MGI:107936	Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854	J:331829	Mouse_Hepatitis_virus	Il18 interleukin 18 protein coding gene	MGI \| Alliance	Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus
Il18r1	interleukin 18 receptor 1	protein coding gene	MGI:105383	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854	J:162707 J:331829	Pathology \| SARS-CoV-MA_virus Mouse_Hepatitis_virus	Il18r1 interleukin 18 receptor 1 protein coding gene	MGI \| Alliance	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology \| SARS-CoV-MA_virus Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus
Il1b	interleukin 1 beta	protein coding gene	MGI:96543	Yang J, Nature 2020 Jul 29;():	J:292665	SARS-CoV-2_virus \| Vaccine	Il1b interleukin 1 beta protein coding gene	MGI \| Alliance	Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine
Il1r1	interleukin 1 receptor, type I	protein coding gene	MGI:96545	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854	J:162707 J:331829	Pathology \| SARS-CoV-MA_virus Mouse_Hepatitis_virus	Il1r1 interleukin 1 receptor, type I protein coding gene	MGI \| Alliance	Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology \| SARS-CoV-MA_virus Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 Mouse_Hepatitis_virus
Il21	interleukin 21	protein coding gene	MGI:1890474	Phares TW, J Neuroimmunol 2013 Oct 15;263(1-2):43-54	J:318137	Mouse_Hepatitis_virus	Il21 interleukin 21 protein coding gene	MGI \| Alliance	Phares TW, J Neuroimmunol 2013 Oct 15;263(1-2):43-54 Mouse_Hepatitis_virus
Il2rg	interleukin 2 receptor, gamma chain	protein coding gene	MGI:96551	Halwe S, bioRxiv 2021 Jun;(): Hu Z, bioRxiv 2021 Nov;(): Ngo VL, Cell Host Microbe 2024 Jan 23;(): Sefik E, bioRxiv 2021;():	J:308648 J:313461 J:345954 J:311907	SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Infection \| SARS-CoV-2_virus Infection \| MERS-CoV-MA_virus SARS-CoV-2_virus	Il2rg interleukin 2 receptor, gamma chain protein coding gene	MGI \| Alliance	Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Hu Z, bioRxiv 2021 Nov;(): Infection \| SARS-CoV-2_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection \| MERS-CoV-MA_virus Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Il3	interleukin 3	protein coding gene	MGI:96552	Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Il3 interleukin 3 protein coding gene	MGI \| Alliance	Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Il6	interleukin 6	protein coding gene	MGI:96559	Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 Imai Y, Cell 2008 Apr 18;133(2):235-49 Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Ndeupen S, bioRxiv 2021 Aug;(): Sefik E, bioRxiv 2021;():	J:337329 J:145306 J:286953 J:308580 J:311907	SARS-CoV-2_virus \| Vaccine SARS-CoV_virus SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment SARS-CoV-2_virus	Il6 interleukin 6 protein coding gene	MGI \| Alliance	Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 SARS-CoV-2_virus \| Vaccine Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Kumaki Y, Antiviral Res 2017 Mar;139():1-12 SARS-CoV-MA_virus \| SARS-CoV_virus \| Treatment Ndeupen S, bioRxiv 2021 Aug;(): SARS-CoV-2_virus \| Vaccine Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Il6ra	interleukin 6 receptor, alpha	protein coding gene	MGI:105304	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Il6ra interleukin 6 receptor, alpha protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Irf1	interferon regulatory factor 1	protein coding gene	MGI:96590	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology \| SARS-CoV-2_virus \| Treatment	Irf1 interferon regulatory factor 1 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment
Irf3	interferon regulatory factor 3	protein coding gene	MGI:1859179	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Imai Y, Cell 2008 Apr 18;133(2):235-49 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195	J:187561 J:308901 J:145306 J:291862 J:296686 J:291588	Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus SARS-CoV_virus Infection \| Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| Treatment HCoV-229E_virus \| Mouse_Hepatitis_virus	Irf3 interferon regulatory factor 3 protein coding gene	MGI \| Alliance	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Pathology \| SARS-CoV-2_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Israelow B, J Exp Med 2020 Dec 7;217(12): Infection \| Pathology \| SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus
Irf5	interferon regulatory factor 5	protein coding gene	MGI:1350924	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195	J:296686 J:291588	Pathology \| SARS-CoV-2_virus \| Treatment HCoV-229E_virus \| Mouse_Hepatitis_virus	Irf5 interferon regulatory factor 5 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus
Irf7	interferon regulatory factor 7	protein coding gene	MGI:1859212	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195	J:187561 J:308901 J:291862 J:296686 J:291588	Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus Infection \| Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| Treatment HCoV-229E_virus \| Mouse_Hepatitis_virus	Irf7 interferon regulatory factor 7 protein coding gene	MGI \| Alliance	Daffis S, Nature 2010 Nov 18;468(7322):452-6 Mouse_Hepatitis_virus Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Pathology \| SARS-CoV-2_virus Israelow B, J Exp Med 2020 Dec 7;217(12): Infection \| Pathology \| SARS-CoV-2_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus
Irf9	interferon regulatory factor 9	protein coding gene	MGI:107587	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology \| SARS-CoV-2_virus \| Treatment	Irf9 interferon regulatory factor 9 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment
Isg15	ISG15 ubiquitin-like modifier	protein coding gene	MGI:1855694	Daczkowski CM, J Mol Biol 2017 Jun 2;429(11):1661-1683 Ma XZ, J Virol 2014 Jun;88(11):6195-204	J:296108 J:214425	Gene \| MERS-CoV_virus \| Mouse_Hepatitis_virus \| SARS-CoV_virus Mouse_Hepatitis_virus	Isg15 ISG15 ubiquitin-like modifier protein coding gene	MGI \| Alliance	Daczkowski CM, J Mol Biol 2017 Jun 2;429(11):1661-1683 Gene \| MERS-CoV_virus \| Mouse_Hepatitis_virus \| SARS-CoV_virus Ma XZ, J Virol 2014 Jun;88(11):6195-204 Mouse_Hepatitis_virus
Itgal	integrin alpha L	protein coding gene	MGI:96606	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104	J:1357	Mouse_Hepatitis_virus	Itgal integrin alpha L protein coding gene	MGI \| Alliance	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 Mouse_Hepatitis_virus
Kctd9	potassium channel tetramerisation domain containing 9	protein coding gene	MGI:2145579	Zhang X, Front Immunol 2019;10():744	J:281803	Mouse_Hepatitis_virus	Kctd9 potassium channel tetramerisation domain containing 9 protein coding gene	MGI \| Alliance	Zhang X, Front Immunol 2019;10():744 Mouse_Hepatitis_virus
Ldlr	low density lipoprotein receptor	protein coding gene	MGI:96765	Ensor CM, bioRxiv 2021-09;():	J:310122	SARS-CoV-2_virus	Ldlr low density lipoprotein receptor protein coding gene	MGI \| Alliance	Ensor CM, bioRxiv 2021-09;(): SARS-CoV-2_virus
Lepr	leptin receptor	protein coding gene	MGI:104993	Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263	J:292007 J:308897	Gene Comorbidity	Lepr leptin receptor protein coding gene	MGI \| Alliance	Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Gene Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263 Comorbidity
Ltb4r1	leukotriene B4 receptor 1	protein coding gene	MGI:1309472	Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682	J:336666	Comorbidity \| SARS-CoV-2_virus	Ltb4r1 leukotriene B4 receptor 1 protein coding gene	MGI \| Alliance	Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 Comorbidity \| SARS-CoV-2_virus
Ly6e	lymphocyte antigen 6 family member E	protein coding gene	MGI:106651	Pfaender S, Nat Microbiol 2020 Jul 23;():	J:291868	Gene \| HCoV-229E_virus \| HCoV-OC43_virus \| MERS-CoV_virus \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus \| SARS-CoV_virus	Ly6e lymphocyte antigen 6 family member E protein coding gene	MGI \| Alliance	Pfaender S, Nat Microbiol 2020 Jul 23;(): Gene \| HCoV-229E_virus \| HCoV-OC43_virus \| MERS-CoV_virus \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus \| SARS-CoV_virus
Lyst	lysosomal trafficking regulator	protein coding gene	MGI:107448	Glass WG, J Immunol 2004 Sep 15;173(6):4030-9	J:92752	Infection \| SARS-CoV_virus	Lyst lysosomal trafficking regulator protein coding gene	MGI \| Alliance	Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus
Lyz2	lysozyme 2	protein coding gene	MGI:96897	Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Imai Y, Cell 2008 Apr 18;133(2):235-49 Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Musiu C, Cell Death Differ 2021 Sep 13;(): Page C, J Virol 2012 Dec;86(24):13334-49 Satta S, Theranostics 2022;12(6):2639-2657 Verma AK, mBio 2021 Oct 26;12(5):e0196921 Wang Y, Sci Adv 2021 Jan;7(1): Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5	J:143484 J:331763 J:145306 J:311033 J:313338 J:286337 J:331825 J:313438 J:314537 J:282479	Mouse_Hepatitis_virus SARS-CoV-2_virus SARS-CoV_virus Comorbidity \| Gene \| Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV_virus SARS-CoV-2_virus \| Variant	Lyz2 lysozyme 2 protein coding gene	MGI \| Alliance	Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Mouse_Hepatitis_virus de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 SARS-CoV-2_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Comorbidity \| Gene \| Mouse_Hepatitis_virus Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology \| SARS-CoV-2_virus Page C, J Virol 2012 Dec;86(24):13334-49 Pathology \| SARS-CoV_virus Satta S, Theranostics 2022;12(6):2639-2657 SARS-CoV-2_virus \| Variant Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus Wang Y, Sci Adv 2021 Jan;7(1): SARS-CoV-2_virus Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Mouse_Hepatitis_virus
Mavs	mitochondrial antiviral signaling protein	protein coding gene	MGI:2444773	Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:337329 J:288107 J:296686 J:291588 J:207380 J:308903	SARS-CoV-2_virus \| Vaccine Infection \| MERS-CoV-MA_virus \| Treatment Pathology \| SARS-CoV-2_virus \| Treatment HCoV-229E_virus \| Mouse_Hepatitis_virus MERS-CoV_virus Pathology \| SARS-CoV-2_virus	Mavs mitochondrial antiviral signaling protein protein coding gene	MGI \| Alliance	Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 SARS-CoV-2_virus \| Vaccine Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection \| MERS-CoV-MA_virus \| Treatment Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus
Mbd2	methyl-CpG binding domain protein 2	protein coding gene	MGI:1333813	Wang Y, Sci Adv 2021 Jan;7(1):	J:314537	SARS-CoV-2_virus	Mbd2 methyl-CpG binding domain protein 2 protein coding gene	MGI \| Alliance	Wang Y, Sci Adv 2021 Jan;7(1): SARS-CoV-2_virus
Mcph1	microcephaly, primary autosomal recessive 1	protein coding gene	MGI:2443308	Carter B, bioRxiv 2021 May;():	J:308712	SARS-CoV-2_virus \| Vaccine	Mcph1 microcephaly, primary autosomal recessive 1 protein coding gene	MGI \| Alliance	Carter B, bioRxiv 2021 May;(): SARS-CoV-2_virus \| Vaccine
Mir155	microRNA 155	miRNA gene	MGI:2676840	Soni DK, bioRxiv 2020 Dec;():	J:299096	SARS-CoV-2_virus \| Treatment	Mir155 microRNA 155 miRNA gene	MGI \| Alliance	Soni DK, bioRxiv 2020 Dec;(): SARS-CoV-2_virus \| Treatment
Mlkl	mixed lineage kinase domain-like	protein coding gene	MGI:1921818	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:296686 J:298138	Pathology \| SARS-CoV-2_virus \| Treatment Mouse_Hepatitis_virus	Mlkl mixed lineage kinase domain-like protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Mmp14	matrix metallopeptidase 14 (membrane-inserted)	protein coding gene	MGI:101900	Guo X, Nat Commun 2022 Dec 23;13(1):7907	J:333743	SARS-CoV-2_virus	Mmp14 matrix metallopeptidase 14 (membrane-inserted) protein coding gene	MGI \| Alliance	Guo X, Nat Commun 2022 Dec 23;13(1):7907 SARS-CoV-2_virus
Mrc1	mannose receptor, C type 1	protein coding gene	MGI:97142	Gao C, bioRxiv 2020 Jul 30;():	J:296125	SARS-CoV-2_virus	Mrc1 mannose receptor, C type 1 protein coding gene	MGI \| Alliance	Gao C, bioRxiv 2020 Jul 30;(): SARS-CoV-2_virus
Muc1	mucin 1, transmembrane	protein coding gene	MGI:97231	Biering SB, Nat Genet 2022 Aug;54(8):1078-1089	J:331758	SARS-CoV-2-MA_virus \| SARS-CoV-2_virus	Muc1 mucin 1, transmembrane protein coding gene	MGI \| Alliance	Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 SARS-CoV-2-MA_virus \| SARS-CoV-2_virus
Muc16	mucin 16	protein coding gene	MGI:1920982	Biering SB, Nat Genet 2022 Aug;54(8):1078-1089	J:331758	SARS-CoV-2-MA_virus \| SARS-CoV-2_virus	Muc16 mucin 16 protein coding gene	MGI \| Alliance	Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 SARS-CoV-2-MA_virus \| SARS-CoV-2_virus
Muc4	mucin 4	protein coding gene	MGI:2153525	Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 Plante JA, bioRxiv 2020;():	J:331758 J:287566	SARS-CoV-2-MA_virus \| SARS-CoV-2_virus Infection \| SARS-CoV-MA_virus \| Sex_bias	Muc4 mucin 4 protein coding gene	MGI \| Alliance	Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 SARS-CoV-2-MA_virus \| SARS-CoV-2_virus Plante JA, bioRxiv 2020;(): Infection \| SARS-CoV-MA_virus \| Sex_bias
Myd88	myeloid differentiation primary response gene 88	protein coding gene	MGI:108005	Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Imai Y, Cell 2008 Apr 18;133(2):235-49 Khan S, bioRxiv 2021 Mar;(): Nagai M, mBio 2021 Aug 31;12(4):e0159821 Salvi V, bioRxiv 2021 Apr;(): Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:337329 J:224849 J:144400 J:145306 J:303202 J:313440 J:304651 J:313336 J:162707 J:207380 J:298138 J:308903	SARS-CoV-2_virus \| Vaccine Infection \| Mouse_Hepatitis_virus \| Pathology Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus SARS-CoV_virus Infection \| SARS-CoV-2_virus SARS-CoV-2_virus Pathology \| SARS-CoV-MA_virus MERS-CoV_virus Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus	Myd88 myeloid differentiation primary response gene 88 protein coding gene	MGI \| Alliance	Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 SARS-CoV-2_virus \| Vaccine Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Infection \| Mouse_Hepatitis_virus \| Pathology Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Khan S, bioRxiv 2021 Mar;(): Infection \| SARS-CoV-2_virus Nagai M, mBio 2021 Aug 31;12(4):e0159821 SARS-CoV-2_virus \| Vaccine Salvi V, bioRxiv 2021 Apr;(): Infection \| SARS-CoV-2_virus Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 SARS-CoV-2_virus Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Pathology \| SARS-CoV-MA_virus Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 MERS-CoV_virus Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus
Ncf1	neutrophil cytosolic factor 1	protein coding gene	MGI:97283	Imai Y, Cell 2008 Apr 18;133(2):235-49	J:145306	SARS-CoV_virus	Ncf1 neutrophil cytosolic factor 1 protein coding gene	MGI \| Alliance	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus
Ndor1	NADPH dependent diflavin oxidoreductase 1	protein coding gene	MGI:1926047	Strine MS, PLoS Biol 2023 Jun;21(6):e3002097	J:341033	Gene \| MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV_virus	Ndor1 NADPH dependent diflavin oxidoreductase 1 protein coding gene	MGI \| Alliance	Strine MS, PLoS Biol 2023 Jun;21(6):e3002097 Gene \| MERS-CoV_virus \| SARS-CoV-2_virus \| SARS-CoV_virus
Nell1	NEL-like 1	protein coding gene	MGI:2443902	Biswas R, bioRxiv 2021 Feb;():	J:302158	Gene \| SARS-CoV-2_virus	Nell1 NEL-like 1 protein coding gene	MGI \| Alliance	Biswas R, bioRxiv 2021 Feb;(): Gene \| SARS-CoV-2_virus
Nfe2l2	nuclear factor, erythroid derived 2, like 2	protein coding gene	MGI:108420	Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823	J:357765	Gene \| Variant \| VOC_B.1.1.529_Omicron	Nfe2l2 nuclear factor, erythroid derived 2, like 2 protein coding gene	MGI \| Alliance	Qu Y, Microbiol Spectr 2023 Jun 15;11(3):e0037823 Gene \| Variant \| VOC_B.1.1.529_Omicron
Nfkb1	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	protein coding gene	MGI:97312	DeDiego ML, J Virol 2014 Jan;88(2):913-24	J:286180	Pathology \| SARS-CoV-MA_virus \| Treatment	Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 protein coding gene	MGI \| Alliance	DeDiego ML, J Virol 2014 Jan;88(2):913-24 Pathology \| SARS-CoV-MA_virus \| Treatment
Nlrc4	NLR family, CARD domain containing 4	protein coding gene	MGI:3036243	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Nlrc4 NLR family, CARD domain containing 4 protein coding gene	MGI \| Alliance	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Nlrp12	NLR family, pyrin domain containing 12	protein coding gene	MGI:2676630	Moustaqil M, Emerg Microbes Infect 2021 Dec;10(1):178-195	J:304591	Gene \| SARS-CoV-2_virus	Nlrp12 NLR family, pyrin domain containing 12 protein coding gene	MGI \| Alliance	Moustaqil M, Emerg Microbes Infect 2021 Dec;10(1):178-195 Gene \| SARS-CoV-2_virus
Nlrp3	NLR family, pyrin domain containing 3	protein coding gene	MGI:2653833	Chang YS, Int J Mol Sci 2020 Apr 30;21(9):3179 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Pan P, Nat Commun 2021 Aug 2;12(1):4664 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yalcinkaya M, Sci Rep 2021 Dec 24;11(1):24432 Yang J, Nature 2020 Jul 29;(): Zeng J, EBioMedicine 2021 Dec 31;75():103803 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:291870 J:331762 J:313326 J:323769 J:329139 J:292665 J:319443 J:298138 J:308903	SARS-CoV_virus Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus Gene \| Pathology SARS-CoV-2_virus \| Vaccine	Nlrp3 NLR family, pyrin domain containing 3 protein coding gene	MGI \| Alliance	Chang YS, Int J Mol Sci 2020 Apr 30;21(9):3179 SARS-CoV_virus Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Mouse_Hepatitis_virus Pan P, Nat Commun 2021 Aug 2;12(1):4664 Pathology \| SARS-CoV-2_virus Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene \| Pathology Yalcinkaya M, Sci Rep 2021 Dec 24;11(1):24432 Pathology \| SARS-CoV-2_virus Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine Zeng J, EBioMedicine 2021 Dec 31;75():103803 Pathology \| SARS-CoV-2_virus Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus
Nos2	nitric oxide synthase 2, inducible	protein coding gene	MGI:97361	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17	J:296686	Pathology \| SARS-CoV-2_virus \| Treatment	Nos2 nitric oxide synthase 2, inducible protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment
Notch1	notch 1	protein coding gene	MGI:97363	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch1 notch 1 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Notch2	notch 2	protein coding gene	MGI:97364	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch2 notch 2 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Notch3	notch 3	protein coding gene	MGI:99460	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch3 notch 3 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Notch4	notch 4	protein coding gene	MGI:107471	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Notch4 notch 4 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Nrp1	neuropilin 1	protein coding gene	MGI:106206	Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Gao J, bioRxiv 2021 Apr;():	J:297122 J:304619	Infection \| SARS-CoV-2_virus	Nrp1 neuropilin 1 protein coding gene	MGI \| Alliance	Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Infection \| SARS-CoV-2_virus Gao J, bioRxiv 2021 Apr;(): Infection \| SARS-CoV-2_virus
Oas1a	2'-5' oligoadenylate synthetase 1A	protein coding gene	MGI:2180860	Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72	J:318622	Mouse_Hepatitis_virus	Oas1a 2'-5' oligoadenylate synthetase 1A protein coding gene	MGI \| Alliance	Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Mouse_Hepatitis_virus
Omp	olfactory marker protein	protein coding gene	MGI:97436	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880	J:288137 J:319436	Infection \| SARS-CoV-2_virus Gene	Omp olfactory marker protein protein coding gene	MGI \| Alliance	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Infection \| SARS-CoV-2_virus Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880 Gene
Parp12	poly (ADP-ribose) polymerase family, member 12	protein coding gene	MGI:2143990	Kerr CM, J Virol 2023 Sep 28;97(9):e0088523	J:340885	Gene \| Infection \| Mouse_Hepatitis_virus	Parp12 poly (ADP-ribose) polymerase family, member 12 protein coding gene	MGI \| Alliance	Kerr CM, J Virol 2023 Sep 28;97(9):e0088523 Gene \| Infection \| Mouse_Hepatitis_virus
Pdcd1	programmed cell death 1	protein coding gene	MGI:104879	Phares TW, J Immunol 2009 May 1;182(9):5430-8	J:147948	Mouse_Hepatitis_virus	Pdcd1 programmed cell death 1 protein coding gene	MGI \| Alliance	Phares TW, J Immunol 2009 May 1;182(9):5430-8 Mouse_Hepatitis_virus
Pdgfb	platelet derived growth factor, B polypeptide	protein coding gene	MGI:97528	He L, bioRxiv 2020;():	J:295372	Infection \| SARS-CoV-2_virus	Pdgfb platelet derived growth factor, B polypeptide protein coding gene	MGI \| Alliance	He L, bioRxiv 2020;(): Infection \| SARS-CoV-2_virus
Pla2g2d	phospholipase A2, group IID	protein coding gene	MGI:1341796	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 WOng LY, bioRxiv 2021 Apr;(): Zheng J, J Clin Invest 2021 Jun 1;131(11):	J:229035 J:304684 J:311966	Infection \| SARS-CoV-MA_virus SARS-CoV-2-MA_virus \| Treatment Comorbidity \| MERS-CoV_virus	Pla2g2d phospholipase A2, group IID protein coding gene	MGI \| Alliance	Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 Infection \| SARS-CoV-MA_virus WOng LY, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus \| Treatment Zheng J, J Clin Invest 2021 Jun 1;131(11): Comorbidity \| MERS-CoV_virus
Plat	plasminogen activator, tissue	protein coding gene	MGI:97610	Gralinski LE, mBio 2013 Aug 6;4(4):	J:288556	Infection \| Pathology \| SARS-CoV-MA_virus	Plat plasminogen activator, tissue protein coding gene	MGI \| Alliance	Gralinski LE, mBio 2013 Aug 6;4(4): Infection \| Pathology \| SARS-CoV-MA_virus
Ppp1r14c	protein phosphatase 1, regulatory inhibitor subunit 14C	protein coding gene	MGI:1923392	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology \| SARS-CoV-MA_virus	Ppp1r14c protein phosphatase 1, regulatory inhibitor subunit 14C protein coding gene	MGI \| Alliance	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology \| SARS-CoV-MA_virus
Prkdc	protein kinase, DNA activated, catalytic polypeptide	protein coding gene	MGI:104779	Abdelnabi R, J Virol 2022 Aug 24;96(16):e0075822 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Halwe S, bioRxiv 2021 Jun;(): Hu Z, bioRxiv 2021 Nov;(): Pewe L, J Virol 1997 Oct;71(10):7640-7	J:331764 J:286309 J:308648 J:313461 J:42952	Treatment \| VOC_B.1.351_Beta SARS-CoV_virus \| Vaccine SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Infection \| SARS-CoV-2_virus Mouse_Hepatitis_virus	Prkdc protein kinase, DNA activated, catalytic polypeptide protein coding gene	MGI \| Alliance	Abdelnabi R, J Virol 2022 Aug 24;96(16):e0075822 Treatment \| VOC_B.1.351_Beta Graham RL, Nat Med 2012 Dec;18(12):1820-6 SARS-CoV_virus \| Vaccine Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Hu Z, bioRxiv 2021 Nov;(): Infection \| SARS-CoV-2_virus Pewe L, J Virol 1997 Oct;71(10):7640-7 Mouse_Hepatitis_virus
Prt4	protease 4	heritable phenotypic marker	MGI:97779	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104	J:1357	Mouse_Hepatitis_virus	Prt4 protease 4 heritable phenotypic marker	MGI \| Alliance	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 Mouse_Hepatitis_virus
Prt5	protease 5	heritable phenotypic marker	MGI:97780	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104	J:1357	Mouse_Hepatitis_virus	Prt5 protease 5 heritable phenotypic marker	MGI \| Alliance	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 Mouse_Hepatitis_virus
Psg16	pregnancy specific beta-1-glycoprotein 16	protein coding gene	MGI:1347249	Chen DS, Proc Natl Acad Sci U S A 1995 Dec 19;92(26):12095-9 Hirai A, J Virol 2010 Jul;84(13):6654-66	J:30292 J:198335	Mouse_Hepatitis_virus Infection \| Mouse_Hepatitis_virus	Psg16 pregnancy specific beta-1-glycoprotein 16 protein coding gene	MGI \| Alliance	Chen DS, Proc Natl Acad Sci U S A 1995 Dec 19;92(26):12095-9 Mouse_Hepatitis_virus Hirai A, J Virol 2010 Jul;84(13):6654-66 Infection \| Mouse_Hepatitis_virus
Psg17	pregnancy specific beta-1-glycoprotein 17	protein coding gene	MGI:1347250	Chen DS, Proc Natl Acad Sci U S A 1995 Dec 19;92(26):12095-9	J:30292	Mouse_Hepatitis_virus	Psg17 pregnancy specific beta-1-glycoprotein 17 protein coding gene	MGI \| Alliance	Chen DS, Proc Natl Acad Sci U S A 1995 Dec 19;92(26):12095-9 Mouse_Hepatitis_virus
Ptgdr	prostaglandin D receptor	protein coding gene	MGI:102966	Verma AK, mBio 2021 Oct 26;12(5):e0196921 Vijay R, Proc Natl Acad Sci U S A 2017 Jul 03;114(27):E5444-E5453 WOng LY, bioRxiv 2021 Apr;():	J:313438 J:243958 J:304684	Mouse_Hepatitis_virus SARS-CoV-2-MA_virus \| Treatment	Ptgdr prostaglandin D receptor protein coding gene	MGI \| Alliance	Verma AK, mBio 2021 Oct 26;12(5):e0196921 Mouse_Hepatitis_virus Vijay R, Proc Natl Acad Sci U S A 2017 Jul 03;114(27):E5444-E5453 Mouse_Hepatitis_virus WOng LY, bioRxiv 2021 Apr;(): SARS-CoV-2-MA_virus \| Treatment
Ptges2	prostaglandin E synthase 2	protein coding gene	MGI:1917592	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93	J:288523	Pathology \| SARS-CoV-MA_virus	Ptges2 prostaglandin E synthase 2 protein coding gene	MGI \| Alliance	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology \| SARS-CoV-MA_virus
Ptpn2	protein tyrosine phosphatase, non-receptor type 2	protein coding gene	MGI:97806	Spalinger MR, bioRxiv 2020 Dec 9;():	J:300213	SARS-CoV-2_virus \| Treatment	Ptpn2 protein tyrosine phosphatase, non-receptor type 2 protein coding gene	MGI \| Alliance	Spalinger MR, bioRxiv 2020 Dec 9;(): SARS-CoV-2_virus \| Treatment
Ptx3	pentraxin related gene	protein coding gene	MGI:104641	Han B, Lab Invest 2012 Sep;92(9):1285-96	J:188421	Mouse_Hepatitis_virus	Ptx3 pentraxin related gene protein coding gene	MGI \| Alliance	Han B, Lab Invest 2012 Sep;92(9):1285-96 Mouse_Hepatitis_virus
Pycard	PYD and CARD domain containing	protein coding gene	MGI:1931465	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:298138	Mouse_Hepatitis_virus	Pycard PYD and CARD domain containing protein coding gene	MGI \| Alliance	Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Rag1	recombination activating 1	protein coding gene	MGI:97848	Channappanavar R, J Infect Dis 2015 Dec 15;212(12):1894-903 Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Halwe S, bioRxiv 2021 Jun;(): Hassan AO, Cell 2020 Jun 10;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Mao T, bioRxiv 2021 Jun;(): Ngo VL, Cell Host Microbe 2024 Jan 23;(): Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26	J:287959 J:106738 J:92752 J:286309 J:308648 J:290258 J:308733 J:331753 J:295350 J:308656 J:345954 J:131907	MERS-CoV_virus \| Treatment Mouse_Hepatitis_virus \| Pathology Infection \| SARS-CoV_virus SARS-CoV_virus \| Vaccine SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Infection \| SARS-CoV-2_virus \| Treatment Infection \| SARS-CoV-2_virus MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta \| VOC_P.1_Gamma Infection \| MERS-CoV-MA_virus Mouse_Hepatitis_virus	Rag1 recombination activating 1 protein coding gene	MGI \| Alliance	Channappanavar R, J Infect Dis 2015 Dec 15;212(12):1894-903 MERS-CoV_virus \| Treatment Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Mouse_Hepatitis_virus \| Pathology Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Infection \| SARS-CoV_virus Graham RL, Nat Med 2012 Dec;18(12):1820-6 SARS-CoV_virus \| Vaccine Halwe S, bioRxiv 2021 Jun;(): SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Hassan AO, Cell 2020 Jun 10;(): Infection \| SARS-CoV-2_virus \| Treatment Israelow B, bioRxiv 2021 May;(): Infection \| SARS-CoV-2_virus Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Infection \| SARS-CoV-2_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Mao T, bioRxiv 2021 Jun;(): Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta \| VOC_P.1_Gamma Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection \| MERS-CoV-MA_virus Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Mouse_Hepatitis_virus
Rag2	recombination activating gene 2	protein coding gene	MGI:97849	Mao T, bioRxiv 2021 Jun;(): Sefik E, bioRxiv 2021;():	J:308656 J:311907	Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta \| VOC_P.1_Gamma SARS-CoV-2_virus	Rag2 recombination activating gene 2 protein coding gene	MGI \| Alliance	Mao T, bioRxiv 2021 Jun;(): Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta \| VOC_P.1_Gamma Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Rapgef3	Rap guanine nucleotide exchange factor (GEF) 3	protein coding gene	MGI:2441741	Xiao J, J Biol Chem 2021 Oct 19;():101315	J:313334	Pathology	Rapgef3 Rap guanine nucleotide exchange factor (GEF) 3 protein coding gene	MGI \| Alliance	Xiao J, J Biol Chem 2021 Oct 19;():101315 Pathology
Rbpj	recombination signal binding protein for immunoglobulin kappa J region	protein coding gene	MGI:96522	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Rbpj recombination signal binding protein for immunoglobulin kappa J region protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Ripk3	receptor-interacting serine-threonine kinase 3	protein coding gene	MGI:2154952	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052	J:296686 J:323957 J:298138	Pathology \| SARS-CoV-2_virus \| Treatment Pathology \| SARS-CoV-2_virus \| VOC_B.1.351_Beta Mouse_Hepatitis_virus	Ripk3 receptor-interacting serine-threonine kinase 3 protein coding gene	MGI \| Alliance	Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Pathology \| SARS-CoV-2_virus \| VOC_B.1.351_Beta Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Mouse_Hepatitis_virus
Rnasel	ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)	protein coding gene	MGI:1098272	Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Goldstein SA, J Virol 2017 Mar 01;91(5): Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 Thornbrough JM, mBio 2016 Mar 29;7(2):e00258 Zhang R, Proc Natl Acad Sci U S A 2013 Aug 6;110(32):13114-9 Zhao L, J Virol 2013 Aug;87(15):8408-18	J:318622 J:239306 J:291588 J:292006 J:200706 J:346257	Mouse_Hepatitis_virus Infection \| Mouse_Hepatitis_virus HCoV-229E_virus \| Mouse_Hepatitis_virus MERS-CoV_virus \| Mouse_Hepatitis_virus	Rnasel ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) protein coding gene	MGI \| Alliance	Birdwell LD, J Virol 2016 Jan 6;90(6):3160-72 Mouse_Hepatitis_virus Goldstein SA, J Virol 2017 Mar 01;91(5): Infection \| Mouse_Hepatitis_virus Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus Thornbrough JM, mBio 2016 Mar 29;7(2):e00258 MERS-CoV_virus \| Mouse_Hepatitis_virus Zhang R, Proc Natl Acad Sci U S A 2013 Aug 6;110(32):13114-9 Mouse_Hepatitis_virus Zhao L, J Virol 2013 Aug;87(15):8408-18 Infection \| Mouse_Hepatitis_virus
Rnh1	ribonuclease/angiogenin inhibitor 1	protein coding gene	MGI:1195456	Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226	J:331827	SARS-CoV-2_virus	Rnh1 ribonuclease/angiogenin inhibitor 1 protein coding gene	MGI \| Alliance	Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 SARS-CoV-2_virus
Samhd1	SAM domain and HD domain, 1	protein coding gene	MGI:1927468	Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120	J:338414	SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron	Samhd1 SAM domain and HD domain, 1 protein coding gene	MGI \| Alliance	Tada T, Proc Natl Acad Sci U S A 2023 Jun 6;120(23):e2303509120 SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.529_Omicron
Serpine1	serine (or cysteine) peptidase inhibitor, clade E, member 1	protein coding gene	MGI:97608	Gralinski LE, mBio 2013 Aug 6;4(4): Jain KG, Am J Physiol Lung Cell Mol Physiol 2022 Nov 1;323(5):L515-L524	J:288556 J:329972	Infection \| Pathology \| SARS-CoV-MA_virus Gene	Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 protein coding gene	MGI \| Alliance	Gralinski LE, mBio 2013 Aug 6;4(4): Infection \| Pathology \| SARS-CoV-MA_virus Jain KG, Am J Physiol Lung Cell Mol Physiol 2022 Nov 1;323(5):L515-L524 Gene
Setdb2	SET domain, bifurcated 2	protein coding gene	MGI:2685139	Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118	J:311033	Comorbidity \| Gene \| Mouse_Hepatitis_virus	Setdb2 SET domain, bifurcated 2 protein coding gene	MGI \| Alliance	Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Comorbidity \| Gene \| Mouse_Hepatitis_virus
Sftpc	surfactant associated protein C	protein coding gene	MGI:109517	Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:315719 J:337814	Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron	Sftpc surfactant associated protein C protein coding gene	MGI \| Alliance	Tang AT, bioRxiv 2021 Dec;(): Pathology \| SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron
Shh	sonic hedgehog	protein coding gene	MGI:98297	Anand G, bioRxiv 2020 Dec;(): Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989	J:298270 J:315719 J:337814	Pathology \| SARS-CoV-2_virus Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron	Shh sonic hedgehog protein coding gene	MGI \| Alliance	Anand G, bioRxiv 2020 Dec;(): Pathology \| SARS-CoV-2_virus Tang AT, bioRxiv 2021 Dec;(): Pathology \| SARS-CoV-2_virus Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 Pathology \| SARS-CoV-2_virus \| VOC_B.1.1.529_Omicron
Sirpa	signal-regulatory protein alpha	protein coding gene	MGI:108563	Wenzek C, iScience 2022 Dec 22;25(12):105540	J:331693	SARS-CoV-2_virus	Sirpa signal-regulatory protein alpha protein coding gene	MGI \| Alliance	Wenzek C, iScience 2022 Dec 22;25(12):105540 SARS-CoV-2_virus
Smad3	SMAD family member 3	protein coding gene	MGI:1201674	Wang W, Adv Sci (Weinh) 2022 Jan;9(3):e2103248	J:333753	Pathology \| SARS-CoV-2_virus	Smad3 SMAD family member 3 protein coding gene	MGI \| Alliance	Wang W, Adv Sci (Weinh) 2022 Jan;9(3):e2103248 Pathology \| SARS-CoV-2_virus
Spint1	serine protease inhibitor, Kunitz type 1	protein coding gene	MGI:1338033	Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873	J:271054	MERS-CoV_virus	Spint1 serine protease inhibitor, Kunitz type 1 protein coding gene	MGI \| Alliance	Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873 MERS-CoV_virus
Sry	sex determining region of Chr Y	protein coding gene	MGI:98660	Ensor CM, bioRxiv 2021-09;():	J:310122	SARS-CoV-2_virus	Sry sex determining region of Chr Y protein coding gene	MGI \| Alliance	Ensor CM, bioRxiv 2021-09;(): SARS-CoV-2_virus
Stat1	signal transducer and activator of transcription 1	protein coding gene	MGI:103063	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Hassan AO, Cell 2020 Jun 10;(): Hogan RJ, J Virol 2004 Oct;78(20):11416-21 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 Lassnig C, Transgenic Res 2005 Dec;14(6):803-6 Ngo VL, Cell Host Microbe 2024 Jan 23;(): Page C, J Virol 2012 Dec;86(24):13334-49 Peng X, mBio 2010 Oct 26;1(5): Singh A, Virol Sin 2020 Jun;35(3):290-304 Sun J, Cell 2020 Jun 10;(): Venkataraman T, J Virol 2017 Jun 15;91(12): Zornetzer GA, J Virol 2010 Nov;84(21):11297-309	J:286237 J:286309 J:290258 J:286302 J:295350 J:296686 J:99728 J:103578 J:345954 J:286337 J:276986 J:295349 J:291881 J:243599 J:164586	Pathology \| SARS-CoV-MA_virus SARS-CoV_virus \| Vaccine Infection \| SARS-CoV-2_virus \| Treatment Infection \| SARS-CoV_virus MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Pathology \| SARS-CoV-2_virus \| Treatment HCoV-229E_virus Infection \| MERS-CoV-MA_virus Pathology \| SARS-CoV_virus Infection \| SARS-CoV-MA_virus MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Infection \| Pathology \| SARS-CoV-2_virus \| Treatment	Stat1 signal transducer and activator of transcription 1 protein coding gene	MGI \| Alliance	Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Pathology \| SARS-CoV-MA_virus Graham RL, Nat Med 2012 Dec;18(12):1820-6 SARS-CoV_virus \| Vaccine Hassan AO, Cell 2020 Jun 10;(): Infection \| SARS-CoV-2_virus \| Treatment Hogan RJ, J Virol 2004 Oct;78(20):11416-21 Infection \| SARS-CoV_virus Johansen MD, Mucosal Immunol 2020 Aug 20;(): MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 HCoV-229E_virus Lassnig C, Transgenic Res 2005 Dec;14(6):803-6 HCoV-229E_virus Ngo VL, Cell Host Microbe 2024 Jan 23;(): Infection \| MERS-CoV-MA_virus Page C, J Virol 2012 Dec;86(24):13334-49 Pathology \| SARS-CoV_virus Peng X, mBio 2010 Oct 26;1(5): Infection \| SARS-CoV-MA_virus Singh A, Virol Sin 2020 Jun;35(3):290-304 MERS-CoV-MA_virus \| MERS-CoV_virus \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV_virus Sun J, Cell 2020 Jun 10;(): Infection \| Pathology \| SARS-CoV-2_virus \| Treatment Venkataraman T, J Virol 2017 Jun 15;91(12): Pathology \| SARS-CoV-MA_virus Zornetzer GA, J Virol 2010 Nov;84(21):11297-309 Pathology \| SARS-CoV-MA_virus
Stat3	signal transducer and activator of transcription 3	protein coding gene	MGI:103038	Musiu C, Cell Death Differ 2021 Sep 13;():	J:313338	Pathology \| SARS-CoV-2_virus	Stat3 signal transducer and activator of transcription 3 protein coding gene	MGI \| Alliance	Musiu C, Cell Death Differ 2021 Sep 13;(): Pathology \| SARS-CoV-2_virus
Stat6	signal transducer and activator of transcription 6	protein coding gene	MGI:103034	Page C, J Virol 2012 Dec;86(24):13334-49	J:286337	Pathology \| SARS-CoV_virus	Stat6 signal transducer and activator of transcription 6 protein coding gene	MGI \| Alliance	Page C, J Virol 2012 Dec;86(24):13334-49 Pathology \| SARS-CoV_virus
Sting1	stimulator of interferon response cGAMP interactor 1	protein coding gene	MGI:1919762	Humphries F, Sci Immunol 2021 May 18;6(59): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yang J, Nature 2020 Jul 29;():	J:333769 J:296686 J:323769 J:292665	SARS-CoV-2_virus \| Treatment Pathology \| SARS-CoV-2_virus \| Treatment Gene \| Pathology SARS-CoV-2_virus \| Vaccine	Sting1 stimulator of interferon response cGAMP interactor 1 protein coding gene	MGI \| Alliance	Humphries F, Sci Immunol 2021 May 18;6(59): SARS-CoV-2_virus \| Treatment Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Gene \| Pathology Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine
Terc	telomerase RNA component	telomerase RNA gene	MGI:109558	Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658	J:309195 J:326929	Comorbidity \| Gene Gene	Terc telomerase RNA component telomerase RNA gene	MGI \| Alliance	Sepe S, bioRxiv 2021 Jun;(): Comorbidity \| Gene Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene
Terf2	telomeric repeat binding factor 2	protein coding gene	MGI:1195972	Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658	J:309195 J:326929	Comorbidity \| Gene Gene	Terf2 telomeric repeat binding factor 2 protein coding gene	MGI \| Alliance	Sepe S, bioRxiv 2021 Jun;(): Comorbidity \| Gene Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 Gene
Tfrc	transferrin receptor	protein coding gene	MGI:98822	Tang X, bioRxiv 2020 Oct;():	J:296386	Infection \| SARS-CoV-2_virus	Tfrc transferrin receptor protein coding gene	MGI \| Alliance	Tang X, bioRxiv 2020 Oct;(): Infection \| SARS-CoV-2_virus
Tgfb1	transforming growth factor, beta 1	protein coding gene	MGI:98725	Li SW, Sci Rep 2016 May 13;6():25754	J:291621	SARS-CoV_virus	Tgfb1 transforming growth factor, beta 1 protein coding gene	MGI \| Alliance	Li SW, Sci Rep 2016 May 13;6():25754 SARS-CoV_virus
Thpo	thrombopoietin	protein coding gene	MGI:101875	Sefik E, bioRxiv 2021;():	J:311907	SARS-CoV-2_virus	Thpo thrombopoietin protein coding gene	MGI \| Alliance	Sefik E, bioRxiv 2021;(): SARS-CoV-2_virus
Ticam1	TIR domain containing adaptor molecule 1	protein coding gene	MGI:2147032	Imai Y, Cell 2008 Apr 18;133(2):235-49 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Totura AL, mBio 2015 May 26;6(3):e00638-15 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:145306 J:296686 J:288471 J:308903	SARS-CoV_virus Pathology \| SARS-CoV-2_virus \| Treatment Infection \| SARS-CoV-MA_virus Pathology \| SARS-CoV-2_virus	Ticam1 TIR domain containing adaptor molecule 1 protein coding gene	MGI \| Alliance	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Pathology \| SARS-CoV-2_virus \| Treatment Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection \| SARS-CoV-MA_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus
Ticam2	TIR domain containing adaptor molecule 2	protein coding gene	MGI:3040056	Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Totura AL, mBio 2015 May 26;6(3):e00638-15	J:270045 J:288471	Pathology \| SARS-CoV-MA_virus Infection \| SARS-CoV-MA_virus	Ticam2 TIR domain containing adaptor molecule 2 protein coding gene	MGI \| Alliance	Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 Pathology \| SARS-CoV-MA_virus Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection \| SARS-CoV-MA_virus
Timp1	tissue inhibitor of metalloproteinase 1	protein coding gene	MGI:98752	Savarin C, ASN Neuro 2013 Nov 26;5(5):e00127	J:331803	Mouse_Hepatitis_virus	Timp1 tissue inhibitor of metalloproteinase 1 protein coding gene	MGI \| Alliance	Savarin C, ASN Neuro 2013 Nov 26;5(5):e00127 Mouse_Hepatitis_virus
Tiparp	TCDD-inducible poly(ADP-ribose) polymerase	protein coding gene	MGI:2159210	Grunewald ME, J Virol 2020 Jan 17;94(3):	J:290586	Infection \| Mouse_Hepatitis_virus	Tiparp TCDD-inducible poly(ADP-ribose) polymerase protein coding gene	MGI \| Alliance	Grunewald ME, J Virol 2020 Jan 17;94(3): Infection \| Mouse_Hepatitis_virus
Tlr2	toll-like receptor 2	protein coding gene	MGI:1346060	Khan S, bioRxiv 2021 Mar;(): Yang J, Nature 2020 Jul 29;(): Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:303202 J:292665 J:308903	Infection \| SARS-CoV-2_virus SARS-CoV-2_virus \| Vaccine Pathology \| SARS-CoV-2_virus	Tlr2 toll-like receptor 2 protein coding gene	MGI \| Alliance	Khan S, bioRxiv 2021 Mar;(): Infection \| SARS-CoV-2_virus Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus
Tlr3	toll-like receptor 3	protein coding gene	MGI:2156367	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Imai Y, Cell 2008 Apr 18;133(2):235-49 Totura AL, mBio 2015 May 26;6(3):e00638-15	J:144400 J:145306 J:288471	Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus SARS-CoV_virus Infection \| SARS-CoV-MA_virus	Tlr3 toll-like receptor 3 protein coding gene	MGI \| Alliance	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Totura AL, mBio 2015 May 26;6(3):e00638-15 Infection \| SARS-CoV-MA_virus
Tlr4	toll-like receptor 4	protein coding gene	MGI:96824	Imai Y, Cell 2008 Apr 18;133(2):235-49 Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Khan S, bioRxiv 2021 Mar;(): Yang J, Nature 2020 Jul 29;(): Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:145306 J:153918 J:303202 J:292665 J:308903	SARS-CoV_virus Mouse_Hepatitis_virus \| Pathology Infection \| SARS-CoV-2_virus SARS-CoV-2_virus \| Vaccine Pathology \| SARS-CoV-2_virus	Tlr4 toll-like receptor 4 protein coding gene	MGI \| Alliance	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Mouse_Hepatitis_virus \| Pathology Khan S, bioRxiv 2021 Mar;(): Infection \| SARS-CoV-2_virus Yang J, Nature 2020 Jul 29;(): SARS-CoV-2_virus \| Vaccine Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus
Tlr7	toll-like receptor 7	protein coding gene	MGI:2176882	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 Zheng M, Nat Immunol 2021 Jul;22(7):829-838	J:144400 J:288107 J:291588 J:308903	Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus Infection \| MERS-CoV-MA_virus \| Treatment HCoV-229E_virus \| Mouse_Hepatitis_virus Pathology \| SARS-CoV-2_virus	Tlr7 toll-like receptor 7 protein coding gene	MGI \| Alliance	Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Infection \| Mouse_Hepatitis_virus \| SARS-CoV_virus Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Infection \| MERS-CoV-MA_virus \| Treatment Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 HCoV-229E_virus \| Mouse_Hepatitis_virus Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Pathology \| SARS-CoV-2_virus
Tlr9	toll-like receptor 9	protein coding gene	MGI:1932389	Imai Y, Cell 2008 Apr 18;133(2):235-49 Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008	J:145306 J:325468	SARS-CoV_virus SARS-CoV-2_virus	Tlr9 toll-like receptor 9 protein coding gene	MGI \| Alliance	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008 SARS-CoV-2_virus
Tmem41b	transmembrane protein 41B	protein coding gene	MGI:1289225	Sun L, PLoS Pathog 2021 Dec;17(12):e1010113	J:316472	Gene \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus	Tmem41b transmembrane protein 41B protein coding gene	MGI \| Alliance	Sun L, PLoS Pathog 2021 Dec;17(12):e1010113 Gene \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus
Tmprss11a	transmembrane protease, serine 11a	protein coding gene	MGI:2684853	Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873	J:271054	MERS-CoV_virus	Tmprss11a transmembrane protease, serine 11a protein coding gene	MGI \| Alliance	Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873 MERS-CoV_virus
Tmprss11d	transmembrane protease, serine 11d	protein coding gene	MGI:2385221	Heurich A, J Virol 2014 Jan;88(2):1293-307 Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873	J:207757 J:271054	Infection \| SARS-CoV_virus MERS-CoV_virus	Tmprss11d transmembrane protease, serine 11d protein coding gene	MGI \| Alliance	Heurich A, J Virol 2014 Jan;88(2):1293-307 Infection \| SARS-CoV_virus Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873 MERS-CoV_virus
Tmprss11e	transmembrane protease, serine 11e	protein coding gene	MGI:3513175	Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873	J:271054	MERS-CoV_virus	Tmprss11e transmembrane protease, serine 11e protein coding gene	MGI \| Alliance	Zmora P, J Biol Chem 2018 Sep 7;293(36):13863-13873 MERS-CoV_virus
Tmprss2	transmembrane protease, serine 2	protein coding gene	MGI:1354381	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Brechbuhl J, bioRxiv 2021 Mar;(): Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880 Deng Q, bioRxiv 2020;(): Earnest JT, PLoS Pathog 2017 Jul;13(7):e1006546 Heurich A, J Virol 2014 Jan;88(2):1293-307 Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Li F, Nat Commun 2021 Feb 8;12(1):866 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Qiao J, Biochem Biophys Res Commun 2020 Dec 17;533(4):867-871 Sagawa T, Environ Res 2021 Apr;195():110722 Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Shapira T, bioRxiv 2021 May;(): Song J, J Med Virol 2020 Nov;92(11):2556-2566 Vo T, bioRxiv 2020 Nov;(): Ziegler CGK, Cell 2020 May 28;181(5):1016-1035.e19	J:288137 J:303458 J:319436 J:296182 J:246218 J:207757 J:283077 J:303471 J:294026 J:299392 J:305462 J:309632 J:308716 J:300096 J:296710 J:291435	Infection \| SARS-CoV-2_virus Gene SARS-CoV-2_virus \| Sex_bias Infection \| MERS-CoV_virus Infection \| SARS-CoV_virus MERS-CoV-MA_virus \| MERS-CoV_virus \| Pathology SARS-CoV-2_virus \| Treatment SARS-CoV-2_virus \| SARS-CoV_virus Comorbidity \| Gene Comorbidity SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Infection Pathology \| SARS-CoV-2_virus	Tmprss2 transmembrane protease, serine 2 protein coding gene	MGI \| Alliance	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Infection \| SARS-CoV-2_virus Brechbuhl J, bioRxiv 2021 Mar;(): Gene Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880 Gene Deng Q, bioRxiv 2020;(): SARS-CoV-2_virus \| Sex_bias Earnest JT, PLoS Pathog 2017 Jul;13(7):e1006546 Infection \| MERS-CoV_virus Heurich A, J Virol 2014 Jan;88(2):1293-307 Infection \| SARS-CoV_virus Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): MERS-CoV-MA_virus \| MERS-CoV_virus \| Pathology Li F, Nat Commun 2021 Feb 8;12(1):866 SARS-CoV-2_virus \| Treatment Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 SARS-CoV-2_virus \| SARS-CoV_virus Qiao J, Biochem Biophys Res Commun 2020 Dec 17;533(4):867-871 Gene Sagawa T, Environ Res 2021 Apr;195():110722 Comorbidity \| Gene Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Comorbidity Shapira T, bioRxiv 2021 May;(): SARS-CoV-2_virus \| Treatment \| VOC_B.1.1.7_Alpha \| VOC_B.1.351_Beta Song J, J Med Virol 2020 Nov;92(11):2556-2566 Infection \| SARS-CoV-2_virus Vo T, bioRxiv 2020 Nov;(): Infection Ziegler CGK, Cell 2020 May 28;181(5):1016-1035.e19 Pathology \| SARS-CoV-2_virus
Tmprss4	transmembrane protease, serine 4	protein coding gene	MGI:2384877	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562	J:288137	Infection \| SARS-CoV-2_virus	Tmprss4 transmembrane protease, serine 4 protein coding gene	MGI \| Alliance	Bilinska K, ACS Chem Neurosci 2020 Jun 3;11(11):1555-1562 Infection \| SARS-CoV-2_virus
Tnf	tumor necrosis factor	protein coding gene	MGI:104798	Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32	J:315532	Mouse_Hepatitis_virus	Tnf tumor necrosis factor protein coding gene	MGI \| Alliance	Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32 Mouse_Hepatitis_virus
Tnfrsf1a	tumor necrosis factor receptor superfamily, member 1a	protein coding gene	MGI:1314884	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32	J:288523 J:315532	Pathology \| SARS-CoV-MA_virus Mouse_Hepatitis_virus	Tnfrsf1a tumor necrosis factor receptor superfamily, member 1a protein coding gene	MGI \| Alliance	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology \| SARS-CoV-MA_virus Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32 Mouse_Hepatitis_virus
Tnfrsf1b	tumor necrosis factor receptor superfamily, member 1b	protein coding gene	MGI:1314883	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32	J:288523 J:315532	Pathology \| SARS-CoV-MA_virus Mouse_Hepatitis_virus	Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b protein coding gene	MGI \| Alliance	McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 Pathology \| SARS-CoV-MA_virus Xu H, Immunol Lett 2014 Mar-Apr;158(1-2):25-32 Mouse_Hepatitis_virus
Tpe1	tear protein electrophoretic 1	unclassified gene	MGI:103146	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104	J:1357	Mouse_Hepatitis_virus	Tpe1 tear protein electrophoretic 1 unclassified gene	MGI \| Alliance	Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 Mouse_Hepatitis_virus
Traf3	TNF receptor-associated factor 3	protein coding gene	MGI:108041	Lui PY, Emerg Microbes Infect 2016 Apr 20;5():e39	J:296106	Gene \| Infection \| MERS-CoV_virus	Traf3 TNF receptor-associated factor 3 protein coding gene	MGI \| Alliance	Lui PY, Emerg Microbes Infect 2016 Apr 20;5():e39 Gene \| Infection \| MERS-CoV_virus
Traf3ip2	TRAF3 interacting protein 2	protein coding gene	MGI:2143599	Lin X, iScience 2021 Apr 23;24(4):102293	J:304178	Pathology \| SARS-CoV-2_virus \| Treatment	Traf3ip2 TRAF3 interacting protein 2 protein coding gene	MGI \| Alliance	Lin X, iScience 2021 Apr 23;24(4):102293 Pathology \| SARS-CoV-2_virus \| Treatment
Traf6	TNF receptor-associated factor 6	protein coding gene	MGI:108072	Imai Y, Cell 2008 Apr 18;133(2):235-49	J:145306	SARS-CoV_virus	Traf6 TNF receptor-associated factor 6 protein coding gene	MGI \| Alliance	Imai Y, Cell 2008 Apr 18;133(2):235-49 SARS-CoV_virus
Trem2	triggering receptor expressed on myeloid cells 2	protein coding gene	MGI:1913150	Hwang M, J Neuroinflammation 2022 Nov 4;19(1):267 Wu Y, Sci Adv 2021 Dec 10;7(50):eabi6802	J:331755 J:320018	Mouse_Hepatitis_virus Gene \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus	Trem2 triggering receptor expressed on myeloid cells 2 protein coding gene	MGI \| Alliance	Hwang M, J Neuroinflammation 2022 Nov 4;19(1):267 Mouse_Hepatitis_virus Wu Y, Sci Adv 2021 Dec 10;7(50):eabi6802 Gene \| Mouse_Hepatitis_virus \| SARS-CoV-2_virus
Trim14	tripartite motif-containing 14	protein coding gene	MGI:1921985	Schafer A, bioRxiv 2021 May;():	J:308730	Pathology \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus	Trim14 tripartite motif-containing 14 protein coding gene	MGI \| Alliance	Schafer A, bioRxiv 2021 May;(): Pathology \| SARS-CoV-2-MA_virus \| SARS-CoV-2_virus \| SARS-CoV-MA_virus \| SARS-CoV_virus
Trim55	tripartite motif-containing 55	protein coding gene	MGI:3036269	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504	J:268979	Infection \| SARS-CoV-MA_virus	Trim55 tripartite motif-containing 55 protein coding gene	MGI \| Alliance	Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Infection \| SARS-CoV-MA_virus
Trp53	transformation related protein 53	protein coding gene	MGI:98834	Zhou B, J Virol 2008 Jul;82(14):6962-71	J:289079	SARS-CoV_virus	Trp53 transformation related protein 53 protein coding gene	MGI \| Alliance	Zhou B, J Virol 2008 Jul;82(14):6962-71 SARS-CoV_virus
Trpv2	transient receptor potential cation channel, subfamily V, member 2	protein coding gene	MGI:1341836	Xu J, Theranostics 2021;11(15):7379-7390	J:314372	Infection	Trpv2 transient receptor potential cation channel, subfamily V, member 2 protein coding gene	MGI \| Alliance	Xu J, Theranostics 2021;11(15):7379-7390 Infection
Tyr	tyrosinase	protein coding gene	MGI:98880	Scaglione A, Front Immunol 2021;12():719077	J:335910	SARS-CoV-2_virus \| Treatment \| Vaccine	Tyr tyrosinase protein coding gene	MGI \| Alliance	Scaglione A, Front Immunol 2021;12():719077 SARS-CoV-2_virus \| Treatment \| Vaccine
Usp10	ubiquitin specific peptidase 10	protein coding gene	MGI:894652	Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7	J:333746	SARS-CoV-2_virus \| Vaccine	Usp10 ubiquitin specific peptidase 10 protein coding gene	MGI \| Alliance	Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 SARS-CoV-2_virus \| Vaccine
Usp18	ubiquitin specific peptidase 18	protein coding gene	MGI:1344364	Ma XZ, J Virol 2014 Jun;88(11):6195-204	J:214425	Mouse_Hepatitis_virus	Usp18 ubiquitin specific peptidase 18 protein coding gene	MGI \| Alliance	Ma XZ, J Virol 2014 Jun;88(11):6195-204 Mouse_Hepatitis_virus
Vhl	von Hippel-Lindau tumor suppressor	protein coding gene	MGI:103223	Kotagiri P, EBioMedicine 2022 Feb 18;77():103878	J:322643	SARS-CoV-2_virus	Vhl von Hippel-Lindau tumor suppressor protein coding gene	MGI \| Alliance	Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 SARS-CoV-2_virus
Wwtr1	WW domain containing transcription regulator 1	protein coding gene	MGI:1917649	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Wwtr1 WW domain containing transcription regulator 1 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Yap1	yes-associated protein 1	protein coding gene	MGI:103262	Harb H, Immunity 2021 Apr 22;():	J:347529	Infection	Yap1 yes-associated protein 1 protein coding gene	MGI \| Alliance	Harb H, Immunity 2021 Apr 22;(): Infection
Yif1b	Yip1 interacting factor homolog B (S. cerevisiae)	protein coding gene	MGI:1924504	Lin X, bioRxiv 2021 Dec;():	J:315744	Gene \| Pathology \| SARS-CoV-2_virus	Yif1b Yip1 interacting factor homolog B (S. cerevisiae) protein coding gene	MGI \| Alliance	Lin X, bioRxiv 2021 Dec;(): Gene \| Pathology \| SARS-CoV-2_virus
Zmpste24	zinc metallopeptidase, STE24	protein coding gene	MGI:1890508	Shilagardi K, mBio 2022 Oct 26;13(5):e0254322	J:331759	Mouse_Hepatitis_virus	Zmpste24 zinc metallopeptidase, STE24 protein coding gene	MGI \| Alliance	Shilagardi K, mBio 2022 Oct 26;13(5):e0254322 Mouse_Hepatitis_virus

Human Genes Associated with Coronavirus Infection and Pathology

This table lists human genes implicated in coronavirus infectious disease and pathology with links to the supporting publications. Instances where genes are not implicated are also included in the table. Data for this table are imported from the Alliance of Genome Resources. Only gene associations with Coronavirus infectious disease (DOID:0080599) or any of its descendants are shown. Links to mouse orthologs of the human genes are provided.

Gene symbols and disease terms link to the Alliance of Genome Resources web site. References link to the PubMed web site. Mouse ortholog symbols link to MGI gene detail pages.

1-hgnc	2-humangene	3-assoctype	4-doid	5-doterm	6-refid	7-source	8-mgisymbol	9-mgiid	Gene Symbol	Disease	References	Mouse Ortholog
HGNC:9071	PLG	is_implicated_in	DOID:0080600	COVID-19	PMID:32275753	RGD	MGI:97620	Plg	PLG	COVID-19	PMID:32275753	Plg
HGNC:5434	IFNB1	is_implicated_in	DOID:0080600	COVID-19	PMID:32401715	RGD	MGI:107657	Ifnb1	IFNB1	COVID-19	PMID:32401715	Ifnb1
HGNC:13557	ACE2	is_implicated_in	DOID:0080600 DOID:2945	COVID-19 severe acute respiratory syndrome	PMID:34668775 PMID:34668780 PMID:32380511 PMID:32220422 PMID:17974127 PMID:32553273	RGD	MGI:1917258	Ace2	ACE2	COVID-19 severe acute respiratory syndrome	PMID:34668775 PMID:34668780 PMID:32380511 PMID:32220422 PMID:17974127 PMID:32553273	Ace2
HGNC:18363	IFNL1	is_implicated_in	DOID:0080600	COVID-19	PMID:32854108	RGD	MGI:2450574 MGI:3647279	Ifnl3 Ifnl2	IFNL1	COVID-19	PMID:32854108	Ifnl3 Ifnl2
HGNC:3009	DPP4	is_implicated_in	DOID:0080642	Middle East respiratory syndrome	PMID:31838832 PMID:30256968 PMID:30626685	RGD	MGI:94919	Dpp4	DPP4	Middle East respiratory syndrome	PMID:31838832 PMID:30256968 PMID:30626685	Dpp4
HGNC:2707	ACE	is_implicated_in is_not_implicated_in	DOID:0080599 DOID:0080600	Coronavirus infectious disease COVID-19	PMID:17108019 PMID:32386188 PMID:32286246	RGD	MGI:87874	Ace	ACE	Coronavirus infectious disease COVID-19	PMID:17108019 PMID:32386188 PMID:32286246	Ace
HGNC:336	AGTR1	is_implicated_in	DOID:0080600	COVID-19	PMID:32228222	RGD	MGI:87965 MGI:87964	Agtr1b Agtr1a	AGTR1	COVID-19	PMID:32228222	Agtr1b Agtr1a
HGNC:1641	CD209	is_implicated_in	DOID:0080599	Coronavirus infectious disease	PMID:20864747	RGD	MGI:2157945 MGI:2157942 MGI:1916415 MGI:2157948 MGI:2157947	Cd209c Cd209a Cd209b Cd209e Cd209d	CD209	Coronavirus infectious disease	PMID:20864747	Cd209c Cd209a Cd209b Cd209e Cd209d
HGNC:15631	TLR7	is_implicated_in	DOID:0080600	COVID-19	PMID:33650967	RGD	MGI:2176882	Tlr7	TLR7	COVID-19	PMID:33650967	Tlr7
HGNC:9075	SERPINF2	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD	MGI:107173	Serpinf2	SERPINF2	COVID-19	PMID:32747830	Serpinf2
HGNC:1228	SERPING1	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD	MGI:894696	Serping1	SERPING1	COVID-19	PMID:32747830	Serping1
HGNC:4948	HLA-DRB1	is_implicated_in	DOID:2945	severe acute respiratory syndrome	PMID:19445991 PMID:15243926	RGD	MGI:95902 MGI:95901	H2-Eb2 H2-Eb1	HLA-DRB1	severe acute respiratory syndrome	PMID:19445991 PMID:15243926	H2-Eb2 H2-Eb1
HGNC:5438	IFNG	is_implicated_in	DOID:2945	severe acute respiratory syndrome	PMID:19258635 PMID:16672072	RGD	MGI:107656	Ifng	IFNG	severe acute respiratory syndrome	PMID:19258635 PMID:16672072	Ifng
HGNC:4641	GSTT1	is_implicated_in	DOID:0080600	COVID-19	PMID:32454047	RGD	MGI:107379	Gstt1	GSTT1	COVID-19	PMID:32454047	Gstt1
HGNC:4932	HLA-B	is_implicated_in	DOID:0080600 DOID:2945	COVID-19 severe acute respiratory syndrome	PMID:32424945 PMID:12969506 PMID:15243926	RGD	MGI:2687364 MGI:1276525 MGI:95912 MGI:1276570 MGI:1276527 MGI:1276526 MGI:95896 MGI:95913 MGI:95917 MGI:1276524 MGI:95904 MGI:95936 MGI:95928 MGI:95959 MGI:2676637 MGI:95935 MGI:1276522 MGI:95931 MGI:95933 MGI:95929 MGI:95956 MGI:95914 MGI:95942	H2-M10.6 H2-M10.2 H2-L H2-M9 H2-M10.4 H2-M10.5 H2-D1 H2-M1 H2-M5 H2-M10.3 H2-K1 H2-Q7 H2-Q1 H2-T3 H2-M11 H2-Q6 H2-M10.1 H2-Q2 H2-Q4 H2-Q10 H2-T22 H2-M2 H2-T10	HLA-B	COVID-19 severe acute respiratory syndrome	PMID:32424945 PMID:12969506 PMID:15243926	H2-M10.6 H2-M10.2 H2-L H2-M9 H2-M10.4 H2-M10.5 H2-D1 H2-M1 H2-M5 H2-M10.3 H2-K1 H2-Q7 H2-Q1 H2-T3 H2-M11 H2-Q6 H2-M10.1 H2-Q2 H2-Q4 H2-Q10 H2-T22 H2-M2 H2-T10
HGNC:6340	KIR3DS1	is_implicated_in	DOID:0080600	COVID-19	PMID:33928374	RGD	MGI:2652397 MGI:3612791	Kir3dl1 Kir3dl2	KIR3DS1	COVID-19	PMID:33928374	Kir3dl1 Kir3dl2
HGNC:4933	HLA-C	is_implicated_in	DOID:0080600	COVID-19	PMID:32424945	RGD	MGI:2687364 MGI:1276525 MGI:95912 MGI:1276570 MGI:1276527 MGI:1276526 MGI:95896 MGI:95913 MGI:95917 MGI:1276524 MGI:95904 MGI:95936 MGI:95928 MGI:95959 MGI:2676637 MGI:95935 MGI:1276522 MGI:95931 MGI:95933 MGI:95929 MGI:95956 MGI:95914 MGI:95942	H2-M10.6 H2-M10.2 H2-L H2-M9 H2-M10.4 H2-M10.5 H2-D1 H2-M1 H2-M5 H2-M10.3 H2-K1 H2-Q7 H2-Q1 H2-T3 H2-M11 H2-Q6 H2-M10.1 H2-Q2 H2-Q4 H2-Q10 H2-T22 H2-M2 H2-T10	HLA-C	COVID-19	PMID:32424945	H2-M10.6 H2-M10.2 H2-L H2-M9 H2-M10.4 H2-M10.5 H2-D1 H2-M1 H2-M5 H2-M10.3 H2-K1 H2-Q7 H2-Q1 H2-T3 H2-M11 H2-Q6 H2-M10.1 H2-Q2 H2-Q4 H2-Q10 H2-T22 H2-M2 H2-T10
HGNC:6922	MBL2	is_implicated_in	DOID:0080599	Coronavirus infectious disease	PMID:15838797	RGD	MGI:96924	Mbl2	MBL2	Coronavirus infectious disease	PMID:15838797	Mbl2
HGNC:5414	IFITM3	is_implicated_in	DOID:0080600	COVID-19	PMID:32348495	RGD	MGI:1933382 MGI:1913391 MGI:1921732	Ifitm2 Ifitm3 Ifitm7	IFITM3	COVID-19	PMID:32348495	Ifitm2 Ifitm3 Ifitm7
HGNC:13523	CLEC4M	is_implicated_in is_not_implicated_in	DOID:2945	severe acute respiratory syndrome	PMID:16369534 PMID:18708672 PMID:17534355 PMID:17534354	RGD	MGI:2157942 MGI:1916415	Cd209a Cd209b	CLEC4M	severe acute respiratory syndrome	PMID:16369534 PMID:18708672 PMID:17534355 PMID:17534354	Cd209a Cd209b
HGNC:1325	C4BPA	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD	MGI:88229 MGI:104965	C4bp Zp3r	C4BPA	COVID-19	PMID:32747830	C4bp Zp3r
HGNC:79	ABO	is_implicated_in	DOID:0080600 DOID:2945	COVID-19 severe acute respiratory syndrome	PMID:32379894 PMID:15784866	RGD	MGI:2135738	Abo	ABO	COVID-19 severe acute respiratory syndrome	PMID:32379894 PMID:15784866	Abo
HGNC:1328	C4BPB	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD			C4BPB	COVID-19	PMID:32747830
HGNC:4883	CFH	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD	MGI:3646434 MGI:88385	Cfhr4 Cfh	CFH	COVID-19	PMID:32747830	Cfhr4 Cfh
HGNC:1318	C3	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD	MGI:88227	C3	C3	COVID-19	PMID:32747830	C3
HGNC:10632	CCL5	is_implicated_in	DOID:2945	severe acute respiratory syndrome	PMID:19258635	RGD	MGI:98262	Ccl5	CCL5	severe acute respiratory syndrome	PMID:19258635	Ccl5
HGNC:3541	F3	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD	MGI:88381	F3	F3	COVID-19	PMID:32747830	F3
HGNC:7	A2M	is_implicated_in	DOID:0080600	COVID-19	PMID:32747830	RGD	MGI:2449119	A2m	A2M	COVID-19	PMID:32747830	A2m

About SARS-CoV-2

SARS-CoV-2 is positive single strand RNA virus and is a member of the Coronaviridae family of viruses which are known to target the respiratory systems of mammals.

There are four genera within Coronaviridae: alpha, beta, delta, and gamma. Only alpha and beta genera are transmissible to humans.

Although the genome of SARS-CoV-2 is similar to the zoonotic coronaviruses SARs-CoV and MERS-CoV that caused the SARs outbreak of 2003 and the MERS outbreak of 2012, the emerging evidence suggests that SARS-CoV-2 did not descend from SARS-CoV. SARS-CoV-2 causes a different range of diseases in humans and has a different transmission efficiency.

SARS-CoV-2 was likely transmitted to humans from an animal reservoir. The exact nature of this transmission is still under investigation.

Other Research Resources With Special Coronavirus Information

Model Organisms
Ontologies
Clinical Data
Epidemiology
Molecular Data
Treatments & Vaccines
Coronavirus Biology

Model Organisms

Additional Mouse & Other Model Organism Resources

Alliance of Genome Resources Model Organism Databases Relevant to COVID-19 Research
Charles River Laboratories Support for Your COVID-19 Research
Cam-Su Genomic Resource Center COVID-19 Services
Envigo Research Tools to Combat COVID-19
GMMCC Global Mouse Models For COVID-19 Consortium
Infrafrontier: COVID-19 Resources and Measures
International Mouse Phenotyping Consortium (IMPC)
MMRRC Mouse Models for COVID-19 Research
National Center for Advancing Translational Sciences (NCATS) Animal Model Summary Overview, OpenData COVID-19 Portal
Rat Genome Database (RGD) COVID-19 Resources
RIKEN BioResource Research Center (RIKEN BRC) COVID-19 Related Mouse Resources
Taconic Biosciences Coronavirus (COVID-19) Toolkit
The Jackson Laboratory: Coronavirus Information

Ontologies

Biomedical Ontologies & Vocabularies

CIDO: Ontology of Coronavirus Infectious Disease
CODO COVID-19 Ontology for Cases and Patient information
COVID-19 Surveillance Ontology COVID19
Human Disease Ontology (DO) terms for Coronavirus infectious disease
Gene Ontology (GO) terms for SARS-CoV-2/COVID-19
Homeostasis Imbalance Process Ontology (HOIP)
COVID-19 Infectious Disease Ontology (IDO-COVID- 19)
Logical Observation Identifiers Names and Codes for SARS-CoV-2/COVID-19 (LOINC)
COVID-19 and SARS-CoV-2 MeSH Terms
Protein Ontology (PRO) terms for SARS-CoV-2 proteins
SNOMED CT COVID-19 Related Content

Clinical Data

Clinical Presentation & Course

US Centers for Disease Control and Prevention (CDC) Symptoms of Coronavirus
Clinical Data Related to COVID-19 Symptoms and Patient Outcomes from the National COVID Cohort Collaborative (N3C)

Epidemiology

Epidemiology & COVID-19 Situation Reports

Chinese Center for Disease Control and Prevention (CCDC): Tracking the Epidemic (2021)
European Centre for Disease Prevention and Control (ECDC) COVID-19 Situation Dashboard: Cases in Europe and Worldwide
Global cases of COVID-19 from The Johns Hopkins University
NextStrain visualization of the genomic epidemiology of novel coronavirus
Pan American Health Organization (PAHO) COVID-19 Situation Reports
US Centers for Disease Control and Prevention (CDC COVID-19 Data Tracker) COVID Maps, Charts, and Data
World Health Organization (WHO) Coronavirus Disease (COVID-19) Dashboard

Molecular Data

Genes, Molecular Interactions, Pathways & Networks

COVID-19 Data Portal from Europe
COVID-19 Data Portal from Japan
COVID-19 Disease Map: SARS-CoV-2 Virus-Host Interactions
The COVID-19 Host Genetics Initiative (COVID-19 hg)
GENCODE: Human Protein-coding Genes Linked to SARS-CoV-2/COVID-19
OncoMX: COVID-19 Biomarkers Database
PAGER-CoV: Pathways, Annotated Gene-Lists, and Gene Signatures Related to Coronavirus Diseases
Protein Data Bank in Europe Knowledge Base (PDBe-KB): COVID-19 Data Portal
Reactome SARS-CoV Infection Pathways
UniProt Portal for SARS-CoV-2 Proteins & Receptors
WikiPathways: COVID-19 Pathways Portal

Treatments & Vaccines

Treatments, Therapeutic Interventions & Vaccines

Cov19VaxKB: COVID-19 Vaccine Knowledge Base
DRUGS4COVID
Global Health Drug Discovery Institute (GHDDI): Targeting COVID-19 Portal
National Institutes of Health (NIH) Treatments & Vaccines for COVID-19
Regulatory Affairs Professionals Society (RAPS): COVID-19 Vaccine Tracker
The New York Times Coronavirus Vaccine Tracker
US (CDC COVID Data Tracker) Vaccination Data
WHO Draft Landscape of COVID-19 Candidate Vaccines

Coronavirus Biology

Genome Organization, Sequence Resources, Phylogeny & Taxonomy

EBI's NCBI Organismal Classification (NCBITaxon) for Coronaviridae from Ontology Lookup Service (OLS)
Elsevier Novel Coronavirus Resource Directory
ICTV: International Committee on Taxonomy of Viruses
National Center for Biotechnology Information (NCBI) SARS-CoV-2 Resources
NCBI Taxonomy Browser
NextStrain Phylogeny of SARS-like betacoronaviruses
PDB-101 Molecular Landscapes by David S. Goodsell
Viralzone SARS-CoV-2 Circulating Variants

Mice In The News

Delayed antibody treatment may improve efficacy of mRNA vaccines

Investigators led by Pablo Penaloza-MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA…

Read at medicalxpress.com

Repeated COVID vaccines enhance mucosal immunity against the virus

Part of the global response strategy against the COVID pandemic involves the administration of booster shots, or ‘vaccine updates’ to ensure protection against new variants…

Read at vib.be

Inflammation in severe COVID linked to bad fungal microbiome

An imbalance of fungi in the gut could contribute to excessive inflammation in people with severe COVID-19 or long COVID. A study found that individuals with severe disease had elevated …

Read at nature.com

Novel Antibody Platform Tackles Viral Mutations

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving…

Read at mountsinai.org

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against infection …

Read at medicalxpress.com

New humanized mouse models created to study COVID-19

Scientists at La Jolla Institute for Immunology (LJI) have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19.

Read at news-medical.net

2024 News

MedicalXpress “Delayed antibody treatment may improve efficacy of mRNA vaccines” (October 28, 2024)
Vlaams Instituut voor Biotechnologie “Repeated COVID vaccines enhance mucosal immunity against the virus” (October 24, 2024)
Nature News “Inflammation in severe COVID linked to bad fungal microbiome” (October 23, 2024)
Mount Sinai Health System “Novel Antibody Platform Tackles Viral Mutations” (October 23, 2024)
MedicalXpress “Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells” (October 2, 2024)
La Jolla Institute for Immunology “New mouse models offer valuable window into COVID-19 infection” (October 1, 2024)
News Medical Life Sciences “New humanized mouse models created to study COVID-19” (October 1, 2024)
MedicalXpress “COVID-induced immune memory could protect against severe cases of flu, mouse study suggests” (September 30, 2024)
The Rockefeller University “Could a bout of COVID protect you from a severe case of flu?” (September 30, 2024)
News Medical Life Sciences “Chemical genetics uncovers promising anti-COVID compounds” (September 25, 2024)
The Hindu “Mice study claims to have found long COVID’s ‘real’ perpetrator” (September 9, 2024)
Northwestern University Feinberg News Center “Spike Mutations Help SARS-CoV-2 Infect the Brain” (September 9, 2024)
Texas Biomedical Research Institute “Monoclonal antibody shows protection against all COVID variants” (September 5, 2024)
University of Virginia Health “Cause, Potential Treatment ID’d for Persistent COVID-19 Lung Problems” (September 5, 2024)
Georgia State University “Study: Late Start of COVID Treatment May Still Benefit Immunocompromised Patients” (September 3, 2024)
News Medical Life Sciences “Intranasal vaccine shows broad SARS-CoV-2 variant protection” (September 1, 2024)
News Medical Life Sciences “Fibrin fuels thromboinflammation and brain damage in COVID-19” (August 29, 2024)
Gladstone Institutes “Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy” (August 28, 2024)
News Medical Life Sciences “SARS-CoV-2 evolves differently in the brain, revealing critical insights into viral tropism” (August 27, 2024)
Griffith University News “Game-changing needle-free COVID-19 intranasal vaccine” (August 27, 2024)Live Science “Virus that causes COVID-19 uses a secret back door to infect the brain” (August 23, 2024)
Technology Networks “SARS-CoV-2 Mutation Enhances Brain Infection, Potentially Explaining Long COVID” (August 23, 2024)
News Medical Life Sciences “Mutation in SARS-CoV-2 spike protein enhances brain infection” (August 23, 2024)
New Scientist “Intestinal parasites may reduce covid-19 vaccine effectiveness” (August 21, 2024)
News Medical Life Sciences “New fluorescent probe offers non-invasive detection of smell loss” (August 20, 2024)
University of Virginia Health “Arthritis Drugs May Relieve Long COVID Lung Symptoms” (July 30, 2024)
News Medical Life Sciences “UVA researchers identify a potential treatment for respiratory symptoms of long COVID” (July 30, 2024)
Yale School of Medicine “New Evidence Supports Autoimmunity as One of Long COVID’s Underlying Drivers” (July 22, 2024)
Nature News “Long COVID lung damage linked to immune system response” (July 18, 2024)
Science News “Rogue antibodies may cause some long COVID symptoms” (July 16, 2024)
Fierce Biotech “Drug prevents COVID symptoms in mice by protecting mitochondria, without resistance risk” (July 16, 2024)
News Medical Life Sciences “Mitochondrially-targeted antioxidants could reduce SARS-CoV-2 effects across multiple organs” (July 15, 2024)
News Medical Life Sciences “Study reveals how inflammation weakens muscles during illness” (July 13, 2024)
Washington University School of Medicine in St. Louis “Brain inflammation triggers muscle weakness after infections” (July 12, 2024)
MedicalXpress.com “Scientists identify possible way to block muscle fatigue in long COVID, other diseases” (July 12, 2024)
Live Science “Scientists breed most human-like mice yet” (July 12, 2024)
Fierce Biotech “Active vaccine adjuvant boosts COVID-19 and flu antibodies in mice” (July 9, 2024)
MedicineNet “Could a Cancer Drug Curb the Organ Damage of Severe COVID?” (July 8, 2024)
News Medical Life Sciences “Breakthrough humanized mouse model offers new insights for immunotherapy development” (July 5, 2024)
UT Health San Antonio “Scientists create first mouse model with complete, functional human immune system” (July 5, 2024)
News Medical Life Sciences “Repurposing cancer drug to prevent organ damage in infectious diseases” (July 3, 2024)
UC San Diego “Fighting COVID-19 With a Cancer Drug” (July 3, 2024)
Western University Ontario “Research team finds vaccination may reduce memory loss from COVID-19 infections” (June 27, 2024)
MedicalXpress.com “Vaccination may reduce memory loss from COVID-19 infections” (June 27, 2024)
Science.org “Antibodies from Long Covid patients prompt symptoms in mice” (June 21, 2024)
Nature.com “What causes long COVID? Case builds for rogue antibodies” (June 13, 2024)
Fortune.com “COVID can seriously damage your vision, even if you didn’t have symptoms, new study says. Experts say to watch for these signs” (June 11, 2024)
MedicalXpress.com “New study helps explain how elderly individuals react differently to COVID-19 than young people” (Jun 10, 2024)
Forbes.com “How A New Covid-19 Antibody Could Contribute To Advanced Vaccine Development” (June 7, 2024)
News Medical Life Sciences “Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics” (June 4, 2024)
News Medical Life Sciences “IgG from long COVID patients induces specific symptoms in mice, confirming autoimmunity's role” (June 3, 2024)
News Medical Life Sciences “Biological similarities found between chemo brain and brain fog after COVID-19” (May 22, 2024)
News Medical Life Sciences “LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants” (May 20, 2024)
Washington University School of Medicine in St. Louis “Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses” (May 17, 2024)
University of Missouri School of Medicine “COVID-19 Virus Could Damage Vision” (May 14, 2024)
News Medical Life Sciences “Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants” (May 9, 2024)
University of Cambridge “New vaccine effective against coronaviruses that haven’t even emerged yet” (May 6, 2024)
MedicalNewsToday “Common antibiotic Neosporin may shield against viral respiratory infections” (April 26, 2024)
News Medical Life Sciences “Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections” (April 24, 2024)
U.S. News & World Report “Neosporin Ointment in the Nose Might Be Potent Antibiotic” (April 23, 2024)
News Medical Life Sciences “Innovative peptide-based hydrogel therapy for virus prevention” (April 23, 2024)
Yale School of Medicine News “A Better COVID Treatment for the Immunocompromised?” (April 23, 2024)
YaleNews “Common antibiotic may be helpful in fighting respiratory viral infections” (April 22, 2024)
Technology Networks “Building Better Antibodies and Curbing Autoimmune Diseases” (April 19, 2024)
SciTechDaily “Groundbreaking Study Reveals Potential Treatment for COVID-19 Brain Fog” (April 3, 2024)
National Institutes of Health (NIH) “How lung distress from SARS-CoV-2 can cause heart damage” (April 2, 2024)
MedicalXpress “Researchers race to develop Paxlovid replacement” (March 28, 2024)
Usc.edu “COVID-19 research: New details about potentially deadly inflammation revealed in USC study” (March 28, 2024)
News Medical Life Sciences “Heart at risk from ARDS: Inflammatory responses fuel cardiovascular complications” (March 24, 2024)
News Medical Life Sciences “Researchers identify mechanism behind COVID-19 related brain fog” (March 21, 2024)
University of Illinois Today “Research offers hope for preventing post-COVID 'brain fog' by targeting brain's blood vessels” (March 21, 2024)
UPI.com Health News “Study shows heart damage from COVID-19” (March 21, 2024)
Healio.com “Virus that causes COVID-19 can damage heart even if heart tissue not directly affected” (March 20, 2024)
National Institutes of Health (NIH) “Severe lung infection during COVID-19 can cause damage to the heart” (March 20, 2024)
News Medical Life Sciences “SARS-CoV-2-associated ARDS can damage the heart without direct infection” (March 20, 2024)
Fierce Biotech “New protease inhibitor outperforms Paxlovid in protecting lungs of mice with COVID” (March 14, 2024)
News Medical Life Sciences “New drug candidate designed at the atomic level could help halt emerging SARS-CoV-2 variants” (March 14, 2024)
Stanford News “Going atom-by-atom, Stanford researchers craft a new precision drug for fighting COVID-19” (March 13, 2024)
News Medical Life Sciences “Metal organic frameworks enhance immune response in experimental vaccine” (March 6, 2024)
News Medical Life Sciences “New class of antiviral drugs could shield against future viral outbreaks” (March 4, 2024)
News Medical Life Sciences “Scientists uncover a new doorway for SARS-CoV-2 into human cells” February 27, 2024)
News Medical Life Sciences “Gut microbial metabolite plays a role in exacerbating thrombosis” February 23, 2024)
MedicalXpress “Mouse study shows long COVID-19 infection linked with tangled protein that causes Alzheimer's disease” (February 23, 2024)
University of Alberta Folio “New class of antivirals works against broad range of RNA viruses including SARS-CoV-2: study” (February 22, 2024)
SciTechDaily “The Invisible Defense: Gut Bacteria’s Surprising Role in Combating Flu and COVID-19” (February 12, 2024)
News Medical Life Sciences “SARS-CoV-2 fragments found to mimic immune system peptides, fueling inflammation” (February 5, 2024)
News Medical Life Sciences “New DNA-based vaccine can induce strong antibody response against SARS-CoV-2” (January 30, 2024)
MIT News “DNA particles that mimic viruses hold promise as vaccines” (January 30, 2024)
News Medical Life Sciences “Gut microbiome may hold key to fighting common respiratory viruses” (January 30, 2024)
News Medical Life Sciences “Zombie viral fragments trigger inflammation to cause serious COVID-19 outcomes” (January 30, 2024)
News Medical Life Sciences “How does the nasal cavity's immune system combat SARS-CoV-2?” (January 28, 2024)
News Medical Life Sciences “Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2” (January 27, 2024)
MedicalXpress “Common cold or COVID-19? Some T cells are ready to combat both” (January 26, 2024)
Science.org “Why does COVID-19 make you sneeze?” (January 23, 2024)
Phys.org “Scientists make COVID receptor protein in mouse cells” (January 22, 2024)
News Medical Life Sciences “Scientists demonstrate way to produce SARS-CoV-2 receptor protein in mouse cells” (January 22, 2024)
Dagens.com (AU) “Groundbreaking development in COVID19-research: Scientists make receptor protein in mouse cells” (January 22, 2024)
Healthnews.com “Don't Panic Over Chinese Experiment Modifying Coronavirus, Scientists Say” (January 19, 2024)
abc3340.com “China 'cloned' COVID-like virus to test on mice, acknowledges 'spillover' risk to humans” (January 17, 2024)
Toronto Sun “Chinese scientists create mutant COVID strain that kills mice” (January 17, 2024)
The Sun “Chinese scientists test chilling new Covid Franken-virus ‘with 100% kill rate’ in humanised mice” (January 17, 2024)
News Medical Life Sciences “Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine” (January 17, 2024)
News Medical Life Sciences “New vaccine turns preexisting flu immunity into COVID-19 weapon” (January 17, 2024)
New York Post “Chinese lab crafts mutant COVID-19 strain with 100% kill rate in ‘humanized’ mice: ‘Surprisingly’ rapid death” (January 16, 2024)
Cornell Chronicle “Mice without immune cells show no SARS-CoV-2 symptoms” (January 11, 2024)
Karolinska Institutet News “Nasal spray with antibodies could prevent COVID-19” (January 10, 2024)

2023 News

News Medical Life Sciences “New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity” (December 28, 2023)
News Medical Life Sciences “New dry powder aerosol COVID-19 vaccine shows promise against multiple virus strains” (December 15, 2023)
News Medical Life Sciences “IFN-gamma identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows” (December 14, 2023)
News Medical Life Sciences “Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants” (December 12, 2023)
EurekAlert! “HKUMed reveals new strategy for updating vaccines against evolving COVID-19 variants” (December 10, 2023)
News Medical Life Sciences “A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation” (December 7, 2023)
MedicalXpress “New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought” (December 7, 2023)
News Medical Life Sciences “Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials” (December 5, 2023)
BioWorld “GHRH-R antagonist attenuates pulmonary dysfunction, heart injury in COVID-19 mice” (November 27, 2023)
University of Florida Health “Combination of two common compounds improves COVID survival in mice, UF researchers find” (November 22, 2023)
University of Queensland News “Turning back the clock on brains aged by COVID-19” (November 22, 2023)
News Medical Life Sciences “Researchers discover way to reverse brain aging caused by COVID-19” (November 22, 2023)
ABC News Australia “University of Queensland trial on mice, tissue cells, a potential first step in treating COVID-19 brain fog” (November 21, 2023)
News Medical Life Sciences “Senolytics show promise in combating brain aging and COVID-19 neuropathology” (November 15, 2023)
National Public Radio (NPR) “Pain, fatigue, fuzzy thinking: How long COVID disrupts the brain” (November 13, 2023)
Infectious Disease Special Edition (IDSE) “The Gut’s Lasting Impact on Severe COVID-19 Immune Response” (November 8, 2023)
University of Wisconsin-Madison News “New study shows mRNA vaccine harnesses T-cell power to combat COVID-19 in lungs” (November 6, 2023)
MedicalXpress “Researchers develop a nasal vaccine that prevents COVID-19 in preclinical studies” (November 6, 2023)
European Animal Research Association “Modified mice have ‘human-like’ COVID-19 symptoms” (November 6, 2023)
University of Maryland AGNR News “UMD Researchers Developed a Nasal Vaccine that Prevents COVID in Preclinical Studies” (November 6, 2023)
News Medical Life Sciences “New nasal vaccine for COVID-19 shows promise in animal studies” (November 6, 2023)
Inside Precision Medicine “First Human-Like COVID-19 Mouse Model Created” (November 6, 2023)
LaboratoryEquipment.com “Humanized Mouse Model Survives COVID-19 like the Young” (November 3, 2023)
News Medical Life Sciences “New gene editing method creates first mice with human-like COVID-19” (November 1, 2023)
NYU Langone Health “First Mice Engineered to Survive COVID-19 Are Like Young, Healthy Humans” (November 1, 2023)
InterestingEngineering.com “Scientists engineer first mice to tolerate COVID-19 like young humans” (November 1, 2023)
SienceDaily “First mice engineered to survive COVID-19 like young, healthy humans” (November 1, 2023)
Yale School of Medicine “Could a New Vaccine Head Off the Next Pandemic?” (October 25, 2023)
News Medical Life Sciences “Study sheds light on role of gut fungi in severe COVID-19 and long COVID” (October 24, 2023)
News Medical Life Sciences “Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity” (October 24, 2023)
National Public Radio “Long COVID brain fog may originate in a surprising place, say scientists” (October 24, 2023)
Nature News “Inflammation in severe COVID linked to bad fungal microbiome” (October 23, 2023)
The Conversation “Could gut fungi be linked to severe COVID? What to make of new research findings” (October 23, 2023)
National Public Radio “Does long COVID brain fog start in the gut?” (October 22, 2023)
TheNewsMill.com “Vaccine that offers protection against three deadly coronavirus types has shown promise in mouse trials” (October 21, 2023)
SciTechDaily “Triple Threat – Single Vaccine Protects Against Three Deadly Strains of Coronavirus” (October 21, 2023)
The Times of India “Vaccine that offers protection against three deadly coronavirus types has shown promise in mouse trials” (October 21, 2023)
News Medical Life Sciences “Low serotonin levels observed in long COVID and other viral infections” (October 20, 2023)
News Medical Life Sciences “Pan-coronavirus vaccine shows success in mouse studies” (October 18, 2023)
Smithsonian Magazine “Reduced Serotonin Levels Could Cause Long Covid Symptoms, Study Finds” (October 18, 2023)
News Medical Life Sciences “Paxlovid treatment provides protection against COVID-19 for both mother and child” (October 16, 2023)
News Medical Life Sciences “Next-gen intranasal vaccine takes on measles, mumps, and multiple COVID-19 variants in one shot” (October 8, 2023)
Emerging and Pandemic Infections Consortium “University of Toronto researchers unveil new preclinical insights into why males are more likely to have severe COVID-19” (September 29, 2023)
News Medical Life Sciences “Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests” (September 28, 2023)
News Medical Life Sciences “Zoonotic spillover safeguarding: computationally designed antigen targets range of coronaviruses” (September 27, 2023)
The Times of India “Omicron subvariant BA.5 more virulent, study in mice finds” (September 27, 2023)
Cornell Chronicle “Contagious omicron strain replicates early in infection” (September 25, 2023)
News Medical Life Sciences “Study identifies a molecule that may be behind COVID-19 brain fog” (September 20, 2023)
Mirage News “Tau Proteins Linked to COVID-19 Brain Fog” (September 19, 2023)
News Medical Life Sciences “Nanoparticle gene delivery system shows promise for treating ARDS” (September 19, 2023)
Newsweek.com “Was New COVID Vaccine Booster Tested on Only 8 Mice? What We Know” (September 13, 2023)
Yale Daily News “Yale researchers develop nasal spray mRNA vaccine for COVID-19” (September 8, 2023)
News Medical Life Sciences “Self-adjuvanting RNA vaccines boost immune response 10x more than existing vaccines” (September 8, 2023)
MIT News “MIT engineers design more powerful RNA vaccines” (September 7, 2023)
Reuters.com “Pfizer says updated COVID shot generated strong reaction vs new variant in mice” (September 6, 2023)
News Medical Life Sciences “Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants” (September 5, 2023)
Mirage News “Inhaled Molecules Block Covid in Mice” (August 31, 2023)
Phys.org “Inhalable molecules neutralize SARS-CoV-2 in mice” (August 30, 2023)
Mirage News “Texas Biomed, Scancell Collaborate on New COVID Vaccine Test” (August 29, 2023)
MedicalXpress “New grasp of key COVID-19 protein may lead to a live-attenuated vaccine effective against more variants for longer” (August 28, 2023)
Specialty Pharmacy Continuum “Severe COVID-19 May Lead to Long-Term Innate Immune System Changes” (August 23, 2023)
National Institutes of Health (NIH) “Severe COVID-19 may lead to long-term innate immune system changes” (August 18, 2023)
News Medical Life Sciences “Severe COVID-19 may cause long-term changes to innate immune system” (August 18, 2023)
Healio.com “Moderna, Pfizer say updated COVID-19 vaccines protect against EG.5” (August 18, 2023)
Reuters.com “Pfizer's updated COVID shot effective against 'Eris' variant in mice study” (August 17, 2023)
News Medical Life Sciences “Study reveals the roles of a nucleic acid sensor for COVID-19 in pan-cancer” (August 17, 2023)
Genetic Engineering & Biotechnology News “Inhalable Polymer-Based Nanoparticles Deliver COVID-19 Vaccines to Mice” (August 16, 2023)
News Medical Life Sciences “Genetically diverse mice reveal key differences in innate immune responses to SARS-CoV-2” (August 11, 2023)
News Medical Life Sciences “Adjuvanted intranasal vaccine shows promise for long-lasting immunity to COVID-19” (August 7, 2023)
Deccan Herald “Vaccine 'accessory' found to stop Covid infection in the nasal tract” (August 5, 2023)
Mirage News “Intranasal COVID-19 Vaccine Shields Mice of All Ages” (August 5, 2023)
News Medical Life Sciences “Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load” (August 2, 2023)
LabPulse.com “Viral vector-based decoy receptors protect mice against COVID-19 infection” (August 2, 2023)
News Medical Life Sciences “Antiviral protein protects against COVID-19 in live mouse models” (August 1, 2023)
UTSouthwestern.edu “Protein inhibits development of COVID-19 in live animals” (July 31, 2023)
Agencia FAPESP “Compound reduced inflammation in COVID-19-infected mice without compromising immune response to virus” (July 26, 2023)
News Medical Life Sciences “Brazilian researchers identify new way to stop excessive inflammation in COVID-19” (July 25, 2023)
InvestorIntel “Zentek’s Breakthrough Aptamer Platform Shows Promise in Fighting COVID-19” (July 25, 2023)
Pasadena Now “New Breakthrough Vaccine Technology Developed at Caltech” (July 25, 2023)
MedicalXpress “New vaccine technology produces more antibodies against SARS-CoV-2 in mice” (July 25, 2023)
Caltech “New Vaccine Technology Produces More Antibodies Against SARS-CoV-2 in Mice” (July 25, 2023)
MedicalXpress “COVID-19 can cause inflammation that results in bone loss, higher fracture risk” (July 24, 2023)
News Medical Life Sciences “High body temperature may boost gut microbiota to fight viral infections” (July 20, 2023)
Health Feedback “Claim that a mouse study shows COVID-19 vaccine causes “turbo cancer” distorts study findings” (July 20, 2023)
News Medical Life Sciences “SARS-CoV-2 spike protein's role in lung injury unraveled: promising new approach uncovered” (July 19, 2023)
News Medical Life Sciences “Omicron subvariant BA.5 can cause more severe disease” (July 17, 2023)
News Medical Life Sciences “Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity” (July 14, 2023)
News Medical Life Sciences “Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants” (July 14, 2023)
News Medical Life Sciences “IL-9 identified as contributor to viral spread and airway inflammation in COVID-19” (July 13, 2023)
News Medical Life Sciences “mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species” (July 11, 2023)
News Medical Life Sciences “Researchers identify glycolipid that blocks infection with SARS-CoV-2 and RSV” (July 11, 2023)
MedicalXpress “New anticoagulants may help treat sepsis and COVID-19” (June 21, 2023)
News Medical Life Sciences “Apple-shaped obesity associated with greater inflammation and mortality in COVID-19 patients” (June 20, 2023)
News Medical Life Sciences “Trained immunity: its role in COVID-19 and potential in preparing for future infectious outbreaks” (June 16, 2023)
National Institutes of Health (NIH) “Designing a SARS-CoV-2 decoy” (June 13, 2023)
News Medical Life Sciences “Mechanistic insights into how the SARS-CoV-2 virus affects the nervous system, alters its function, and causes neuropathology” (June 9, 2023)
Yahoo!News “Fused brain cells, neuron damage may explain long COVID” (June 8, 2023)
MedicalXpress “In mice, naturally derived nanocarriers reduce lung inflammation, tissue damage” (June 6, 2023)
MedicalXpress “New monoclonal antibodies targeting ACE2 receptor could treat the next waves of SARS-CoV-2” (June 5, 2023)
News Medical Life Sciences “A SARS-CoV-2 spike-targeting bispecific T-cell engager strategy for controlling SARS-CoV-2 infection” (June 5, 2023)
News Medical Life Sciences “Lymphoid depletion associated with suppressed APC function characterizes the lethality of COVID-19 in mice” (June 2, 2023)
Pharmacy Times “COVID-19 Infection Could Be Detected in Lungs, Heart, Causing Inflammatory Damage” (June 2, 2023)
Inside Precision Medicine “A Molecular Decoy Provides 100% Protection against COVID-19 in Lab Studies” (June 1, 2023)
MedicalXpress “Study in SARS-CoV2 infected mice may lay the groundwork for novel therapies to reduce the severity of COVID-19” (June 1, 2023)
News Medical Life Sciences “Experimental decoy provides long-term protection from SARS-Cov-2 infection” (May 30, 2023)
News Medical Life Sciences “Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation” (May 30, 2023)
NYU Langone Health NewsHub “Experimental Decoy Protects Against SARS-CoV-2 Infection” (May 30, 2023)
MedicalXpress “T helper cells determine the course of disease in viral infections such as COVID-19: Study” (May 29, 2023)
News Medical Life Sciences “T-cell-inducing mRNA COVID-19 vaccine improves effectiveness” (May 25, 2023)
The Weather Channel “Indian Researchers Create Antiviral Drugs that Could Stop COVID-19 and Influenza – Including New Strains!” (May 25, 2023)
News Medical Life Sciences “COVID-19 'bites the apple': Abdominal obesity ignites cytokine storm” (May 24, 2023)
News Medical Life Sciences “Synthetic delivery vector STxB induces mucosal immunity against viral antigens” (May 21, 2023)
News Medical Life Sciences “Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses” (May 17, 2023)
News Medical Life Sciences “Study identifies extremely potent monoclonal antibodies that neutralized multiple sarbecoviruses” (May 12, 2023)
MedicalXpress “Abdominal aortic aneurysm: New treatment may reduce size; COVID infection may speed growth” (May 11, 2023)
News Medical Life Sciences “COVID-19 infection may promote aortic aneurysms and new treatment may slow its growth” (May 10, 2023)
Northwestern University Feinberg News Center “Bioengineered Protein May Prevent COVID Infections and Improve Survival” (May 9, 2023)
Nature News “Remarkable AI tool designs mRNA vaccines that are more potent and stable” (May 2, 2023)
SciTechDaily “MIT’s Vaccine Printer: The Game-Changer in Vaccine Distribution” (May 2, 2023)
FierceBiotech “New type of RNA degrader lowers COVID-19 viral load in mice, opening path to new drug class” (April 28, 2023)
News Medical Life Sciences “Neurological phenotypes induced by SARS-CoV-2 spike protein in neurons” (April 27, 2023)
News Medical Life Sciences “Research uncovers antibodies that are still effective against new variants of SARS-CoV-2” (April 26, 2023)
News Medical Life Sciences “Print your own vaccine: automatic printing of microneedle patch COVID-19 mRNA vaccines” (April 26, 2023)
MedicalXpress “Even as SARS-CoV-2 mutates, some human antibodies fight back” (April 25, 2023)
News Medical Life Sciences “A mobile vaccine printer could enable rapid vaccination of large numbers of people” (April 24, 2023)
MedicalXpress “Vaccine printer could help vaccines reach more people” (April 24, 2023)
MedicalXpress “Research unveils paths to stopping cytokine storms in COVID-19” (April 21, 2023)
The Weather Channel “Scientists Develop New T-Cell COVID Vaccine That Could Provide Sustained Immunity Against Future Variants!” (April 21, 2023)
News Medical Life Sciences “Protective mucosal and systemic immunity provided by a single-dose novel live-attenuated intranasal SARS-CoV-2 vaccine candidate” (April 20, 2023)
News Medical Life Sciences “New DCFHP-alum COVID-19 vaccine candidate shows durable, broad-spectrum protection in non-human primates” (April 18, 2023)
News Medical Life Sciences “Cocktail of IgG3 antibodies could have a potent clinical effect against SARS-CoV-2” (April 18, 2023)
SciTechDaily “New AI-Generated T-Cell Vaccine Showcases Long-Lasting Immunity Against COVID-19” (April 18, 2023)
The American Bazaar “AI generated Covid-19 vaccine may provide long-lasting immunity” (April 17, 2023)
The New Indian Express “Researchers claim AI-designed T-cell vaccine could offer protection against severe Covid-19” (April 15, 2023)
News Medical Life Sciences “How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity” (April 15, 2023)
News Medical Life Sciences “Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2” (April 14, 2023)
News Medical Life Sciences “AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice” (April 13, 2023)
News Medical Life Sciences “The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity” (April 12, 2023)
News Medical Life Sciences “Study highlights the potential long-term neurological effects post-COVID-19” (April 10, 2023)
News Medical Life Sciences “Omicron BA.5 variant demonstrates increased neuroinvasiveness and pathogenicity in mice” (April 5, 2023)
RepublicWorld.com “Spike Protein Of SARS-CoV-2 Implicated In Memory Impairment Post-Covid” (April 4, 2023)
MedicalXpress “Spike protein implicated in post-COVID-19 memory loss” (April 3, 2023)
News Medical Life Sciences “Spike protein could be responsible for memory loss in post-COVID-19 syndrome” (April 3, 2023)
Contagion Live “Nasal Spray Blocks SARS-CoV-2 Variants” (April 3, 2023)
News Medical Life Sciences “Red blood cell hitch-hiking facilitates SARS-CoV-2 multi-organ spread” (April 3, 2023)
News Medical Life Sciences “Study identifies ultra-broad SARS-CoV-2 neutralizing antibodies that target various spike epitopes” (April 3, 2023)
News Medical Life Sciences “What is the effect of prior BCG vaccination on the immunogenicity and efficacy of subsequent COVID-19 vaccination?” (March 28, 2023)
Mirage News “Drug Targets Found for Key Pathophysiologies in J. Pharm. Analysis” (March 23, 2023)
The Standard “Scientists find therapeutic target for Covid” (March 21, 2023)
News Medical Life Sciences “Next-gen Mpro inhibitor: Promising new drug candidate against Omicron and other SARS-CoV-2 variants” (March 21, 2023)
MedicalXpress “Runaway immune reactions can cause long COVID breathing problems” (March 20, 2023)
News Medical Life Sciences “Does vitamin D play an antiviral role against SARS-CoV-2?” (March 17, 2023)
News Medical Life Sciences “Researchers identify a potential treatment to prevent severe COVID-19 in high-risk patients” (March 15, 2023)
MIT News “Creating a versatile vaccine to take on Covid-19 in its many guises” (March 9, 2023)
National Institutes of Health “Inhalable hydrogel protects lungs from SARS-CoV-2” (March 7, 2023)
News Medical Life Sciences “Antibody levels from prime COVID-19 mRNA vaccine influences the efficacy of booster doses” (March 6, 2023)
MedicalXpress “New COVID-19 booster vaccine offers high level of protection in mice” (March 3, 2023)
News Medical Life Sciences “Study identifies the essential genetic and immunologic perturbations occurring in patients with long COVID lung fibrosis” (March 3, 2023)
Shanghai Daily “NZ-made COVID-19 booster vaccine offers full protection in preclinical study” (March 3, 2023)
ET Health World “Human antibodies found that can block multiple coronaviruses: Study” (March 1, 2023)
NewsDrum “New, naturally-derived, nanovaccine against COVID-19 shows success in mice trials: Study” (February 28, 2023)
MedicalXpress “A possible way to prevent or treat lung damage associated with long COVID” (February 28, 2023)
Business Wire “Xlear Provides New Data to the Dept. Of Justice; Study Showing Nasal Spray Reduces COVID-19 Infections by 62% Included” (February 27, 2023)
University of Washington Newsroom “Inflammation is culprit behind long COVID, study suggests” (February 24, 2023)
SciTechDaily “New artificial model validates antibodies ability to reach the brain” (February 24, 2023)
News Medical Life Sciences “RBD-NTD-subunit protein vaccine provides a promising booster vaccination strategy capable of protecting against known SARS-CoV-2 variants” (February 22, 2023)
News Medical Life Sciences “Researchers report the circulation of a novel MERS-like coronavirus in Malayan pangolins” (February 21, 2023)
SciTechDaily “Outsmarting COVID-19: Weaponizing the Spike Protein Against Itself To Prevent Infection” (February 21, 2023)
Earth.com “COVID-19 patients experience changes in heart tissue” (February 20, 2023)
NBC News “Covid can cause heart problems. Here's how the virus may do its damage” (February 20, 2023)
Northwestern Now “Your first COVID-19 vaccination ‘hurts’ subsequent boosters” (February 20, 2023)
Fortune.com “COVID increases your risk for heart failure and stroke for at least a year, experts say. Here are 8 ways to protect your health” (February 18, 2023)
Mirage News “Weaponizing Spike Protein to Block Covid Infection” (February 18, 2023)
ABP Live “Next-Gen Covid-19 Vaccine Developed by IIT Delhi Using Immune Cells Can Reduce Blood Clotting: Study” (February 16, 2023)
The Weather Channel “Inhalable Powder Could Protect Against Flu, COVID” (February 15, 2023)
News Medical Life Sciences “Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel” (February 13, 2023)
Yahoo!Finance “Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Fully Human and Murine Anti-SARS-CoV-2 Monoclonal Antibodies” (February 13, 2023)
News Medical Life Sciences “Study suggests SARS-CoV-2 is likely to only infect placental mammals” (February 9, 2023)
News Medical Life Sciences “Novel COVID-19 protein component vaccine elicits durable immune response in rodents” (February 9, 2023)
MedicalXpress “Researcher might have found key to understanding why COVID-19 kills more men than women” (February 2, 2023)
Genetic Library Project “It’s not just humans that get COVID — other animals are susceptible too” (February 1, 2023)
GlobeNewswire “EnGeneIC publishes the COVID-EDV vaccine’s novel mechanism of action in a leading Immunology journal” (January 31, 2023)
Genetic Engineering & Biotechnology News “Broad Range Antibodies Neutralize All SARS-CoV-2 Variants and Other Coronaviruses” (January 30, 2023)
News Medical Life Sciences “Repression of endothelial TLR3 is a potential mechanism of SARS-CoV-2 infection-associated lung vascular remodeling” (January 30, 2023)
MedicalXpress “Evolutionary history of SARS-CoV-2 leads to a universal vaccine already being tested in animal models” (January 30, 2023)
Contagion Live “Study Identifies Links Between Gut Dysbiosis and COVID-19” (January 26, 2023)
NIH COVID-19 Research “How COVID-19 Changes the Gut Microbiome” (January 25, 2023)
Yahoo!Finance “Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations” (January 24, 2023)
News Medical Life Sciences “Senolytics could be a beneficial therapeutic for COVID neuropathology” (January 22, 2023)
News Medical Life Sciences “Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine” (January 22, 2023)
Miami Herald “No-needle COVID vaccine may protect you better, researchers say. How does it work?” (January 20, 2023)
MedicalXpress “Antiviral compound could be broadly efficient in the treatment of SARS-CoV-2” (January 20, 2023)
Mirage News “Antiviral Compound Shown Effective Against Covid” (January 20, 2023)
Futurity “B cell ‘boot camp’ insights could inform future vaccines” (January 19, 2023)
News Medical Life Sciences “Upregulation of Robo4 expression reduces mortality from severe infection” (January 18, 2023)
The Washington Post “Lab-leak fears are putting virologists under scrutiny” (January 18, 2023)
News Medical Life Sciences “What is the effectiveness of a multivalent exosome-based COVID-19 vaccine?” (January 16, 2023)
News Medical Life Sciences “Researchers report that vectored expression of a high-affinity ACE2 microbody protein establishes a high degree of protection from SARS-CoV-2” (January 16, 2023)
ScienceDaily “How sex differences influence lung injury in mice” (January 12, 2023)
News Medical Life Sciences “CNB-CSIC vaccine fully protects against SARS-CoV-2 infection of the brain” (January 12, 2023)
News Medical Life Sciences “Study on the ecology of viruses in urban rodents with special emphasis on SARS-CoV-2” (January 12, 2023)
Boston University “NEIDL Researchers Discover New SARS-CoV-2 Weak Spot—Which Could Inspire Improved Vaccines” (January 11, 2023)
MirageNews.com “CSIC Vaccine Prevents COVID-19 Infection, Brain Damage” (January 10, 2023)
News Medical Life Sciences “Researchers demonstrate how CNB-CSIC vaccine fully protects against SARS-CoV-2 infection of the brain” (January 9, 2023)
News Medical Life Sciences “COVID-19 vaccine potency and breadth improved by nanoparticle-conjugated adjuvants” (January 8, 2023)
Global News “A mucosal vaccine could be a COVID-19 game-changer. So why doesn’t Canada have one?” (January 7, 2023)
News Medical Life Sciences “Pan-vaccine antigen strategy confers protection against cross-clade SARS-CoV-2 variants, including vaccine-resistant Omicron variants” (January 6, 2023)
Drug Target Review “The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes” (January 4, 2023)
The Conversation “COVID and your gut: how a healthy microbiome can reduce the severity of infection – and vice versa” (December 29, 2022)
Yahoo!Finance “Oragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate (December 22, 2022)
News Medical Life Sciences “Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein” (December 20, 2022)

2022 News

News Medical Life Sciences “Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2” (December 19, 2022)
SciTechDaily “A New Drug Could Fight Both COVID and Cancer” (December 18, 2022)
ABP Live “Mucosal DNA Vaccine Found Effective In Stopping COVID-19 In Its Tracks: Study” (December 17, 2022)
EurekAlert! “COVID-19: a respiratory vaccine effective in mice” (December 16, 2022)
News Medical Life Sciences “Research reveals that a viral toxin may contribute to the severity of COVID-19” (December 14, 2022)
The Bakersfield Californian “Dyadic's DYAI-100 COVID-19 Vaccine Study Publishedin a Leading Peer-Reviewed Scientific Article” (December 14, 2022)
News Medical Life Sciences “Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model” (December 13, 2022)
News Medical Life Sciences “Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice” (December 11, 2022)
ASBMB Today “What next-gen Covid-19 vaccines might look like” (December 10, 2022)
UC Berkeley News “How a viral toxin may exacerbate severe COVID-19” (December 9, 2022)
ScienceDaily “New findings on how to avert excessive weight loss from COVID-19” (December 8, 2022)
News Medical Life Sciences “The requirement for Fc effector functions to protect against SARS-CoV-2 infection” (December 1, 2022)
Genetic Engineering & Biotechnology News “SARS-CoV-2 May Be Thwarted by Nasally Administered DARPins” (November 29, 2022)
News Medical Life Sciences “Researchers uncover a link between D-amino acids and severe viral infection” (November 28, 20222)
National Institutes of Health “COVID-19 disrupts gut microbiome” (November 22, 2022)
News Medical Life Sciences “Novel nasal vaccine approach induces potent lung immunity and protection against SARS-CoV-2” (November 16, 2022)
TheScientist “Scientists ID Heart-Damaging SARS-CoV-2 Protein” (November 16, 2022)
News Medical Life Sciences “The impact of lung remodeling from prior helminth infection on SARS-CoV-2 disease pathogenesis” (November 15, 2022)
News Medical Life Sciences “Novel drug could help to fight both COVID-19 and cancer” (November 14, 2022)
Genetic Engineering & Biotechnology News “COVID-19 and Cancer May Have Common Drug Target in GRP78” (November 14, 2022)
News Medical Life Sciences “How mRNA vaccines work without an added adjuvant” (November 13, 2022)
Yale Daily News “New Yale study finds promising results with nasal COVID-19 vaccine” (November 10, 2022)
News Medical Life Sciences “SARS-CoV-2 activates NLRP3 inflammasome” (November 7, 2022)
News Medical Life Sciences “An innovative nasal vaccine strategy to combat COVID” (October 31, 2022)
News Medical Life Sciences “The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination” (October 28, 2022)
EurekAlert! “Cancer therapy shows potential to treat severe COVID-19 in pre-clinical trials” (October 27, 2022)
Wired.com “Where Did Omicron Come From? Maybe Its First Host Was Mice” (October 27, 2022)
The New York Times “Lab Manipulations of Covid Virus Fall Under Murky Government Rules” (October 22, 2022)
FactCheck.org “Social Media Claims Misrepresent Boston U. Study of What Causes Severity of COVID-19 Strains” (October 21, 2022)
PolitiFact “Claim that Boston University created COVID-19 strain with an 80% kill rate omits important details” (October 20, 2022)
News Medical Life Sciences “Immune-suppressing drug reverses symptoms of delirium in mice” (October 19, 2022)
Vox.com “Why do labs keep making dangerous viruses?” (October 19, 2022)
WVUToday “Obesity and biological sex may make individuals more vulnerable to COVID-19, WVU study suggests” (October 18, 2022)
1News “Scientists make new Covid variant with 80% kill rate in mice” (October 18, 2022)
Oregon State University Newsroom “Nanotechnology, messenger RNA combined in possible new ‘universal’ COVID-19 treatment” (October 18, 2022)
STAT News “Boston University researchers’ testing of lab-made version of Covid virus draws government scrutiny” (October 17, 2022)
Boston University “NEIDL Researchers Refute UK Article about COVID Strain” (October 17, 2022)
abpLIVE.com “What Makes Covid-19 Severe? Study Uncovers Role of Virus Proteins Other Than Spike” (October 10, 2022)
News Medical Life Sciences “Neonatal mice-based model established that allows for the transmission of clinical SARS-CoV-2 isolates” (October 7, 2022)
University of Maryland School of Medicine News “Other SARS-CoV-2 Proteins are Important for Disease Severity, Aside from the Spike” (October 7, 2022)
EurekAlert! “New type of RNA discovered that inhibits a broad range of viral infection” (October 5, 2022)
News Medical Life Sciences “Omicron reduces host antibody response by lower B-cell antigenicity” (October 4, 2022)
News Medical Life Sciences “Common germline variants of APOE contribute to differential COVID-19 outcomes” (September 26, 2022)
News Medical Life Sciences “Prophylactic administration of SARS-CoV-2 specific immunoglobulin Y generated in chicken eggs displays protective effects in infected mice” (September 21, 2022)
News Medical Life Sciences “Molecular engineered low-cost highly effective RBD-based COVID vaccine” (September 19, 2022)
News Medical Life Sciences “An improved COVID-19 vaccine shows promise against Omicron in experimental models” (September 18, 2022)
News Medical Life Sciences “Customized bivalent mRNA COVID boosters protect against BA.5 Omicron variant” (September 14, 2022)
News Medical Life Sciences “Intranasal administration of liposomes displaying SARS-CoV-2 antigen induces mucosal immunity” (September 14, 2022)
News Medical Life Sciences “What is the impact of COVID-19 treatments targeting intracellular Neu1?” (September 14, 2022)
News Medical Life Sciences “Parenteral-prime mucosal boost an effective strategy to protect against SARS-CoV-2” (September 14, 2022)
The Boston Globe “Boston Children’s Hospital researchers find antibody that neutralizes all major COVID variants in tests on mice” (September 13, 2022)
Freethink.com “Newly discovered antibody neutralizes all variants of the coronavirus” (September 13, 2022)
Forbes “Have The New Bivalent Covid-19 Vaccine Boosters Been Tested On Humans?” (September 12, 2022)
Live Science “Should you get the new COVID-19 booster shot? Here's everything you need to know” (September 12, 2022)
The Atlantic “One of Long COVID’s Worst Symptoms Is Also Its Most Misunderstood” (September 12, 2022)
DW.com “Scientists identify a single antibody that may fight all COVID strains” (September 8, 2022)
Mashable.com “Scientists claim to have found new antibody that destroys all forms of COVID-19” (September 8, 2022)
Prevention.com “Scientists Discovered an Antibody That Can Take Out All COVID-19 Variants” (September 6, 2022)
Healthline.com “Q&A: What You Need to Know About the New COVID-19 Omicron-Specific Vaccine Boosters” (September 6, 2022)
MIT Technology Review “This nanoparticle could be the key to a universal covid vaccine” (September 5, 2022)
University of Colorado Anschutz Newsroom “First Variant-Specific COVID-19 Vaccine Approved Targeting BA.4/BA.5” (September 5, 2022)
Infection Control Today “The Autumn COVID-19 Booster Is Here: Is it Safe and Effective?” (September 2, 2022)
Kera News “FDA expected to authorize new omicron-specific COVID boosters this week” (August 30, 2022)
The Hindu “Artificial protein shell to combat COVID-19” (August 30, 2022)
The Weather Channel “New Generation COVID-19 Vaccine Shows Promising Results Against Severe Infection from the Beta Variant of SARS-Cov2” (August 26, 2022)
News Medical Life Sciences “Susceptibility of deer mice and California mice to COVID-19” (August 25, 2022)
Drug Target Review “New generation of COVID-19 vaccines show promising results” (August 25, 2022)
News@Northeastern “Benefits of new COVID-19 booster targeting variants outweigh any potential risks, experts say” (August 24, 2022)
Deseret News “Why mouse data may determine the next round of COVID-19 booster shots” (August 23, 2022)
National Public Radio (NPR) “What's behind the FDA's controversial strategy for evaluating new COVID boosters” (August 18, 2022)
Weill Cornell Medicine Newsroom “Preclinical Study Suggests Gut Bacteria May Influence Viral Entry, Immune Response and Coagulation in COVID-19” (August 17, 2022)
National Institutes of Health News “Fighting current and future coronaviruses with a single vaccine” (August 16, 2022)
Harvard Medical School News & Research “One for All? New antibody neutralizes all known SARS-CoV-2 variants in lab tests” (August 15, 2022)
News Medical Life Sciences “Gut microbiota-derived metabolites offer protection against SARS-CoV-2” (August 5, 2022)
News Medical Life Sciences “mRNA vaccines induce faster antibody response against infectious diseases” (August 2, 2022)
Medical News Today “Scientists compare skin patch vs. needle vaccine against SARS-CoV-2 variants” (August 1, 2022)
Medical News Today “How does COVID-19 affect the heart? New clues arise” (August 1, 2022)
ScienceDaily “COVID vaccine patch fights variants better than needles, study in mice shows” (July 28, 2022)
CTInsider.com “Yale vaccine against Omicron shows flexibility of mRNA technology” (July 28, 2022)
News Medical Life Sciences “Novel compound inhibits SARS-CoV-2 replication by binding a genome target” (July 27, 2022)
The News & Observer “Duke researchers edit genes to prevent, treat COVID-19 in the lab. Will it work in people? (July 26, 2022)
News Medical Life Sciences “Nasal spray highly effective against HIV and SARS-CoV-2 in animal models” (July 26, 2022)
Forbes “Progress In The Search For Broadly Neutralizing Monoclonal Antibodies III” (July 26, 2022)
Wired.com “These Vaccines Will Take Aim at Covid—and Its Entire SARS Lineage” (July 26, 2022)
News Medical Life Sciences “Scientists identify papain-like protease inhibitor against COVID-19” (July 25, 2022)
News Medical Life Sciences “A VSV-based COVID vaccine effective against SARS-CoV-2 variants” (July 25, 2022)
News Medical Life Sciences “SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process” (July 25, 2022)
ScienceDaily “Coronavirus spike protein activated natural immune response, damaged heart muscle cells, study finds” (July 25, 2022)
The Week “Nasal sprays will be essential to tackle Covid-19 variants, study says” (July 23, 2022)
CTV News “With a sniff or a swallow, new vaccines aim to put the brakes on COVID-19 spread” (July 23, 2022)
Business Standard “Nasal sprays will be essential to tackle emerging Covid-19 variants: Study” (July 22, 2022)
Drug Target Review “Scientists discover an antibody that potentially acts as a therapy against SARS-CoV-2” (July 22, 2022)
EurekAlert! “A novel COVID-19 vaccine using modified bacterial DNA” (July 21, 2022)
ScienceDaily “A novel COVID-19 vaccine using modified bacterial DNA” (July 21, 2022)
UAB News “Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants” (July 21, 2022)
EurekAlert! “Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants” (July 21, 2022)
NBC29.com “UVA researchers: Nasal sprays important in fighting COVID-19 variants” (July 21, 2022)
Firstpost.com “Novel COVID-19 vaccine offers superior protection against Omicron variants” (July 20, 2022)
News Medical Life Sciences “The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans” (July 20, 2022)
Pharmaceutical-Technology.com ”Gladstone and UCSF scientists discover BET protein role in Covid-19” (July 20, 2022)
Yale News “Yale-developed vaccine offers superior protection against Omicron variants” (July 19, 2022)
EurekAlert! “BETting on COVID-19: Study probes role of BET proteins in coronavirus infection” (July 19, 2022)
NBC News “Nasal vaccines may stop Covid infections. Will we get them soon?” (July 19, 2022)
EurekAlert! “Nasal sprays will be essential to thwart variants, UVA collaborative research confirms” (July 19, 2022)
News Medical Life Sciences “Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection” (July 18, 2022)
News Medical Life Sciences “Novel nanoligomer approach to treat severe COVID-19” (July 17, 2022)
News Medical Life Sciences “The potential of circular RNA COVID-19 vaccines” (July 17, 2022)
NeurologyAdvisor.com “Mild Respiratory COVID-19 Can Cause Neural Cell and Myelin Dysregulation” (July 14, 2022)
MedicalNewsToday.com “Nanoparticle-based vaccine protects against COVID-19 variants, similar viruses” (July 12, 2022)
News Medical Life Sciences “Experimental model reveals possible causes and treatments for long-COVID” (July 11, 2022)
News Medical Life Sciences “Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19” (July 8, 2022)
News Medical Life Sciences “Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants” (July 8, 2022)
WebMD.com “Study Finds Possible Causes of, and Treatments for, Long COVID” (July 7, 2022)
News Medical Life Sciences “Vitamin D protects against H1N1 and SARS-CoV-2 infection in mice” (July 5, 2022)
Caltech.com News “Nanoparticle Vaccine Protects Against a Spectrum of COVID-19-causing Variants and Related Viruses” (July 5, 2022)
ScienceDaily “Inhalable COVID-19 vaccine shows promise in rodent model” (July 5, 2022)
Wired.com “The Secrets of Covid ‘Brain Fog’ Are Starting to Lift” (July 1, 2022)
ScienceDaily “COVID-19 Omicron variant leads to less severe disease in mice, study finds” (June 27, 2022)
Economic Times Healthorld.com “Covid infection may increase risk of Parkinson's, mice study suggests” (June 20, 2022)
News Medical Life Sciences “GPR183 gene a novel drug target for severe COVID-19” (June 17, 2022)
News Medical Life Sciences “Effectiveness of a hybrid vaccine against COVID-19 and influenza” (June 16, 2022)
NIH Covid-19 Research “Antiviral Nasal Spray Shows Promise Fighting COVID-19” (June 16, 2022)
News Medical Life Sciences “Fc-effector functions for selecting COVID-19 convalescent plasma” (June 15, 2022)
News Medical Life Sciences “Even mild respiratory COVID can affect the brain” (June 14, 2022)
Infectious Disease Special Edition “The Intersection of SARS-CoV-2 With TB: It's Complicated” (June 13, 2022)
News Medical Life Sciences “Animal study suggests intranasal COVID vaccine delivery more efficient than intramuscular” (June 12, 2022)
Outsourcing-Pharma.com “Envigo is addressing the need for models that mimic the long-term effects of COVID-19” (June 7, 2022)
National Institutes of Health (NIH) News “T cells protect against COVID-19 in absence of antibody response” (June 7, 2022)
News Medical Life Sciences “The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis” (June 2, 2022)
The Week “New strategy may reduce fatigue after Covid vaccination: Study” (June 2, 2022)
News Medical Life Sciences “Inhibiting immune response-related enzyme holds promise in preventing or treating severe COVID-19” (June 1, 2022)
Ohio State News “Blocking enzyme could hold the key to preventing, treating severe COVID-19” (June 1, 2022)
The Economic Times “Acute stress may make it hard to fight against COVID-19” (May 31, 2022)
EurekAlert! “New study points to potential strategy to reduce fatigue after COVID-19 vaccination” (May 31, 2022)
News Medical Life Sciences “Researchers identify molecular characteristics linked to increased likelihood of post-vaccination fatigue” (May 31, 2022)
EurekAlert! “Acute stress may be detrimental to fighting off COVID-19 and influenza” (May 30, 2022)
News Medical Life Sciences “Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses” (May 30, 2022)
Medical News Today “Parkinson’s: SARS-CoV-2 infection raises risk in mice” (May 26, 2022)
Parkinson’s News Today “In Mice, COVID-19 Leaves Nerve Cells Vulnerable to Further Injury” (May 25, 2022)
Medical News Today “COVID-19: Repurposed antibiotic shows promise in mouse model” (May 24, 2022)
Yale News “COVID vaccines do not impact fertility or pregnancy outcomes, study shows” (May 24, 2022)
News Medical Life Sciences “New study counters claims that COVID-19 vaccines reduce fertility and affect fetal growth” (May 24, 2022)
Outlook India “Covid-19 May Increase Risk Of Parkinson’s Disease, Finds Study” (May 23, 2022)
News Medical Life Sciences “Repurposed drug clofoctol blocks SARS-CoV-2 replication in mouse study” (May 23, 2022)
News Medical Life Sciences “Natural immunity weak and short-lived in unvaccinated after Omicron infection” (May 20, 2022)
EurekAlert! “Study in mice suggests that COVID-19 increases risk of developing Parkinson’s disease” (May 18, 2022)
News Medical Life Sciences “Evaluating efficacy of SARS-CoV-2 antivirals in a mouse model” (May 18, 2022)
MIT Technology Review “Anti-aging drugs are being tested as a way to treat covid” (May 17, 2022)
China Global Television Network “China develops mosaic vaccine for protection against COVID-19 variants” (May 17, 2022)
The Scientist “Diabetes Marker Linked to COVID-19 Severity in Mice” (May 16, 2022)
University of Wisconsin-Madison News “Experimental COVID-19 vaccine provides mutation-resistant T cell protection in mice” (May 13, 2022)
Xinhua “Study finds glucose-like metabolite effective against COVID-19” (May 12, 2022)
National Institutes of Health News “Intranasal proteins could protect against COVID-19 variants” (May 10, 2022)
News Medical Life Sciences “Needle- and adjuvant-free vaccination with non-infectious T4-COVID nanoparticles induces strong immunity in mice” (May 3, 2022)
News Medical Life Sciences “Does re-freezing COVID-19 mRNA vaccines affect immunogenicity?” (April 27, 2022)
News Medical Life Sciences “Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19” (April 26, 2022)
News Medical Life Sciences “mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2” (April 26, 2022)
News Medical Life Sciences “A novel mouse model to test SARS-CoV-2 viral infection” (April 26, 2022)
News Medical Life Sciences “Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious” (April 22, 2022)
Yahoo!Finance “CureVac and GSK's Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study” (April 21, 2022)
News Medical Life Sciences “Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants” (April 21, 2022)
News Medical Life Sciences “Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models” (April 20, 2022)
Drug Target Review “Blocking host proteins: an improved COVID-19 treatment approach?” (April 19, 2022)
News Medical Life Sciences “SARS-CoV-2 infection patterns in olfactory epithelium” (April 18, 2022)
Hindustan Times “India's ‘warm’ vaccine candidate effective against Delta, Omicron variants in mice: Study” (April 16, 2022)
Northwestern Now “New COVID-19 nasal spray outperforms current antibody treatments in mice” (April 13, 2022)
National Institutes of Health “Nasal antiviral blocks SARS-CoV-2 infection in mice” (April 12, 2022)
KHQA “New UI study shows treatment prevents COVID-19 deaths on older mice” (April 8, 2022)
ThePrint “Study on mice shows Covid virus leads to brain neuron death, higher anxiety, reduced cognition” (April 8, 2022)
Healthline “In Early Testing, Nasal Spray Shows Signs It Can Fight COVID-19” (April 8, 2022)
News Medical Life Sciences “Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice” (April 7, 2022)
YaleNews “Immune system culprit in severe COVID cases found” (April 6, 2022)
News Medical Life Sciences “Self-assembling SARS-CoV-2 spike protein-directed nanoparticle vaccines” (April 6, 2022)
Shanghai Daily “New candidate vaccines against COVID-19 variants designed: study” (April 6, 2022)
European Pharmaceutical Review “Designed for success – new SNA vaccine proves highly effective in mice” (April 6, 2022)
MedicalNewsToday “Long COVID pain explained: Gene signature may play a role” (April 4, 2022)
News Medical Life Sciences “Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice” (March 31, 2022)
University of Iowa Health Care News “Drug protects older mice from worst effects of COVID-19” (March 31, 2022)
News Medical Life Sciences “ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential” (March 30, 2022)
Wion News “Anti-COVID-19 nasal spray works on mice, effective against Delta variant: Study” (March 30, 2022)
News Medical Life Sciences “Divalent SARS-CoV-2 fusion vaccine found to be effective in mice” (March 30, 2022)
News Medical Life Sciences “Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice” (March 29, 2022)
Genetic Engineering & Biotechnology News “Nasal Spray for Prevention/Early Treatment of COVID-19 Works in Mice” (March 28, 2022)
University of British Columbia Science “New nasal spray treats Delta variant infection in mice, indicating broad spectrum results” (March 28, 2022)
Cornell Chronicle “Promising nose spray could prevent and treat COVID-19” (March 28, 2022)
CTV News “Chemical in broccoli slows COVID-19 virus replication in cells, mice: study” (March 27, 2022)
Genetic Engineering & Biotechnology News “COVID-19 Potentially Thwarted by TB Infection… at Least in Mice” (March 25, 2022)
ScienceDaily “Tuberculosis infection protects mice from developing COVID-19” (March 24, 2022)
News Medical Life Sciences “A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers” (March 24, 2022)
News Medical Life Sciences “New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases” (March 23, 2022)
Northwestern Now “Nanoparticle-based COVID-19 vaccine could target future infectious diseases” (March 22, 2022)
News Medical Life Sciences “Study discovers potent and selective human monoclonal antibodies against Omicron variant of SARS-CoV-2” (March 23, 2022)
Genetic Engineering & Biotechnology News “Oral Formulation of Remdesivir Protective against SARS-CoV-2 in Mice” (March 23, 2022)
ScienceDaily “Study shows effectiveness of pill form of remdesivir to treat COVID-19 in mice” (March 22, 2022)
Laboratory Equipment “Inhalable ‘Aerogel’ Triggers Immunity to COVID-19 in Mice” (March 21, 2022)
SciTechDaily “New BioAge Drug Prevents Death From COVID-19 in Old Mice by Reversing Immune Aging” (March 21, 2022)
MedicalXpress “Oral drug prevents death from COVID-19 in old mice by reversing immune aging” (March 21, 2022)
News Medical Life Sciences “Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model” (March 21, 2022)
BioSpace “Nature Paper: BioAge’s Oral Drug Targeting the Aging Immune System Prevents Death From COVID-19 in Aged Mice” (March 21, 2022)
The Hill “AstraZeneca says COVID-19 drug neutralizes omicron variants” (March 21, 2022)
Genetic Engineering & Biotechnology News “COVID-19 Drug Targets Immune Aging, Enters Phase II” (March 21, 2022)
University of Alabama News “Preclinical demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants” (March 18, 2022)
Penn Today “From a pandemic, scientific insights poised to impact more than just COVID-19” (March 18, 2022)
EurekAlert! “Excess neuropeptides disrupt lung function in infant disease and COVID-19” (March 17, 2022)
News Medical Life Sciences “Researchers receive grant to find answers to taste loss in COVID patients” (March 15, 2022)
EurekAlert! “Scientists look for answers to taste loss with COVID” (March 15, 2022)
News Medical Life Sciences “Study explores neutralization of SARS-CoV-2 Omicron variant by subunit vaccine boosters” (March 14, 2022)
ScienceDaily "New strategy for COVID-19 prophylaxis" (March 8, 2022)
News Medical Life Sciences “Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice” (March 8, 2022)
BioSpace “Angiotensin Therapeutics Inc. announces publication of a study using a soluble ACE2 protein designed for COVID-19” (March 8, 2022)
EurekAlert! “New strategy for COVID-19 prophylaxis: Researchers of the Cluster of Excellence ImmunoSensation2 at the University of Bonn specifically stimulate the RNA receptor RIG-I” (March 8, 2022)
News Medical Life Sciences “Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques” (March 6, 2022)
News Medical Life Sciences “Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice” (March 3, 2022)
China Global Television Network “Chinese mRNA COVID-19 antibody shields mice long-term” (March 3, 2022)
News Medical Life Sciences “Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response” (February 28, 2022)
News Medical Life Sciences “Mouse-adapted virus model to study persistent COVID induced lung disease” (February 21, 2022)
News Medical Life Sciences “Study suggests non-classical inhibition of TBK1/IKKepsilon is protective against severe COVID-19 immunopathology in vivo” (February 21, 2022)
The Weather Channel “Rogue Antibodies Responsible for Inflammation and Clotting in Severe COVID-19 Patients: Study” (February 21, 2022)
The Jerusalem Post “Experimental BioVaxys COVID-19 vaccine may eliminate risk of myocarditis” (February 20, 2022)
News Medical Life Sciences “Study reports a highly attenuated SARS-CoV-2 that could serve as a live-attenuated vaccine platform” (February 18, 2022)
News Medical Life Sciences “Study examines lyophilized mRNA-lipid nanoparticle vaccines with long-term stability” (February 16, 2022)
The Asahi Shimbun “Cell aging likely cause of lingering COVID-19 aftereffects” (February 16, 2022)
Yale School of Medicine “HHMI Gives Major Support to Yale COVID-19 Research” (February 15, 2022)
UPI.com Health News “Inhaled COVID-19 vaccine could offer benefits over shots” (February 15, 2022)
News Medical Life Sciences “Variations in the neutralization of SARS-CoV-2 variants in vaccinated mice and primates” (February 14, 2022)
EurekAlert! “Study shows new drug combination more effective against SARS-CoV-2” (February 14, 2022)
News Medical Life Sciences “Study describes a beta-CoV spike protein target for protective antibodies that may facilitate pan-beta-CoV vaccine development” (February 14, 2022)
Yale Daily News “New nasal vaccine could provide protection against COVID-19 infection, Yale study suggests” (February 11, 2022)
The New Yorker “Did Omicron come from mice?” (February 10, 2022)
Washington University School of Medicine in St. Louis News “Researchers unravel omicron’s secrets to better understand COVID-19” (February 9, 2022)
The Daily Iowan “UI research shows omicron variant causes weak disease in mice, hamsters” (February 9, 2022)
Howard Hughes Medical Institute News “Nasal Spray Booster Keeps COVID-19 at Bay” (February 8, 2022)
News Medical Life Sciences “Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage” (February 8, 2022)
South China Morning Post “Did Omicron jump from mice to men? Chinese scientists say it’s possible” (February 4, 2022)
AZoNano.com “Novel Nanoarray SARS-CoV-2 Vaccine Helps Protect Immunocompromised” (February 4, 2022)
News Medical Life Sciences “Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses” (February 4, 2022)
Technology Networks “New COVID-19 Mouse Model Developed To Advance Research” (January 31, 2022)
The Jerusalem Post “Could the Omicron COVID-19 variant have originated in mice? - Study” (January 31, 2022)
The Scientist “Brain Fog Caused by Long COVID and Chemo Appear Similar” (January 28, 2022)
News Medical Life Sciences “Early-stage alveolar epithelial cell necrosis linked to COVID-19-induced acute respiratory distress syndrome” (January 27, 2022)
RT.com “Omicron Covid strain evolved in mice – Chinese study” (January 25, 2022)
Outsourcing-Pharma.com “Charles River joins with immunology lab on COVID-19 research” (January 24, 2022)
News Medical Life Sciences “Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model” (January 24, 2022)
Forbes “Even Mild Covid-19 Can Cause Brain Dysfunction And Cognitive Issues” (January 24, 2022)
SciTechDaily “New Research Suggests High-Purity CBD May Help Block COVID-19 Virus From Replicating” (January 24, 2022)
News Medical Life Sciences “Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice” (January 21, 2022)
University of Wisconsin-Madison News “Omicron causes less severe illness in animal models than previous variants” (January 21, 2022)
Pharmacy Times “Study: Antibodies in Blood Soon After COVID-19 Onset May Predict Severity” (January 21, 2022)
NBC Chicago “Mild COVID-19 Infections Can Lead to Long-Term Neurological Damage: Study” (January 21, 2022)
Fierce Biotech “Decoy vesicles protect against COVID-19 from coronavirus variants in early tests” (January 20, 2022)
Technology Networks “Decoy Protein Effective Against SARS-CoV-2 Variants in Mouse Study” (January 20, 2022)
IFLScience “Snorting Superpower Nano Bubbles Can Protect Against COVID-19 Variants, Says Mice Study” (January 20, 2022)
News Medical Life Sciences “Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals” (January 20, 2022)
The Indian Express “Study says: By itself, Omicron does not boost immunity level” (January 20, 2022)
NBC Connecticut “Study Says People With Mild COVID-19 Symptoms Could Suffer From Long-Term Neurological Damage” (January 20, 2022)
Georgia State University News “Researchers Find Newer Variants of SARS-CoV-2 Can Infect Mice, Unlike the Original Version of the Virus” (January 19, 2022)
Genetic Engineering & Biotechnology News “COVID-19 Severity Predicted by Early Presence of Afucosylated Antibodies” (January 19, 2022)
News Medical Life Sciences “An alternative mouse model of SARS-CoV-2 infection” (January 17, 2022)
Fox News “Anti-COVID nasal spray could protect against infection for up to 8 hours” (January 12, 2022)
MedicalNewsToday “COVID-19: Did Omicron evolve in mice?” (January 7, 2022)
The Washington Post “Omicron could have a silver lining by boosting immunity, some experts say. But don’t bet on it” (January 7, 2022)
Deseret News “The omicron variant may have come from mice, new study says” (January 7, 2022)
10News.com San Diego ”In-Depth: Melatonin helps people with severe COVID recover. How about long haulers?” (January 7, 2022)
News Medical Life Sciences “Melatonin found to inhibit SARS-CoV-2 entry into mice brains” (January 6, 2022)
EurekAlert! “LJI and Charles River Laboratories to collaborate on COVID-19 research” (January 6, 2022)
Nature News “Omicron’s feeble attack on the lungs could make it less dangerous” (January 5, 2022)
Deseret News “Where omicron variant symptoms develop right now” (January 4, 2022)
The Economic Times News “RNA-based therapy can protect from many Covid variants: Study” (January 4, 2022)
WebMD News “Omicron Variant Appears to Cause Less Damage to Lungs, Studies Say” (January 3, 2022)
The Guardian “New studies reinforce belief that Omicron is less likely to damage lungs” (January 2, 2022)

2021 News

The New York Times “Studies Suggest Why Omicron Is Less Severe: It Spares the Lungs” (December 31, 2021)
News Medical Life Sciences “Less severe clinical consequences of infection with SARS-CoV-2 Omicron variant” (December 31, 2021)
ABC News Australia “As Omicron COVID cases continue to surge, the race is on to find a variant-proof vaccine” (December 27, 2021)
Western University News “Novel approach to COVID-19 vaccine shows early promise” (December 20, 2021)
News Medical Life Sciences “Humanized mice reveals why few COVID-19 cases are more severe than others” (December 20, 2021)
News Medical Life Sciences “Efficacy of SARS-CoV2 variant-specific replicating RNA vaccines on SARS-CoV-2 variants of concern” (December 19, 2021)
DocWire News “A humanized mouse model of chronic COVID-19” (December 18, 2021)
YaleNews “Why are some COVID cases more severe? ‘Humanized’ mice offer a clue” (December 17, 2021)
NewScientist “How did the omicron coronavirus variant evolve to be so dangerous?” (December 17, 2021)
News Medical Life Sciences “MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice” (December 13, 2021)
GlobeNewswire.com “Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research” (December 13, 2021)
News Medical Life Sciences “Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice” (December 12, 2021)
News Medical Life Sciences “Immunogenicity and safety of COVID-19 subunit vaccine Nanocovax in animal models” (December 9, 2021)
PBS NewsHour “Some experts suggest omicron variant may have evolved in an animal host” (December 8, 2021)
News Medical Life Sciences “SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach” (December 6, 2021)
Technology Networks “Telomere Damage May Increase SARS-CoV-2 Susceptibility” (December 3, 2021)
ScienceDaily “Damaged telomeres in the elderly may increase susceptibility to SARS-CoV-2” (December 2, 2021)
EurekaAlert! “Damaged telomeres in the elderly may increase susceptibility to SARS-CoV-2” (December 2, 2021)
Technology Networks “How To Freeze-Dry a Potential COVID-19 Vaccine” (December 2, 2021)
EurekaAlert! “Study: How to freeze-dry a potential COVID-19 vaccine” (December 1, 2021)
GlobeNewswire.com “Cocrystal Pharma Presents Preclinical Data from COVID-19 Antiviral Programs and Outlines Near-Term Clinical Plans at the World Antiviral Congress 2021” (December 1, 2021)
News Medical Life Sciences “Northwestern researchers continue to tackle every facet of COVID-19 pandemic” (November 30, 2021)
OregonLive.com “Safe, low-cost antidepressant pill prevents COVID-19 patients from developing severe symptoms, studies show” (November 30, 2021)
News Medical Life Sciences “Extended host range for SARS-CoV-2 variants of concern” (November 29, 2021)
News Medical Life Sciences “Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine” (November 26, 2021)
SciTechDaily “COVID-19 Can Infect Nerve Cells and Cause a Range of Neurological and Psychiatric Symptoms” (November 26, 2021)
PR Newswire “Biotron Drug Effective Against COVID-19 In Animals” (November 25, 2021)
News Medical Life Sciences “Tobacco mosaic virus nanoparticle-based novel COVID-19 vaccine candidate” (November 23, 2021)
Forbes “Stimulating Innate Immunity Stops SARS-CoV-2 Infection” (November 17, 2021)
News Medical Life Sciences “Potential COVID-19 nasal spray vaccine shows promise in mice” (November 15, 2021)
Chapelboro.com “UNC, Duke Scientists Identify New Antibody To Fight COVID-19 and Its Variants” (November 15, 2021)
News Medical Life Sciences “Mycobacterium tuberculosis may induce resistance to secondary SARS-CoV-2 infection” (November 14, 2021)
Stanford Medicine News “COVID-19 nasal spray vaccine in the works at Stanford Medicine” (November 11, 2021)
News Medical Life Sciences “Phage-like particle system provides a platform for quick and easy vaccine generation” (November 11, 2021)
News18.com “New RNA-based Therapy Protects Mice from Coronavirus, Variants Including Delta: Study” (November 11, 2021)
YaleNews “Immune system early responder can combat COVID-19” (November 10, 2021)
EurekAlert! “Yale researchers develop RNA-based therapy that clears SARS-CoV-2 from mice” (November 10, 2021)
University of Miami News “Researchers develop a ‘net’ to prevent the coronavirus from entering cells” (November 10, 2021)
DailyMail.com “Scientists discover an antibody that can protect people against several coronaviruses including COVID-19 and its variants” (November 9, 2021)
The Jerusalem Post “COVID: Scientists find super-antibody that might help fight new variants” (November 9, 2021)
Brown University News “Study offers insights on why the elderly are more susceptible to COVID-19” (November 8, 2021)
News Medical Life Sciences “Rapid antibody response induced by mRNA COVID vaccines in mice” (November 7, 2021)
Genetic Engineering & Biotechnology News “Cross-Reactive Antibody Blocks Infections against Multiple Coronaviruses in Mice” (November 4, 2021)
ScienceDaily “Scientists identify new antibody for COVID-19 and variants” (November 2, 2021)
24-7pressrelease.com “An Oral Drug from Holy basil (Tulsi) is Effective Against COVID-19 Symptoms in Lab Study” (November 2, 2021)
SciTechDaily “Needle-Free COVID-19 Vaccine Shows Promise – Protection via a Single Pain-Free Click” (October 30, 2021)
Fierce Biotech “A COVID-19 vaccine delivered with a patch rivals traditional shots in mice: study” (October 29, 2021)
SciTechDaily “COVID Vaccine Dosing ‘Mistake’ Leads to Surprising Discovery” (October 26, 2021)
News Medical Life Sciences “Blood pressure drug increases SARS-CoV-2 receptors in transmission and pathogenesis associated tissues” (October 25, 2021)
News.northwestern.edu “AstraZeneca’s vaccine dosing ‘mistake’ led to new dosage finding in mice” (October 25, 2021)
EurekaAlert! “AstraZeneca’s vaccine dosing ‘mistake’ led to new dosage finding in mice” (October 25, 2021)
Washington University School of Medicine in St. Louis News “Antiviral compound blocks SARS-CoV-2 from entering cells” (October 11, 2021)
Fierce Biotech “Novel vaccine strategy protects mice from COVID-19 and 4 related coronaviruses (October 8, 2021)
EurekaAlert! “Researchers demonstrate vaccination approach in mice that could prevent future coronavirus outbreaks” (October 8, 2021)
SciTechDaily “New Vaccination Strategy Developed That Could Prevent Future Coronavirus Outbreaks” (October 8, 2021)
Indiana University School of Medicine Blogs “IU researchers study long-term effects of COVID-19 on bone growth” (October 4, 2021)
Advanced Science News “Biomaterial-based COVID-19 vaccine shows adaptive immunity in mice” (October 4, 2021)
European Pharmaceutical Review “Temperature stable microneedle patch successfully delivers DNA COVID-19 vaccine” (September 23, 2021)
Technology Networks “Microneedle Patch Delivers COVID-19 Vaccine” (September 23, 2021)
News Medical Life Sciences “Dynamics of innate immune responses decide COVID-19 severity in genetically diverse mice” (September 21, 2021)
JAX News “Host genetic backgrounds underlie variable COVID-19 pathology” (September 20, 2021)
The Hill “No-fridge coronavirus vaccine looks promising: study” (September 15, 2021)
MedicalNewsToday “COVID-19: Experimental vaccine lasts 1 month at room temperature” (September 14, 2021)
ConnexionFrance.com “Promising results in trials of French Covid nasal spray vaccine” (September 10, 2021)
News Medical Life Sciences “Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model” (September 10, 2021)
National Institute on Aging News “Senolytics show potential to protect against coronavirus in older mice” (September 9, 2021)
Technology Networks “Virus-Like Particle Vaccine Protects Animals Against COVID-19” (September 9, 2021)
Technology Networks “Developing Nanobodies and Antibodies Against SARS-CoV-2” (September 8, 2021)
University of Minnesota News “U of M scientists develop a novel virus-like particle COVID-19 candidate vaccine” (September 8, 2021)
UC San Diego News Center “These Fridge-Free COVID-19 Vaccines Are Grown in Plants and Bacteria” (September 7, 2021)
Advanced Science News “Fridge-free COVID-19 vaccine candidates offer hope to billions” (September 7, 2021)
SciTechDaily.com “Viruses From Plants/Bacteria Key Ingredient for New COVID-19 Vaccine Candidates” (September 7, 2021)
University of Michigan Health Lab “Why Do People with Diabetes Develop Severe COVID-19?” (September 7, 2021)
YaleNews “In the immune arsenal, antibodies offer best long-term hope against COVID” (September 2, 2021)
News Medical Life Sciences “Study shows bacille Calmette-Guérin vaccine can protect mice against lethal SARS-CoV-2 challenge” (September 1, 2021)
SciTechDaily “Antibody-Disease Enhancement (ADE) of COVID-19 Does Not Appear To Occur in Animal Models” (August 31, 2021)
Yahoo! Finance “Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice with Intramuscular and Intranasal Adjuvants” (August 30, 2021)
News Medical Life Sciences “The influence of COVID-19 on platelet activation and aggregation” (August 26, 2021)
SciTechDaily.com “Antibody Discovered That Protects Against Broad Range of COVID-19 Virus Variants” (August 23, 2021)
Washington University School of Medicine in St. Louis News “Antibody protects against broad range of COVID-19 virus variants” (August 20, 2021)
Times of India “Covid-19: Alpha, Beta, Gamma variants infect mice; Delta may not” (August 19, 2021)
News.northwestern.edu “2.0 of COVID-19 vaccine quickly kicks immune system into high gear” (August 18, 2021)
YaleNews “Videos capture lethal progress of COVID-19 virus” (August 18, 2021)
ScienceDaily “A COVID-19 vaccine strategy to give the body border protection” (August 11, 2021)
News Medical Life Sciences “SARS-CoV-2 variants and their ability to infect mice” (August 10, 2021)
News Medical Life Sciences “Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model” (August 10, 2021)
Drug Target Review “Masitinib found to be an effective COVID-19 treatment in mouse model” (August 3, 2021)
Genetic Engineering & Biotechnology News "Potential COVID-19 Treatment, Masitinib Inhibits SARS-CoV-2 Replication in Mice" (July 22, 2021)
News Medical Life Sciences “Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice” (July 20, 2021)
News Medical Life Sciences “New OMV-based COVID-19 vaccine candidate proves effective in mice” (July 14, 2021)
HealthDay News “Inhaled COVID Vaccine Shows Promise in Animal Trials” (July 13, 2021)
SciTechDaily “Virologists Demonstrate Successful Treatment for SARS-CoV-2, the Virus That Causes COVID-19” (July 13, 2021)
The Hill “New one-dose COVID-19 vaccine that can be inhaled tested in animals” (July 12, 2021)
Fox News “Inhaled COVID-19 vaccine successful in animal study” (July 9, 2021)
ScienceDaily “Inhaled COVID-19 vaccine prevents disease and transmission in animals” (July 8, 2021)
India News “Scientists identify post-infection treatment for Covid-19” (July 5, 2021)
The Jerusalem Post “COVID-19: Could vaping make the virus more infectious? - study” (July 2, 2021)
Yahoo! News “Vaping Increases Your Chances of Catching Covid-19, Finds New Study” (July 1, 2021)
Newswise “Vaping Increases Susceptibility to Coronavirus in Mice” (June 29, 2021)
The Scientist “The Quest for a Universal Coronavirus Vaccine” (June 29, 2021)
Chemical & Engineering News “The antivirals that weren’t: drug repurposing for COVID-19 produced misleading results” (June 29, 2021)
The Science Times “COVID-19 Virus Being Copied and Trapped, 'Nanodecoy' Cells Produced by Human Lungs” (June 25, 2021)
SciTechDaily “Nanodecoys – Made From Human Lung Spheroid Cells – Bind and Neutralize SARS-CoV-2 (COVID-19) Virus” (June 24, 2021)
Howard Hughes Medical Institute News “Universal Vaccine Could Protect Against Future Coronaviruses” (June 23, 2021)
Drug Target Review “Novel vaccine against coronaviruses protects mice from infection” (June 23, 2021)
Genetic Engineering & Biotechnology News “SARS-CoV-2 Variants May Succumb to Multivalent Nanobodies” (June 22, 2021)
WRAL TechWire.com “UNC researchers develop potential universal coronavirus vaccine” (June 22, 2021)
Channel News Asia “Dual-antibody drugs effective against COVID-19 variants in animal study” (June 22, 2021)
ScienceDaily “Antibody disease enhancement of COVID-19 does not appear to occur in animal models” (June 21, 2021)
Washington University School of Medicine in St. Louis News “COVID-19 dual-antibody therapies effective against variants in animal study” (June 21, 2021)
MedicalXpress “Vaccination, previous infection, protect against SARS-CoV-2 gamma variant in animal model” (June 18, 2021)
News Medical Life Sciences “Mouse-adapted SARS-CoV-2 and simian adenovirus vector advance COVID-19 vaccine research” (June 17, 2021)
Drug Target Review “Stem cells may be key for new vaccines against COVID-19” (June 17, 2021)
News18.com “Covid-19 May Reactivate Dormant Tuberculosis in Patients, Finds Study” (June 17, 2021)
News Medical Life Sciences “Could urine tests predict kidney injury and mortality in COVID-19?” (June 15, 2021)
NIH Director’s Blog “Could a Nasal Spray of Designer Antibodies Help to Beat COVID-19?” (June 15, 2021)
Genetic Engineering & Biotechnology News “Novavax Plans FDA Filing for COVID-19 Vaccine after Positive Efficacy Data” (June 14, 2021)
UMassMedNews “UMMS research identifies potential antiviral compound for COVID-19, flu, other viral infection” (June 11, 2021)
News Medical Life Sciences “Could the COVID-19 vaccination rollout protect against future coronavirus outbreaks?” (June 10, 2021)
Drug Target Review “Senolytic drugs reduce COVID-19 symptoms in mice, study shows” (June 9, 2021)
The Week “Nasal spray antibody treatment shows promise against COVID-19, variants in mouse study” (June 9, 2021)
Genetic Engineering & Biotechnology News “COVID-19’s Toll on the Elderly May Be Halted by Targeting Cell Senescence” (June 9, 2021)
MedicalXpress “Common diabetes drug shows promise as treatment for COVID-19 lung inflammation” (June 9, 2021)
Reuters “New antibody drug shows promise in mouse study; vaping may increase lung vulnerability to virus” (June 8, 2021)
ScienceDaily “Preclinical study suggests new approach to reduce COVID-19 death among the elderly” (June 8, 2021)
News Medical Life Sciences “New vaccine candidate with RBD and N protein targets protects against SARS-CoV-2 in preclinical trials” (June 2, 2021)
Business Standard “Drug that blocks multiple coronavirus variants in mice identified” (May 31, 2021)
News-Medical.Net “New drug effectively prevents severe COVID-19 in mice infected with SARS-CoV-2” (May 29, 2021)
MedicalNewsToday “COVID-19 DNA vaccine candidates show promise in hamsters, mice” (May 29, 2021)
CTV News “U.S. researchers find drug blocks severe COVID-19 symptoms in mice, including variants” (May 29, 2021)
ScienceDaily “Researchers discover drug that blocks multiple SARS-CoV-2 variants in mice” (May 28, 2021)
EconomicTimes “New DNA vaccine for COVID-19 effective in mice, hamsters: Study” (May 28, 2021)
EurekAlert! “DNA vaccines for COVID-19 effective in mice, hamsters” (May 27, 2021)
NewsGP “Potential COVID treatment reduces viral count in mice lungs by 99.9%” (May 20, 2021)
Nature.com News “Mice with severe COVID symptoms could speed vaccine effort” (May 11, 2021)
Business Today “New COVID-19 vaccine protects monkeys, mice from coronavirus” (May 11, 2021)
Drug Discovery World-online.com “Taconic biosciences launches new Covid-19 mouse model” (May 7, 2021)
News-Medical.Net “Researchers develop a multivalent vaccine for COVID-19 and influenza” (May 6, 2021)
The Chicago Maroon “UChicago Researchers Develop Novel “Nanotrap” COVID-19 Treatment” (May 6, 2021)
MIT Technology Review “Why mixing vaccines could help boost immunity” (May 6, 2021)
Nature.com “COVID research: a year of scientific milestones” (May 5, 2021)
News-Medical.Net “Pan-COVID-19 vaccine protects mice against SARS-CoV-2 variants” (May 5, 2021)
News-Medical.Net “Vaccine candidate targeting SARS-CoV-2 nucleocapsid protein elicits protective immune response in animal model” (May 4, 2021)
News-Medical.Net “Study reveals new broadly neutralizing and protective antibody against coronaviruses” (May 3, 2021)
News-Medical.Net “Live "attenuated" influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2” (May 2, 2021)
SciTechDaily.com “SARS-CoV-2 Spike Protein Alone May Cause COVID-19 Lung Damage – Even Without the Presence of Intact Virus” (April 30, 2021)
MedicalXpress “SARS-CoV-2 spike protein alone may cause lung damage” (April 27, 2021)
News-Medical.Net “Interfering RNA nanoparticles could be a potential COVID-19 therapy” (April 21, 2021)
Medicine.wustl.edu “Podcast: A year later, scientists recall efforts to jump-start research into mysterious new coronavirus” (April 21, 2021)
News-Medical.Net “Characterization of lab-produced neutralizing antibodies targeting SARS-CoV-2” (April 21, 2021)
News-Medical.Net “Study identifies how SARS-CoV-2 enters and infects the brain” (April 21, 2021)
Reuters “COVID SCIENCE-Moderna vaccines promising vs variants in mouse study; no higher risk for poor outcomes found with UK variant” (April 14, 2021)
News-Medical.Net “Experimental evidence that ADAM17 inhibition prevents severe COVID-19” (April 13, 2021)
NationalGeographic.com “Microbes in your gut may be new recruits in the fight against viruses” (April 13, 2021)
News-Medical.Net “New mRNA COVID-19 vaccine candidate shows promise in vivo” (March 31, 2021)
New York Times Virus Variants Can Infect Mice, Scientists Report (March 31, 2021)
Forbes “From Cats And Dogs To Minks And Mice, Covid-19 Variants Are Infecting The Ecosystem” (March 26, 2021)
WebMD “COVID Variants Detected in Animals, May Find Hosts in Mice” (March 25, 2021)
News-Medical.Net “Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function” (March 24, 2021)
Fierce Biotech “CureVac’s COVID-19 mRNA vaccine protects mice against aggressive coronavirus variant” (March 24, 2021)
News-Medical.Net “A new COVID-19 candidate vaccine induces robust humoral and cellular immune responses in mice” (March 23, 2021)
Reuters “No virus variants can evade all antibody types, so far; new variants can infect mice” (March 19, 2021)
Global News “COVID-19: No variants can escape human antibodies yet, though some can infect mice” (March 19, 2021)
News-Medical.Net “Novel protein construct prevents lethal COVID-19 in mice” (March 16, 2021)
China Global Television Network Influenza virus can promote COVID-19 infection in cells, mice: study (February 21, 2021)
News Medical Life Sciences SARS-CoV-2 DNA vaccine tested in animal model (February 21, 2021)
News Medical Life Sciences New mouse model of SARS-CoV-2 infection reflects features of human infection (February 14, 2021)
MedicalNewsToday “COVID-19: Antiviral prevents and treats infection in lab tests” (February 12, 2021)
New York Times Could a Single Vaccine Work Against All Coronaviruses? (February 9, 2021)
University of Maryland Baltimore News "Novavax Vaccine Demonstrates Strong Immune Response" (February 9, 2021)
Karolinska Institutet News "COVID-19 vaccine from new vaccine platform effective in mice" (February 4, 2021)
News-Medical.Net "Emory MVA COVID-19 vaccine proven safe and effective in mice and monkeys" (February 4, 2021)
Mount Desert Islander "Mouse research aids COVID-19 response" (January 29, 2021)
Yahoo News "Researchers found far higher levels of coronavirus in the brains of mice than the lungs - a possible explanation for neurological symptoms" (January 28, 2021)
EurekAlert "NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests" (January 22, 2021)
Science Daily "Study finds COVID-19 attack on brain, not lungs, triggers severe disease in mice" (January 19, 2021)
News-Medical.Net "Modified Vaccinia Ankara model vaccine prevents COVID-19 in transgenic mice study" (January 6, 2021)

2020 News

The Science Times "Inhaled vaccines show effectiveness in strengthening immune response in mice, primates" (December 11, 2020)
MedicalXpress "Scientists discover how COVID-19 virus causes multiple organ failure in mice" (December 8, 2020)
TexasStandard "Meet the lab mice helping scientists find a COVID-19 vaccine" (December 7, 2020)
FIERCE Biotech "COVID-19 vaccines based on novel platforms show early promise in mice" (December 3, 2020)
LaboratoryEquipment.com "Repurposed mouse model sheds light on loss of smell in COVID-19 patients" (December 2, 2020)
Drug Target Review "COVID-19 vaccine candidate is 96.4 percent effective in mice, study shows" (December 1, 2020)
Medicine at Michigan "Making a new mouse could transform COVID-19 research" (Autumn 2020)
News-Medical.Net "Transgenic mouse model could recapitulate severe COVID-19 in humans" (November 26, 2020)
FIERCE Biotech "Adagio's COVID-19 antibody protects mice and zaps related viruses in lab tests" (November 20, 2020)
News-Medical.Net "Promising yeast-expressed SARS-CoV-2 vaccine candidate effective in mice" (November 9, 2020)
The Scientist "The many model systems of COVID-19" (November 4, 2020)
Genetic Engineering & Biotechnology News "COVID-19 nanoparticle vaccine elicits high levels of protective antibodies in mice" (November 3, 2020)
ScienceNews "How two immune system chemicals may trigger COVID-19’s deadly cytokine storms" (October 30, 2020)
GlobeNewsWire "Global mice model market report 2020-2025: impact of COVID-19 - increasing demand for humanized mice models" (October 19, 2020)
News-Medical.Net "Obesity changes ACE2 and TMPRSS2 expression in mice: Implications for COVID-19" (October 18, 2020)
News-Medical.Net "Nasal spray COVID-19 vaccine shows promising results in mice" (October 12, 2020)
News-Medical.Net "Keto diet could be beneficial for elderly COVID-19 patients" (September 14, 2020)
LIVE SCIENCE "The new coronavirus can infect brain cells, study finds" (September 13, 2020)
TheWeek News India "NII's potential COVID-19 vaccine shows encouraging results in study on mice" (September 12, 2020)
The New York Times "How the coronavirus attacks the brain" (September 9, 2020)
bneINTELLINEWS "Slovenian researchers develop coronavirus vaccine effective in mice" (September 1, 2020)
ScienceDaily "Mouse-adapted SARS-CoV-2 model provides new tool for COVID-19 discoveries" (August 31, 2020)
The Science Advisory Board "New mouse-adapted models helps accelerate COVID-19 vaccines, therapies" (August 28, 2020)
Washington University School of Medicine in St. Louis News "Nasal vaccine against COVID-19 prevents infection in mice" (August 21, 2020)
Washington University School of Medicine in St. Louis News "Experimental COVID-19 vaccine prevents severe disease in mice" (August 11, 2020)
The New York Times Magazine "How covid sends some bodies to war with themselves" (August 11, 2020)
The New Yorker "Can designer mice save us from COVID-19?" (August 10, 2020)
The Daily Iowan "University of Iowa researchers develop mice model to study COVID-19 symptoms" (June 28, 2020)
Drug Target Review "Method to convert any mouse into COVID-19 model made available to researchers" (June 22, 2020)
MedicalXpress "Off-the-shelf tool for making mouse models of COVID-19" (June 16, 2020)
Study Finds "COVID-19 mouse model may hold key to new treatments, understanding risk factors" (June 13, 2020)
The Economist "An animal model of COVID-19 is now available" (June 11, 2020)
MedicalXpress "COVID-19 mouse model will speed search for drugs, vaccines" (June 10, 2020)
Arizona Republic "Mice can't catch COVID-19, so a UA lab is making new kind of mouse" (June 10, 2020)
Nordic Life Science News "A vaccine against COVID-19, developed by researchers from the Univ. of Copenhagen, has been tested in mice and shows promising results" (June 10, 2020)
HospiMedica "Transgenic mouse that models immune disease's cytokine storms could point to treatment solution for COVID-19" (June 5, 2020)
RegMedNet "COVID-19 treatment breakthrough using fibroblast cell therapy in mice" (June 1, 2020)
SciTechDaily "New research points to treatment for COVID-19 cytokine storms, solution to global pandemic" (May 31, 2020)
Taconic "An overview of mouse models for COVID-19" (May 30, 2020)
Times Now "Coronavirus: Mouse model mimics COVID-19 infection in humans, may help test drugs" (May 28, 2020)
News-Medical.Net "Transgenic mouse model of HLH may play key role in saving lives during COVID-19" (May 28, 2020)
ScienceDaily "HLH research points to treatment for COVID-19 cytokine storms" (May 28, 2020)
Genetic Engineering & Biotechnology News "COVID-19 mouse CRISPR engineered to recapitulate human COVID-19" (May 27, 2020)
WHYY PBS "The great research mouse rescue amid the pandemic" (May 15, 2020)
Scientific American "From Hamsters to Baboons: The Animals Helping Scientists Understand the Coronavirus" (May 14, 2020)
Knowable Magazine, "Building a mouse squad against Covid-19" (May 14, 2020)
Emerging Microbes & Infections "Animal models for emerging coronavirus: progress and new insights" (May 13, 2020)
Technology Networks "Mouse Study Explores Why COVID-19 Patients Can Lose Their Sense of Smell" (May 13, 2020)
LabAnimal "Mobilizing animal models against a pandemic" (May 12, 2020)
EurekAlert "Russia creates its own humanized mice to test COVID-19 vaccines and drugs" (May 4, 2020)
NIH News "Microneedle coronavirus vaccine triggers immune response in mice." (April 14, 2020)
Science, "Mice, hamsters, ferrets, monkeys. Which lab animals can help defeat the new coronavirus?" (April 13, 2020)
Advanced Science News, "Mouse study shows engineered virus could block coronavirus infections" (April 8, 2020)
Technology Networks "Antiviral against COVID-19 reduces damage in mouse lungs" (April 7, 2020)
Scientific American, "New coronavirus drug shows promise in animal tests" (April 7, 2020)
The Hill, "First peer-reviewed coronavirus vaccine shows promise in mice" (April 2, 2020)
Science, "'It’s heartbreaking.' Labs are euthanizing thousands of mice in response to coronavirus pandemic" (Mar. 23, 2020)
Bangor Daily News, "Maine lab starts breeding mice for coronavirus vaccine" (March 18, 2020)
National Public Radio (NPR) "Mouse Hunt: Lab Races to Grow Mice for COVID-19 Research." (March 14, 2020)
The New York Times, "These lab animals will help fight coronavirus" (March 14, 2020)
STAT News, "Researchers rush to test coronavirus vaccine in people without knowing how well it works in animals" (March 11, 2020)
Bloomberg, "A Virus Cure Depends on Rare Lab Mice, But There Aren’t Enough" (March 11, 2020)
Nature, "Labs rush to study coronavirus in transgenic animals – some are in short supply" (March 9, 2020)
STAT News, "From ferrets to mice and marmosets, labs scramble to find right animals for coronavirus studies" (March 5, 2020)

Mouse Models for Coronavirus Research

The Global COVID-19 Pandemic

About this Site: Coronavirus Research using the Laboratory Mouse

Mouse Strains Used in Coronavirus Research